Back

---

Total:3000cells

Cell No.	Cell Name
RCB0002
	ARM193
		Comment	Anti-recA protein mAb.
		Comment from the depositor
RCB0005
	BALB/3T3 clone A31
		Comment	A subline of BALB/3T3 cell line. Contact inhibition is well observed.
		Comment from the depositor
RCB0007
	HeLa
		Comment	Human cell line derived from cervical cancer.
		Comment from the depositor
RCB0008
	V79
		Comment	Chinese hamster lung fibroblast
		Comment from the depositor
RCB0009
	PC-12
		Comment	Pheochromocytoma, differentiate by NGF stimulation. Application consideration
		Comment from the depositor
RCB0012
	M227
		Comment	Infected with ts mutant of Kirsten sarcoma virus
		Comment from the depositor
RCB0016
	CCRF-HSB-2
		Comment	T cell leukemia
		Comment from the depositor
RCB0026
	PAb1400
		Comment	Anti-SV40 large T antigen mAb.
		Comment from the depositor
RCB0027
	K562
		Comment	Human cell line derived from chronic myelogenous leukemia. Can be a target of NK cells (reference). Can produce hemoglobin in the presence of NaB.
		Comment from the depositor
RCB0032
	FM3A FT-101
		Comment	Temperature-sensitive, forms multiple nuclei
		Comment from the depositor
RCB0033
	FM3A tscl.T85 Tsai
		Comment	Temperature-sensitive at chromosome condensation
		Comment from the depositor
RCB0034
	FM3A ts T244
		Comment	Temperature-sensitive at DNA polymerase
		Comment from the depositor
RCB0035
	WEHI-3
		Comment	Mouse cell line derived from leukemia. Secretes cytokines for hematopoietic cells.
		Comment from the depositor
RCB0036
	C127
		Comment	Host for bovine papiloma virus
		Comment from the depositor
RCB0041
	HL60
		Comment	Human cell line derived from promyelocytic leukemia. Differentiates to granulocytes and macrophages.
		Comment from the depositor
RCB0043
	NRK
		Comment	Contact-inhibited semi-normal, original of NRK49F
		Comment from the depositor
RCB0056
	NIH3T3/14-1
		Comment	Spontaneous transformant of NIH3T3
		Comment from the depositor
RCB0057
	NIH3T3/13C7
		Comment	SV40 large T (tsA58)-pBR322 transformed NIH3T3.
		Comment from the depositor
RCB0063
	JTC-15
		Comment	Subclone of AH-66, lost transplantability in rats.
		Comment from the depositor
RCB0065
	JTC-27
		Comment	Ascites hepatoma.
		Comment from the depositor
RCB0067
	M
		Comment	Capable to form collagen network
		Comment from the depositor
RCB0069
	RLC-16
		Comment	Epithelial cell from rat liver
		Comment from the depositor
RCB0070
	RLC-18
		Comment	Non tumorigenic in nude mice
		Comment from the depositor
RCB0072
	RLC-27
		Comment	Liver-derived cell, tumorigenic in nude mice
		Comment from the depositor
RCB0074
	JTC-19
		Comment	Rat lung fibroblast once said interferon-producing. Serum-& protein-free culturable.
		Comment from the depositor
RCB0075
	RCR-1
		Comment	Astroglia cell line
		Comment from the depositor
RCB0076
	LYM-1
		Comment	Sticky cell from lymph node.
		Comment from the depositor
RCB0083
	HLC-1
		Comment	Lung adenocarcinoma
		Comment from the depositor
RCB0086
	FM3A
		Comment	Mammary carcinoma, grow in vitro and in vivo
		Comment from the depositor
RCB0095
	P3/NSI/1-AG4-1
		Comment	Mouse myeloma cell line. Utilized for genration of hybridoma. Reported in the literature to synthesize kappa chain, but do not secrete free light chain.
		Comment from the depositor
RCB0096
	Don(D-6)
		Comment	Pseudodiploid, two marker chromosomes
		Comment from the depositor
RCB0097
	CHL
		Comment	Widely used in chromosome aberration test
		Comment from the depositor
RCB0098
	A549
		Comment	Human cell line derived from lung cancer.
		Comment from the depositor
RCB0101
	L·P3
		Comment	Protein- & lipid-free medium growing
		Comment from the depositor
RCB0102
	IC-2
		Comment	Mast cell precursor, respond to IL-3. Conditioned medium.
		Comment from the depositor
RCB0112
	NRK49F
		Comment	Contact-inhibited semi-normal cell line
		Comment from the depositor
RCB0115
	ARM321
		Comment	Anti-recA protein mAb.
		Comment from the depositor
RCB0116
	7501
		Comment	S. cerevisiae Endo.Sce I large subunit mAb.
		Comment from the depositor
RCB0120
	LT4Tr
		Comment	Spontaneous transformant of LT4
		Comment from the depositor
RCB0135
	L5178Y
		Comment	Rapidly growing lymphoma
		Comment from the depositor
RCB0136
	M10
		Comment	Highly sensitive to X-ray irradiation
		Comment from the depositor
RCB0137
	M10^(-)
		Comment	Resistant to 6TG, isolated from M10
		Comment from the depositor
RCB0138
	LX830
		Comment	Highly sensitive to X-ray irradiation
		Comment from the depositor
RCB0142
	Ehrlich
		Comment	Ehrlich's ascite tumor
		Comment from the depositor
RCB0153
	HUC-F
		Comment	Normal umbilical cord fibroblast, female
		Comment from the depositor
RCB0156
	305M
		Comment	Normal human skin fibroblast
		Comment from the depositor
RCB0159
	HS-K
		Comment	Normal diploid fibroblast from Japanese
		Comment from the depositor
RCB0162
	NHSF46
		Comment	Diploid fibroblast from normal Japanese skin.
		Comment from the depositor
RCB0163
	RGB3T3-1
		Comment	Original cloned line from RCB, just like BALB/3T3
		Comment from the depositor
RCB0164
	RGB3T3-5
		Comment	Siblings of RGB3T3-1, contact-inhibited
		Comment from the depositor
RCB0165
	REF-RGB
		Comment	Suitable as feeders for hybridoma cloning
		Comment from the depositor
RCB0169
	M1
		Comment	Differentiate to macrophage and granulocyte
		Comment from the depositor
RCB0171
	7T1
		Comment	Contact inhibited, may transform spontaneously
		Comment from the depositor
RCB0174
	SUSM-1
		Comment	Transformed in vitro with carcinogen
		Comment from the depositor
RCB0180
	MDBK
		Comment	A cell line derived from kidney of bovine. Information about BVDV (ATCC) . Information about BVDV (ECACC) . Information about BVDV (DSMZ) .
		Comment from the depositor
RCB0183
	RK13
		Comment	A cell line derived from kidney of rabbit. Susceptible to viruses such as rubella virus. A cell line derived from kidney of bovine. Information about BVDV (ATCC) . Information about BVDV (ECACC) .
		Comment from the depositor
RCB0184
	OLF-136
		Comment	Fish (medaka) fin fibroblast. Application consideration
		Comment from the depositor
RCB0185
	CAEP
		Comment	Gold fish erythrophoroma with 4n chromosomal mode
		Comment from the depositor
RCB0186
	CAF
		Comment	Pinna fibroblast
		Comment from the depositor
RCB0187
	OLHE-131
		Comment	H04C medaka hepatoma pretreated with MAM-acetate. Application consideration
		Comment from the depositor
RCB0188
	OLME-104
		Comment	HB32C medaka treated with MNNG. From peritoneum. Amelanotic. Application consideration
		Comment from the depositor
RCB0191
	HeLa.S3
		Comment	Most famous cultured human cell line
		Comment from the depositor
RCB0193
	KMM-1
		Comment	Human myeloma. Lambda- chain producing.
		Comment from the depositor
RCB0195
	PAb419
		Comment	Anti-SV40 large T antigen mAb.
		Comment from the depositor
RCB0197
	HUC-Fm
		Comment	Normal umbilical cord fibroblast, male
		Comment from the depositor
RCB0202
	A431
		Comment	Human cell line derived from epidermoid carcinoma. Expressing EGF receptor.
		Comment from the depositor
RCB0205
	BU25 TK-
		Comment	Thymidine kinase defective HeLa. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 85022104 prior to order.
		Comment from the depositor
RCB0206
	MOLT-4
		Comment	T cell leukemia, the same patient as RCB1164 MOLT-3. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 85011413 prior to order.
		Comment from the depositor
RCB0207
	MRC-5 SV1 TG1
		Comment	SV40-transformed, 6TG-resistant and HAT-sensitive. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 85042501 prior to order.
		Comment from the depositor
RCB0208
	LTK-
		Comment	Thymidine kinase defective L cell. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 85011432 prior to order.
		Comment from the depositor
RCB0209
	SP2/0-Ag14
		Comment	Mouse myeloma cell line. Utilized for generation of hybridoma. This is a non-Ig-secreting or synthesising line. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to the ECACC 85072401 prior to order.
		Comment from the depositor
RCB0210
	HF19
		Comment	Normal human lung fibroblast. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 85011418 prior to order.
		Comment from the depositor
RCB0211
	MRC-5
		Comment	Distribution terminated. Normal embryonic lung fibroblast. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to the website of ECACC prior to order.
		Comment from the depositor
RCB0218
	MRC-5
		Comment	Normal embryonic lung fibroblast with accurate PDL
		Comment from the depositor
RCB0222
	NB1RGB
		Comment	Normal human skin fibroblast, RCB original
		Comment from the depositor
RCB0224
	ST2
		Comment	Bone marrow stroma cell-derived
		Comment from the depositor
RCB0243
	Nil2C2
		Comment	A fibroblastic cell line derived from a fetus of Syrian hamster. Transformed cells. Tumor formation and metastasis can be observed after transplantation.
		Comment from the depositor
RCB0244
	Nil2C1
		Comment	A fibroblastic cell line derived from a fetus of Syrian hamster. Transformed cells. Tumor formation and metastasis can be observed after transplantation, but these abilities are lower than Nil2C2.
		Comment from the depositor
RCB0245
	Nil1C1
		Comment	A fibroblastic cell line derived from a fetus of Syrian hamster. Transformed cells. Tumor formation and metastasis can be observed after transplantation, but these abilities are much lower than Nil2C2.
		Comment from the depositor
RCB0247
	10T1/2
		Comment	Fibroblast-like cells derived from mouse embryo. Can be used for experiments regarding cell transformation.
		Comment from the depositor
RCB0248
	3T6
		Comment	Non-contact inhibited
		Comment from the depositor
RCB0249
	CKT-1
		Comment	Very flat and thin kidney epithelial cell
		Comment from the depositor
RCB0251
	VA-13
		Comment	SV40-transformed WI-38.
		Comment from the depositor
RCB0252
	W-V
		Comment	SV40-transformed Werner's syndrome fibroblast
		Comment from the depositor
RCB0256
	BALL-1
		Comment	Human cell line derived from B cell leukemia.
		Comment from the depositor
RCB0266
	CLA1RGB
		Comment	Pseudo congenital lactic acidosis.
		Comment from the depositor
RCB0270
	KG-1-C
		Comment	Glioma, S-100 Protein producing.
		Comment from the depositor
RCB0271
	HeLa S3 (SC)
		Comment	Suspension culturable. Useful for JIS medium inspection
		Comment from the depositor
RCB0273
	BRL
		Comment	ES cell differentiation inhibitory activity (DIA)
		Comment from the depositor
RCB0275
	SES-MaBr-1
		Comment	Cabbage armyworm cell line applicable to large scale insect virus production.
		Comment from the depositor
RCB0276
	SES-MaBr-3
		Comment	Cabbage armyworm cell line applicable to large scale production of insect virus.
		Comment from the depositor
RCB0278
	NIAS-MB-25
		Comment	Show finely branched cytoplasmic processes
		Comment from the depositor
RCB0279
	NIAS-MaBr-92
		Comment	Susceptible to nuclear polyhedrosis virus
		Comment from the depositor
RCB0282
	NFSa Y83
		Comment	A subline of NFSa which is a mouse cell line derived from fibrosarcoma. Transplantable.
		Comment from the depositor
RCB0283
	C-1300
		Comment	Highly metastatic neuroblastoma
		Comment from the depositor
RCB0284
	Sq-1979
		Comment	Metastatic epithelial cell
		Comment from the depositor
RCB0285
	CHO-K1
		Comment	A cell line derived from ovary of Chinese hamster. Frequently used for production of recombinant proteins etc.
		Comment from the depositor
RCB0286
	tk^(-)ts13
		Comment	Thymidine kinase-defective mutant of ts13
		Comment from the depositor
RCB0288
	3Y1-B clone 1-6-2
		Comment	Subclone of 3Y1-B clone 1.
		Comment from the depositor
RCB0289
	3Y1-B cl 1-6-K5-4-2
		Comment	Subclone of 3Y1-B clone 1-6.
		Comment from the depositor
RCB0290
	3Y1-B clone 1
		Comment	Mother clone of 3Y1 series.
		Comment from the depositor
RCB0291
	3Y1ts-101
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0292
	3Y1tsC102
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0293
	3Y1ts-103
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0294
	3Y1ts-104
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0295
	3Y1ts-105
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0296
	3Y1tsA106
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0297
	3Y1tsB107
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0298
	3Y1ts-108
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0299
	3Y1ts-109
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0301
	3Y1ts-111
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0302
	3Y1tsC112
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0303
	3Y1tsC113
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0304
	3Y1ts-114
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0305
	3Y1ts-115
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0306
	3Y1tsC116
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0307
	3Y1ts-117
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0308
	3Y1ts-118
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0309
	3Y1tsC119
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0310
	3Y1ts-120
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0311
	3Y1tsF121
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0312
	3Y1ts-122
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0313
	3Y1tsD123
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0314
	3Y1tsD124
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0315
	3Y1tsG125
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0316
	3Y1tsF126
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0317
	3Y1ts-201
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0318
	3Y1ts-202
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0319
	3Y1tsH203
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0320
	3Y1tsE204
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0321
	3Y1tsC205
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0322
	3Y1tsD206
		Comment	A subline of 3Y1 cell line. Temperature-sensitive mutant.
		Comment from the depositor
RCB0323
	3Y1-SB-15
		Comment	A subline of 3Y1 cell line. Tetraploid clone.
		Comment from the depositor
RCB0324
	3Y1-SB-16
		Comment	A subline of 3Y1 cell line. Tetraploid clone.
		Comment from the depositor
RCB0325
	3Y1BU^(r-1)
		Comment	A subline of 3Y1 cell line. Thymidine kinase-defective.
		Comment from the depositor
RCB0326
	3Y1BU^(r-2)
		Comment	A subline of 3Y1 cell line. Thymidine kinase-defective.
		Comment from the depositor
RCB0327
	3Y1BU^(r-3)
		Comment	A subline of 3Y1 cell line. Thymidine kinase-defective.
		Comment from the depositor
RCB0328
	Ad12-3Y1-Z11
		Comment	A subline of 3Y1 cell line. Transformed by adenovirus type 12.
		Comment from the depositor
RCB0329
	Ad12-3Y1-Z13
		Comment	A subline of 3Y1 cell line. Transformed by adenovirus type 12.
		Comment from the depositor
RCB0330
	Ad12-3Y1-Z19
		Comment	A subline of 3Y1 cell line. Transformed by adenovirus type 12.
		Comment from the depositor
RCB0331
	Ad12-3Y1-W5
		Comment	A subline of 3Y1 cell line. Transformed by adenovirus type 12.
		Comment from the depositor
RCB0332
	E1A-3Y1-1
		Comment	A subline of 3Y1 cell line. Transformed by adenovirus type 12 E1A gene.
		Comment from the depositor
RCB0333
	E1A-3Y1-2
		Comment	A subline of 3Y1 cell line. Transformed by adenovirus type 12 E1A gene.
		Comment from the depositor
RCB0334
	E1A-3Y1-3
		Comment	A subline of 3Y1 cell line. Transformed by adenovirus type 12 E1A gene.
		Comment from the depositor
RCB0335
	in203-3Y1-7
		Comment	A subline of 3Y1 cell line. Transformed by adenovirus in203.
		Comment from the depositor
RCB0336
	in203-3Y1-19
		Comment	A subline of 3Y1 cell line. Transformed by adenovirus in203.
		Comment from the depositor
RCB0337
	in203-3Y1-23
		Comment	A subline of 3Y1 cell line. Transformed by adenovirus in203.
		Comment from the depositor
RCB0338
	Ad2-3Y1-1
		Comment	A subline of 3Y1 cell line. Transformed by adenovirus type 2.
		Comment from the depositor
RCB0339
	Ad2-3Y1-2
		Comment	A subline of 3Y1 cell line. Transformed by adenovirus type 2.
		Comment from the depositor
RCB0340
	Ad2-3Y1-3
		Comment	A subline of 3Y1 cell line. Transformed by adenovirus type 2.
		Comment from the depositor
RCB0343
	SV-3Y1-C66
		Comment	A subline of 3Y1 cell line. Transformed by SV40 virion.
		Comment from the depositor
RCB0344
	A640-3Y1-1
		Comment	A subline of 3Y1 cell line. Transformed by SV40 tsA640.
		Comment from the depositor
RCB0347
	dl-884-3Y1-KO1
		Comment	A subline of 3Y1 cell line. Transformed by SV40 dl-884.
		Comment from the depositor
RCB0350
	Py-3Y1-S2
		Comment	A subline of 3Y1 cell line. Transformed by mouse polyoma virus.
		Comment from the depositor
RCB0353
	SR-3Y1-1
		Comment	A subline of 3Y1 cell line. Transformed by Rous sarcoma virus.
		Comment from the depositor
RCB0354
	SR-3Y1-2
		Comment	A subline of 3Y1 cell line. Transformed by Rous sarcoma virus.
		Comment from the depositor
RCB0356
	HR-3Y1-1
		Comment	A subline of 3Y1 cell line. Transformed by v-Ha-ras oncogene.
		Comment from the depositor
RCB0357
	HR-3Y1-2
		Comment	A subline of 3Y1 cell line. Transformed by v-Ha-ras oncogene.
		Comment from the depositor
RCB0359
	NG-3Y1-D303
		Comment	A subline of 3Y1 cell line. Transformed by nitrosoguanidine.
		Comment from the depositor
RCB0371
	NG-3Y1-T18D
		Comment	A subline of 3Y1 cell line. Transformed by nitrosoguanidine.
		Comment from the depositor
RCB0379
	mos-3Y1-10
		Comment	A subline of 3Y1 cell line. Transformed by v-mos oncogene.
		Comment from the depositor
RCB0380
	mos-3Y1-16
		Comment	A subline of 3Y1 cell line. Transformed by v-mos oncogene.
		Comment from the depositor
RCB0381
	V12S-3Y1-2
		Comment	A subline of 3Y1 cell line. Transformed by adenovirus type 12 12S-E1A.
		Comment from the depositor
RCB0384
	V13S-3Y1-4
		Comment	A subline of 3Y1 cell line. Transformed by adenovirus type 12 12S-E1A.
		Comment from the depositor
RCB0388
	NCU-F1
		Comment	Ehlers-Danlos syndrome
		Comment from the depositor
RCB0389
	NCU-F2
		Comment	Morquio syndrome
		Comment from the depositor
RCB0390
	NCU-F3
		Comment	Wilson's disease
		Comment from the depositor
RCB0391
	NCU-F4
		Comment	Wilson's disease
		Comment from the depositor
RCB0393
	NCU-F6
		Comment	Citrullinemia
		Comment from the depositor
RCB0394
	NCU-F7
		Comment	Citrullinemia
		Comment from the depositor
RCB0395
	NCU-F8
		Comment	Wilson's disease
		Comment from the depositor
RCB0397
	NCU-F10
		Comment	Cockayne's syndrome
		Comment from the depositor
RCB0402
	HeLa·P3
		Comment	Protein- free, serm- free, lipid-free medium growing
		Comment from the depositor
RCB0403
	CHO-K1 (SC)
		Comment	A subline of CHO-K1 (RCB0285). Suspension culture is possible.
		Comment from the depositor
RCB0404
	SES-MaBr-4
		Comment	Sensitive to nuclear polyhedrosis virus. Possible to grow in sea-water based low-cost medium.
		Comment from the depositor
RCB0405
	NIAS-LeSe-11
		Comment	Susceptible to insect viruses.
		Comment from the depositor
RCB0407
	WS2TKB
		Comment	Werner's syndrome
		Comment from the depositor
RCB0409
	WS1TKB
		Comment	Werner's syndrome, the same patient as RCB0433 WS1TKB2.
		Comment from the depositor
RCB0410
	MEN1RGB
		Comment	Fibroblasts from multiple endocrine neoplasia
		Comment from the depositor
RCB0411
	HaP-T1
		Comment	Mucin producing, BHP-induced pancreatic tumor
		Comment from the depositor
RCB0412
	NIAS-PX-64
		Comment	Pupal ovary.
		Comment from the depositor
RCB0413
	NIAS-MB-32
		Comment	Show finely branched cytoplasmic processes. Application consideration
		Comment from the depositor
RCB0414
	NIAS-MaBr-93
		Comment	larval hemocyte
		Comment from the depositor
RCB0417
	KU-1
		Comment	Bovine B cell leukemia cell line. It is described in the paper that bovine leukaemia virus (BLV) particles and BLV antigen are both negative. In relation to the production of virus, RIKEN Cell Bank has not confirmed it.
		Comment from the depositor
RCB0418
	KU-17
		Comment	Bovine leukemia cell line. It is described in the paper that this cell line produces bovine leukosis virus (BLV). In relation to the production of virus, RIKEN Cell Bank has not confirmed it. Application consideration
		Comment from the depositor
RCB0420
	BHK-21C13-2P
		Comment	Culturable in suspension, cf. ECACC ( BHK-21C13-3P). Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 84111301 prior to order.
		Comment from the depositor
RCB0421
	MEN2RGB
		Comment	Fibroblasts from multiple endocrine neoplasia
		Comment from the depositor
RCB0423
	BL312
		Comment	Bovine derived lymphocyte. It is described in the paper that this cell line produces bovine leukemia virus (BLV). Syncytium formation assay performed in RIKEN Cell Bank also suggested production of BLV (Figure).
		Comment from the depositor
RCB0429
	SES-MaBr-5
		Comment	Larval fat body hemocyte.
		Comment from the depositor
RCB0431
	T24
		Comment	Bladder transitional-cell carcinoma
		Comment from the depositor
RCB0432
	MT-5
		Comment	MNNG-initiated clone of BALB/c 3T3 clone A31
		Comment from the depositor
RCB0433
	WS1TKB2
		Comment	Werner's syndrome, the same patient as RCB0409 WS1TKB.
		Comment from the depositor
RCB0434
	J774.1
		Comment	Macrophage-like cell
		Comment from the depositor
RCB0435
	U-937 DE-4
		Comment	Cloned U-937, differentiate with TNF
		Comment from the depositor
RCB0436
	HUC-F2
		Comment	Normal umbilical cord fibroblast, female
		Comment from the depositor
RCB0437
	HUC-Fm2
		Comment	Normal umbilical cord fibroblast, male
		Comment from the depositor
RCB0438
	LC-1/sq-SF
		Comment	Human cell line derived from lung cancer. Squamous cell carcinoma. A subline of LC-1/sq (RCB0455) able to be cultured in serum-free conditions. LC-1/sq-SF (RCB0438), LC-1F (RCB0439), and LC-1/sq (RCB0455) are derived from the same patient. Application consideration
		Comment from the depositor
RCB0439
	LC-1F
		Comment	Human cell line derived from lung cancer. Squamous cell carcinoma. Floating cells (non-adherent cells). LC-1/sq-SF (RCB0438), LC-1F (RCB0439), and LC-1/sq (RCB0455) are derived from the same patient.
		Comment from the depositor
RCB0440
	LC-2/ad
		Comment	Adenocarcinoma, moderately differentiated. Application consideration
		Comment from the depositor
RCB0441
	SCCKN
		Comment	Highly sensitive to bleomycin
		Comment from the depositor
RCB0443
	TC-YIK
		Comment	Integrating HPV16, neurosecretory granules(+)
		Comment from the depositor
RCB0444
	RERF-LC-AI
		Comment	Japanese lung squamous carcinoma.
		Comment from the depositor
RCB0447
	ARLJ301-3
		Comment	Diploid rat liver epithelial cell line
		Comment from the depositor
RCB0448
	ARLJ301-3TR1
		Comment	Spontaneous transformant of ARLJ301-3
		Comment from the depositor
RCB0449
	Anr4
		Comment	EJ-ras oncogene transformed ARLJ301-3
		Comment from the depositor
RCB0450
	Anr9-1
		Comment	EJ-ras oncogene transformed ARLJ301-3
		Comment from the depositor
RCB0451
	Anr13-1
		Comment	EJ-ras oncogene transformed ARLJ301-3
		Comment from the depositor
RCB0452
	HTC/C3
		Comment	Secretes IL-1,TGFα,GM-CSF but not thyroglobulin
		Comment from the depositor
RCB0453
	SHOK
		Comment	Contact-inhibited hamster embryonal cell line
		Comment from the depositor
RCB0455
	LC-1/sq
		Comment	Human cell line derived from lung cancer. Squamous cell carcinoma. The parental cell line of LC-1/sq-SF (RCB0438). LC-1/sq-SF (RCB0438), LC-1F (RCB0439), and LC-1/sq (RCB0455) are derived from the same patient.
		Comment from the depositor
RCB0457
	BM-N
		Comment	Useful for recombinant BmNPV expression. Application consideration
		Comment from the depositor
RCB0466
	Lu-134-A
		Comment	Small cell carcinoma, classic type. See Lu-134-B. Application consideration
		Comment from the depositor
RCB0467
	Lu-134-B
		Comment	Small cell carcinoma, classic type. See Lu-134-A. Application consideration
		Comment from the depositor
RCB0468
	Lu-135
		Comment	Small cell carcinoma, variant type. Application consideration
		Comment from the depositor
RCB0469
	Lu-139
		Comment	Small cell carcinoma, classic type. Application consideration
		Comment from the depositor
RCB0470
	Lu-140
		Comment	Small cell carcimoma, classic type. Application consideration
		Comment from the depositor
RCB0471
	CYNOM-K1
		Comment	CITES. Cynomolgus monkey embryo skin, early passage.Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
		Comment from the depositor
RCB0473
	DD762
		Comment	Mammary tumor cell line without C-type virus
		Comment from the depositor
RCB0474
	K562/MTX-2
		Comment	Methotrexate(MTX)-resistant K562 cell line
		Comment from the depositor
RCB0475
	ILT-Mat
		Comment	IL-2 dependent ATL cell line. Based on the information by depositor; (1) this cell line possesses HTLV-1 pro-virus DNA, (2) the HTLV-1 proteins (p19, p24, p53, gp46) cannot be detected with western blotting, (3) it is expressing CD2, CD4, Ia, and IL-2R, but is not expressing CD3 or CD8.
		Comment from the depositor
RCB0476
	Had-1
		Comment	A subline of FM3A (mouse breast cancer cell line). Resistant to Newcastle virus and Sendai virus. Dye by GS-II lectin. The revertant cells (parent cell-like cells) dye by WGA lectin.
		Comment from the depositor
RCB0477
	NB9
		Comment	Human cell line derived from Neuroblastoma. N-myc gene is amplified. Another name is CHP-212 (PMID: 6871857). Application consideration
		Comment from the depositor
RCB0478
	NB16
		Comment	Human cell line derived from Neuroblastoma. N-myc gene is amplified.
		Comment from the depositor
RCB0480
	NB69
		Comment	Human cell line derived from Neuroblastoma. N-myc gene is not amplified. Application consideration
		Comment from the depositor
RCB0481
	TNB1
		Comment	Human cell line derived from Neuroblastoma. N-myc gene is amplified. Another name is TGW (PMID: 2335222). Application consideration
		Comment from the depositor
RCB0482
	MC-NB-1
		Comment	Human cell line derived from Neuroblastoma. Possess N-myc gene amplicon. Application consideration
		Comment from the depositor
RCB0483
	LA-N-1
		Comment	Human cell line derived from Neuroblastoma. N-myc gene is amplified. Derived from metastatic tumor in bone marrow.
		Comment from the depositor
RCB0484
	LA-N-2
		Comment	Human cell line derived from Neuroblastoma. N-myc gene is amplified.
		Comment from the depositor
RCB0485
	LA-N-5
		Comment	Human cell line derived from Neuroblastoma. N-myc gene is amplified.
		Comment from the depositor
RCB0486
	CHP-126
		Comment	Human cell line derived from Neuroblastoma. N-myc gene is amplified. Application consideration
		Comment from the depositor
RCB0487
	CHP-134
		Comment	Human cell line derived from Neuroblastoma. N-myc gene is amplified. Application consideration
		Comment from the depositor
RCB0488
	3Y1-B clone 1-6
		Comment	Standard clone of 3Y1 series. So called 3Y1
		Comment from the depositor
RCB0489
	NEC8
		Comment	Embryonal carcinoma, testis.
		Comment from the depositor
RCB0490
	NEC14
		Comment	Embryonal carcinoma, testis. Application consideration
		Comment from the depositor
RCB0492
	OTCD1TKB
		Comment	Human adherent cells derived from skin of a patient suffering from ornithine transcarbamylase deficiency.
		Comment from the depositor
RCB0494
	NEC15
		Comment	Embryonal carcinoma, testis. Application consideration
		Comment from the depositor
RCB0495
	KU812
		Comment	Chronic myelogeneous leukemia, Ph1 chromosome (+), basophil-like cells.
		Comment from the depositor
RCB0496
	KU812E
		Comment	Chronic myelogenous leukemia , subclone of RCB0495 KU812.
		Comment from the depositor
RCB0497
	KU812F
		Comment	Chronic myelogeneous leukemia, subclone of RCB0495 KU812.
		Comment from the depositor
RCB0500
	HGC-27
		Comment	Human cell line derived from metastatic lymph node of gastric cancer (undifferentiated carcinoma).
		Comment from the depositor
RCB0503
	HeLa.S3(Mer^(-))
		Comment	Repair deficient (mer-)
		Comment from the depositor
RCB0504
	MR1-3
		Comment	MNNG-reistant HeLa.S3(Mer-) cells
		Comment from the depositor
RCB0505
	MR6
		Comment	MNNG-resistant HeLa.S3(Mer-) cells
		Comment from the depositor
RCB0507
	MR10-1
		Comment	MNNG-resistant HeLa.S3(Mer-) cells
		Comment from the depositor
RCB0508
	H-EMC-SS
		Comment	Extraskeletal myxoid chondrosarcoma
		Comment from the depositor
RCB0510
	ACL-15
		Comment	Metastasis to liver, lung
		Comment from the depositor
RCB0511
	RCN-9
		Comment	Metastasis to liver, lung
		Comment from the depositor
RCB0512
	RCN-H-4
		Comment	Metastasis to liver
		Comment from the depositor
RCB0513
	SKN
		Comment	Human cell line derived from uterine leiomyosarcoma. Sensitive to estradiol-17 beta. Metastasis to kidney was observed in the clinic.
		Comment from the depositor
RCB0515
	HSKTC
		Comment	Human cell line derived from Krukenberg tumor. Metastasis to ovary of gastric signet ring cell carcinoma. Producing mucin. Expressing CA19-9, CEA, and TPA.
		Comment from the depositor
RCB0520
	WR216
		Comment	APRT(-) EB transformed B cell line
		Comment from the depositor
RCB0521
	HFL-I
		Comment	Human fibroblasts derived from fetal lung (11 weekly age).
		Comment from the depositor
RCB0522
	HFL-II
		Comment	Human fibroblasts derived from fetal lung (14 weekly age).
		Comment from the depositor
RCB0523
	HFL-III
		Comment	Human fibroblasts derived from fetal lung (11 weekly age).
		Comment from the depositor
RCB0524
	HFL-AE-I
		Comment	Human fibroblasts derived from lung of anencephalic fetus. 46XY,17p+ or 17ph+
		Comment from the depositor
RCB0525
	HFL-AE-II
		Comment	Human fibroblasts derived from lung of anencephalic fetus. 46XX, inv(9p+,q-)
		Comment from the depositor
RCB0526
	Jyg-MC(A)
		Comment	murine mammary tumor cell lines. High level MMTV producer line.
		Comment from the depositor
RCB0527
	Jyg-MC(B)
		Comment	Murine mammary tumor cell lines. Higher incidence in lung metastasis.
		Comment from the depositor
RCB0528
	MtT/S
		Comment	Rat cell line derived from pituitary tumor. Estrogen-induced tumor. Producing growth hormone. Able to induce the cells producing prolactin. Four cell lines (MtT/E, MtT/S, MtT/SM, MtT/Se) were established simultaneously.Application consideration.
		Comment from the depositor
RCB0529
	MtT/Se
		Comment	Rat cell line derived from pituitary tumor. Estrogen-induced tumor. Estrogen-dependent cell line. Producing a small amount of growth hormone. Four cell lines (MtT/E, MtT/S, MtT/SM, MtT/Se) were established simultaneously.Application consideration.
		Comment from the depositor
RCB0530
	MtT/SM
		Comment	Rat cell line derived from pituitary tumor. Estrogen-induced tumor. Producing prolactin and growth hormone. Four cell lines (MtT/E, MtT/S, MtT/SM, MtT/Se) were established simultaneously. Application consideration.
		Comment from the depositor
RCB0531
	TtT/M-87
		Comment	Mouse cell line derived from pituitary tumor (thyrotropin-producing tumor). Macrophage-like cells. Dependent on conditioned medium of L929 cells. Conditioned medium.
		Comment from the depositor
RCB0533
	Y1
		Comment	Mouse steroid hormone secreting adrenal cortex cell line. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 85062807 prior to order.
		Comment from the depositor
RCB0535
	RAW 264
		Comment	Mouse leukemic monocyte. Abelson leukemia virus induced. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 85062803 prior to order. Application consideration(PDF 580KB)
		Comment from the depositor
RCB0536
	STO
		Comment	Tioguanine- and ouabain-resistant and HAT-sensitive fibroblasts. Suitable for ES cell feeder layer. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 86032003 prior to order.
		Comment from the depositor
RCB0537
	JM
		Comment	Human cell line derived from T-cell leukemia. Isolated from the same patient as “Jurkat”. Has the ability to grow HIV. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 86010201 prior to order.
		Comment from the depositor
RCB0538
	PU5-18
		Comment	Mouse lymphoid tumor, macrophage like. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 85051501 prior to order.
		Comment from the depositor
RCB0540
	HAL-01
		Comment	Acute lymphatic leukemia
		Comment from the depositor
RCB0544
	MBT-2
		Comment	A mouse cell line derived from bladder cancer.
		Comment from the depositor
RCB0545
	OHTA
		Comment	Mouse embryonic carcinoma
		Comment from the depositor
RCB0546
	AT-PDH1TKB
		Comment	Pyruvate dehydrogenase deficiency fibroblasts.
		Comment from the depositor
RCB0548
	IA-5
		Comment	Human cell line derived from lung cancer. Large cell carcinoma. Derived from skin metastasis. Transplantable in immuno-deficient mouse, but metastasis to lymph nodes is rarely observed. IA-5 (RCB0548) and IA-LM (RCB0554) were derived from the same patient.
		Comment from the depositor
RCB0549
	Cle-H3
		Comment	NIH3T3 transformant expressing human activated k-ras-2.
		Comment from the depositor
RCB0550
	Cle-H3^(neo+)
		Comment	pSV2neo-introduced G418-resistant Cle-H3 mutant.
		Comment from the depositor
RCB0554
	IA-LM
		Comment	Human cell line derived from lung cancer. Large cell carcinoma. Derived from skin metastasis. Transplantable in immuno-deficient mouse, and metastasis to lymph nodes can be observed. IA-5 (RCB0548) and IA-LM (RCB0554) were derived from the same patient.
		Comment from the depositor
RCB0555
	GCIY
		Comment	Stomach cancer (Borrmann IV). Mucin, CA19-9, CEA, alphafetoprotein positive.
		Comment from the depositor
RCB0556
	NIAS-PX-58
		Comment	Pupal ovary hemocyte-like.
		Comment from the depositor
RCB0557
	B16 melanoma 4A5
		Comment	Melanin pigment producing mouse melanoma. Application consideration
		Comment from the depositor
RCB0558
	LLC
		Comment	Highly metastatic and drug-resistant mouse tumor. Application consideration
		Comment from the depositor
RCB0559
	K-1.fl
		Comment	SFFV producing Friend leukemia cell line. Non-differentiating.
		Comment from the depositor
RCB0560
	F5-5.fl
		Comment	Friend leukemia. Differentiate to erythroblastoid cells with benzidine etc.
		Comment from the depositor
RCB0561
	T-3-Cl-2-0.fl
		Comment	Friend leukemia. Differentiate to erythroblastoid cells with 1.5% DMSO etc. A clone of TSFAT-3.fl
		Comment from the depositor
RCB0562
	TSFAT-3.fl
		Comment	Friend leukemia. Differentiate to erythroblastoid cells.
		Comment from the depositor
RCB0565
	ATDC5
		Comment	Differentiate to chondrocytes, unidentifiable pigment cells. Teratocarcinoma AT805 derived.
		Comment from the depositor
RCB0566
	CGM1
		Comment	EB transformed B cell line
		Comment from the depositor
RCB0568
	ULF-23
		Comment	Cold water fish cell line. Cultured at 25 C. Relatively large chromosomes (Mode 23).
		Comment from the depositor
RCB0569
	707.fl
		Comment	Friend leukemia cell line. High ability to differentiate to erythroblastoid cells.
		Comment from the depositor
RCB0570
	GM86.fl
		Comment	Friend leukemia cell line from DBA/2 mouse.
		Comment from the depositor
RCB0571
	FVTCT.fl
		Comment	Friend leukemia cell line from BALB/c mouse. Virusnon-producing.
		Comment from the depositor
RCB0580
	SF8402
		Comment	Control from a nonexposed individual with breast cancer, different specimen from RCB0635
		Comment from the depositor
RCB0582
	SF8404
		Comment	Control from a nonexposed individual without cancer
		Comment from the depositor
RCB0583
	SF8405
		Comment	Control from a nonexposed individual without cancer.
		Comment from the depositor
RCB0584
	SF8406
		Comment	Control from a nonexposed individual without cancer.
		Comment from the depositor
RCB0585
	SF8657
		Comment	Control from a nonexposed individual with stomach cancer
		Comment from the depositor
RCB0587
	SF8759
		Comment	Atomic bomb survivor with breast cancer
		Comment from the depositor
RCB0588
	SF8760
		Comment	Atomic bomb survivor with breast cancer.
		Comment from the depositor
RCB0589
	SF8761
		Comment	Control from a nonexposed individual without cancer.
		Comment from the depositor
RCB0590
	SF8762
		Comment	Atomic bomb survivor with breast cancer.
		Comment from the depositor
RCB0591
	HNS1A
		Comment	Salamander cell line with large chromosomes.
		Comment from the depositor
RCB0592
	HNS2
		Comment	Larger epithelial cells than HNS1A.
		Comment from the depositor
RCB0593
	HNS3
		Comment	Salamander cell line. Fibroblast-like cells.
		Comment from the depositor
RCB0594
	HNS4
		Comment	Salamander cell line. Epithelial-like cells.
		Comment from the depositor
RCB0595
	HNS5
		Comment	Salamander cell line. Fibroblast-like cells.
		Comment from the depositor
RCB0596
	SF8758
		Comment	Atomic bomb survivor with breast cancer
		Comment from the depositor
RCB0597
	SF8656
		Comment	Control from a non-exposed individual without breast cancer but with thyroid & colon cancer.
		Comment from the depositor
RCB0598
	SF8655
		Comment	Atomic bomb survivor without cancer.
		Comment from the depositor
RCB0600
	SF8653
		Comment	Atomic bomb survivor without breast cancer but with thyroid cancer.
		Comment from the depositor
RCB0602
	SF8650
		Comment	Atomic bomb survivor with breast cancer
		Comment from the depositor
RCB0603
	SF8649
		Comment	Atomic bomb survivor with breast cancer
		Comment from the depositor
RCB0604
	SF8647
		Comment	Atomic bomb survivor with breast cancer.
		Comment from the depositor
RCB0605
	SF8546
		Comment	Control from a nonexposed individual without cancer.
		Comment from the depositor
RCB0608
	SF8543
		Comment	Control from a nonexposed individual with breast cancer
		Comment from the depositor
RCB0610
	SF8541
		Comment	Control from a nonexposed individual with uterus cancer
		Comment from the depositor
RCB0614
	SF8536
		Comment	Atomic bomb survivor without cancer
		Comment from the depositor
RCB0617
	SF8433
		Comment	Atomic bomb survivor with breast cancer
		Comment from the depositor
RCB0620
	SF8429
		Comment	Atomic bomb survivor with breast cancer
		Comment from the depositor
RCB0621
	SF8428
		Comment	Atomic bomb survivor with breast cancer, different specimen from RCB0624
		Comment from the depositor
RCB0624
	SF8425
		Comment	Atomic bomb survivor with breast cancer, different specimen from RCB0621.
		Comment from the depositor
RCB0631
	SF8416
		Comment	Atomic bomb survivor with breast cancer
		Comment from the depositor
RCB0633
	SF8414
		Comment	Control from a nonexposed individual with breast cancer
		Comment from the depositor
RCB0634
	SF8413
		Comment	Control from a nonexposed individual with chest cancer
		Comment from the depositor
RCB0635
	SF8410
		Comment	Control from a nonexposed individual with breast cancer, different specimen from RCB0580.
		Comment from the depositor
RCB0637
	CTLL-2
		Comment	Cytotoxic T-cell line. IL-2 dependent.
		Comment from the depositor
RCB0638
	TCS
		Comment	Human cell line derived from uterine cervix cancer. Keratinizing squamous carcinoma. Said producing CEA.
		Comment from the depositor
RCB0641
	EoL-1 cell
		Comment	Eosinophilic leukemia. Differenciate by n-butylate treatment.
		Comment from the depositor
RCB0644
	D134
		Comment	MoAb IgM to sea urchin sperm dynein alpha-heavy chain.
		Comment from the depositor
RCB0646
	D264
		Comment	MoAb IgM to sea urchin sperm dynein beta-heavy chain.
		Comment from the depositor
RCB0648
	D308
		Comment	MoAb IgM to sea urchin sperm dynein beta-heavy chain.
		Comment from the depositor
RCB0649
	D52
		Comment	MoAb IgM to sea urchin sperm dynein IC1.
		Comment from the depositor
RCB0650
	D9
		Comment	MoAb IgM to sea urchin sperm dynein IC2.
		Comment from the depositor
RCB0651
	D58
		Comment	MoAb IgG1 to sea urchin sperm dynein IC2.
		Comment from the depositor
RCB0654
	D16
		Comment	MoAb IgG1 to sea urchin sperm dynein IC3.
		Comment from the depositor
RCB0657
	HOKUG
		Comment	Human cell line derived from uterine cervix cancer. Glassy cell carcinoma.
		Comment from the depositor
RCB0658
	HHUA
		Comment	Human cell line derived from endometrial cancer. HHUA (RCB0658) was derived from the same patient of SNG-M (JCRB0179), another “human endometrial cancer-derived cell line” distributed from another cell repository, JCRB cell bank in Japan (precise explanation).
		Comment from the depositor
RCB0659
	HOUA-I
		Comment	Human cell line derived from uterine cancer (endometrial cancer).
		Comment from the depositor
RCB0660
	HTMMT
		Comment	Human cell line derived from malignant mixed mesodermal tumor found in uterus (malignant mixed Müllerian tumor).
		Comment from the depositor
RCB0662
	HOTHC
		Comment	Human cell line derived from undifferentiated carcinoma of thyroid (pleomorphous). Expressing tumor angiogenesis factor (TAF) and G-CSF.
		Comment from the depositor
RCB0665
	HFWT
		Comment	Human cell line derived from Wilms' tumor. Expressing CA125 and TPA.
		Comment from the depositor
RCB0666
	HSNB
		Comment	Human cell line derived from Neuroblastoma. N-myc gene is amplified. Producing neuron specific enolase.Application consideration
		Comment from the depositor
RCB0669
	PCH42-63
		Comment	Hybridoma against differentiated PC-12 cell surface
		Comment from the depositor
RCB0673
	PCH41-43
		Comment	Hybridoma against differentiated PC-12 cell surface
		Comment from the depositor
RCB0674
	PCH41-44
		Comment	Hybridoma producing monoclonal antibody against differentiated PC-12 cell surface molecules.
		Comment from the depositor
RCB0676
	PCH42-58
		Comment	Hybridoma producing monoclonal antibody against differentiated PC-12 cell surface molecules.
		Comment from the depositor
RCB0678
	PCH54-37
		Comment	Hybridoma against differentiated PC-12 cell surface
		Comment from the depositor
RCB0679
	HDC
		Comment	Human fibroblasts derived from uterine. 46XX,t(2/q2/q). The first child of this donor suffers from Down's syndrome, 46XX,t(2/q2/q).
		Comment from the depositor
RCB0680
	HKBMM
		Comment	Human cell line derived from malignant meningioma.
		Comment from the depositor
RCB0684
	HFL-AE-III
		Comment	Human fibroblasts derived from lung of anencephalic fetus (15 weekly age).
		Comment from the depositor
RCB0685
	SKG-II-SF
		Comment	A subline of SKG-II (human cell line derived from uterine cervix cancer, large cell non-keratinizing squamous cell carcinoma). Serum-free culture is possible. HPV type 18 integrated.
		Comment from the depositor
RCB0687
	KP-N-NS
		Comment	Adrenal neuroblastoma derived from brain metastasis
		Comment from the depositor
RCB0688
	QG-U
		Comment	Japanese cervix carcinoma.
		Comment from the depositor
RCB0689
	TCO-2
		Comment	Human cell line derived from uterine cervix cancer. Adenocarcinoma. Said producing CEA, CA125, TPA.
		Comment from the depositor
RCB0690
	HOTHC-SF
		Comment	A subline of HOTHC. Serum-free and protein-free culture is possible.
		Comment from the depositor
RCB0697
	GM2-1TKB
		Comment	Tay-Sachs' disease
		Comment from the depositor
RCB0698
	HFSKF-II
		Comment	Human fibroblasts derived from fetal skin (11 weekly age).
		Comment from the depositor
RCB0700
	HTMM
		Comment	Human cell line derived from malignant melanoma. Established from a metastasis to a lymph node. The origin is unknown.
		Comment from the depositor
RCB0701
	143B/TK^(-)neo^(R)
		Comment	v-Ki-ras transformant TE85 cell line. HAT sensitive, neo resistant.
		Comment from the depositor
RCB0702
	WI-38
		Comment	The most famous normal human fibroblast. Obtained directly from L. Hayflick. Younger PDL than RCB704 at time of deposit.
		Comment from the depositor
RCB0704
	WI-38
		Comment	The most famous normal human fibroblast. Obtained directly from L. Hayflick.
		Comment from the depositor
RCB0705
	10H
		Comment	Anti poly(ADP-ribose) IgG3 kappa producing.
		Comment from the depositor
RCB0708
	HF10B4
		Comment	Anti-human lung carcinoma mAb (IgM). Possible to culture in serum-free medium.
		Comment from the depositor
RCB0709
	HyLDH·YK-1
		Comment	Anti-rabbit muscle lactate dehydrogenase (LDH) mAb (IgG1). Possible to culture in serum-free medium.
		Comment from the depositor
RCB0710
	HyLDH·YK-2
		Comment	Anti-rabbit muscle lactate dehydrogenase (LDH) mAb (IgG2b). Possible to culture in serum-free medium
		Comment from the depositor
RCB0711
	HyGPD·YK-1-1
		Comment	Anti-rabbit muscle glyceraldehyde-3-phosphate dehydrogenase mAb (IgG). Serum-free culturable.
		Comment from the depositor
RCB0713
	HTUD1
		Comment	Large cells with large chromosomes.
		Comment from the depositor
RCB0715
	CHAUT-G
		Comment	Smooth muscle cell sarcoma from Chinese hamster.
		Comment from the depositor
RCB0721
	GOTO·P3
		Comment	Subline of GOTO. Protein-free medium adapted.
		Comment from the depositor
RCB0725
	MS-1
		Comment	Small lung carcinoma. PTHrP producing.
		Comment from the depositor
RCB0733
	NLS-6-5
		Comment	Nalidixic acid sensitive mutant. Also sensitive toVP-16 and VM-26 Topo II inhibitors.
		Comment from the depositor
RCB0735
	OS-RC-2
		Comment	Renal tumor cell from a Japanese. Transplantable to nude mice.
		Comment from the depositor
RCB0736
	DJM-1
		Comment	Malignant trichilemmal cyst cells. Strongly laminin positive on cell surface. Serum-free culturable.
		Comment from the depositor
RCB0738
	MTHC-1
		Comment	Rat thymoma cell line without mouse chromosome contamination. Compare to MTHC-2 and -3.
		Comment from the depositor
RCB0739
	MTHC-2
		Comment	Rat thymoma cell line fused to mouse cells during nude-mouse transplantation. Mouse chr. 5, 15, 17.
		Comment from the depositor
RCB0740
	MTHC-3
		Comment	Rat thymoma cell line fused to mouse cells during nude-mouse transplantation. Mouse chr. 5,7,15,17.
		Comment from the depositor
RCB0748
	Mm1
		Comment	Spontaneouly differentiated cell line derived from M1. Non-tumorigenic.
		Comment from the depositor
RCB0749
	MFH-ino
		Comment	Human fibrous histiocytoma. Showing fibroblastic- and histiocytic features.
		Comment from the depositor
RCB0750
	TLR2
		Comment	Hepatocytes containing temperature sensitive SV40 large T antigen. P450IA1 inducible.
		Comment from the depositor
RCB0752
	TKD2
		Comment	Mouse kidney cell line. Derived from a transgenic mouse expressing temperature sensitive SV40 large T antigen (SV40tsA58).
		Comment from the depositor
RCB0753
	OMC-1
		Comment	Japanese cervix squamous cell carcinoma. Once said TA-4 positive.
		Comment from the depositor
RCB0755
	OMC-3
		Comment	Mucinous cystadenocarcinoma. Said CA125,CA19-9 (+).
		Comment from the depositor
RCB0760
	MT-8
		Comment	Rat cell line derived from malignant fibrous histiocytoma. Characteristics of histiocytes are lacking. The tumor formed by this cell line consists of immature cells.
		Comment from the depositor
RCB0761
	505-05-01
		Comment	Methylcholanthrene-induced fibrosarcoma. Metastatic to lung.
		Comment from the depositor
RCB0762
	MT-9
		Comment	Rat cell line derived from malignant fibrous histiocytoma. Possessing characteristics of histiocytes.
		Comment from the depositor
RCB0763
	GI-1
		Comment	Human glioma separated from gliosarcoma.
		Comment from the depositor
RCB0764
	Fvp^(r)B350
		Comment	Topoisomerase II inhibitor VP-16 resistant FM3A mutant.
		Comment from the depositor
RCB0768
	HP50-2
		Comment	Hydrogen peroxide resistant HL60-derived clone.
		Comment from the depositor
RCB0769
	HP100-1
		Comment	Hydrogen peroxide resistant HL60-derived clone. More resistant than HP50-2.
		Comment from the depositor
RCB0770
	XTY
		Comment	Frog (Xenopus laevis) cell line derived from subcutaneous tumor.
		Comment from the depositor
RCB0771
	XTC-YF
		Comment	Frog (Xenopus laevis) cell line derived from tadpole.
		Comment from the depositor
RCB0772
	A6
		Comment	Frog (Xenopus laevis) cell line derived from kidney.
		Comment from the depositor
RCB0773
	A8
		Comment	Frog (Xenopus laevis) cell line derived from liver.
		Comment from the depositor
RCB0774
	EC-GI-10
		Comment	Produce hypercalcemia in nude mice. PTH-related protein, IL-1alpha producing.
		Comment from the depositor
RCB0775
	F-36P
		Comment	GM-CSF- or IL-3-dependent cell line. Differentiate to erythoid cells with erythropoietin.
		Comment from the depositor
RCB0776
	F-36E
		Comment	Subline of F-36P. Erythropoietin-dependent
		Comment from the depositor
RCB0777
	HMV-II
		Comment	Melanin producing. Originated from the same site of HMV-I.
		Comment from the depositor
RCB0778
	CW-2
		Comment	Colon carcinoma. CEA-positive, nude mouse-transplantable.
		Comment from the depositor
RCB0782
	RC4
		Comment	Normal rabbit cornea cells. Usually transform spontaneously during serial culture.
		Comment from the depositor
RCB0783
	FCP-S1M
		Comment	Skin fibroblasts from a familial colon polyposis patient.
		Comment from the depositor
RCB0784
	FCP-S2H
		Comment	Skin fibroblasts from a familial colon polyposis patient at Hiroshima.
		Comment from the depositor
RCB0785
	FCP-S3H
		Comment	Skin fibroblasts from a familial colon polyposis patient at Hiroshima.
		Comment from the depositor
RCB0786
	FCP-S4H
		Comment	Skin fibroblasts from a familial colon polyposis patient at Hiroshima.
		Comment from the depositor
RCB0787
	FCP-S5H
		Comment	Skin fibroblasts from a familial colon polyposis patient at Hiroshima.
		Comment from the depositor
RCB0788
	FCP-S6H
		Comment	Skin fibroblasts from a familial colon polyposis patient at Hiroshima.
		Comment from the depositor
RCB0789
	HSQ-89
		Comment	Japanese maxillary simus squamous carcinoma
		Comment from the depositor
RCB0792
	T88-M
		Comment	IL-5 dependent early B-cell line. Also grows on IL-3. The population contain non-IL-5-dependent cell
		Comment from the depositor
RCB0793
	B151K12
		Comment	IL-5 producing T-cell hybridoma. Culture sup is useful for T88-M cell culture.
		Comment from the depositor
RCB0794
	2C6
		Comment	Human cell line derived from embryonic pancreas. Four cell lines (RCB0794,RCB0795,RCB0796,RCB0797) were derived from the same individual.
		Comment from the depositor
RCB0795
	1B2C6
		Comment	Human cell line derived from embryonic pancreas. Four cell lines (RCB0794,RCB0795,RCB0796,RCB0797) were derived from the same individual.
		Comment from the depositor
RCB0796
	1C3D3
		Comment	Human cell line derived from embryonic pancreas. Four cell lines (RCB0794,RCB0795,RCB0796,RCB0797) were derived from the same individual.
		Comment from the depositor
RCB0797
	1C3IKEI
		Comment	Human cell line derived from embryonic pancreas. Four cell lines (RCB0794,RCB0795,RCB0796,RCB0797) were derived from the same individual.
		Comment from the depositor
RCB0803
	NBsusSR
		Comment	Isolated from a patient with hiper dopaminemia andnorepinephrinemia.
		Comment from the depositor
RCB0804
	BRF41
		Comment	Zebrafish fin fibroblast.
		Comment from the depositor
RCB0805
	Ba/F3
		Comment	IL-3 dependent pro B cell line.　Conditioned medium. Information.
		Comment from the depositor
RCB0806
	Jurkat
		Comment	Human T cell line, the same patient as JM. IL-2 productivity of this line was undetermined.
		Comment from the depositor
RCB0808
	MMAc
		Comment	Human melanoma, spindle-shaped. Said DOPA (+).
		Comment from the depositor
RCB0819
	HMMME
		Comment	Human cell line derived from malignant mesothelioma.
		Comment from the depositor
RCB0820
	HKBML
		Comment	Human cell line derived from malignant lymphoma occurred in brain. Epstein-Barr virus positive.
		Comment from the depositor
RCB0844
	8C9
		Comment	Producing anti-human CD36 MoAb.
		Comment from the depositor
RCB0867
	3-2H3
		Comment	Anti-human-myeloperoxidase MoAb producing.
		Comment from the depositor
RCB0868
	4-2C11
		Comment	Anti-human-myeloperoxidase MoAb producing.
		Comment from the depositor
RCB0869
	9-1A11
		Comment	Anti-human-myeloperoxidase MoAb producing.
		Comment from the depositor
RCB0870
	12-1B6
		Comment	Anti-human-myeloperoxidase MoAb producing.
		Comment from the depositor
RCB0871
	LLC-GA5-CoL150
		Comment	Pig kidney (LLC-PK1) cells expressing human P-glycoproteins.
		Comment from the depositor
RCB0872
	LLC-GA5-CoL300
		Comment	Pig kidney (LLC-PK1) cells expressing human P-glycoproteins.
		Comment from the depositor
RCB0875
	Chab1KMM
		Comment	Chromosomal aberration; 46XX + (11;12)(q23.3, q15). Need confirmation.
		Comment from the depositor
RCB0876
	RGM1
		Comment	So called clear cells from rat stomach mucosa.
		Comment from the depositor
RCB0881
	OCUB-M
		Comment	Same as OCUB-1, OCUB-F.
		Comment from the depositor	Chromosome = pseudotetraploid.
RCB0882
	OCUB-F
		Comment	Same as OCUB-1, OCUB-M.
		Comment from the depositor	Chromosome = pseudodiploid
RCB0959
	HH13-1
		Comment	Producing IgG MoAb against human 29 kDa lectin detectable in many human tumors. Also see HH17-4.
		Comment from the depositor
RCB0960
	HH17-4
		Comment	Producing IgG MoAb against human 29 kDa lectin detectable in many human tumors. Also see HH13-1.
		Comment from the depositor
RCB0966
	HGRT
		Comment	Human cell line derived from retroperitoneal teratoma.
		Comment from the depositor
RCB0967
	HTST
		Comment	Human cell line derived from sacrococcygeal teratoma.
		Comment from the depositor
RCB0978
	HIRS-BM
		Comment	Human cell line derived from malignant mixed mesodermal tumor found in uterus (malignant mixed Müllerian tumor). Established from metastasis in bone marrow.
		Comment from the depositor
RCB0980
	Sa3
		Comment	Squamous carcinoma cells derived from human oral cancer.
		Comment from the depositor
RCB0982
	ECC4
		Comment	Human cell line derived from rectum cancer (small cell cancer). Expressing creatinine kinase of brain isoenzyme etc. ( PubMed ID: 8392984).
		Comment from the depositor
RCB0983
	ECC10
		Comment	Human cell line derived from stomach cancer (small cell cancer). Expressing creatinine kinase of brain isoenzyme etc. ( PubMed ID: 8392984).
		Comment from the depositor
RCB0985
	Ae
		Comment	Worm cell line established by Grace. Culturable in MGM-450-10%FBS.
		Comment from the depositor
RCB0987
	C2C12
		Comment	Said differentiate to myotubes, but need confirmation. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 91031101 prior to order.
		Comment from the depositor
RCB0988
	CACO-2
		Comment	Human colon carcinoma. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 86010202 prior to order. Application consideration
		Comment from the depositor
RCB0989
	COLO 679
		Comment	Melanoma from a 47 year old female. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 87061210 prior to order.
		Comment from the depositor
RCB0990
	CPAE
		Comment	Bovine pulmonary artery endothelial cells producing angiotensin-converting enzyme. Bovine Viral Diarrhea Virus (BVDV) positive. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 86111401 prior to order.
		Comment from the depositor
RCB0991
	G-361
		Comment	Human melanoma producing melanin up to 50 PDL. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 88030401 prior to order.
		Comment from the depositor
RCB0992
	HOS
		Comment	Sensitive to further transformation with both virus and chemicals. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 87070202 prior to order.
		Comment from the depositor
RCB0993
	IEC 6
		Comment	Rat small intestine epithelial cells. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 88071401 prior to order.
		Comment from the depositor
RCB0995
	MDCK
		Comment	Canine kidney epithelial. Sensitive to wide range of viruses. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 84121903 prior to order.
		Comment from the depositor
RCB0996
	Mv.1.Lu(NBL-7)
		Comment	Aleutian mink cells. Used for focus forming assays for murine and ferine sarcoma viruses. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 88050503 prior to order.
		Comment from the depositor
RCB0998
	117-13
		Comment	Anti-lactotetraosylceramide antibody producing. Discriminates metastatic cells from mesothelial cell
		Comment from the depositor
RCB0999
	MKN7
		Comment	c-erbB-2 expressing gastric adenocarcinoma. Differentiated type.
		Comment from the depositor
RCB1001
	MKN45
		Comment	Poorly differentiated gastric adenocarcinoma. Producing high level of CEA.
		Comment from the depositor
RCB1002
	MKN74
		Comment	Moderately differentiated adenocarcinoma. Once they were hypodiploids.
		Comment from the depositor
RCB1003
	MKN1
		Comment	Potentially differentiatable to both direction of adenomatous and squamous epithelial cells.
		Comment from the depositor
RCB1005
	KP4
		Comment	Pancreatic ductal cell carcinoma. Mother cell line of KP4-1, -2, and -3.
		Comment from the depositor
RCB1006
	KP4-1
		Comment	Pancreatic ductal cell carcinoma. PTHrP producing.
		Comment from the depositor
RCB1007
	KP4-2
		Comment	Pancreatic ductal cell carcinoma. PTHrP producing.
		Comment from the depositor
RCB1008
	KP4-3
		Comment	Pancreatic ductal cell carcinoma. PTHrP producing.
		Comment from the depositor
RCB1009
	ECC12
		Comment	Stomach cancer (small cell cancer + glandular cancer)-derived cell line. Expressing creatinine kinase of brain isoenzyme etc. ( PubMed ID: 8392984). Application consideration
		Comment from the depositor
RCB1010
	HOEF
		Comment	Human fibroblasts derived from endometrium. The donor was suffering from infertility. 47,XX,+X (analyzed by the depositor).
		Comment from the depositor
RCB1011
	H-AE-IV
		Comment	Human fibroblasts derived from anencephalic fetus (11 weekly age).
		Comment from the depositor
RCB1012
	T3M-5
		Comment	G-CSF producing thyroidal squamous carcinoma.
		Comment from the depositor
RCB1015
	T3M-1 Clone2
		Comment	G-CSF producing oral squamous cell carcinoma, the same patient as T3M-1 Cl-10 and CJM.
		Comment from the depositor
RCB1017
	T3M-1 Cl-10
		Comment	G-CSF and IL-1 producing oral squamous cell carcinoma, the same patient as T3M-1 Clone2 and CJM.
		Comment from the depositor
RCB1018
	T3M-3
		Comment	Trophoblastic cell. Producing chorionic gonadotropin, estrogen, progesterone.
		Comment from the depositor
RCB1020
	T3M-10
		Comment	Lung large cell carcinoma producing CSF.
		Comment from the depositor
RCB1021
	T3M-4
		Comment	Pancreatic adenocarcinoma producing CEA. K-ras activated.
		Comment from the depositor
RCB1022
	T3M-11
		Comment	Human cell line derived from lung cancer (small cell carcinoma). Expressing insulin-like growth factor II (IGF-II).
		Comment from the depositor
RCB1024
	IMR-90-SV
		Comment	SV40 transformed human lung fibroblast.
		Comment from the depositor
RCB1025
	RTH33
		Comment	SV40-Adeno Vector transformed hepatocytes. Albumin secretion and urea synthesis were reported.
		Comment from the depositor
RCB1026
	GM95
		Comment	Glucosylceramide synthetase-deficient B16 melanoma mutant.
		Comment from the depositor
RCB1027
	MEB4
		Comment	Not expressing melanoma antigen. Control for GM-95(RCB1026) cell line.
		Comment from the depositor
RCB1032
	NOS-1
		Comment	Osteoid producing in vitro and in nude mice.
		Comment from the depositor
RCB1033
	NOS-2
		Comment	Human osteosarcoma producing osteoid in vitro and in vivo(mouse).
		Comment from the depositor
RCB1034
	CJM
		Comment	Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
		Comment from the depositor
RCB1035
	CJM Cl4
		Comment	Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
		Comment from the depositor
RCB1036
	CJM Cl5
		Comment	Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
		Comment from the depositor
RCB1037
	CJM Cl6
		Comment	Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
		Comment from the depositor
RCB1038
	CJM Cl7
		Comment	Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
		Comment from the depositor
RCB1039
	CJM Cl8
		Comment	Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
		Comment from the depositor
RCB1062
	LMSU
		Comment	Human cell line derived from lymph node metastasis of gastric cancer.
		Comment from the depositor
RCB1088
	ψCRIP-P131
		Comment	High-titer producer of MoMLV-derived retrovirus. A subline of ψCRIP.
		Comment from the depositor
RCB1089
	ψCRIP-MFGmGM-CSF
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express mouse GM-CSF. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1090
	ψCRIP-MFGmIL-1α
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express mouse IL-1alpha. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1091
	ψCRIP-MFGmIL-1RA
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express mouse IL-1 receptor antagonist. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1092
	ψCRIP-MFGmIL-2
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express mouse IL-2. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1093
	ψCRIP-MFGmIL-3
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express mouse IL-3. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1094
	ψCRIP-MFGmIL-4
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express mouse IL-4. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1095
	ψCRIP-MFGmIL-6
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express mouse IL-6. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1096
	ψCRIP-MFGmIL-7
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express mouse IL-7. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1097
	ψCRIP-MFGmIL-10
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express mouse IL-10. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1098
	ψCRIP-MFGmIL-12p40
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express mouse IL-12 (p40 subunit). Refer to RCB1099. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1099
	ψCRIP-MFGmIL-12p35
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express mouse IL-12 (p35 subunit). Refer to RCB1098. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1100
	ψCRIP-MFGmTNF-α
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express mouse TNF-alpha. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1101
	ψCRIP-MFGhTNF-α
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express human TNF-alpha. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1102
	ψCRIP-MFGmLT
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express mouse lymphotoxin. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1103
	ψCRIP-MFGmG-CSF
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express mouse G-CSF. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1104
	ψCRIP-MFGhM-CSF
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express human M-CSF. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1105
	ψCRIP-MFGmIFN-γ
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express mouse IFN-gamma. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1106
	ψCRIP-MFGhMIF
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express human MIF. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1107
	ψCRIP-MFGmLIF
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express mouse leukemia inhibitory factor (LIF). Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1108
	ψCRIP-MFGmKitLigand
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express mouse kit ligand (SCF). Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1109
	ψCRIP-MFGhOncost-M
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express human oncostatin M. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1110
	ψCRIP-MFGmB7
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express mouse B7 (CD80). Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1111
	ψCRIP-MFGmB7-2
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express mouse B7-2 (CD86). Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1112
	ψCRIP-MFGtrγIFNR
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express a truncated form of mouse IFN-gamma. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1113
	ψCRIP-MFGrab-IL1RA
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express rabbit IL-1 receptor antagonist. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1114
	ψCRIP-MFGratGM-CSF
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express rat GM-CSF. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1115
	ψCRIP-MFGneo
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express neomycin. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1116
	ψCRIP-MFGHSVtk
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express HSV thymidine kinase. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1117
	ψCRE-MFGts-c-src
		Comment	Cartagena Protocol on Biosafety.Producer of MoMLV-derived retrovirus including mouse c-src cDNA with ts mutation.
		Comment from the depositor
RCB1118
	ψCRIP-MFGts-c-src
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express mouse c-src possessing ts mutation. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1119
	ψCRE-MFGtsT
		Comment	Cartagena Protocol on Biosafety.High-titer producer of MoMLV-derived retrovirus including SV40 large T temperature-sensitive cDNA.
		Comment from the depositor
RCB1120
	ψCRIP-MFGtsT
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express temperature-sensitive SV40 large T. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1124
	OP9
		Comment	Support hematpoietic stem cell and ES cell differentiation to blood cells and lymphocytes.
		Comment from the depositor
RCB1125
	TOM-2
		Comment	Glassy cell carcinoma from cervix.
		Comment from the depositor
RCB1126
	MC3T3-E1
		Comment	Differentiate to osteoblasts. Collagen producing.
		Comment from the depositor
RCB1127
	MC3T3-G2/PA6
		Comment	Support hematpoietic stem cell and osteoclast differentiation. Pre-adipocyte.
		Comment from the depositor
RCB1129
	TGBC1TKB
		Comment	Japanese gallbadder carcinoma metastated to lymph node from the same patient of TGBC2TKB. Application consideration
		Comment from the depositor
RCB1130
	TGBC2TKB
		Comment	Japanese gallbladder carcinoma from the same patient of TGBC1TKB. Application consideration
		Comment from the depositor
RCB1139
	HFSKF-AE-V
		Comment	Human fibroblasts derived from fetal skin (31 weekly age).
		Comment from the depositor
RCB1142
	10H-2
		Comment	Anti poly(ADP-ribose) IgG3 kappa producing.
		Comment from the depositor
RCB1143
	DA-1
		Comment	IL-3 dependent mouse myeloid cells. MoLV induced.
		Comment from the depositor
RCB1144
	DA-3
		Comment	IL-3 dependent mouse myeloid cells. MoLV induced.
		Comment from the depositor
RCB1145
	32D
		Comment	IL-3 dependent cells from Friend leukemia virus-infected mouse bone marrow.
		Comment from the depositor
RCB1148
	TGBC11TKB
		Comment	Japanese gastric cancer, lymph node metastated. Application consideration
		Comment from the depositor
RCB1151
	RCC10RGB
		Comment	Kidney carcinoma from a Japanese patient.
		Comment from the depositor
RCB1152
	Sawano
		Comment	Human cell line derived from endometrial adenocarcinoma of uterus. Resistant to cisplatin.
		Comment from the depositor
RCB1153
	S2 (Drosophila)
		Comment	Fruit fly Oregon-R derived cell line. Highly sensitive in RNA interference compared with CHO-K1. Application consideration
		Comment from the depositor
RCB1154
	KGN
		Comment	Human cell line derived from ovarian granulosa cell tumor. Aromatase activity is increased by stimulation of FSH and hMG.
		Comment from the depositor
RCB1155
	Hepa-E1
		Comment	Eel hepatocyte. Application consideration
		Comment from the depositor
RCB1157
	UV-P3U1-B8
		Comment	Anti-thymine dimer antibody producing. Serum-free cultured hybridoma.
		Comment from the depositor
RCB1158
	B16F10/mGM
		Comment	Mouse GM-CSF producing B16 melanoma.
		Comment from the depositor
RCB1164
	MOLT-3
		Comment	Human T cell leukemia, the same patient as RCB0206 MOLT-4. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 84 prior to order.
		Comment from the depositor
RCB1165
	YAC-1
		Comment	Natural killer cell-sensitive mouse lymphoma.Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 96 prior to order.
		Comment from the depositor
RCB1166
	KG-1
		Comment	Human acute myeloid leukemia. The variant subline (RCB1928 KG-1a) CD3-,CD13+,CD14-,CD15+,CD19-,CD33+. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 14 prior to order.
		Comment from the depositor
RCB1167
	P-815
		Comment	Mouse mastocytoma. Used as a target cells for cytotoxic T cell assays. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 1 prior to order.
		Comment from the depositor
RCB1168
	SKW-3
		Comment	Human cell line derived from acute lymphoblastic leukemia (ALL). A subline of KE-37. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 53 prior to order.
		Comment from the depositor
RCB1169
	TGBC18TKB
		Comment	Papillotubular adenocarcinoma of the Vater's papilla. Application consideration
		Comment from the depositor
RCB1171
	HOUFXXX
		Comment	Stopped distribution. This cell line has been distributed as “Human fibroblasts derived from vagina. 47,XX,+X” until August 2023. It was proved that this cell line was a misidentified cell line of HOEF (RCB1010), human fibroblasts derived from endometrium with 47,XX,+X, deposited from the same scientist.
		Comment from the depositor
RCB1174
	GEM-81
		Comment	Tumor cells derived from Gold Fish red pigment cells.
		Comment from the depositor
RCB1175
	GEM-199
		Comment	Tumor cells derived from Gold Fish red pigment cells.
		Comment from the depositor
RCB1176
	GEM-218
		Comment	Tumor cells derived from Gold Fish red pigment cells.
		Comment from the depositor
RCB1178
	HuG1-PI
		Comment	Human cell line derived from ascites of a gastric cancer patient. Expressing hybrid type of alkaline phosphatase. HuG1-N is another cell line derived from the same patient.
		Comment from the depositor
RCB1179
	HuG1-N
		Comment	Human cell line derived from ascites of a gastric cancer patient. Expressing Nagao-type alkaline phosphatase. HuG1-PI is another cell line derived from the same patient.
		Comment from the depositor
RCB1180
	Tanoue
		Comment	B-lineage acute lymphoblastic leukemia.
		Comment from the depositor
RCB1181
	ST
		Comment	A subclone of RCB1180 Tanoue.
		Comment from the depositor
RCB1182
	GR-ST
		Comment	RCB1181 ST cells transformed with human G-CSF receptor cDNA. Responds to G-CSF.
		Comment from the depositor
RCB1184
	Lu-165
		Comment	Producing high level of anti-diuretic hormone. Application consideration
		Comment from the depositor
RCB1185
	TT1TKB
		Comment	Rectal carcinoma from a Japanese patient. Application consideration
		Comment from the depositor
RCB1186
	TGBC14TKB
		Comment	Japanese gallbladder tumor passed through a nude mouse. Application consideration
		Comment from the depositor
RCB1187
	TUHR3TKB
		Comment	Japanese kidney carcinoma cells. RCB original.
		Comment from the depositor
RCB1188
	NRS-1
		Comment	Human rhabdomyosarcoma showing myogenic differentiation. TGFbeta inhibits it. Application consideration
		Comment from the depositor
RCB1189
	THP-1
		Comment	Human cell line derived from acute monocytic leukemia. Differentiate to macrophage-like cells by treatment of phorbol ester. The characteristics are somewhat different from THP-1 distributed from ATCC such as in cell size and drug sensitivities. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 16 prior to order.Application consideration
		Comment from the depositor
RCB1190
	7-TD-1
		Comment	Responding to IL-6 in the bioassay. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 23 prior to order.
		Comment from the depositor
RCB1191
	5637
		Comment	Described to produce SCF, IL-1, IL-3, IL-6, G-CSF, GM-CSF, etc. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 35 prior to order.
		Comment from the depositor
RCB1192
	MDA-MB-453
		Comment	Human breast carcinoma established from an effusion. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 65 prior to order.Application consideration
		Comment from the depositor
RCB1193
	COLO-320
		Comment	Described to produce serotonin, epinephrine. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 144 prior to order.
		Comment from the depositor
RCB1196
	TGBC24TKB
		Comment	Japanese gallbladder carcinoma established from metastated ascite. Application consideration
		Comment from the depositor
RCB1197
	P2UR/K-562
		Comment	Expressing P2U receptor acting in signal transduction pathway.
		Comment from the depositor
RCB1198
	TUHR4TKB
		Comment	Japanese renal carcinoma cells.
		Comment from the depositor
RCB1200
	MMAc·SF
		Comment	Serum-free medium-adapted MMAc cells. For SF culture, + insulin, hEGF, hydrocortisone, bovine pituit
		Comment from the depositor
RCB1205
	Anti-PT-S1-1B7
		Comment	Anti-pertussis toxin subunit S-1 MoAb (IgG2a) producing.
		Comment from the depositor
RCB1208
	Anti-PT-S1-10D6
		Comment	Anti-pertussis toxin subunit S-1 MoAb (IgG1) producing.
		Comment from the depositor
RCB1209
	Anti-PT-S1-8G4
		Comment	Anti-pertussis toxin subunit S-1 MoAb (IgG1) producing.
		Comment from the depositor
RCB1212
	Anti-PT-S1-3F10
		Comment	Anti-pertussis toxin subunit S-1 MoAb (IgG1) producing.
		Comment from the depositor
RCB1214
	Anti-PT-S1-4D10
		Comment	Anti-pertussis toxin subunit S-1 MoAb (IgG1) producing.
		Comment from the depositor
RCB1215
	Anti-PT-S23-11E6
		Comment	Anti-pertussis toxin subunit S-2,3 MoAb (IgG1) producing.
		Comment from the depositor
RCB1220
	Anti-PT-S2-3A12
		Comment	Anti-pertussis toxin subunit S-2 MoAb (IgG1) producing.
		Comment from the depositor
RCB1222
	Anti-PT-S2-9G8
		Comment	Anti-pertussis toxin subunit S-2 MoAb (IgG1) producing.
		Comment from the depositor
RCB1223
	Anti-PT-S3-7E10
		Comment	Anti-pertussis toxin subunit S-3 MoAb (IgG1) producing.
		Comment from the depositor
RCB1229
	Anti-PT-S4-7F2
		Comment	Anti-pertussis toxin subunit S-4 MoAb (IgG1) producing.
		Comment from the depositor
RCB1233
	Anti-PT-S4-1H2
		Comment	Anti-pertussis toxin subunit S-4 MoAb (IgG1) producing.
		Comment from the depositor
RCB1238
	Anti-FHA(2)2E9
		Comment	Anti-pertussis filamentous hemagglutinin (FHA) MoAb producing.
		Comment from the depositor
RCB1239
	Anti-FHA(1)1C6
		Comment	Anti-pertussis filamentous hemagglutinin (FHA) MoAb producing.
		Comment from the depositor
RCB1240
	Anti-α(1)1C6F4
		Comment	MoAb to Clostridium perfringens alpha-toxin (phospholipase C).
		Comment from the depositor
RCB1243
	Anti-α(4)11D9G5
		Comment	MoAb to Clostridium perfringens alpha-toxin (phospholipase C).
		Comment from the depositor
RCB1244
	Anti-α(5)11D10B6
		Comment	MoAb to Clostridium perfringens alpha-toxin (phospholipase C).
		Comment from the depositor
RCB1246
	Anti-α(7)7C9A10
		Comment	MoAb to Clostridium perfringens alpha-toxin (phospholipase C).
		Comment from the depositor
RCB1247
	Anti-α(8)9F3A6
		Comment	MoAb to Clostridium perfringens alpha-toxin (phospholipase C).
		Comment from the depositor
RCB1248
	Anti-α(9)12G8B11
		Comment	MoAb to Clostridium perfringens alpha-toxin (phospholipase C).
		Comment from the depositor
RCB1250
	Anti-θ(1)3H10
		Comment	MoAb to Clostridium perfringens theta-toxin.
		Comment from the depositor
RCB1264
	tsBN2
		Comment	Temperature-sensitive mutant of BHK-21. Causing premature chromosome condensation.
		Comment from the depositor
RCB1267
	tsBN7
		Comment	Temperature-sensitive mutant of BHK-21 with mutated DAD1 gene. Causing apoptosis at 39.5 C.
		Comment from the depositor
RCB1268
	tsBN462
		Comment	Temperature-sensitive mutant of BHK-21. Complemented with human X-linked CCG1 gene. Application consideration
		Comment from the depositor
RCB1269
	tsBN75
		Comment	Temperature-senstive mutant of BHK-21. Complemented with ubiquitin-activating enzyme E1 cDNA.
		Comment from the depositor
RCB1270
	tsBN51
		Comment	Temperature-sensitive mutant of BHK-21 with defect in RNA polymerase III subunit.
		Comment from the depositor
RCB1271
	tsBN67
		Comment	Temperature-sensitive mutant of BHK-21. Stop growth after 2-day culture at 39.5 C.
		Comment from the depositor
RCB1272
	tsBN250
		Comment	Temperature-sensitive mutant of BHK-21. Complementation group A. Dye rapidly at 39.5 C.
		Comment from the depositor
RCB1273
	tsBN269
		Comment	Temperature-sensitive mutant of BHK-21 selected after MNNG treatment.
		Comment from the depositor
RCB1275
	TUHR10TKB
		Comment	Japanese renal carcinoma cells expressing HLA-A2402.
		Comment from the depositor
RCB1278
	MtT/E
		Comment	Rat cell line derived from pituitary tumor. Estrogen-induced tumor. Producing no pituitary hormone. Four cell lines (MtT/E, MtT/S, MtT/SM, MtT/Se) were established simultaneously.Application consideration.
		Comment from the depositor
RCB1279
	TtT/GF
		Comment	Mouse cell line derived from pituitary tumor (thyrotropin-producing tumor). Pituitary folliculo-stellate-like cells. FGF-dependent cell line. GFAP positive. S-100 positive. Said producing IL-6.
		Comment from the depositor
RCB1280
	TGBC50TKB
		Comment	3 cell lines from different metastases were established from the same patient. See TGBC51TKB. Application consideration
		Comment from the depositor
RCB1281
	TGBC51TKB
		Comment	3 cell lines from different metastases were established from the same patient. See TGBC52TKB. Application consideration
		Comment from the depositor
RCB1282
	TGBC52TKB
		Comment	3 cell lines from different metastases were established from the same patient. See TGBC50TKB. Application consideration
		Comment from the depositor
RCB1283
	B16 melanoma
		Comment	Mouse melanoma producing melanin. Application consideration
		Comment from the depositor
RCB1284
	B16 melanoma/lacZ
		Comment	Mouse melanoma expressing E.coli lac Z. Strongly positive with beta-galactosidase.
		Comment from the depositor
RCB1285
	3A21
		Comment	Anti-ribonuclease A antibody producing.
		Comment from the depositor
RCB1286
	ECPC-3
		Comment	Choroid plexus carcinoma cell line transfected with IgH enhancer-SV40 T fusion gene.
		Comment from the depositor
RCB1287
	ECPC-4
		Comment	Choroid plexus carcinoma cell line transfected with IgH enhancer-SV40 T fusion gene. Different shape
		Comment from the depositor
RCB1290
	OIH-1
		Comment	A human cell line derived from acute myeloid leukemia (AML). AML was originated from MDS. Possessing a mutation in DCC gene. Application consideration
		Comment from the depositor
RCB1292
	RBE
		Comment	Human intrahepatic cholangiocarcinoma.Please read carefully this information before use.
		Comment from the depositor
RCB1293
	SSP-25
		Comment	Human intrahepatic cholangiocarcinoma. Please read carefully this information before use.
		Comment from the depositor
RCB1294
	HRC-17
		Comment	Hybridoma producing anti-E antigen of the human Rh blood group system
		Comment from the depositor
RCB1296
	HNT-34
		Comment	A human cell line derived from acute myeloid leukemia (AML). AML was originated from CMMoL. Possessing Philadelphia chromosome and t(3;3)(q21;q26). Expressing EVI1 and BCR/ABL. Application consideration
		Comment from the depositor
RCB1297
	HYT-1
		Comment	A human cell line derived from acute myeloid leukemia (AML). Secondary AML. Able to differentiate to megakaryocyte-like cells.
		Comment from the depositor
RCB1303
	anti-αA-crystallin
		Comment	Anti-chick αA-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
		Comment from the depositor
RCB1304
	anti-αB-crystallin
		Comment	Anti-chick αB-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
		Comment from the depositor
RCB1305
	anti-β5-crystallin
		Comment	Anti-chick β5-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
		Comment from the depositor
RCB1306
	anti-β6-crystallin
		Comment	Anti-chick β6-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
		Comment from the depositor
RCB1307
	anti-γ1-crystallin
		Comment	Anti-newt γ1-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
		Comment from the depositor
RCB1308
	anti-δ-crystallin
		Comment	Anti-chick δ-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
		Comment from the depositor
RCB1311
	C3H/HeN-emb
		Comment	Mouse(C3H/HeN Jcl) embryonic fibroblasts cultured under the 3T3 schedule.
		Comment from the depositor
RCB1312
	C57BL/6J-emb
		Comment	Mouse(C57BL/6J) embryonic fibroblasts cultured under the 3T3 schedule.
		Comment from the depositor
RCB1313
	RERF-LC-KJ
		Comment	Japanese lung adenocarcinoma, highly metastatic in SCID mice. Also refer to RCB0444 RCRF-LC-AI.
		Comment from the depositor
RCB1316
	CTB-1
		Comment	Fas-antigen expressing. Ligation with anti-Fas mAb does not induce apoptosis.
		Comment from the depositor
RCB1317
	KU-SN
		Comment	Rare peripheral neuroectodermal tumor cells. Use collagen-coated dish.
		Comment from the depositor
RCB1366
	HuH-7
		Comment	Said producing alpha-fetoprotein, alpha-antitrypsin, ceruloplasmin, fibrinogen, fibronectin, etc.
		Comment from the depositor
RCB1367
	HuH-6
		Comment	Hepatoblastoma. Said albumin and alpha-fetoprotein producing.
		Comment from the depositor
RCB1369
	NBT-T1
		Comment	A subline of NBT-II. Low invasive bladder carcinoma. Relatively high cadherin expression.
		Comment from the depositor
RCB1370
	NBT-T2
		Comment	A subline of NBT-II. Almost non-invasive bladder carcinoma. Relatively high cadherin expression.
		Comment from the depositor
RCB1371
	NBT-L1
		Comment	A subline of NBT-II. Invasive bladder carcinoma. Relatively low cadherin expression.
		Comment from the depositor
RCB1372
	NBT-L2a
		Comment	A subline of NBT-II. Highly invasive bladder carcinoma. Relatively low cadherin expression.
		Comment from the depositor
RCB1373
	NBT-L2b
		Comment	A subline of NBT-II. The most invasive bladder carcinoma. Relatively low cadherin expression.
		Comment from the depositor
RCB1374
	1-8
		Comment	CITES. CAG-loxP-neopA-loxP-LacZ(incomplete) was inserted. Control cell line for 2-2 and 2-7 cells.　Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES). Origin animal species details
		Comment from the depositor
RCB1375
	2-2
		Comment	CITES. 35 copies of CAG-loxP-neopA-loxP-LacZ were tandemly inserted. Cre will delete neopA and induce LacZ.　Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES). Origin animal species details
		Comment from the depositor
RCB1376
	2-7
		Comment	CITES. A copy of CAG-loxP-neopA-loxP-LacZ was inserted. Cre will delete neopA and induce LacZ. Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES). Origin animal species details
		Comment from the depositor
RCB1377
	32Dcl3
		Comment	Mouse IL-3 dependent cells cloned from 32D. Differentiate with G-CSF stimulation. Conditioned medium.
		Comment from the depositor
RCB1378
	MuSS
		Comment	A-Jackson mouse-derived histiocyte-like cells from spontaneous sarcoma.
		Comment from the depositor
RCB1382
	CF1TKB
		Comment	Japanese cystic fibrosis fibroblast.
		Comment from the depositor
RCB1383
	TUHR14TKB
		Comment	Japanese renal carcinoma cells.
		Comment from the depositor
RCB1422
	L929
		Comment	TNFalpha-sensitive L929. Do not confuse with RCB0081 L929 that is insensitive to TNFalpha.
		Comment from the depositor
RCB1423
	BHK-21
		Comment	The parent cell line used for the temperature sensitive cell line series of BN.
		Comment from the depositor
RCB1425
	LCAM1
		Comment	Human lung cancer derived cell.
		Comment from the depositor
RCB1426
	PMF-ko14
		Comment	Stopped distribution.. Until September 2023, we have distributed this cell line as “Japanese colon carcinoma cell line. Family of the patient also exhibited high risk, but not so-called HNPCC.” This cell line was a mix-up of KM12, a colon carcinoma cell line registered in the National Cancer Institute of USA.
		Comment from the depositor
RCB1429
	SN-512
		Comment	A human cell line derived from acute myeloid leukemia (AML, M2).
		Comment from the depositor
RCB1433
	TEN
		Comment	Human cell line derived from endometrial cancer. Clear cell carcinoma. Said c-erb-2(+), cathepsin D(+), CA125(+) in a part of cells.
		Comment from the depositor
RCB1434
	KE-39
		Comment	Human cell line derived from gastric cancer
		Comment from the depositor
RCB1435
	KE-97
		Comment	Stopped distribution. Until 2022, this cell line has been distributed as “Human cell line derived from intraperitoneal metastasis of gastric cancer”. However, this cell line was proved to be derived from B cells, and thus we stopped the distribution.
		Comment from the depositor
RCB1437
	AW-EBV-LCL
		Comment	B95-8 EB virus transformed B cell line (derived from B cells present in a patient suffering from leukemia).
		Comment from the depositor
RCB1438
	TW-EBV-LCL
		Comment	B95-8 EB virus transformed (originally normal) B cell line.
		Comment from the depositor
RCB1440
	ATN-1
		Comment	Adult T-cell leukemia. HTLV-1 pro-virus DNA(+). Based on the information by depositor; (1) this cell line possesses HTLV-1 pro-virus DNA, (2) the HTLV-1 proteins (p19, p24, p53, gp46) cannot be detected with western blotting.
		Comment from the depositor
RCB1444
	MBHL-2
		Comment	Insect cell line derived from Mamestra brassicae.
		Comment from the depositor
RCB1445
	MBHL-3
		Comment	Insect cell line derived from Mamestra brassicae
		Comment from the depositor
RCB1449
	C7
		Comment	p53 deficient mouse bone marrow derived cell. Useful for study of p53 suppressor oncogene.
		Comment from the depositor
RCB1450
	LM8
		Comment	A highly metastatic cell line derived from Dunn's osteosarcoma (C3H mouse origin).
		Comment from the depositor
RCB1451
	L929
		Comment	Sanford's original, brought by Katsuta at 7/5/1955. Insensitive to TNFalpha. Possible to culture in MEM medium.
		Comment from the depositor
RCB1456
	RCR-1
		Comment	Astroglia cell line. Possible to culture in DMEM medium. See RCB0075.
		Comment from the depositor
RCB1460
	PCM6
		Comment	Human myeloma cell.
		Comment from the depositor
RCB1464
	DT40
		Comment	Chicken B cell line transformed by avian leukosis virus. c-myc and IgM expressing.
		Comment from the depositor
RCB1465
	SHIP^(-) DT40
		Comment	SHIP deficient DT40 cells
		Comment from the depositor
RCB1466
	SHP1^(-) DT40
		Comment	SHP1 deficient DT40 cells
		Comment from the depositor
RCB1467
	IP3R^(-) DT40
		Comment	IP3R(type1,type2,type3) deficient DT40 cells
		Comment from the depositor
RCB1468
	Btk^(-) DT40
		Comment	Btk deficient DT40 cells
		Comment from the depositor
RCB1469
	PLC-γ2^(-) DT40
		Comment	PLC-γ2 deficient DT40 cells
		Comment from the depositor
RCB1470
	Syk^(-) DT40
		Comment	Syk deficient DT40 cells
		Comment from the depositor
RCB1471
	Lyn^(-) DT40
		Comment	Lyn deficient DT40 cells
		Comment from the depositor
RCB1472
	M
		Comment	Capable to form collagen network. Possible to culture in DMEM medium. See RCB0067.
		Comment from the depositor
RCB1473
	LYM-1
		Comment	Sticky cell from lymph node. Possible to culture in DMEM medium.
		Comment from the depositor
RCB1474
	RLC-16
		Comment	Epithelial cell from rat liver. Possible to culture in DMEM medium.
		Comment from the depositor
RCB1477
	CHO-RD
		Comment	Subline of CHO cells. Derived from CHO-K1 cell line. Serum-free medium adapted. Application consideration
		Comment from the depositor
RCB1483
	OV2944-HM-1
		Comment	Lymphnode-metastatic ovarian tumor. So called HM-1 cells.
		Comment from the depositor
RCB1484
	RLC-18
		Comment	Non tumorigenic in nude mice. Possible to culture in DMEM medium.
		Comment from the depositor
RCB1486
	JTC-19
		Comment	Rat lung fibroblast once said interferon-producing. Possible to culture in DMEM medium. See RCB0074 .
		Comment from the depositor
RCB1487
	MY-EBV-LCL
		Comment	B95-8 EB virus transformed (originally normal) B cell line.
		Comment from the depositor
RCB1489
	RLC-27
		Comment	Liver-derived cell, tumorigenic in nude mice. Possible to culture in DMEM medium.
		Comment from the depositor
RCB1495
	FU-RPNT-1
		Comment	Scarcely found primitive neuroectodermal tumor from a Japanese kidney. Application consideration
		Comment from the depositor
RCB1498
	Grap^(-) DT40
		Comment	Grap deficient DT40 cells
		Comment from the depositor
RCB1499
	Grb2^(-) DT40
		Comment	Grb2 deficient DT40 cells
		Comment from the depositor
RCB1500
	Lyn^(-)/Syk^(-) DT40
		Comment	Lyn and Sky deficient DT40 cells
		Comment from the depositor
RCB1501
	SHP1^(-)/SHP2^(-) DT40
		Comment	SHP1 and SHP2 deficient DT40 cells
		Comment from the depositor
RCB1502
	SHP2^(-) DT40
		Comment	SHP2 deficient DT40 cells
		Comment from the depositor
RCB1503
	Shc^(-) DT40
		Comment	Shc deficient DT40 cells
		Comment from the depositor
RCB1506
	clone YP1N25
		Comment	Subline of mouse C127 cell line. Inducible expression of influenza virus protein (PB1, NP) is possible.
		Comment from the depositor
RCB1507
	clone YP1N27
		Comment	A subline of C127. PB1 RNA polymerase subunit and nucleoprotein are inducible by dexamethasone.
		Comment from the depositor
RCB1508
	clone 76
		Comment	Subline of mouse C127 cell line. Inducible expression of influenza virus protein (PB1, NP, PA, PB2) is possible.
		Comment from the depositor
RCB1509
	clone 64
		Comment	Subline of mouse C127 cell line. Inducible expression of influenza virus protein (PB1, NP, PA) is possible.
		Comment from the depositor
RCB1510
	BLNK^(-) DT40
		Comment	BLNK deficient DT40 cells
		Comment from the depositor
RCB1512
	MH7A
		Comment	Rheumatoid fibroblast-like synoviocyte transformed with SV40 T antigen. Respond to IL-1beta.
		Comment from the depositor
RCB1513
	HOMM
		Comment	Human cell line derived from melanoma occurred in uterine cervix. Possessing melanin granules.
		Comment from the depositor
RCB1514
	HOCE
		Comment	Stopped distribution due to the limited proliferation capacity. Human cell line derived from choriocarcinoma. Application consideration
		Comment from the depositor
RCB1517
	A-6(ES derived)
		Comment	Mouse ES ( AES0001 H-1 ) cell derived cell, useful for study of hematopoiesis.
		Comment from the depositor
RCB1518
	SS-A3-1
		Comment	F344 male rat fibrosarcoma cells, but with histiocytic and/or myofibroblastic characteristics.
		Comment from the depositor
RCB1520
	JHOC-5
		Comment	Human cell line derived from ovarian clear cell adenocarcinoma. Said CA125 and CA72-4 producing. Application consideration
		Comment from the depositor
RCB1521
	JHOS-2
		Comment	Human cell line derived from ovarian serous adenocarcinoma. Said CA125 and CA15-3 producing. Application consideration
		Comment from the depositor
RCB1525
	HeLa.S3
		Comment	RCB0191 HeLa.S3, that has been cultured in MEM(susp.). This line is cultured in MEM.
		Comment from the depositor
RCB1528
	CCP-2
		Comment	Bone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.
		Comment from the depositor
RCB1530
	CCP-7
		Comment	Bone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.
		Comment from the depositor
RCB1531
	CCP-8
		Comment	Bone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.
		Comment from the depositor
RCB1534
	MLC-1-B
		Comment	Bone marrow stroma cell line, depositing calcified matrix on the culture surface.
		Comment from the depositor
RCB1535
	MLC-2-4
		Comment	Bone marrow stroma cell line, depositing calcified matrix on the culture surface.
		Comment from the depositor
RCB1536
	MLC-6
		Comment	Osteoclast-like cell line derived from mouse (C3H/He).
		Comment from the depositor
RCB1537
	MLC-7
		Comment	Bone marrow stroma cell line, depositing calcified matrix on the culture surface.
		Comment from the depositor
RCB1538
	32Dcl3
		Comment	Subclone of 32D cell line. Differentiate to mature granulocytes by G-CSF. Conditioned medium.
		Comment from the depositor
RCB1539
	P19.CL6
		Comment	Mouse cell line derived from embryonal carcinoma. C3H strain. Following differentiation, beating cardiomyocytes appear. The efficiency of differentiation is lower compared to RCB 2318.
		Comment from the depositor
RCB1541
	HFL9t
		Comment	Human fibroblasts derived from fetal lung (19 weekly age). 47,+del(9)(q12). RCB1542 is derived from the same fetus.
		Comment from the depositor
RCB1542
	HFSK9t
		Comment	Human fibroblasts derived from fetal skin (19 weekly age). 47,+del(9)(q12). RCB1541 is derived from the same fetus.
		Comment from the depositor
RCB1543
	JHTKI-col-L
		Comment	Human B cell-like cell line derived from colon cancer tissue.
		Comment from the depositor
RCB1544
	JHUAS-1
		Comment	Human cell line derived from uterine adenosquamous carcinoma. Said CEA and CA125 producing. Application consideration
		Comment from the depositor
RCB1545
	JHUAS-2-L
		Comment	Human B cell-like cell line derived from uterine cancer tissue (Adenosquamous carcinoma).
		Comment from the depositor
RCB1546
	JHOS-3
		Comment	Human cell line derived from ovarian serous adenocarcinoma. Said CA125 producing. Application consideration
		Comment from the depositor
RCB1547
	JHUCS-1
		Comment	Human cell line derived from uterine carcinosarcoma. Nude mouse transplantable. Application consideration
		Comment from the depositor
RCB1548
	JHUEM-1
		Comment	Human cell line derived from uterine endometrioid adenocarcinoma. Said CA125 and CEA producing. Application consideration
		Comment from the depositor
RCB1549
	YSCCC
		Comment	Human cell line derived from cholangiocellular carcinoma.
		Comment from the depositor
RCB1550
	HL-60-R2
		Comment	Variant of HL60. Resistant to retinoic acid and active Vit. D derivatives.
		Comment from the depositor
RCB1551
	JHUEM-2
		Comment	Human cell line derived from uterine endometrioid adenocarcinoma. Application consideration
		Comment from the depositor
RCB1552
	JHUEM-3
		Comment	Human cell line derived from uterine endometrioid adenocarcinoma. Application consideration
		Comment from the depositor
RCB1555
	F9
		Comment	Said to differentiate to parietal endoderm with retinoic acid and dibutyryl cAMP.
		Comment from the depositor
RCB1558
	JHUS-nk1
		Comment	Human cell line derived from uterine cervix cancer. Squamous cell carcinoma. Application consideration
		Comment from the depositor
RCB1560
	PWS-Yamaguchi
		Comment	Prader-Willi syndrome with obesity. del(15) was found in lymphocytes of the patient.
		Comment from the depositor
RCB1561
	RML-Yoshi
		Comment	Severe insulin-resistance by uncleaved insulin proreceptor. G->T mutation in interconnecting region.
		Comment from the depositor
RCB1564
	ψCRIP-RxnZ
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express LacZ possessing nuclear localization signal. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1572
	ψCRIP-hBax-i-hCD25-CS
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express human Bax. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1573
	ψCRIP-ATR-bsr
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express angiotensin receptor and blasticidin S deaminase. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1574
	ψCRIP-RxhCD82
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express human CD82. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1575
	ψCRIP-Rx-crmA-bsr
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express anti-apoptotic crmA and blasticidin S deaminase. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1576
	ψCRIP-Rx-ETBR-bsr
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express human endothelin receptor and blasticidin S deaminase. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1577
	ψCRIP-mPCNF1-bsr
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express mouse calcineurin and blasticidin S deaminase. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1579
	ψCRIP-MFG-Z
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express lac Z. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1580
	ψCRIP-MFG-T37
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express SV40 large T antigen. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1581
	ψCRIP-MSHR
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express human MSH receptor. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1582
	ψCRIP-NCre
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express Cre recombinase. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1583
	ψCRIP-hp53-bsr
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express human p53 and blasticidin S deaminase. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1584
	ψCRIP-RxBcl-XL-i-bsr
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express human Bcl-xL and blasticidin S deaminase. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1585
	ψCRIP-RxhFAS-i-CD80
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express human FAS and human CD80. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1587
	ψCRIP-RxhSecR-bsr
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express human secretin receptor and blasticidin S deaminase. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1588
	ψCRIP-hSSR-bsr
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express human somatostatin receptor and blasticidin S deaminase. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1589
	ψCRIP-RxmPCNT1-i-bsr
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express a truncated form of mouse calcineurin and blasticidin S deaminase. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1590
	ψCRIP-RxhVIPR-bsr
		Comment	Cartagena Protocol on Biosafety. Cell line producing MoMLV-derived retrovirus to express human VIP receptor and blasticidin S deaminase. Long term culture results in decrease of virus production.
		Comment from the depositor
RCB1591
	SRA 01/04
		Comment	alpha, beta-crystaline expressing human lense epithelial cell line. plasmid DNA: pRSV-B-T Ag.
		Comment from the depositor
RCB1593
	OS3
		Comment	ori- SV40 DNA transformed C3H mouse brain-derived cells. GFAP+ astrocytes and GFAP- oligodendrocytes
		Comment from the depositor
RCB1597
	KKC
		Comment	Mouse T cell line transformed by Gross leukemia virus.
		Comment from the depositor
RCB1598
	NCKA
		Comment	Mouse T cell line transformed by Gross leukemia virus.
		Comment from the depositor
RCB1600
	KKF
		Comment	Mouse T cell line transformed by Gross leukemia virus.
		Comment from the depositor
RCB1601
	KKB
		Comment	Mouse T cell line transformed by Gross leukemia virus.
		Comment from the depositor
RCB1604
	DHA3-1
		Comment	Mouse T cell hybridoma expressing double HA-tag alone.
		Comment from the depositor
RCB1605
	DHA3-26
		Comment	Mouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2.
		Comment from the depositor
RCB1606
	DMyc3-45
		Comment	Mouse T cell hybridoma (DO-11.10) expressing double Myc-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2 .
		Comment from the depositor
RCB1607
	DHA9-3
		Comment	Mouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein).
		Comment from the depositor
RCB1608
	DHA9-13
		Comment	Mouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein).
		Comment from the depositor
RCB1609
	DHA9-15
		Comment	Mouse T cell hybridoma (DO-11.10)expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein).
		Comment from the depositor
RCB1610
	DMyc9-36
		Comment	Mouse T cell hybridoma (DO-11.10) expressing double Myc-tagged HS1BP3 (HS1 SH3 domain binding protein).
		Comment from the depositor
RCB1611
	M4
		Comment	Anti-chicken IgM antibody secreting. Able to stimulate DT40 cell surface antigen.
		Comment from the depositor
RCB1613
	HFL-AE-VI
		Comment	Human fibroblasts derived from lung of anencephalic fetus (18 weekly age).
		Comment from the depositor
RCB1615
	HFSKF-AE-VII
		Comment	Human fibroblasts derived from skin of anencephalic fetus (17 weekly age). RCB1617 and RCB1618 are derived from the same fetus.
		Comment from the depositor
RCB1617
	HFL-AE-VII
		Comment	Human fibroblasts derived from lung of anencephalic fetus (17 weekly age). RCB1615 and RCB1618 are derived from the same fetus.
		Comment from the depositor
RCB1618
	HFLI-AE-VII
		Comment	Human fibroblasts derived from liver of anencephalic fetus (17 weekly age). RCB1615 and RCB1617 are derived from the same fetus.
		Comment from the depositor
RCB1620
	ΔDNAPK-DT40
		Comment	DNA PK gene deleted DT40 (chicken B cell line).
		Comment from the depositor
RCB1621
	ΔKu70-DT40
		Comment	Ku70 gene deleted DT40 (chicken B cell line).
		Comment from the depositor
RCB1622
	ΔRad51B-DT40
		Comment	Rad51B gene deleted DT40 (chicken B cell line).
		Comment from the depositor
RCB1623
	ΔRad51C-DT40
		Comment	Rad51C gene deleted DT40 (chicken B cell line).
		Comment from the depositor
RCB1624
	ΔRad51D-DT40
		Comment	Rad51D gene deleted DT40 (chicken B cell line).
		Comment from the depositor
RCB1625
	ΔXRCC2-DT40
		Comment	XRCC2 gene deleted DT40 (chicken B cell line).
		Comment from the depositor
RCB1626
	ΔXRCC3-DT40
		Comment	XRCC3 gene deleted DT40 (chicken B cell line).
		Comment from the depositor
RCB1627
	ΔRad52-DT40
		Comment	Rad52 gene deleted DT40 (chicken B cell line).
		Comment from the depositor
RCB1628
	ΔRad54-DT40
		Comment	Rad54 gene deleted DT40 (chicken B cell line).
		Comment from the depositor
RCB1629
	ΔMre11-DT40(#190)
		Comment	Mre11 gene deleted DT40 (chicken B cell line), subclone of RCB1630.
		Comment from the depositor
RCB1630
	ΔMre11-DT40(#194)
		Comment	Mre11 gene deleted DT40 (chicken B cell line), subclone of RCB1629.
		Comment from the depositor
RCB1631
	ΔRad51+hRad51-DT40
		Comment	Rad51 gene deleted and human Rad51 gene inserted DT40 (chicken B cell line).
		Comment from the depositor
RCB1632
	ΔKu70ΔRad54B-DT40
		Comment	Ku70 and Rad54B gene double-deleted DT40 (chicken B cells).
		Comment from the depositor
RCB1633
	ΔMre11ΔKu70-DT40
		Comment	Mre11 and Ku70 gene double-deleted DT40 (chicken B cells).
		Comment from the depositor
RCB1634
	ΔRad54ΔRad54B-DT40
		Comment	Rad54 and Rad54B gene double-deleted DT40 (chicken B cells).
		Comment from the depositor
RCB1635
	K-562
		Comment	Human cell line derived from chronic myelogenous leukemia. Can produce hemoglobin in the presence of NaB. Directly deposited from the institution that has established this cell line.
		Comment from the depositor
RCB1637
	293
		Comment	A human cell line derived from kidney of a fetus. Transformed with sheared human Ad5 DNA. Sensitive to human adenoviruses and adenovirus DNA. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 85120602 prior to order.
		Comment from the depositor
RCB1638
	Hepa 1-6
		Comment	Mouse cell line derived from hepatoma. Derived from BW7756 tumour in a C57L mouse. Secretes several products such as albumin, alpha-fetoprotein, alpha 1-antitrypin and amylase. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 92110305 prior to order.
		Comment from the depositor
RCB1639
	LoVo
		Comment	CEA-producing colon adenocarcinoma. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 87060101 prior to order.
		Comment from the depositor
RCB1640
	DAUDI
		Comment	Burkitt's lymphoma. Sensitive to lymphokine-activated killer cells but resistant to natural killer cells. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 85011437 prior to order.
		Comment from the depositor
RCB1641
	EL4
		Comment	9,10-dimethyl-1,2benzanthracene induced lymphoma. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 85023105 prior to order.
		Comment from the depositor
RCB1642
	3T3 Swiss Albino
		Comment	Contact inhibition. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 85022108 prior to order.
		Comment from the depositor
RCB1644
	BeWo
		Comment	It was initiated from a malignant gestational choriocarcinoma of the fetal placenta. Need to check response to hormones before use. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 86082803 prior to order.
		Comment from the depositor
RCB1645
	Y79
		Comment	Caucasian retinoblastoma. May have reverse transcriptase. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 86093003 prior to order.
		Comment from the depositor
RCB1647
	RAJI
		Comment	Burkitt's lymphoma. Sensitive to LAK cells but resistant to NK cells. Back up of culture ECA2673. Resistant to VSV. This cell line carries the latent Epstein-Barr Virus (EBV) genome and is positive for EBNA. RAJI is sometimes referred to as a 'non-producer'; the EBV genome carries deletions attributed to preventing the formation of virus particles. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 85011429 prior to order.
		Comment from the depositor
RCB1648
	Hep G2
		Comment	Human cell line derived from hepatoblastoma. Secretes several products such as albumin, alpha2-macroglobulin, alpha 1-antitrypsin, transferrin and plasminogen. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ECACC 85011430 prior to order. Information
		Comment from the depositor
RCB1649
	ΔAtm-DT40
		Comment	ATM gene deleted DT40 (chicken B cells).
		Comment from the depositor
RCB1650
	ΔAtmΔKu70-DT40
		Comment	ATM and Ku70 gene double-deleted DT40 (chicken B cells).
		Comment from the depositor
RCB1651
	ΔAtmΔRad54+hRad54-DT40
		Comment	ATM and Rad54 gene double-deleted DT40 (chicken B cells). Inducible expression of human Rad54 is possible.
		Comment from the depositor
RCB1652
	G1MF285D
		Comment	Hybridoma that produce anti-human G1MF (allotype of IgG1) antibody.
		Comment from the depositor
RCB1668
	293/CrmA
		Comment	A subline of 293. Expressing caspase-inhibiting CrmA gene.
		Comment from the depositor
RCB1672
	ΔRad54+hRad54-DT40
		Comment	Rad54 gene deleted DT40 (chicken B cells). Inducible expression of human Rad54 is possible.
		Comment from the depositor
RCB1675
	Cbl^(-) DT40
		Comment	Cbl deficient DT40 cells
		Comment from the depositor
RCB1676
	JHOM-1
		Comment	Human cell line derived from ovarian mucinous adenocarcinoma. Application consideration
		Comment from the depositor
RCB1677
	JHUEM-7
		Comment	Human cell line derived from uterine endometrioid adenocarcinoma. Application consideration
		Comment from the depositor
RCB1678
	JHOS-4
		Comment	Human cell line derived from ovarian serous cyst adenocarcinoma. Application consideration
		Comment from the depositor
RCB1680
	TUHR25TKB
		Comment	Human cell line derived from kidney cancer.
		Comment from the depositor
RCB1681
	GS-HepG2
		Comment	A subline of Hep G2. Expressing abundant glutamine synthetase. Information
		Comment from the depositor
RCB1682
	JHOM-2B
		Comment	Human cell line derived from ovarian mucinous tubular adenocarcinoma. Application consideration
		Comment from the depositor
RCB1687
	ΔRad54ΔKu70-DT40
		Comment	Rad54 and Ku70 gene double-deleted DT40 (chicken B cells).
		Comment from the depositor
RCB1688
	JHOC-7
		Comment	Human cell line derived from ovarian clear cell carcinoma. Application consideration
		Comment from the depositor
RCB1690
	CPN4B
		Comment	Cell line derived from embryo of Cynops pyrrhogaster.
		Comment from the depositor
RCB1691
	Tpit/F1
		Comment	Pituitary folliculo-stellate-like cell line. Derived from a transgenic mouse expressing temperature sensitive SV40 large T antigen.
		Comment from the depositor
RCB1692
	Tpit/E
		Comment	Vascular endothelial cell-like cell line derived from an anterior pituitary gland of a transgenic mouse expressing temperature sensitive SV40 large T antigen. Producing endothelin.
		Comment from the depositor
RCB1695
	RMS-YM
		Comment	Embryonal rhabdomyosarcoma cell line derived from human. Transplantable in nude mouse.
		Comment from the depositor
RCB1696
	SPB-1
		Comment	Serine-palmitoyl transferase deficient (temperature-sensitive) cells derived from CHO-K1 cell line.
		Comment from the depositor
RCB1697
	SPB-1/cLCB1
		Comment	SPB-1 derivative complemented the Serine-palmitoyl transferase deficiency.
		Comment from the depositor
RCB1698
	LY-B
		Comment	Serine-palmitoyl transferase (LCB1 subunit) deficient cells derived from CHO-K1 cell line.
		Comment from the depositor
RCB1699
	LY-B/cLCB1
		Comment	LY-B derivative complemented the Serine-palmitoyl transferase (LCB1 subunit) deficiency.
		Comment from the depositor
RCB1701
	MY
		Comment	Human cell line derived from p180-BCR-ABL dependent leukemia.
		Comment from the depositor
RCB1702
	SLVL
		Comment	Human cell line derived from splenic B cell lymphoma.
		Comment from the depositor
RCB1704
	BLNK^(-)/Syk^(-) DT40
		Comment	BLNK and Syk deficient DT40 cells
		Comment from the depositor
RCB1705
	JHCA-ov
		Comment	Human cell line derived from metastasis at ovary of colon cancer. Moderately differentiated adenocarcinoma. Application consideration
		Comment from the depositor
RCB1706
	JHCOLOYI
		Comment	Human cell line derived from rectal cancer. Application consideration
		Comment from the depositor
RCB1708
	JHTSK-col-L
		Comment	Human B cell-like cell line derived from colon cancer tissue.
		Comment from the depositor
RCB1709
	GE1
		Comment	Mouse-derived gingival epithelial cell line. Derived from SV40-Large T antigen transgenic mouse. Application consideration
		Comment from the depositor
RCB1716
	BCAP^(-) DT40
		Comment	BCAP deficient DT40 cells
		Comment from the depositor
RCB1717
	IP3R type1^(-)/2^(-) DT40
		Comment	IP3R type1 and IP3R type2 deficient DT40 cells
		Comment from the depositor
RCB1718
	IP3R type1^(-)/3^(-) DT40
		Comment	IP3R type1 and IP3R type3 deficient DT40 cells
		Comment from the depositor
RCB1719
	IP3R type2^(-)/3^(-) DT40
		Comment	IP3R type2and IP3R type3 deficient DT40
		Comment from the depositor
RCB1721
	JHUCS-3
		Comment	Human cell line derived from uterine cervix cancer. Application consideration
		Comment from the depositor
RCB1723
	JHOC-8
		Comment	Human cell line derived from ovarian clear cell adenocarcinoma. Application consideration
		Comment from the depositor
RCB1724
	JHSK-rec
		Comment	Human cell line derived from rectal cancer. Application consideration
		Comment from the depositor
RCB1728
	Hpr-4
		Comment	H2O2 resistant Chinese Hamster V79 cells
		Comment from the depositor
RCB1731
	TM-31
		Comment	Human cell line derived from astrocytoma developed in a patient with NF-1 (neurofibromatosis type 1)
		Comment from the depositor
RCB1734
	LAH3
		Comment	Melanophore derived cell line. Derived from Rana porosa brevipoda (albino).
		Comment from the depositor
RCB1741
	NHOS
		Comment	Mouse osteosarcoma cell line. Transplantable to mouse and form bone tissue in mouse.
		Comment from the depositor
RCB1747
	ΔNBS1-DT40
		Comment	Subline of DT40 (chicken B cell line), lacking Nbs1 expression.
		Comment from the depositor
RCB1749
	ΔDinB-DT40
		Comment	Subline of DT40 cell line, lacking DinB expression.
		Comment from the depositor
RCB1750
	ΔRad18-DT40
		Comment	Subline of DT40 cell line, lacking Rad18 expression.
		Comment from the depositor
RCB1752
	BS-SHI-4M
		Comment	Human cell line derived from Bloom syndrome patient. Transformed by EBV. Can express certain antigen on the cell surface, such as cancer-specific antigen.
		Comment from the depositor
RCB1753
	KMY-J
		Comment	Meningioma derived cell line. Derived from rat F344.
		Comment from the depositor
RCB1754
	KMY-1
		Comment	Subline of KMY-J. Fibroblast-like.
		Comment from the depositor
RCB1755
	KMY-2
		Comment	Subline of KMY-J. Epithelial-like.
		Comment from the depositor
RCB1756
	KMY-3
		Comment	Subline of KMY-J. Polyploidy.
		Comment from the depositor
RCB1757
	HS-P
		Comment	Rat cell line derived from histiocytic sarcoma. Possessing characteristics of macrophage.
		Comment from the depositor
RCB1759
	ΔDNAPKΔKu70-DT40
		Comment	Subline of DT40 cell line, lacking both of DNAPK and Ku70 expression.
		Comment from the depositor
RCB1764
	ΔRev3-DT40
		Comment	Subline of DT40 cell line, lacking Rev3 expression.
		Comment from the depositor
RCB1766
	ΔligIV-DT40
		Comment	Subline of DT40 cell line, lacking ligase IV expression.
		Comment from the depositor
RCB1767
	ΔRad52ΔXRCC3-DT40
		Comment	Subline of DT40 cell line, lacking both of Rad52 and XRCC3 expression.
		Comment from the depositor
RCB1768
	ΔXRCC3-cond1-DT40
		Comment	Subline of DT40 cell line, which lacks XRCC3 inducibly by tamoxifen.
		Comment from the depositor
RCB1769
	ΔXRCC3-cond2-DT40
		Comment	Subline of DT40 cell line, which lacks XRCC3 inducibly by tamoxifen.
		Comment from the depositor
RCB1770
	XRCC3+/--DT40
		Comment	Subline of DT40 cell line, lacking XRCC3 only in one allele.
		Comment from the depositor
RCB1771
	Lu-24
		Comment	Human cell line derived from lung cancer. Oat cell type. Application consideration
		Comment from the depositor
RCB1772
	Lu-141
		Comment	Human cell line derived from lung cancer. Small cell carcinoma. Application consideration
		Comment from the depositor
RCB1773
	Lu-143
		Comment	Human cell line derived from lung cancer. Small cell carcinoma. Application consideration
		Comment from the depositor
RCB1785
	Lu-138
		Comment	Human cell line derived from lung cancer. Small cell carcinoma. Application consideration
		Comment from the depositor
RCB1788
	AT805
		Comment	Mouse teratoma-derived cell line. Parent cell line of ATDC5.
		Comment from the depositor
RCB1790
	P19C6
		Comment	Embryonal carcinoma cell line derived from mouse C3H. Differentiate to nervous system.
		Comment from the depositor
RCB1791
	PCC3/A/1
		Comment	Mouse teratoma-derived cell line.
		Comment from the depositor
RCB1792
	SIL-6/1
		Comment	Subline of A-6. Dependent on SCF and IL-6 for proliferation. Differentiate to erythroid cells by IL-3.
		Comment from the depositor
RCB1794
	ΔRad18ΔXPA-DT40
		Comment	Subline of DT40 cell line, lacking both of Rad18 and XPA expression.
		Comment from the depositor
RCB1795
	ΔRad18ΔDinB-DT40
		Comment	Subline of DT40 cell line, lacking both of Rad18 and DinB expression.
		Comment from the depositor
RCB1797
	BP7(R80)
		Comment	Rat renal tumor derived cell line.
		Comment from the depositor
RCB1798
	BP11(R2)
		Comment	Rat (Wistar) cell line derived from renal (kidney) tumor.
		Comment from the depositor
RCB1799
	BP11(R100)
		Comment	Rat (Wistar) cell line derived from renal (kidney) tumor.
		Comment from the depositor
RCB1800
	BP13(R2)
		Comment	Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.
		Comment from the depositor
RCB1801
	BP13(R100)
		Comment	Rat cell line derived from kidney carcinoma. After passage 100. Wistar rat.
		Comment from the depositor
RCB1802
	BP26(R2)
		Comment	Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.
		Comment from the depositor
RCB1803
	BP26(R80)
		Comment	Rat cell line derived from kidney carcinoma. After passage 80. Wistar rat.
		Comment from the depositor
RCB1804
	BP30(R2)
		Comment	Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.
		Comment from the depositor
RCB1805
	BP30(R100)
		Comment	Rat cell line derived from kidney carcinoma. After passage 100. Wistar rat.
		Comment from the depositor
RCB1806
	BP36B(R2)
		Comment	Rat cells derived from kidney carcinoma. After passage 2. Wistar rat.
		Comment from the depositor
RCB1807
	BP36B(R100)
		Comment	Rat cell line derived from kidney carcinoma. After passage 100. Wistar rat.
		Comment from the depositor
RCB1809
	Vav3^(-) DT40
		Comment	Vav3 deficient DT40 cells
		Comment from the depositor
RCB1810
	PI3Kp110α^(-) DT40
		Comment	PI3Kp110α deficient DT40 cells
		Comment from the depositor
RCB1811
	ΔBLM-DT40
		Comment	Subline of DT40 cell line, lacking BLM (Bloom syndrome gene) expression.
		Comment from the depositor
RCB1812
	ΔWRN-DT40
		Comment	Subline of DT40 cell line, lacking WRN (Werner syndrome gene) expression.
		Comment from the depositor
RCB1813
	ΔWRNΔBLM-DT40
		Comment	Subline of DT40 cell line, lacking both of WRN (Werner syndrome gene) and BLM (Bloom syndrome gene) expression.
		Comment from the depositor
RCB1814
	ΔDinBΔXPA-DT40
		Comment	Subline of DT40 cell line, lacking both of DinB and XPA expression.
		Comment from the depositor
RCB1817
	DT40(v-myb^+)WT
		Comment	A subline of avian cell line, DT40, expressing v-myb exogenously.
		Comment from the depositor
RCB1818
	DT40(v-myb^+)Δpolβ
		Comment	A subline of avian cell line, DT40, expressing v-myb exogenously and lacking polβ gene.
		Comment from the depositor
RCB1819
	DT40(v-myb^+)Δpolλ
		Comment	A subline of avian cell line, DT40, expressing v-myb exogenously and lacking polλ gene.
		Comment from the depositor
RCB1820
	DT40(v-myb^+)Δpolλβ
		Comment	A subline of avian cell line, DT40, expressing v-myb exogenously and lacking both polβ and polλ gene.
		Comment from the depositor
RCB1821
	CHO-FLAG-hBLT1
		Comment	Subline of CHO-K1 that expresses human leukotriene B4 receptor (BLT1).
		Comment from the depositor
RCB1822
	CHO-HA-hBLT2
		Comment	Subline of CHO-K1 that expresses human leukotriene B4 receptor (BLT2).
		Comment from the depositor
RCB1823
	CHO·1F8
		Comment	Subline of CHO-K1 that expresses human platelet activating factor receptor.
		Comment from the depositor
RCB1824
	TRP1^(-) DT40
		Comment	TRP1 deficient DT40
		Comment from the depositor
RCB1829
	SC-1
		Comment	Embryonal cell line derived from wild mouse. Sensitive to leukemia viruses.
		Comment from the depositor
RCB1830
	Rat-1
		Comment	Rat fibroblast-like cell line that can be transformed by oncogenes.
		Comment from the depositor
RCB1831
	XC
		Comment	Cell line for titration of murine leukemia virus.
		Comment from the depositor
RCB1832
	THK
		Comment	SV40 transformed hamster cell line. Fibroblast-like cells.
		Comment from the depositor
RCB1833
	Mink
		Comment	Lung epithelial cell line derived from mink. Useful for focus forming assays for murine leukemia virus.
		Comment from the depositor
RCB1834
	S+L-Mink
		Comment	Mink (RCB1833) cells transformed by Moloney murine sarcoma virus.
		Comment from the depositor
RCB1835
	Sirc
		Comment	Fibroblast-like cell line derived from rabbit.
		Comment from the depositor
RCB1836
	Grb2^(-)/Grap^(-) DT40
		Comment	Grb2and Grap deficient DT40 cells
		Comment from the depositor
RCB1837
	MVP1
		Comment	Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.
		Comment from the depositor
RCB1838
	MVP25
		Comment	Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.
		Comment from the depositor
RCB1839
	MVP47
		Comment	Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.
		Comment from the depositor
RCB1840
	MVP49
		Comment	Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.
		Comment from the depositor
RCB1841
	MVP51
		Comment	Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.
		Comment from the depositor
RCB1845
	ΔUbc9+cUbc9-DT40
		Comment	Endogenous Ubc9 deficient DT40 cells but expressing Ubc9 exogenously
		Comment from the depositor
RCB1846
	HSC-F
		Comment	CITES. T cell line derived from Cynomolgus Monkey (Macaca fascicularis). Monkey cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
		Comment from the depositor
RCB1847
	ES-8040 20-2
		Comment	Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.
		Comment from the depositor
RCB1848
	ES-8047 2-1
		Comment	Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.
		Comment from the depositor
RCB1849
	C-8049
		Comment	Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.
		Comment from the depositor
RCB1850
	C-8052
		Comment	Erythroleukemia cell line derived from mouse C3H/He. TER119(+) cells.
		Comment from the depositor
RCB1851
	DT40 Cre1
		Comment	A subline of avian cell line, DT40, expressing v-myb/pMerCreMer exogenously (see reference : BMC Biotechnol. 2001;1:7).
		Comment from the depositor
RCB1853
	MSH6-1-[ClX3.16]DT40
		Comment	A subline of avian cell line, DT40, lacking MSH6 (see reference : BMC Biotechnol. 2001;1:7).
		Comment from the depositor
RCB1854
	HSP-239
		Comment	CITES. T cell line derived from Chimpanzee (Pan troglodytes). Chimpanzee cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
		Comment from the depositor
RCB1855
	HSP-250
		Comment	CITES. T cell line derived from Chimpanzee (Pan troglodytes). Chimpanzee cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
		Comment from the depositor
RCB1856
	TX-7F (hybridoma)
		Comment	Hybridoma producing a monoclonal antibody against tetrodotoxin.
		Comment from the depositor
RCB1857
	DA-3 (hybridoma)
		Comment	Hybridoma producing a monoclonal antibody against domoic acid.
		Comment from the depositor
RCB1858
	GT-13A (hybridoma)
		Comment	Hybridoma producing a monoclonal antibody against gonyautoxin.
		Comment from the depositor
RCB1859
	MDBK-NST
		Comment	A cell line derived from kidney of bovine. FBS independent for culture. A cell line derived from kidney of bovine. Information about BVDV (ATCC) . Information about BVDV (ECACC) . Information about BVDV (DSMZ) .
		Comment from the depositor
RCB1860
	BLNK^(-)Grb2^(-)DT40
		Comment	BLNK and Grb2 deficient DT40 cells
		Comment from the depositor
RCB1861
	T-23
		Comment	CITES. Lung fibroblastic cell line derived from Tupaia belangeri. Tupaia cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
		Comment from the depositor
RCB1862
	NIH3T3-3-4
		Comment	Subclone of NIH3T3. Application consideration
		Comment from the depositor
RCB1863
	GRP1^(-)DT40
		Comment	Ras GRP1 deficient DT40 cells
		Comment from the depositor
RCB1864
	GRP3^(-)DT40
		Comment	Subline of DT40 cell line, lacking RasGRP3 expression.
		Comment from the depositor
RCB1865
	GRP1^(-)/GRP3^(-)DT40
		Comment	Subline of DT40 cell line, lacking both of RasGRP1 and RasGRP3 expression.
		Comment from the depositor
RCB1866
	Sos1^(-)DT40
		Comment	Subline of DT40 cell line, lacking Sos1 expression.
		Comment from the depositor
RCB1867
	Sos2^(-)DT40
		Comment	Subline of DT40 cell line, lacking Sos2 expression.
		Comment from the depositor
RCB1868
	Sos1^(-)/Sos2^(-)DT40
		Comment	Subline of DT40 cell line, lacking both Sos1 and Sos2 expression.
		Comment from the depositor
RCB1869
	LY-A
		Comment	Subline of CHO-K1 cell line in which trafficking of ceramide is deficient
		Comment from the depositor
RCB1870
	LY-A/hCERT
		Comment	Subline of LY-A in which human CERT cDNA are expressed and trafficking of ceramide is recovered
		Comment from the depositor
RCB1871
	TL-1
		Comment	Human lymphoid cell line derived from Burkitt's lymphoma. Tumorigenic in nude mouse. TKG0607 (Deposited from Tohoku Univ.). Application consideration
		Comment from the depositor
RCB1872
	A431
		Comment	Human cell line derived from epidermoid carcinoma. TKG0182 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1873
	JTK-LCL
		Comment	Human B cell line transformed by Epstein-Barr Virus. HLA: A0206 and A2402. TKG0585 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1874
	KOIA-LCL
		Comment	EBV-transformed cell line from a patient (male) with p53 germ line mutation. Mutation was noted at codon 242 (TGC→TAC) by FASAY. TKG0506 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1875
	XPL 5
		Comment	Lymphoblastoid cell line established by EBV infection from XP patient, variant type. TKG0309 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1876
	211-LCL-MUC1
		Comment	Human B lymphoblastoid cell line (RCB2288 211-LCL) transformed with APR-MUC1 and PRC-MUC1 cDNAs. TKG0615 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1878
	RPMI1788
		Comment	IgM (lambda) secreting B cell line. Established from peripheral blood lymphocytes of apparently normal 33-y-o male. HLA profile: A2, Aw33, B7, B14. TKG0464 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1879
	PEER
		Comment	Human T cell line derived from acute T cell leukemia. TKG0377 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1881
	TL-Mor
		Comment	Human derived T cell line. HTLV-1 pro-virus DNA(+). TKG0369 (Deposited from Tohoku Univ.). Based on the information by depositor; (1) this cell line possesses HTLV-1 pro-virus DNA, (2) the HTLV-1 proteins (p19, p24, p53, gp46) cannot be detected with western blotting.
		Comment from the depositor
RCB1882
	BALL-1
		Comment	Human cell line derived from B cell leukemia. TKG0467 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1884
	H-111-TC
		Comment	Human cell line derived from gastric cancer. TKG0411 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1886
	Hep G2
		Comment	Human cell line derived from hepatoblastoma. Secretes several products such as albumin, alpha2-macroglobulin, alpha 1-antitrypsin, transferrin and plasminogen. TKG0205 (Deposited from Tohoku Univ.). Information
		Comment from the depositor
RCB1889
	HEp-2
		Comment	Supports growth of arvovirus and measles virus. A subline of HeLa cell (HeLa contamination). TKG0403 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1890
	MG-63
		Comment	Osteosarcoma cell line derived from human. High yield of IFN production by induction with poly IC, cyclohexmide, actinomycin D. Antigenically, MG-63 IFN is closely related to human fibroblast IFN. TKG0294 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1891
	HeLa TG
		Comment	A subline of HeLa. 6-thioguanine resistant. TKG0204 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1892
	SKG-IIIa
		Comment	Cervical carcinoma cell line derived from human. TA-4, CA-4, TPA, placental ALP are positive. Regan isoenzyme producing. p53 normal, p51 mutation (+), HLA-A 2402/. TKG0462 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1894
	TE-1
		Comment	Human cell line derived from esophageal cancer. Squamous cell carcinoma. TKG0252 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1896
	TN-2
		Comment	Human cell line derived from neuroblastoma of adrenal gland. TKG0278 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1897
	K562
		Comment	Human cell line derived from chronic myelogenous leukemia. IMPORTANT NOTICE: Can NOT produce hemoglobin in the presence of NaB. Of note, K562 (RCB0027) and K-562 (RCB1635) can produce hemoglobin in the presence of NaB. TKG0210 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1898
	K562/Adr
		Comment	Subline of K562. Resistant to adriamycin. TKG0211 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1900
	Lu99
		Comment	Lung giant cell carcinoma cell line derived from human. TKG0495 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1901
	PK-59
		Comment	Human cell line derived from pancreatic cancer. TKG0492 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1902
	HSC-4
		Comment	Human tongue squamous cell carcinoma derived cell line. TKG0489 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1903
	OVK18
		Comment	Human cell line derived from ovarial cancer, subclone of RCB2535. TKG0323 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1904
	MCF7
		Comment	Human cell line derived from breast adenocarcinoma. TKG0479 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1905
	Sq-1
		Comment	Human cell line derived from lung squamous cell carcinoma. Many granules are found in cytoplasma. HLA-A 11/24. TKG0301 (Deposited from Tohoku Univ.). Application consideration
		Comment from the depositor
RCB1907
	TKKK
		Comment	Human cell line derived from intrahepatic bile duct cancer. TKG0456 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1909
	8305C
		Comment	Human thyroid anaplastic carcinoma derived cell line. TKG0446 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1911
	CCD-IC
		Comment	Rabbit kidney cell line transformed by SV40 large T antigen. Derived from renal cortical collecting tubules.
		Comment from the depositor
RCB1912
	CNT
		Comment	Rabbit kidney cell line transformed by SV40 large T antigen. Derived from renal distal tubules.
		Comment from the depositor
RCB1913
	PST-S2
		Comment	Rabbit kidney cell line transformed by SV40 large T antigen. Derived from renal proximal tubules.
		Comment from the depositor
RCB1914
	BBWV-22K3-9B
		Comment	Hybridoma producing a monoclonal antibody against Broad bean wilt virus 2 22-kDa coat protein.
		Comment from the depositor
RCB1915
	BBWV-22K5-12A
		Comment	Hybridoma producing a monoclonal antibody against Broad bean wilt virus 2 22-kDa coat protein.
		Comment from the depositor
RCB1916
	BBWV-22K6-2A
		Comment	Hybridoma producing a monoclonal antibody against Broad bean wilt virus 2 22-kDa coat protein.
		Comment from the depositor
RCB1918
	J#176-3.2
		Comment	Hybridoma producing a monoclonal antibody against mouse JDP2.
		Comment from the depositor
RCB1919
	J#214.2-2
		Comment	Hybridoma producing a monoclonal antibody against mouse JDP2. The antibody recognizes a truncated from of JDP2.
		Comment from the depositor
RCB1920
	J#249.1-1
		Comment	Hybridoma producing a monoclonal antibody against mouse JDP2.
		Comment from the depositor
RCB1921
	NRG
		Comment	Mouse bone marrow derived fibroblast-like cells line. Differentiates to neuron.
		Comment from the depositor
RCB1922
	1C7
		Comment	Hybridoma producing antibody against the purified basal apparatus of sperm of the an-1 strain of fern Lygodium.
		Comment from the depositor
RCB1923
	13D10
		Comment	Hybridoma producing antibody against the purified basal apparatus of sperm of the an-1 strain of fern Lygodium.
		Comment from the depositor
RCB1924
	h1c
		Comment	Hybridoma producing antibody against the purified basal apparatus of sperm of the an-1 strain of fern Lygodium.
		Comment from the depositor
RCB1925
	WA-mFib
		Comment	Mouse stromal cell line for human lung small cell carcinoma cell line, WA-ht.
		Comment from the depositor
RCB1926
	OT11
		Comment	RBP-J deficient mouse fibroblasts
		Comment from the depositor
RCB1927
	OT13
		Comment	Control cell line for OT11 (normal fibroblasts derived from the same mouse strain)
		Comment from the depositor
RCB1928
	KG-1a
		Comment	Human cell line derived from acute myelogenous leukemia. The variant subline of KG-1(RCB1166) cell line. TKG0402 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1932
	T2
		Comment	Human hybrid (T and B lymphoblast) cell line. Fusion cll line between 174 and CEM.T2. This hybrid cells do not express MHC class II. HLA-A2 positive. TKG0599 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1933
	NALM-6
		Comment	Human cell line derived from B cell leukemia. TKG0413 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1934
	HUT78
		Comment	Human cell line derived from T cell of a patient with Sezary syndrome. Producing IL-2. TKG0375 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1935
	HPB-ALL
		Comment	Human cell line derived from T cell leukemia. TKG0199 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1936
	MOLT-4F
		Comment	Human T leukemic cell line (CD4+). CR2 receptor (+). TKG0229 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1938
	P30/OHK
		Comment	Human cell line derived from T cell leukemia. TKG0463 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1939
	NUGC-4
		Comment	Human cell line derived from signet ring cell carcinoma of stomach. TKG0449 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1940
	SH-10-TC
		Comment	Human cell line derived from gastric cancer. Derived from nude mouse xenograft tumor (TKG 0338, SH-10). TKG0412 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1941
	Li-7
		Comment	Human hepatoma cell line. This cell line was established from nude mouse xenograft tumor (Dr. Hirohashi., National Cancer Center, Tokyo) by Tanno, H. (Tohoku Univ., 1st Surg). AFP producing. TKG0368 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1943
	HuH-28
		Comment	Human cell line derived from cholangiocellular carcinoma. TKG0438 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1945
	HSC-2
		Comment	Human cell line derived from oral squamous cell carcinoma occurred in 69-yo, male patient. HLA-A 24/. TKG0487 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1947
	Ca Ski
		Comment	Human cell line derived from uterine cervical epidermoid carcinoma. TKG0366 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1949
	TE-5
		Comment	Human cell line derived from poorly differntiated esophageal squamous cell carcinoma. Not transplantable to nude mouse. TKG0256 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1950
	TE-6
		Comment	Highly differentiated squamous carcinoma (esophagus), not transplantable to nude mouse. Progeny were cured by Treatments with BM Cycline and MC210. TKG0257 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1951
	TE-15
		Comment	Human cell line derived from esophageal cancer (highly differentiated squamous cell carcinoma). Not transplantable to nude mouse. TKG0266 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1952
	SCCH-26
		Comment	Human neuroblastoma cell line. TKG0460 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1953
	NB-1
		Comment	Human cell line derived from neuroblastoma. Dibuty-cAMP (1 mM) induces differentiation. TKG0486 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1954
	T98G
		Comment	Human cell line derived from glioblastoma multiforme (Caucasian). Hyperpentaploid chromosome count. TKG0471 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1955
	KMST-6
		Comment	Human cell line derived from embryonic fibroblasts. Characteristics Embryonal fibroblast immortalized by 60-Co irradiation (400 Rad x 1 time and 200 rad x 12 times). Non-tumorigenic. TKG0482 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1960
	HuCCT1
		Comment	Human bile duct carcinoma. This cell line produces carbohydrate antigen 19/9 in serum-free medium. TKG0389 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1963
	VMRC-RCW
		Comment	Human renal cell carcinoma cell line. TKG0447 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1965
	EBC-1
		Comment	Human lung squamous cell carcinoma cell line. TKG0481 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1966
	S1
		Comment	Human cell line derived from lung cancer. Small cell carcinoma. TKG0244 (Deposited from Tohoku Univ.). Application consideration
		Comment from the depositor
RCB1967
	LU65
		Comment	Human lung carcinoma cell line. TKG0442 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1970
	LK-2
		Comment	Human lung squamous cell carcinoma cell line. TKG0494 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1971
	Lu99B
		Comment	Human lung giant cell carcinoma cell line. TKG0496 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1972
	PK-1
		Comment	Human pancreatic carcinoma cell line. RCB2138 was derived from the same patient. TKG0239 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1973
	PK-45H
		Comment	Human pancreatic carcinoma cell line, the same patient as RCB2141. TKG0491 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1974
	SAS
		Comment	Human cell line derived from tongue cancer. Squamous cell carcinoma. TKG0470 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1975
	HSC-3
		Comment	Human tongue squamous cell carcinoma cell line. HLA-A 2/24. TKG0484 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1976
	Ca9-22
		Comment	Human gingival carcinoma cell line. Expressing remarkable EGF receptor. HLA-A 2/24. TKG0485 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1980
	CCRF-CEM
		Comment	Human cell line derived from T cell leukemia. TKG0563 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1981
	HD-Mar2
		Comment	A cell line derived from the pleural effusion of a patient with a recurrent T-lymphoblastic lymphoma after treatment of the originally diagnosed Hodgkin's lymphoma. The characteristics is T cell lymphoma. TKG0198 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1988
	TE-9
		Comment	Human esophageal squamous cell carcinoma (poorly differentiated) cell line. Not transplantable to nude mouse. TKG0260 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB1990
	KUSA-H1
		Comment	Mouse bone marrow-derived stromal cells.
		Comment from the depositor
RCB1991
	KUSA-O
		Comment	Mouse multipotent mesenchymal cells. Derived from bone marrow.
		Comment from the depositor
RCB1992
	UV♂1d
		Comment	Mouse cell line derived from UV-induced fibroblast sarcome.
		Comment from the depositor
RCB1993
	UV♀1A
		Comment	Mouse cell line derived from UV-induced fibroblast sarcome.
		Comment from the depositor
RCB1994
	UV♀2
		Comment	Mouse cell line derived from UV-induced angioendothelioma-like tumor.
		Comment from the depositor
RCB1995
	UV·BAL-1.1
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB1996
	UV·BAL-2.1D
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB1997
	UV·B6-1.1
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB1998
	UV·B6-2.1A
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB1999
	UV·B6-4.1
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2000
	UV·B6-5.1
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2013
	GMR3
		Comment	Hybridoma producing a monoclonal antibody against N-glycolylneuraminic acid-containing gangliosides (GD3 gangliosides).
		Comment from the depositor
RCB2014
	GMB7
		Comment	Hybridoma producing a monoclonal antibody against GD2 gangliosides (b-pathway gangliosides).
		Comment from the depositor
RCB2015
	GMR8
		Comment	Hybridoma producing a monoclonal antibody against N-glycolylneuraminic acid-containing gangliosides (GM3 gangliosides).
		Comment from the depositor
RCB2016
	AMR19
		Comment	Hybridoma producing a monoclonal antibody against ganglioside lactones.
		Comment from the depositor
RCB2021
	GGR41
		Comment	Hybridoma producing a monoclonal antibody against GQ1ba gangliosides.
		Comment from the depositor
RCB2024
	UV·BAL-3.3
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2025
	UV·BAL-5.4G
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2026
	UV·BAL-6.1E
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2027
	UV·BAL-7.1
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2028
	UV·BAL-8.1
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2029
	UV·BAL-8.1C
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2030
	UV·BAL-12.1
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2031
	UV·BAL-13.1
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2032
	UV·BAL-14.2
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2033
	UV·BAL-15.1
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2034
	UV·BAL-16.1
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2035
	UV·BAL-17.1
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2036
	UV·BAL-18.1
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2037
	NGR54
		Comment	Hybridoma producing a monoclonal antibody against 2-3NeuAca-nLc4Cer gangliosides.
		Comment from the depositor
RCB2039
	NMR52
		Comment	Hybridoma producing a monoclonal antibody against nLc4Cer.
		Comment from the depositor
RCB2040
	NGR50
		Comment	Hybridoma producing a monoclonal antibody against SGPG.
		Comment from the depositor
RCB2041
	AMR20
		Comment	Hybridoma producing a monoclonal antibody against GalCer.
		Comment from the depositor
RCB2042
	AGB43
		Comment	Hybridoma producing a monoclonal antibody against Sulfatide.
		Comment from the depositor
RCB2046
	BMR26
		Comment	Hybridoma producing a monoclonal antibody against Globoside.
		Comment from the depositor
RCB2048
	OMB4
		Comment	Hybridoma producing a monoclonal antibody against N-linked neutral oligosaccharides of glycoproteins.
		Comment from the depositor
RCB2049
	OMR5
		Comment	Hybridoma producing a monoclonal antibody against F1-linked neutral oligosaccharides of glycoproteins.
		Comment from the depositor
RCB2050
	OMR6
		Comment	Hybridoma producing a monoclonal antibody against M1-linked neutral oligosaccharides of glycoproteins.
		Comment from the depositor
RCB2053
	UV·C3H-3.3
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2056
	UV·C3H-8.2
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2057
	UV·BAL-19.1A
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2058
	UV·BAL-20.1
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2059
	UV·BAL-21.1
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2060
	UV·BAL-23.1
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2061
	UV·C3B6-1.1
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2062
	UV·C3B6-1.1C
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2065
	UV·CB6-2.1F
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2066
	UV·CB6-3.4B
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2067
	UV·CB6-4.1D
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2068
	UV·CB6-4.1F
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2070
	UV·CB6-5.2
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2071
	UV·CB6-5.2B
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2072
	UV·CB6-6.1
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2073
	UV·CB6-6.1B
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2074
	UV·CC3-11.1
		Comment	Mouse cell line derived from UV-induced skin tumor.
		Comment from the depositor
RCB2076
	Has
		Comment	Chinese hamster cell line. Epithelial-like adherent cells.
		Comment from the depositor
RCB2078
	FU-RPNT-2
		Comment	Human primitive neuroectodermal tumor cell line derived from kidney.
		Comment from the depositor
RCB2079
	UCB-TERT-21
		Comment	Human mesenchymal cell line derived from umbilical cord blood. Immortalized by hTERT.
		Comment from the depositor
RCB2080
	UCB408E6E7TERT-33
		Comment	Human mesenchymal cell line derived from umbilical cord blood. Immortalized by HPV E6, E7, and hTERT.
		Comment from the depositor
RCB2081
	KUSA-A1
		Comment	Mesenchymal stem cell line derived from C3H/He mouse strain.
		Comment from the depositor
RCB2082
	103-LCL
		Comment	Human B cell line transformed by Epstein-Barr Virus. TKG0614 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2083
	141-LCL
		Comment	Human B cells transformed by Epstein-Barr virus. RCB2541 was derived from the same patient. TKG0611 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2084
	TALL-1
		Comment	Human T-cell line derived from acute lynphblastic leukemia. TKG0251 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2088
	Kato III
		Comment	Human cell line derived from gastric cancer. Signet ring carcinoma. TKG0213 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2092
	87-5
		Comment	Human cell line derived from lung cancer. Small cell carcinoma. TKG0503 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2093
	II-18
		Comment	Human cell line derived from lung cancer. Adenocarcinoma. TKG0177 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2094
	MIA Paca2
		Comment	Human cell line derived from pancreatic cancer. TKG0227 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2095
	PANC-1
		Comment	Human cell line derived from pancreatic cancer. Ductal origin. TKG0606 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2097
	TE-4
		Comment	Human cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma. TKG0255 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2098
	TE-8
		Comment	Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0259 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2099
	TE-10
		Comment	Human cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma. TKG0261 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2100
	TE-11
		Comment	Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0262 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2101
	TE-14
		Comment	Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0265 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2102
	HO-1-u-1
		Comment	Human cell line derived from squamous cell carcinoma at mouth floor. TKG0455 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2103
	8505C
		Comment	Human cell line derived from thyroid cancer. Poorly differentiated papillary adenocarcinoma. TKG0439 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2104
	HuO-3N1
		Comment	Human cell line derived from osteosarcoma. TKG0452 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2105
	D98-AH2
		Comment	Human cell line derived from cervical cancer. The cells were converted to HGPRT(-). A subline of HeLa cell. TKG0191 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2106
	ME-180
		Comment	Human cell line derived from cervical cancer. TKG0437 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2107
	TN-1
		Comment	Human cell line derived from neuroblastoma formed at adrenal gland. TKG0277 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2108
	NH-12
		Comment	Human cell line derived from neuroblastoma. TKG0448 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2109
	NH-6
		Comment	Human cell line derived from neroblastoma of adrenal gland. TKG0468 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2110
	YKG1
		Comment	Human cell line derived from glioblastoma. TKG0453 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2111
	K562/Vin
		Comment	Subline of K562 cell line. Resistant to vincristine. TKG0212 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2112
	KUM4
		Comment	Mouse mesenchymal cell line derived from bone marrow.　C3H/He
		Comment from the depositor
RCB2113
	KUM6
		Comment	Mouse mesenchymal cell line derived from bone marrow.　C3H/He
		Comment from the depositor
RCB2114
	KUM7
		Comment	Mouse mesenchymal cell line derived from bone marrow.　C3H/He
		Comment from the depositor
RCB2115
	KUM9
		Comment	Mouse mesenchymal cell line derived from bone marrow.　C3H/He
		Comment from the depositor
RCB2116
	TSt-4
		Comment	Murine mesenchymal cell line derived from fetal thymus tissue. Can support the generation of myeloid cells and B cells from muirne hematopietic stem/progenitors.
		Comment from the depositor
RCB2117
	TSt-4/G
		Comment	Murine mesenchymal cell line derived from fetal thymus tissue. Can support the generation of myeloid cells and B cells from muirne hematopietic stem/progenitors. Established originally as a cotrol cells for TSt-4/G-DLL1. By retorviral transduction, EGFP is expressed.
		Comment from the depositor
RCB2118
	TSt-4/G-DLL1
		Comment	Original murine mesenchymal cell line was derived from fetal thymus tissue. DLL1 gene was retrovirally introduced. Can support the generation of T cells (up to DP stage) from muirne hematopietic stem/progenitors. EGFP was also introduced, and is expressed as a marker.
		Comment from the depositor
RCB2119
	TSt-4/N
		Comment	Original murine mesenchymal cell line was derived from fetal thymus tissue. Can support the generation of myeloid cells and B cells from muirne hematopietic stem/progenitors. Established originally as a cotrol cells for TSt-4/N-DLL1. By retorviral transduction, huma NGF receptor is expressed.
		Comment from the depositor
RCB2120
	TSt-4/N-DLL1
		Comment	Original murine mesenchymal cell line was derived from fetal thymus tissue. By retrovirally introducing DLL1 gene, this cell line can support the generation of T cells (up to DP stage) from muirne hematopietic stem/progenitors. Human NGF receptor is also introduced, and is expressed as a marker on cell surface.
		Comment from the depositor
RCB2125
	BmN4-DR
		Comment	Silkworm (Bombyx mori) cell line derived from ovary. Useful for the identification and analysis of homologous recombination-related genes in the silkworm. Application consideration
		Comment from the depositor
RCB2126
	BmN4-IR
		Comment	Silkworm (Bombyx mori) cell line derived from ovary. Useful for the identification and analysis of homologous recombination-related genes in the silkworm. Application consideration
		Comment from the depositor
RCB2127
	COLO205
		Comment	Human cell line derived from colon cancer. Derived from ascites metastasis. TKG0457 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2133
	S2
		Comment	Human cell line derived from lung cancer. Small cell carcinoma. TKG0245 (Deposited from Tohoku Univ.).Application consideration
		Comment from the depositor
RCB2134
	86-2
		Comment	Human cell line derived from lung cancer. Large cell carcinoma. TKG0181 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2135
	NIH:OVCAR-3
		Comment	Human cell line derived from adenocarcinoma of ovary. TKG0602 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2136
	YST-1
		Comment	Human cell line derived from schwannoma. TKG0454 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2138
	KLM-1
		Comment	Human cell line derived from pancreatic cancer. RCB1972 was derived from the same patient. TKG0490 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2141
	PK-45P
		Comment	Human cell line derived from pancreatic carcinoma. RCB1973 was derived from the same patient. TKG0493 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2143
	DU145
		Comment	Human cell line derived from brain metastasis of prostate carcinoma. TKG0604 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2144
	LNCap.FGC
		Comment	Human cell line derived from prostate adenocarcinoma. Derived from lymph node metastasis. TKG0603 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2145
	PC-3
		Comment	Human cell line derived from bone metastasis of prostatic cancer. TKG0600 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2146
	WERI-Rb-1
		Comment	Human cell line derived from retinoblastoma. TKG0601 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2147
	KUM3
		Comment	Mouse mesenchymal cell line derived from bone marrow.　C3H/He
		Comment from the depositor
RCB2148
	KOP
		Comment	Mouse fibroblast-like cell line lacking p38 MAP kinase expression.
		Comment from the depositor
RCB2149
	RKOP
		Comment	Subline of KOP cell line, expressing FLAG-tagged p38 MAP kinase. Zeocin-resistant.
		Comment from the depositor
RCB2150
	EKOP
		Comment	Subline of KOP cell line, expressing FLAG-tagged EXIP. Zeocin-resistant.
		Comment from the depositor
RCB2151
	ZKOP
		Comment	Subline of KOP cell line. Zeocin-resistant.
		Comment from the depositor
RCB2153
	UE6E7T-2
		Comment	Human mesenchymal cell line derived from bone marrow. Immortalized by HPV E6, E7, and hTERT. RCB2152- RCB2163 are derived from the same bone marrow.
		Comment from the depositor
RCB2154
	UE6E7T-3
		Comment	Human mesenchymal cell line derived from bone marrow. Immortalized by HPV E6, E7, and hTERT.　RCB2152- RCB2163 are derived from the same bone marrow.
		Comment from the depositor
RCB2156
	UBE6T-6
		Comment	Human mesenchymal cell line derived from bone marrow. Immortalized by bmi-1, HPV E6, and hTERT.　RCB2152- RCB2163 are derived from the same bone marrow.
		Comment from the depositor
RCB2157
	UBE6T-7
		Comment	Human mesenchymal cell line derived from bone marrow. Immortalized by bmi-1, HPV E6, and hTERT. RCB2152- RCB2163 are derived from the same bone marrow.
		Comment from the depositor
RCB2158
	UE7T-9
		Comment	Human mesenchymal cell line derived from bone marrow. Immortalized by HPV E7 and hTERT. RCB2152- RCB2163 are derived from the same bone marrow.
		Comment from the depositor
RCB2159
	UE6E7T-11
		Comment	Human mesenchymal cell line derived from bone marrow. Immortalized by HPV E6, E7, and hTERT. RCB2152- RCB2163 are derived from the same bone marrow.
		Comment from the depositor
RCB2160
	UE6E7T-12
		Comment	Human mesenchymal cell line derived from bone marrow. Immortalized by HPV E6, E7, and hTERT. RCB2152- RCB2163 are derived from the same bone marrow.
		Comment from the depositor
RCB2161
	UE7T-13
		Comment	Human mesenchymal cell line derived from bone marrow. Immortalized by HPV E7 and hTERT. RCB2152- RCB2163 are derived from the same bone marrow.
		Comment from the depositor
RCB2162
	UBE6T-15
		Comment	Human mesenchymal cell line derived from bone marrow. Immortalized by bmi-1, HPV E6, and hTERT. RCB2152- RCB2163 are derived from the same bone marrow.
		Comment from the depositor
RCB2163
	UE6E7-16
		Comment	Human mesenchymal cell line derived from bone marrow. Immortalized by HPV E6 and E7. RCB2152- RCB2163 are derived from the same bone marrow.
		Comment from the depositor
RCB2202
	293T
		Comment	A subline of 293. Expressing SV40 large T antigen.
		Comment from the depositor
RCB2203
	TFS-2
		Comment	Hybridoma producing monoclonal antibody against a surface antigen of small cell carcinoma of lung.
		Comment from the depositor
RCB2204
	TFS-4
		Comment	Hybridoma producing monoclonal antibody against a surface antigen of small cell carcinoma of lung.
		Comment from the depositor
RCB2205
	NCC-RbC-39
		Comment	Human retinoblastoma cell line.
		Comment from the depositor
RCB2206
	NCC-RbC-51
		Comment	Human retinoblastoma cell line derived from cervical lymph node metastasis.
		Comment from the depositor
RCB2208
	NCC-RbC-54
		Comment	Human cell line derived from retinoblastoma.
		Comment from the depositor
RCB2212
	NCC-RbC-59
		Comment	Human cell line derived from retinoblastoma.
		Comment from the depositor
RCB2213
	NCC-RbC-60
		Comment	Human cell line derived from retinoblastoma.
		Comment from the depositor
RCB2217
	NCC-RbC-83
		Comment	Human cell line derived from retinoblastoma.
		Comment from the depositor
RCB2218
	NCC-RbC-92
		Comment	Human cell line derived from retinoblastoma.
		Comment from the depositor
RCB2219
	NCC-RbC-T1
		Comment	Human cell line derived from retinoblastoma.
		Comment from the depositor
RCB2223
	NCC-OvC-K119
		Comment	Human cell line derived from ovarian cancer.
		Comment from the depositor
RCB2224
	NCC-StC-K140
		Comment	Human cell line derived from stomach cancer.
		Comment from the depositor
RCB2225
	JHUEM-14
		Comment	Human cell line derived from uterine endometrioid adenocarcinoma. Application consideration
		Comment from the depositor
RCB2226
	JHOC-9
		Comment	Human cell line derived from ovarian clear cell carcinoma. Application consideration
		Comment from the depositor
RCB2227
	JMSU1
		Comment	Human cell line derived from urinary bladder carcinoma. Derived from ascites.
		Comment from the depositor
RCB2229
	HS-Os-1
		Comment	Human cell line derived from osteosarcoma.
		Comment from the depositor
RCB2230
	HS-Sch-2
		Comment	Human cell line derived from malignant peripheral nerve sheath tumor (MPNST).
		Comment from the depositor
RCB2231
	HS-SY-II
		Comment	Human cell line derived from synovial sarcoma. Application consideration
		Comment from the depositor
RCB2233
	HE12
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized. Application consideration
		Comment from the depositor
RCB2234
	HE13
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2237
	HE16
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2238
	HE18
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2239
	HE19
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2240
	HE21
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2241
	HE22
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2244
	HE27
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2245
	HE28
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2246
	HE29
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2247
	HE30
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2248
	HE31
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2249
	HE32
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2250
	HE33
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2251
	HE34
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2253
	HKb20
		Comment	A subline of 293. Expressing BtR175b (Cry 1Aa receptor).
		Comment from the depositor
RCB2254
	HE36
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2256
	HE37
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2257
	HE38
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2258
	HE39
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2259
	HE40
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2260
	HE41
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2261
	HE42
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2262
	HE46
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2263
	HE47
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2264
	HE48
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2265
	HE49
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2266
	HE50
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2267
	HE51
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2268
	HE52
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2269
	HE53
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2270
	HE54
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2271
	HE55
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2273
	HE57
		Comment	Human fibroblast-like cells derived from embryo. Not immortalized.
		Comment from the depositor
RCB2277
	GSS
		Comment	Human gastric cancer cell line derived from metastasis at liver.
		Comment from the depositor
RCB2278
	GSU
		Comment	Human cell line derived from gastric cancer. Established from the cells in ascites.
		Comment from the depositor
RCB2279
	WA-hT
		Comment	Human cell line derived from lung cancer. Small cell carcinoma. Mouse WA-mFib cells are the stromal cells for this cell line.
		Comment from the depositor
RCB2280
	HCE-T
		Comment	SV40-Adeno vector transformed cornea cells. 64kD keratin producing. Choleratoxin-free medium. To the users who purchased this cell line for OECD Test Guideline No. 494 (PDF 91KB)
		Comment from the depositor
RCB2281
	T3M-12
		Comment	Human lung small cell carcinoma cell line. ADH producing.
		Comment from the depositor
RCB2282
	701-LCL
		Comment	Human cell line derived from B cells of healthy volunteer. Transformed by EB virus. TKG0610 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2283
	277-LCL
		Comment	Human B cells transformed by Epstein-Barr virus. TKG0609 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2286
	XPL 17
		Comment	Human B cells derived from a patient of xeroderma pigmentosum. Transformed by Epstein-Barr virus. TKG0311 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2287
	XPL 20
		Comment	Human B cells derived from a patient of xeroderma pigmentosum. Transformed by Epstein-Barr virus. TKG0313 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2288
	211-LCL
		Comment	Human cell line derived from B cells of healthy volunteer. Transformed by EB virus. TKG0616 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2292
	ACC-MESO-1
		Comment	Human malignant pleural mesothelioma cell line.
		Comment from the depositor
RCB2293
	ACC-MESO-4
		Comment	Human malignant pleural mesothelioma cell line.
		Comment from the depositor
RCB2295
	KUM10
		Comment	Mouse mesenchymal cell line derived from bone marrow.　C57/B6.
		Comment from the depositor
RCB2296
	CARMA1^(-)DT40
		Comment	Subline of DT40 cell line, lacking CARMA1 expression.
		Comment from the depositor
RCB2297
	PKCβ^(-)DT40
		Comment	Subline of DT40 cell line, lacking PKC-β expression.
		Comment from the depositor
RCB2298
	TAK1^(-)DT40
		Comment	Subline of DT40 cell line, lacking TAK1 expression.
		Comment from the depositor
RCB2299
	RMC-1
		Comment	Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
		Comment from the depositor
RCB2300
	RMC-2
		Comment	Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
		Comment from the depositor
RCB2301
	RMC-3
		Comment	Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
		Comment from the depositor
RCB2302
	RMC-6
		Comment	Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
		Comment from the depositor
RCB2303
	RMC-11
		Comment	Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
		Comment from the depositor
RCB2304
	RMC-17
		Comment	Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
		Comment from the depositor
RCB2305
	MIH5(GIT)
		Comment	Hybridoma producing a monoclonal antibody against mouse B7-H1.
		Comment from the depositor
RCB2306
	PC3.1
		Comment	Hybridoma producing monoclonal antibody against latexin.
		Comment from the depositor
RCB2307
	T1.7
		Comment	Hybridoma producing monoclonal antibody against C-terminal peptide of rat GSK3-beta.
		Comment from the depositor
RCB2308
	802C11
		Comment	Hybridoma producing monoclonal antibody against MuSc.
		Comment from the depositor
RCB2309
	JFP-J1
		Comment	Hybridoma producing monoclonal antibody against GFP. Rat IgG2a monoclonal antibody.
		Comment from the depositor
RCB2310
	JFP-J5
		Comment	Hybridoma producing monoclonal antibody against GFP. Rat IgG2a monoclonal antibody.
		Comment from the depositor
RCB2311
	JFP-K2
		Comment	Hybridoma producing monoclonal antibody against GFP. Rat IgG2a monoclonal antibody.
		Comment from the depositor
RCB2312
	859H5
		Comment	Hybridoma producing monoclonal antibody against bacterial unknown molecule. Rat IgG2a monoclonal antibody.
		Comment from the depositor
RCB2313
	884F11
		Comment	Hybridoma producing monoclonal antibody against mouse apolipoprotein E.
		Comment from the depositor
RCB2314
	F9/LM10
		Comment	Mouse cell line derived from embryonal carcinoma. Expressing laminin alpha-5 exogenously.
		Comment from the depositor
RCB2315
	F9/LM(1+10)
		Comment	Mouse cell line derived from embryonal carcinoma. Expressing laminin alpha-5 exogenously.
		Comment from the depositor
RCB2316
	AB1
		Comment	Hybridoma producing monoclonal antibody against GD1b gangliosides.
		Comment from the depositor
RCB2317
	AC1
		Comment	Hybridoma producing monoclonal antibody against GD1c gangliosides.
		Comment from the depositor
RCB2318
	P19.CL6
		Comment	Mouse cell line derived from embryonal carcinoma. C3H strain. Following differentiation, beating cardiomyocytes appear efficiently.
		Comment from the depositor
RCB2321
	IP-B12
		Comment	Currently not ready.
		Comment from the depositor	Rat pulmonary carcinoma-derived cell line producing parathyroid hormone-related protein (PTHrP).
RCB2322
	KUM5
		Comment	Mouse mesenchymal cell line derived from bone marrow.　C3H/He
		Comment from the depositor
RCB2323
	9-15C
		Comment	Mouse mesenchymal cell line derived from bone marrow.　C3H/He
		Comment from the depositor
RCB2324
	MIH5(RPMI)
		Comment	Hybridoma producing a monoclonal antibody against mouse B7-H1. Possible to culture in RPMI1640 medium.
		Comment from the depositor
RCB2326
	CHO-AA8
		Comment	A subline of the CHO-K1 cell line. Widely used for the isolation of repair-deficient mutants. Useful for gene mutation assays at the APRT and HPRT loci.
		Comment from the depositor
RCB2327
	EM-9
		Comment	A subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC1 gene deficient.
		Comment from the depositor
RCB2328
	irs1SF
		Comment	A subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC3 gene deficient.
		Comment from the depositor
RCB2329
	V-3
		Comment	A subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC7(DNA-PK) gene deficient.
		Comment from the depositor
RCB2330
	CHO-K1
		Comment	Chinese hamster ovary cell line. Widely used for the isolation of mutants by mutagenesis.
		Comment from the depositor
RCB2331
	XR-1
		Comment	A subline of the CHO-K1 cell line. X-ray-sensitive mutant. XRCC4 gene deficient.
		Comment from the depositor
RCB2332
	V79-4
		Comment	A subline of the V79 cell line following cloning. Widely used for radiation biology, mutagenesis and mammalian cell genetics.
		Comment from the depositor
RCB2335
	V-E5
		Comment	X-ray-sensitive mutant derived from the V79 cell line. XRCC8 gene deficient.
		Comment from the depositor
RCB2336
	V-G8
		Comment	A subline of the V79 cell line. X-ray-sensitive mutant. XRCC8 gene deficient.
		Comment from the depositor
RCB2337
	V79B
		Comment	A subline of the V79 cell line. Widely used for radiation biology, mutagenesis and mammalian cell genetics.
		Comment from the depositor
RCB2338
	XR-V9B-4
		Comment	A subline of the V79B cell line. X-ray-sensitive mutant. XRCC5(ku80) gene deficient.
		Comment from the depositor
RCB2339
	XR-V15B
		Comment	A subline of the V79 cell line. X-ray-sensitive mutant. XRCC5(ku80) gene deficient.
		Comment from the depositor
RCB2341
	NCR-G1
		Comment	Human cell line derived from embryonal carcinoma of testis.
		Comment from the depositor
RCB2342
	NCR-G2
		Comment	Human cell line derived from embryonal carcinoma of testis.
		Comment from the depositor
RCB2343
	NCR-G3
		Comment	Human cell line derived from embryonal carcinoma of testis.Application consideration
		Comment from the depositor
RCB2344
	NCR-G4
		Comment	Human cell line derived from embryonal carcinoma of testis.
		Comment from the depositor
RCB2345
	EEB
		Comment	Human cell line derived from erythroblastic leukemia.
		Comment from the depositor
RCB2346
	NMFH-1
		Comment	Human cell line derived from myxofibrosarcoma.
		Comment from the depositor
RCB2347
	NMS-2
		Comment	Human cell line derived from malignant peripheral nerve sheath tumor.
		Comment from the depositor
RCB2348
	NOS-10
		Comment	Human cell line derived from osteosarcoma.
		Comment from the depositor
RCB2350
	StromaNKtert
		Comment	Human cell line derived from bone marrow stromal cells. Useful to propagate hematopoietic stem cells.
		Comment from the depositor
RCB2351
	OGU1
		Comment	Human cell line derived from primary effusion lymphoma (PEL). Application consideration
		Comment from the depositor
RCB2352
	633
		Comment	Human lung cancer cell line expressing capsid protein of human adenovirus.
		Comment from the depositor
RCB2354
	293gp
		Comment	A subline of 293. Expressing MoMLV (Moloney murine leukemia virus) gag/pol. A retroviral vector packaging cell line.
		Comment from the depositor
RCB2355
	HeLa CD4+Clone1022
		Comment	A subline of the HeLa cells. Expressing human CD4 and Neomycin-resistant gene.
		Comment from the depositor
RCB2356
	HeLa-CD4-LTR-β-gal
		Comment	A subline of the HeLa cells. Expressing human CD4 and Neomycin-resistant gene. One copy of the HIV-1 LTR (nt-138 to +80) linked to the β-galactosidase gene is integrated.
		Comment from the depositor
RCB2358
	HLtat
		Comment	A subline of the HeLa cells. HeLa cells contained stably integrated copies of the HIV-1 LTR promoter linked to a synthetic tat gene.
		Comment from the depositor
RCB2360
	HS-ES-2M
		Comment	Human cell line derived from epithelioid sarcoma. RCB2360 and RCB2361 were derived from the same patient. HS-ES-1 (RCB2364) was derived from another patient.
		Comment from the depositor
RCB2361
	HS-ES-2R
		Comment	Human cell line derived from epithelioid sarcoma. RCB2360 and RCB2361 were derived from the same patient. HS-ES-1 (RCB2364) was derived from another patient.
		Comment from the depositor
RCB2362
	HS-PSS
		Comment	Human cell line derived from malignant peripheral nerve sheath tumor.
		Comment from the depositor
RCB2364
	HS-ES-1
		Comment	Human cell line derived from epithelioid sarcoma. RCB2360 and RCB2361 were derived from another different patient.
		Comment from the depositor
RCB2365
	JHONA
		Comment	Human cell line derived from ovarian squamous cell carcinoma. Application consideration
		Comment from the depositor
RCB2366
	Hu5/E18
		Comment	Human multipotent stem cell line able to differentiate into muscle, bone, and adipocytes.
		Comment from the depositor
RCB2367
	KT01
		Comment	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule.
		Comment from the depositor
RCB2368
	KT02
		Comment	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule.
		Comment from the depositor
RCB2369
	KT03
		Comment	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule and body wall muscle.
		Comment from the depositor
RCB2372
	KT06
		Comment	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule and body wall muscle.
		Comment from the depositor
RCB2375
	KT09
		Comment	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.
		Comment from the depositor
RCB2376
	KT10
		Comment	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.
		Comment from the depositor
RCB2377
	KT11
		Comment	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.
		Comment from the depositor
RCB2378
	KT12
		Comment	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.
		Comment from the depositor
RCB2379
	KT13
		Comment	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that seam cell.
		Comment from the depositor
RCB2380
	KT14
		Comment	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx basement membrane.
		Comment from the depositor
RCB2381
	KT16
		Comment	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx.
		Comment from the depositor
RCB2382
	KT17
		Comment	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx.
		Comment from the depositor
RCB2383
	KT18
		Comment	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx.
		Comment from the depositor
RCB2386
	KT21
		Comment	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on intestine.
		Comment from the depositor
RCB2388
	KT23
		Comment	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on nuclear membrane.
		Comment from the depositor
RCB2389
	KT26
		Comment	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on centrosome.
		Comment from the depositor
RCB2390
	KT27
		Comment	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on hypodermis.
		Comment from the depositor
RCB2392
	KT29
		Comment	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on egg shell.
		Comment from the depositor
RCB2393
	KT30
		Comment	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on egg shell.
		Comment from the depositor
RCB2395
	KT32
		Comment	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule and pharynx.
		Comment from the depositor
RCB2400
	KT54
		Comment	Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on centrosome and P-granule.
		Comment from the depositor
RCB2402
	STIM1^(-)DT40
		Comment	Subline of DT40 cell line, lacking STIM1 expression.
		Comment from the depositor
RCB2403
	MG6
		Comment	Mouse microglial cell line immortalized by a replication-deficient retroviral vector containing human c-myc gene. No significant production of infectious viral particles from MG6 cells was confirmed by bioassay using SC-1 cells.
		Comment from the depositor
RCB2530
	A172
		Comment	Human cell line derived from glioblastoma. TKG0183 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2531
	CB-3512
		Comment	Human cell line derived from B cells in umbilical cord blood. Transformed by EB virus. TKG0305 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2532
	HuO 9N2 (O9N2)
		Comment	Human cell line derived from osteosarcoma. TKG0451 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2534
	M-MOK
		Comment	Human cell line derived from megakaryoblastic leukemia. TKG0458 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2535
	OVK18#102
		Comment	Human cell line derived from ovarian endometrioid carcinoma, subclone of RCB1903. TKG0357 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2536
	T24
		Comment	Human cell line derived from bladder cancer. Transitional cell carcinoma. TKG0443 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2537
	TFK-1
		Comment	Human cell line derived from extrahepatic bile duct carcinoma. TKG0367 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2539
	XPL 19
		Comment	Human B cell line derived from xeroderma pigmentosum (XP) patient and transformed by Epstein-Barr Virus. TKG0312 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2540
	XPL 24
		Comment	Human cell line derived from B cells of Xeroderma pigmentosum (XP) patient. Transformed by EB virus. TKG0314 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2541
	141-LCL-MUC1
		Comment	Human cell line derived from B cells of healthy volunteer. Transformed by EB virus. RCB2083 was derived from the same patient. TKG0634 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2610
	FELV3281-AD
		Comment	Cat cell line derived from lymphoma.
		Comment from the depositor
RCB2611
	MDCK-AD
		Comment	Dog cell line derived from kidney.
		Comment from the depositor
RCB2614
	KLN205-MUC1
		Comment	Mouse cell line derived from lung squamous cell carcinoma. TKG0473 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2618
	BCL1-B20
		Comment	Mouse cell line derived from B cell leukemia. TKG0435 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2619
	L929
		Comment	Mouse fibroblast-like cell line. TKG0217 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2620
	C-1300N18
		Comment	Mouse cell line derived from neuroblastoma. TKG0307 (Deposited from Tohoku Univ.). Application consideration
		Comment from the depositor
RCB2621
	M1(D+)
		Comment	Mouse cell line derived from meyloid leukemia. TKG0319 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2623
	KLN205
		Comment	Mouse cell line derived from lung squamous cell carcinoma. TKG0214 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2627
	BOY-12E
		Comment	Human cell line derived from urinary bladder carcinoma. TKG0641 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2630
	B16F10
		Comment	Mouse cell line derived from melanoma. TKG0348 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2633
	MM46 CEA1-2
		Comment	Mouse cell line derived from mammary carcinoma. TKG0597 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2634
	MM46-APR-MUC1 cl.1
		Comment	Mouse cell line derived from mammary carcinoma. Expressing human MUC1 (APR-MUC1) exogenously. TKG0595 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2637
	A4
		Comment	Subline of NIH/3T3 transformed with an active type c-erb B-2 (V-659 was changed to E659). c-erb B-2 prouct (+). G418 resistant. TKG0298 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2638
	B16/BL6
		Comment	Mouse cell line derived from melanoma.　 TKG0598 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2639
	NB2a
		Comment	Mouse cell line derived from neuroblastoma. TKG0509 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2640
	G-415
		Comment	Human cell line derived from gallbladder carcinoma. TKG0642 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2642
	MUSS
		Comment	Mouse cell line derived from spontaneous malignant fibrous histiocytoma. A/J strain. TKG0497 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2643
	F9
		Comment	Mouse cell line derived from embryonal carcinoma. 129 strain. TKG0519 (Deposited from Tohoku Univ.). Application consideration
		Comment from the depositor
RCB2648
	D4
		Comment	A subline of the NIH/3T3 cell line. NIH/3T3 cell line transfected with wild type c-erb B2 gene with carboxyl-terminal deletion. Swiss strain.TKG0300(Deposited from Tohoku Univ.). TKG0300 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2649
	B16F1
		Comment	Mouse cell line derived from melanoma. C57BL/6J strain. TKG0347 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2651
	JLS-V9
		Comment	Mouse cell line derived from bone marrow. Fibroblast-like cells. BALB/c strain. TKG0355 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2652
	J774-1
		Comment	Mouse cell line derived from ascites. Macrophage-like cells. BALB/c strain. TKG0208 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2657
	Colon-26
		Comment	Mouse cell line derived from colon cancer. BALB/c strain. TKG0518 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2660
	MEDEP-E14
		Comment	Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, E14TG2a. Epo(Erythropoietin) dependent.
		Comment from the depositor
RCB2686
	JTC-35
		Comment	Bovine granulosa cell line.
		Comment from the depositor
RCB2691
	MEDEP-E14 clone 4
		Comment	A subclone of MEDEP-E14(RCB2660) following cloning procedure.
		Comment from the depositor
RCB2692
	MEDEP-BRC4-1
		Comment	Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, BRC4 (AES0008). SCF(Stem cell factor) and Dex(dexamethasone) dependent.
		Comment from the depositor
RCB2693
	MEDMC-NT2
		Comment	Mouse cell line possessing the characteristics of mast cells. IL-3 (Interleukin-3) dependent.
		Comment from the depositor
RCB2694
	MEDMC-BRC6
		Comment	Mouse cell line derived from mouse ES cell line, BRC6 (AES0010). Mast cell-like cells. SCF (Stem cell factor) and IL-3 (Interleukin-3) dependent. C57BL/6 strain.
		Comment from the depositor
RCB2695
	RD-C2
		Comment	Mouse osteoblast-like cell line derived from Runx2 deficient mouse.
		Comment from the depositor
RCB2696
	RD-C6
		Comment	Mouse osteoblast-like cell line derived from Runx2 deficient mouse.
		Comment from the depositor
RCB2700
	PK-8
		Comment	Human cell line derived from liver metastasis of pancreas carcinoma. TKG0383 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2709
	2F8
		Comment	Hybridoma producing monoclonal antibody against oxitocin receptor.
		Comment from the depositor
RCB2710
	Atg5^(+/+)MEF
		Comment	Mouse embryonic fibroblasts. Wild type control for RCB2711.
		Comment from the depositor
RCB2711
	Atg5^(-/-)MEF
		Comment	Mouse embryonic fibroblasts lacking Atg5 gene expression.
		Comment from the depositor
RCB2712
	MAEC
		Comment	Vascular endothelial cell line derived from aorta of p53-deficient mouse.
		Comment from the depositor
RCB2718
	MT-7
		Comment	Rat cell line derived from fibrous histiocytoma. After cloning.
		Comment from the depositor
RCB2719
	MT-10
		Comment	Rat cell line derived from fibrous histiocytoma. After cloning.
		Comment from the depositor
RCB2720
	MT-R8
		Comment	A subline of MT-8, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin.
		Comment from the depositor
RCB2721
	MT-R9
		Comment	A subline of MT-9, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin.
		Comment from the depositor
RCB2722
	MT-10R
		Comment	A subline of MT-10, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin.
		Comment from the depositor
RCB2723
	MT-PR
		Comment	A subline of MT-P, a rat cell line derived from malignant fibrous histiocytoma, which is resistant to cisplatin. T
		Comment from the depositor
RCB2724
	KB-D8
		Comment	Rat cell line derived from dendritic cell carcinoma in thymus.
		Comment from the depositor
RCB2725
	KJ-A
		Comment	Rat cell line derived from malignant fibrous histiocytoma.
		Comment from the depositor
RCB2726
	KE-F11
		Comment	Rat cell line derived from malignant schwannoma.
		Comment from the depositor
RCB2727
	RY-B-E3
		Comment	Rat cell line derived from endometrial stromal sarcoma.
		Comment from the depositor
RCB2728
	LY-H12
		Comment	Rat non-neoplastic cell line derived from malignant peripheral nerve sheath tumor.
		Comment from the depositor
RCB2729
	LY-PPB6
		Comment	Rat cell line derived from malignant peripheral nerve sheath tumor.
		Comment from the depositor
RCB2740
	5A5-WASP
		Comment	Hybridoma producing monoclonal antibody against WASP (Wiskott-Aldrich syndrome protein). TKG0631 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2745
	A20
		Comment	Mouse cell line derived from lymphoma. Balb/c strain. TKG0571 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2758
	LAG
		Comment	Mouse cell line derived from connective tissue. Fibroblast-like. C3H strain. TKG0218 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2766
	Morris 5123D-TC
		Comment	Rat (Buffalo) cell line derived from hepatoma. TKG0365 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2767
	NIH/3T3
		Comment	Mouse fibroblast-like cell line. TKG0299 (Deposited from Tohoku Univ.). Application consideration
		Comment from the depositor
RCB2776
	P388
		Comment	Mouse cell line derived from lymphoid tumor. DBA/2 strain. TKG0326 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2782
	RBL 2H3
		Comment	Rat cell line derived from basophilic leukemia cells. TKG0321 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2783
	RGC-6
		Comment	Rat cell line derived from glioma induced by N-nitrosomethylurea. TKG0242 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2784
	RL♂1(Gloria)
		Comment	Mouse cell line derived from lymphoid tumor. BALB/c strain. TKG0292 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2799
	YAC-1
		Comment	Mouse cell line derived from lymphoma. A/Sn strain. TKG0387 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2800
	PC12-F7
		Comment	A subline of PC-12 lacking synaptotagmin-1.
		Comment from the depositor
RCB2801
	PC12-G11
		Comment	A subline of PC-12 expressing synaptotagmin-1, a control cell line for PC12-F7.
		Comment from the depositor
RCB2806
	MSK-C5.8G
		Comment	Rat cell line derived from osteosarcoma. F344 strain.
		Comment from the depositor
RCB2808
	Odf2-deficient F9 cells
		Comment	A subline of mouse ES cell line, F9 (129), lacking Odf2.
		Comment from the depositor
RCB2809
	CH12F3-2A
		Comment	Mouse cell line derived from B cell lymphoma.
		Comment from the depositor
RCB2811
	7F9 (hybridoma)
		Comment	Hybridoma. Anti-Rat Carboxypeptidase M MoAb producing.
		Comment from the depositor
RCB2812
	HeLa/Fucci
		Comment	A subline of the HeLa cell line expressing Fucci, a cell cycle marker. Cell line name : HeLa/Fucci #4.Important notice regarding nomenclature of Fucci. Research tools : Fucci – Fluorescent Ubiquitination-based Cell Cycle Indicator.
		Comment from the depositor
RCB2813
	NMuMG/Fucci
		Comment	A subline of the NMuMG cell line expressing Fucci, a cell cycle marker. Cell line name : NMuMG/Fucci #1.Important notice regarding nomenclature of Fucci. Research tools : Fucci – Fluorescent Ubiquitination-based Cell Cycle Indicator.
		Comment from the depositor
RCB2815
	P20.1
		Comment	Hybridoma producing monoclonal antibody against a peptide, GYPGQV.
		Comment from the depositor
RCB2816
	A110L
		Comment	Human cell line derived from lung adenocarcinoma cells.
		Comment from the depositor
RCB2817
	A529L
		Comment	Human cell line derived from lung adenosquamous cell carcinoma. HLA A2402/, B5201/, Cw01201/.
		Comment from the depositor
RCB2818
	B1203L
		Comment	Human cell line derived from lung squamous cell carcinoma. HLA A2402/2402, B5201/5401, C0102/1202.
		Comment from the depositor
RCB2819
	C831L
		Comment	Human cell line derived from lung large cell carcinoma. HLA A0206/2601, B0702/3501, Cw0702/0801.
		Comment from the depositor
RCB2820
	N0003(<50)
		Comment	Human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. RCB2820, RCB2821 were derived from the same patient.
		Comment from the depositor
RCB2821
	N0003(>300)
		Comment	Human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. RCB2820, RCB2821 were derived from the same patient.
		Comment from the depositor
RCB2822
	N0005(<50)
		Comment	Human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. RCB2822, RCB2823, RCB2824 were derived from the same patient.
		Comment from the depositor
RCB2823
	N0005(>500)
		Comment	Human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. RCB2822, RCB2823, RCB2824 were derived from the same patient.
		Comment from the depositor
RCB2824
	N0005-A1
		Comment	Human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. RCB2822, RCB2823, RCB2824 were derived from the same patient.
		Comment from the depositor
RCB2825
	N0013(<50)
		Comment	Human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. RCB2825, RCB2826 were derived from the same patient.
		Comment from the depositor
RCB2826
	N0013(>300)
		Comment	Human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. RCB2825, RCB2826 were derived from the same patient.
		Comment from the depositor
RCB2827
	N6803(<50)
		Comment	Human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. RCB2827, RCB2828 were derived from the same patient.
		Comment from the depositor
RCB2828
	N6803(>500)
		Comment	Human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. RCB2827, RCB2828 were derived from the same patient.
		Comment from the depositor
RCB2830
	OMC-2
		Comment	Human cell line derived from endometrial adenocarcinoma.
		Comment from the depositor
RCB2831
	DEOC-1
		Comment	Human cell line derived from malignant melanoma.
		Comment from the depositor
RCB2832
	OMC-9
		Comment	Human cell line derived from endometrial stromal sarcoma.
		Comment from the depositor
RCB2833
	L23immo
		Comment	Human immortalized cell line derived from MRC5 cells.
		Comment from the depositor
RCB2834
	L12.9-2(1)
		Comment	Human immortalized cell line derived from MRC5 cells.
		Comment from the depositor
RCB2843
	43L
		Comment	Somatic tumor hybrid (fusion cell between C3H mammary tumor FM3A#2 and 8-Ag resistant L cell). This hybrid tumor cells induce resistance to MM Ag positive tumor cells. TKG0381 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2844
	L1210 TGR4
		Comment	Mouse cell line derived from leukemia. Resistant to 6TG (10 microgram/ml). DBA/2 strain. TKG0478 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2845
	L1210-5FU-R-TC
		Comment	Mouse cell line derived from leukemia. Lymphoblastoid cells. DBA/2 strain. TKG0409 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2846
	LAG-MUC1
		Comment	A subline of LAG (RCB2758) expressing MUC1. 8-Ag resistant. TKG0466 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2848
	OTT6050(B)
		Comment	Mouse cell line derived from testicular teratoma. This cell line was established by inoculation of tibia (6 days old) to A/He x 129/sv mouse testis. Primary tumor was developed in testis. TKG0330 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2852
	TSA8
		Comment	Mouse cell line derived from erythroleukemia cells transformed by Friend leukemia virus. TKG0370 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2853
	WEHI-3B
		Comment	Mouse cell line derived from myelomonocytic leukemia cells. BALB/c strain. TKG0584 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2854
	C6
		Comment	Rat cell line derived from glial cell tumor induced by N-nitrosomethylurea. TKG0589 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2859
	K-251
		Comment	Rat cell line derived from hepatoma cells in ascites. TKG0130 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2860
	MRMT-1
		Comment	Rat cell line derived from mammary carcinoma. TKG0132 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2862
	SLC
		Comment	Rat cell line derived from lung cancer. TKG0135 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2863
	N14.5
		Comment	Rat neuronal cell line derived from the ventrolateral region of the suprachiasmatic nucleus
		Comment from the depositor
RCB2864
	OLP6
		Comment	Rat neuronal cell line derived from the ventrolateral region of the suprachiasmatic nucleus
		Comment from the depositor
RCB2867
	HeLa/Fucci2
		Comment	A subline of the HeLa cell line expressing Fucci2, a cell cycle marker. Cell line name : HeLa/Fucci2 #3. Important notice regarding nomenclature of Fucci. Research tools : Fucci – Fluorescent Ubiquitination-based Cell Cycle Indicator.
		Comment from the depositor
RCB2868
	NMuMG/Fucci2
		Comment	A subline of the NMuMG cell line expressing Fucci2, a cell cycle marker. Cell line name : NMuMG/Fucci2 #5. Important notice regarding nomenclature of Fucci. Research tools : Fucci – Fluorescent Ubiquitination-based Cell Cycle Indicator.
		Comment from the depositor
RCB2869
	CHO-K1
		Comment	A subline of CHO cells. Require proline. TKG0328 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2896
	JLS-V9 6TG
		Comment	Mouse cell line derived from bone marrow. Fibroblast-like. 6TG resistant. BALB/c strain. TKG0350 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2899
	S180-Kumamoto-TC
		Comment	Mouse cell line derived from Swiss Webster Sarcoma 180. CFW strain. TKG0637 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2900
	S180-Meiji-TC
		Comment	Mouse cell line derived from sarcoma cells in ascites. CFW strain. TKG0672 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2901
	S180-NCC-TC
		Comment	Mouse cell line derived from sarcoma cells in ascites. CFW strain. TKG0638 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2904
	WEHI164R
		Comment	Mouse cell line derived from fibrosarcoma. TNF resistant. BALB/c strain. TKG0281 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2905
	WEHI164S
		Comment	Mouse cell line derived from fibrosarcoma. TNF sensitive. BALB/c strain. TKG0282 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2908
	AH272-TC
		Comment	Rat cell line derived from hepatoma cells in ascites. TKG0535 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2909
	Walker256-TC
		Comment	Rat cell line derived from mammary carcinoma. TKG0565 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2910
	LY-6-TC
		Comment	Rat cell line derived from sarcoma cells in ascites. TKG0648 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB2911
	MEDEP-BRC5
		Comment	Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, BRC5 (AES0009). SCF(Stem cell factor) dependent.
		Comment from the depositor
RCB2924
	OP9/G
		Comment	Subline of OP9 cell line, expressing EGFP. See RCB2117 TSt-4/G.
		Comment from the depositor
RCB2925
	OP9/G-DLL1
		Comment	Subline of OP9 cell line, expressing DLL1 and EGFP. See RCB2118 TSt-4/G-DLL1.
		Comment from the depositor
RCB2926
	OP9/N
		Comment	Subline of OP9 cell line, expressing human NGF receptor. See RCB2119 TSt-4/N.
		Comment from the depositor
RCB2927
	OP9/N-DLL1
		Comment	Subline of OP9 cell line, expressing DLL1 and human NGF receptor. See RCB2120 TSt-4/N-DLL1.
		Comment from the depositor
RCB2931
	6E2
		Comment	Hybridoma cell line expressing anti-human SSEA-4 monoclonal antibody.
		Comment from the depositor
RCB2932
	MEDEP-BRC4-2
		Comment	Mouse erythroid cell line able to differentiate into enucleated red blood cells. Derived from mouse ES cell line, BRC4 (AES0008). SCF (Stem cell factor) and Dexamethasone dependent. C57BL/6 strain.
		Comment from the depositor
RCB2942
	OLHNI-2
		Comment	Medaka cell line derived from HNI strain.
		Comment from the depositor
RCB2943
	OLHdrR-e3
		Comment	Medaka cell line derived from HdrR strain.
		Comment from the depositor
RCB2944
	OLCAB-e31
		Comment	Medaka cell line.
		Comment from the depositor
RCB2945
	DIT29
		Comment	Medaka cell line derived from hepatoma cells.
		Comment from the depositor
RCB2946
	OLCAB-e3
		Comment	Medaka cell line.
		Comment from the depositor
RCB2979
	HCT116
		Comment	Human cell line derived from colon cancer.　Loss of the DNA mismatch repair gene (hMLH1).
		Comment from the depositor
RCB2980
	HCT116-XRCC4(+/-)
		Comment	Subline of HCT116 cell line lacking XRCC4 gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
		Comment from the depositor
RCB2981
	HCT116-XRCC4(-/-)
		Comment	Subline of HCT116 cell line lacking XRCC4 gene in both alleles.　Loss of the DNA mismatch repair gene (hMLH1).
		Comment from the depositor
RCB2982
	HCT116-RAD18(+/-)
		Comment	Subline of HCT116 cell line lacking RAD18 gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
		Comment from the depositor
RCB2983
	HCT116-RAD18(-/-)
		Comment	Subline of HCT116 cell line lacking RAD18 gene in both alleles.　Loss of the DNA mismatch repair gene (hMLH1).
		Comment from the depositor
RCB2984
	HCT116-ARTEMIS(+/-)
		Comment	Subline of HCT116 cell line lacking ARTEMIS gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
		Comment from the depositor
RCB2985
	HCT116-ARTEMIS(-/-)
		Comment	Subline of HCT116 cell line lacking ARTEMIS gene in both alleles.　Loss of the DNA mismatch repair gene (hMLH1).
		Comment from the depositor
RCB2986
	HCT116-MDC1(+/-)
		Comment	Subline of HCT116 cell line lacking MDC1 gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
		Comment from the depositor
RCB2987
	HCT116-MDC1(-/-)
		Comment	Subline of HCT116 cell line lacking MDC1 gene in both alleles.　Loss of the DNA mismatch repair gene (hMLH1).
		Comment from the depositor
RCB2988
	HCT116-REV1(+/-)
		Comment	Subline of HCT116 cell line lacking REV1 gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
		Comment from the depositor
RCB2989
	HCT116-REV1(-/-)
		Comment	Subline of HCT116 cell line lacking REV1 gene in both alleles.　Loss of the DNA mismatch repair gene (hMLH1).
		Comment from the depositor
RCB2990
	HCT116-REV3L(+/-)
		Comment	Subline of HCT116 cell line lacking REV3L gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
		Comment from the depositor
RCB2991
	HCT116-KU70(+/-)
		Comment	Subline of HCT116 cell line lacking Ku70 gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
		Comment from the depositor
RCB2992
	HCT116-DNAPKcs(+/-)
		Comment	Subline of HCT116 cell line lacking DNAPKcs gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
		Comment from the depositor
RCB2993
	HCT116-POLM(+/-)
		Comment	Subline of HCT116 cell line lacking DNA polymerase m gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
		Comment from the depositor
RCB2994
	HCT116-LIG3(+/-)
		Comment	Subline of HCT116 cell line lacking Ligase 3 gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
		Comment from the depositor
RCB2995
	HCT116-LIG4(+/-)
		Comment	Subline of HCT116 cell line lacking Ligase 4 gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
		Comment from the depositor
RCB2996
	HCT116-53BP1(+/-)
		Comment	Subline of HCT116 cell line lacking 53BPI gene in one allele.　Loss of the DNA mismatch repair gene (hMLH1).
		Comment from the depositor
RCB2997
	H414
		Comment	Subline of HCT116 cell line which has intact DNA mismatch repair gene (hMLH1).
		Comment from the depositor
RCB2998
	H414-RAD18(+/-)
		Comment	Subline of H414 cell line lacking RAD18 gene in one allele.
		Comment from the depositor
RCB2999
	H414-RAD18(-/-)
		Comment	Subline of H414 cell line lacking RAD18 gene in both alleles.
		Comment from the depositor
RCB3000
	H414-MDC1(+/-)
		Comment	Subline of H414 cell line lacking MDC1 gene in one allele.
		Comment from the depositor
RCB3001
	H414-MDC1(-/-)
		Comment	Subline of H414 cell line lacking MDC1 gene in both alleles.
		Comment from the depositor
RCB3002
	H414-LIG4(+/-)
		Comment	Subline of H414 cell line lacking Ligase 4 gene in one allele.
		Comment from the depositor
RCB3007
	MOPC-70A
		Comment	Mouse cell line derived from myeloma. This cell line was established from a cell line maintained by in vivo transplantation. TKG0167 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB3010
	RPMI8226
		Comment	Human cell line derived from myeloma. IgG producer. TKG0243 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB3052
	Jurkat
		Comment	Human T cell leukemia. IL-2 receptor (-). Progeny were cured by Treatments with BM Cycline and MC210. TKG0209 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB3055
	C38
		Comment
		Comment from the depositor
RCB3515
	JLS-V9 BudR
		Comment	Mouse cell line derived from bone marrow. Fibroblast-like. BudR resistant. BALB/c strain. TKG0356 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB3516
	ASMF
		Comment	A cell line derived from muscle of large japanese field mouse (Apodemus speciosus).
		Comment from the depositor
RCB3517
	LLKF
		Comment	A cell line derived from kidney of steppe lemming.
		Comment from the depositor
RCB3518
	KM-Y
		Comment	Burkitt lymphoma.
		Comment from the depositor
RCB3520
	KM-S
		Comment	Lung cancer, Immature large cell type
		Comment from the depositor
RCB3521
	HAM1
		Comment	Human cell line derived from ameloblastoma. RCB3522 was derived from the same patient. Application consideration
		Comment from the depositor
RCB3522
	HAM2
		Comment	Human cell line derived from ameloblastoma. RCB3521 was derived from the same patient. Application consideration
		Comment from the depositor
RCB3529
	G603L
		Comment	Human cell line derived from lung large cell carcinoma cells.
		Comment from the depositor
RCB3530
	B901L
		Comment	Human cell line derived from lung adenocarcinoma cells.
		Comment from the depositor
RCB3531
	A904L
		Comment	Human cell line derived from lung large cell carcinoma cells.
		Comment from the depositor
RCB3532
	A129L
		Comment	Human cell line derived from lung adenocarcinoma cells.
		Comment from the depositor
RCB3533
	ED-40515(+)
		Comment
		Comment from the depositor	ATL patient derived leukemic cell line (IL-2 dependent). ED-40515, ED-40810, ED-41214, ED-50823, ED-70423C cell lines were established from the same patient's blood.
RCB3534
	ED-40515(-)
		Comment
		Comment from the depositor	ATL patient derived leukemic cell line (IL-2 independent). ED-40515, ED-40810, ED-41214, ED-50823, ED-70423C cell lines were established from the same patient's blood.
RCB3535
	ATL-43T(+)
		Comment	ATL patient derived leukemic cell line (IL-2 dependent).
		Comment from the depositor	ATL patient derived leukemic cell line (IL-2 dependent). ATL-43T(+), ATL-43Tb(-) cell lines were established from the same patient's blood.
RCB3536
	ATL-43Tb(-)
		Comment
		Comment from the depositor	ATL patient derived leukemic cell line (IL-2 independent). ATL-43T(+), ATL-43Tb(-) cell lines were established from the same patient's blood.
RCB3537
	ATL-55T(+)
		Comment
		Comment from the depositor	ATL patient derived leukemic cell line (IL-2 dependent). ATL-55T(+), ATL-55T(-) cell lines were established from the same patient's blood.
RCB3538
	ATL-55T(-)
		Comment
		Comment from the depositor	ATL patient derived leukemic cell line (IL-2 independent). ATL-55T(+), ATL-55T(-) cell lines were established from the same patient's blood.
RCB3539
	ED-50823(+)
		Comment
		Comment from the depositor	ATL patient derived non-leukemic cell line (IL-2 dependent). ED-40515, ED-40810, ED-41214, ED-50823, ED-70423C cell lines were established from the same patient's blood.
RCB3540
	ED-50823(-)
		Comment
		Comment from the depositor	ATL patient derived non-leukemic cell line (IL-2 independent). ED-40515, ED-40810, ED-41214, ED-50823, ED-70423C cell lines were established from the same patient's blood.
RCB3541
	ATL-72/2(+)
		Comment
		Comment from the depositor	ATL patient derived non-leukemic cell line (IL-2 dependent). ATL-72/2(+), ATL-72/2(-), ATL-72b(+), ATL-72b(-), ATL-72T(+) cell lines were established from the same patient's blood.
RCB3542
	ATL-72/2(-)
		Comment
		Comment from the depositor	ATL patient derived non-leukemic cell line (IL-2 independent). ATL-72/2(+), ATL-72/2(-), ATL-72b(+), ATL-72b(-), ATL-72T(+) cell lines were established from the same patient's blood.
RCB3543
	SezM3(+)
		Comment	Currently not ready.
		Comment from the depositor	Sezary syndrome like patient’s mother derived T cell line (IL-2 dependent).
RCB3544
	SezM3(-)
		Comment	Currently not ready.
		Comment from the depositor	Sezary syndrome like patient’s mother derived T cell line (IL-2 independent).
RCB3545
	ATL-2(+)
		Comment
		Comment from the depositor	ATL patient derived non-leukemic cell line (IL-2 dependent). ATL-2(+), ATL-2(-) cell lines were established from the same patient's blood.
RCB3547
	Sez627(+)
		Comment	Currently not ready.
		Comment from the depositor	Sezary syndrome like patient derived T cell line (IL-2 dependent).
RCB3548
	Sez627C(-)
		Comment	Currently not ready.
		Comment from the depositor	Sezary syndrome like patient’s derived T cell line (IL-2 independent).
RCB3549
	ATL-72b(+)
		Comment
		Comment from the depositor	ATL patient derived non-leukemic cell line (IL-2 dependent). ATL-72/2(+), ATL-72/2(-), ATL-72b(+), ATL-72b(-), ATL-72T(+) cell lines were established from the same patient's blood.
RCB3550
	ATL-72b(-)
		Comment	Important Notice : unidentified autonomous proliferative particles
		Comment from the depositor	ATL patient derived non-leukemic cell line (IL-2 independent). ATL-72/2(+), ATL-72/2(-), ATL-72b(+), ATL-72b(-), ATL-72T(+) cell lines were established from the same patient's blood.
RCB3551
	ATL-21C(+)
		Comment
		Comment from the depositor	Non-leukemic cell line (IL-2 dependent). ATL-21C(+), ATL-21C(-)/2, ATL-21C(-)/8.9 cell lines were established from the same patient's blood.
RCB3552
	ATL-21C(-)/2
		Comment
		Comment from the depositor	Non-leukemic cell line (IL-2 independent). Cultured for 2-years without IL-2. ATL-21C(+), ATL-21C(-)/2, ATL-21C(-)/8.9 cell lines were established from the same patient's blood.
RCB3553
	ATL-21C(-)/8.9
		Comment
		Comment from the depositor	Non-leukemic cell line (IL-2 independent). Cultured for 8.9-years without IL-2. ATL-21C(+), ATL-21C(-)/2, ATL-21C(-)/8.9 cell lines were established from the same patient's blood.
RCB3554
	ATL-16T(-)
		Comment	Currently not ready.
		Comment from the depositor	Non-leukemic cell line (IL-2 independent).
RCB3555
	ATL-35T(-)
		Comment	Currently not ready.
		Comment from the depositor	Non-leukemic cell line (IL-2 independent).
RCB3556
	ED-40810(-)
		Comment	Currently not ready.
		Comment from the depositor	ATL patient derived leukemic cell line (IL-2 independent). ED-40515, ED-40810, ED-41214, ED-50823, ED-70423C cell lines were established from the same patient's blood.
RCB3557
	ED-41214(-)
		Comment	Currently not ready.
		Comment from the depositor	ATL patient derived leukemic cell line (IL-2 independent). ED-40515, ED-40810, ED-41214, ED-50823, ED-70423C cell lines were established from the same patient's blood.
RCB3558
	ED-70423C(-)
		Comment
		Comment from the depositor	ATL patient derived leukemic cell line (IL-2 independent). ED-40515, ED-40810, ED-41214, ED-50823, ED-70423C cell lines were established from the same patient's blood.
RCB3559
	ATL-6(+)
		Comment
		Comment from the depositor	Non-leukemic cell line (IL-2 dependent).
RCB3560
	ATL-7(+)
		Comment	Currently not ready.
		Comment from the depositor	Non-leukemic cell line (IL-2 dependent).
RCB3561
	ATL-11-6(+)
		Comment	Currently not ready.
		Comment from the depositor	Non-leukemic cell line (IL-2 dependent).
RCB3562
	ATL-12A(+)
		Comment	Currently not ready.
		Comment from the depositor	Non-leukemic cell line (IL-2 dependent).
RCB3563
	ATL-17C(+)
		Comment	Currently not ready.
		Comment from the depositor	Non-leukemic cell line (IL-2 dependent). ATL-17C(+), ATL-17-2(+) cell lines were established from the same patient's blood.
RCB3564
	ATL-17-2(+)
		Comment
		Comment from the depositor	Non-leukemic cell line (IL-2 dependent). ATL-17C(+), ATL-17-2(+) cell lines were established from the same patient's blood.
RCB3565
	ATL-18C(+)
		Comment	Currently not ready.
		Comment from the depositor	Non-leukemic cell line (IL-2 dependent).
RCB3566
	ATL-23(+)
		Comment	Currently not ready.
		Comment from the depositor	Non-leukemic cell line (IL-2 dependent).
RCB3567
	ATL-26C(+)
		Comment	Currently not ready.
		Comment from the depositor	Non-leukemic cell line (IL-2 dependent).
RCB3568
	ATL-42T(+)
		Comment	Currently not ready.
		Comment from the depositor	Leukemic cell line (IL-2 dependent).
RCB3569
	ATL-46T(+)
		Comment	Currently not ready.
		Comment from the depositor	Non-leukemic cell line (IL-2 dependent).
RCB3570
	ATL-48T(+)
		Comment
		Comment from the depositor	Leukemic cell line (IL-2 dependent).
RCB3571
	ATL-67T(+)
		Comment	Currently not ready.
		Comment from the depositor	Non-leukemic cell line (IL-2 dependent).
RCB3572
	ATL-72T(+)
		Comment	Currently not ready.
		Comment from the depositor	Non-leukemic cell line (IL-2 dependent). ATL-72/2(+), ATL-72/2(-), ATL-72b(+), ATL-72b(-), ATL-72T(+) cell lines were established from the same patient's blood.
RCB3574
	CATL-3(+)
		Comment
		Comment from the depositor	Non-leukemic cell line derived from healthy carrier of HTLV-1 (IL-2 dependent).
RCB3576
	Aska-SS
		Comment	Human cell line derived from synovial sarcoma.
		Comment from the depositor
RCB3577
	Yamato-SS
		Comment	Human cell line derived from synovial sarcoma.
		Comment from the depositor
RCB3579
	ASF-4-2
		Comment	Normal human skin fibroblast. RCB3579〜RCB3585 were derived from the same person.
		Comment from the depositor
RCB3580
	ASF-4-3L
		Comment	Normal human skin fibroblast. RCB3579〜RCB3585 were derived from the same person.
		Comment from the depositor
RCB3582
	ASF-4-4L1
		Comment	Normal human skin fibroblast. RCB3579〜RCB3585 were derived from the same person.
		Comment from the depositor
RCB3583
	ASF-4-4L2
		Comment	Normal human skin fibroblast. RCB3579〜RCB3585 were derived from the same person.
		Comment from the depositor
RCB3585
	ASF-4-4R2
		Comment	Normal human skin fibroblast. RCB3579〜RCB3585 were derived from the same person.
		Comment from the depositor
RCB3588
	hPSC-5
		Comment	Human cell line derived from pacreatic cancer. Pancreatic stellate cells.
		Comment from the depositor
RCB3589
	hPSC-14
		Comment	Human cell line derived from pacreatic cancer. Pancreatic stellate cells.
		Comment from the depositor
RCB3600
	SDR-P-1D5
		Comment	Rat prolactin secreting cell line derived from anterior pituitary lacking growth hormone.
		Comment from the depositor
RCB3601
	SDRL-1
		Comment	Rat cell line derived from liver lacking growth hormone.
		Comment from the depositor
RCB3602
	SDRL-2
		Comment	Rat cell line derived from liver lacking growth hormone.
		Comment from the depositor
RCB3673
	Raji
		Comment	Human cell line derived from Burkitt lymphoma. EBNA (EBV—nuclear antigen) positive. TKG0371 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB3675
	SCC-TC
		Comment	Rectal carcinoma. Culture cell line of SCC (TKG 0340) . TKG0646 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB3676
	5637
		Comment	Human cell line derived from bladder carcinoma. TKG0605 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB3677
	A549
		Comment	Human cell line derived from lung cancer. Epithelial-like cells. HLA-A 2603/3001. A culture submitted to the Cell Resource Center for Biomedical Research was found to be contaminated with mycoplasma. Progeny were cured by Treatments with BM Cycline and MC210. TKG0184 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB3678
	BeWo
		Comment	Human cell line derived from choriocarcinoma. TKG0567 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB3680
	HeLa
		Comment	Human cell line derived from cervical cancer. A culture submitted to the Cell Resource Center for Biomedical Research was found to be contaminated with mycoplasma. Progeny were cured by Treatments with BM Cycline and MC210. TKG0331 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB3681
	HeLa.P3(S)
		Comment	Subline of HeLa cell line. Serum-free culture is possible. TKG0465 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB3682
	HeLa S3
		Comment	Human cell line derived from cervical cancer. TKG0444 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB3683
	HL-60
		Comment	Human cell line derived from promyelocytic leukemia cells. HL60 (RCB0041) can proliferate better than this HL-60 immediately after thawing. TKG0345 (Deposited from Tohoku Univ.). Application consideration
		Comment from the depositor
RCB3685
	HMV-II
		Comment	Human cell line derived from melanotic melanoma (highly melanotic). TKG0318 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB3686
	THP-1
		Comment	Human cell line derived from monocytic leukemia. TKG0267 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB3687
	MKN-7
		Comment	Human cell line derived from stomach cancer (gastric cancer; highly differentiated tubular adenocarcinoma). TKG0228 (Deposited from Tohoku Univ.).
		Comment from the depositor
RCB3706
	Atg7 +/+ MEFs
		Comment	Mouse embryonic fibroblasts derived from wild type mouse (C57BL/6).
		Comment from the depositor
RCB3707
	Atg7 -/- MEFs
		Comment	Mouse embryonic fibroblasts derived from Atg-deficient mouse (C57BL/6).
		Comment from the depositor
RCB3708
	Atg3 +/+ MEFs
		Comment	Mouse embryonic fibroblast cell line derived from wild type C57BL/6 strain.
		Comment from the depositor
RCB3709
	Atg3 -/- MEFs
		Comment	Mouse embryonic fibroblast cell line derived from Atg3-deficient C57BL/6 strain.
		Comment from the depositor
RCB3710
	CRP2(A1311A)
		Comment	Currently not ready. Hybridoma against CRP2 (full length) antigen.
		Comment from the depositor
RCB3711
	CDX2(A3701A)
		Comment	Currently not ready. Hybridoma against CDX2 (full length) antigen.
		Comment from the depositor
RCB3712
	CDX2(A3707A)
		Comment	Currently not ready. Hybridoma against CDX2 (full length) antigen.
		Comment from the depositor
RCB3713
	CDX2(A3715A)
		Comment	Currently not ready. Hybridoma against CDX2 (full length) antigen.
		Comment from the depositor
RCB3714
	CDX2(A3719A)
		Comment	Currently not ready. Hybridoma against CDX2 (full length) antigen.
		Comment from the depositor
RCB3715
	CDX2(A3722A)
		Comment	Currently not ready. Hybridoma against CDX2 (full length) antigen.
		Comment from the depositor
RCB3716
	NNMT(A2402A)
		Comment	Currently not ready. Hybridoma against NNMT (full length) antigen.
		Comment from the depositor
RCB3717
	NNMT(A2418A)
		Comment	Currently not ready. Hybridoma against NNMT (full length) antigen.
		Comment from the depositor
RCB3718
	NNMT(A2433A)
		Comment	Currently not ready. Hybridoma against NNMT (full length) antigen.
		Comment from the depositor
RCB3719
	NNMT(A2434A)
		Comment	Currently not ready. Hybridoma against NNMT (full length) antigen.
		Comment from the depositor
RCB3720
	NNMT(A2438A)
		Comment	Currently not ready. Hybridoma against NNMT (full length) antigen.
		Comment from the depositor
RCB3721
	NNMT(A2440A)
		Comment	Currently not ready. Hybridoma against NNMT (full length) antigen.
		Comment from the depositor
RCB3722
	Olig1(A5501A)
		Comment	Currently not ready. Hybridoma against Olig1 (full length) antigen.
		Comment from the depositor
RCB3723
	Olig1(A5507A)
		Comment	Currently not ready. Hybridoma against Olig1 (full length) antigen.
		Comment from the depositor
RCB3724
	Olig1(A5508A)
		Comment	Currently not ready. Hybridoma against Olig1 (full length) antigen.
		Comment from the depositor
RCB3725
	Olig1(A5515A)
		Comment	Currently not ready. Hybridoma against Olig1 (full length) antigen.
		Comment from the depositor
RCB3726
	Olig1(A5518A)
		Comment	Currently not ready. Hybridoma against Olig1 (full length) antigen.
		Comment from the depositor
RCB3727
	Olig2(A5618A)
		Comment	Currently not ready. Hybridoma against Olig2 (full length) antigen.
		Comment from the depositor
RCB3728
	Olig2(A5628A)
		Comment	Currently not ready. Hybridoma against Olig2 (full length) antigen.
		Comment from the depositor
RCB3729
	Olig2(A5629A)
		Comment	Currently not ready. Hybridoma against Olig2 (full length) antigen.
		Comment from the depositor
RCB3730
	Olig2(A5643A)
		Comment	Currently not ready. Hybridoma against Olig2 (full length) antigen.
		Comment from the depositor
RCB3731
	SFRP4(A7113A)
		Comment	Currently not ready. Hybridoma against SFRP4 (full length) antigen.
		Comment from the depositor
RCB3732
	SFRP4(A7116-2A)
		Comment	Currently not ready. Hybridoma against SFRP4 (full length) antigen.
		Comment from the depositor
RCB3733
	SFRP4(A7118A)
		Comment	Currently not ready. Hybridoma against SFRP4 (full length) antigen.
		Comment from the depositor
RCB3734
	SFRP4(A7123A)
		Comment	Currently not ready. Hybridoma against SFRP4 (full length) antigen.
		Comment from the depositor
RCB3735
	SFRP4(A7127-74A)
		Comment	Currently not ready. Hybridoma against SFRP4 (full length) antigen.
		Comment from the depositor
RCB3736
	EPST11(H9209)
		Comment	Currently not ready. Hybridoma against EPST11 (full length) antigen.
		Comment from the depositor
RCB3737
	EPST11(H9214)
		Comment	Currently not ready. Hybridoma against EPST11 (full length) antigen.
		Comment from the depositor
RCB3738
	EPST11(H9219)
		Comment	Currently not ready. Hybridoma against EPST11 (full length) antigen.
		Comment from the depositor
RCB3739
	EPST11(H9220)
		Comment	Currently not ready. Hybridoma against EPST11 (full length) antigen.
		Comment from the depositor
RCB3740
	EPST11(H9228)
		Comment	Currently not ready. Hybridoma against EPST11 (full length) antigen.
		Comment from the depositor
RCB3741
	C20-ORF102(H9613)
		Comment	Currently not ready. Hybridoma against C20-0RF102 (full length) antigen.
		Comment from the depositor
RCB3742
	C20-ORF102(H9615)
		Comment	Currently not ready. Hybridoma against C20-0RF102 (full length) antigen.
		Comment from the depositor
RCB3743
	C20-ORF102(H9616)
		Comment	Currently not ready. Hybridoma against C20-0RF102 (full length) antigen.
		Comment from the depositor
RCB3744
	C20-ORF102(H9625)
		Comment	Currently not ready. Hybridoma against C20-0RF102 (full length) antigen.
		Comment from the depositor
RCB3745
	C20-ORF102(H9627)
		Comment	Currently not ready. Hybridoma against C20-0RF102 (full length) antigen.
		Comment from the depositor
RCB3746
	C20-ORF102(H9638)
		Comment	Currently not ready. Hybridoma against C20-0RF102 (full length) antigen.
		Comment from the depositor
RCB3747
	C20-ORF102(H9645)
		Comment	Currently not ready. Hybridoma against C20-0RF102 (full length) antigen.
		Comment from the depositor
RCB3748
	SP-5AD5(N2901)
		Comment	Currently not ready. Hybridoma against SP-5AD5 (full length) antigen.
		Comment from the depositor
RCB3749
	SP-5AD5(N2906)
		Comment	Currently not ready. Hybridoma against SP-5AD5 (full length) antigen.
		Comment from the depositor
RCB3750
	SP-5AD5(N2922)
		Comment	Currently not ready. Hybridoma against SP-5AD5 (full length) antigen.
		Comment from the depositor
RCB3751
	SP-5AD5(N2927)
		Comment	Currently not ready. Hybridoma against SP-5AD5 (full length) antigen.
		Comment from the depositor
RCB3752
	SP-5AD5(N2931)
		Comment	Currently not ready. Hybridoma against SP-5AD5 (full length) antigen.
		Comment from the depositor
RCB3753
	SP-5AD5(N2933)
		Comment	Currently not ready. Hybridoma against SP-5AD5 (full length) antigen.
		Comment from the depositor
RCB3754
	SP-5AD5(N2935)
		Comment	Currently not ready. Hybridoma against SP-5AD5 (full length) antigen.
		Comment from the depositor
RCB3755
	SP-5AD5(N2942)
		Comment	Currently not ready. Hybridoma against SP-5AD5 (full length) antigen.
		Comment from the depositor
RCB3756
	PTCH1-2(N7333)
		Comment	Currently not ready. Hybridoma against PTCH1-2 : Patched 1 (268-319(52aa)) antigen.
		Comment from the depositor
RCB3757
	PTCH1-2(N7346)
		Comment	Currently not ready. Hybridoma against PTCH1-2 : Patched 1 (268-319(52aa)) antigen.
		Comment from the depositor
RCB3758
	PTCH1-2(N7357)
		Comment	Currently not ready. Hybridoma against PTCH1-2 : Patched 1 (268-319(52aa)) antigen.
		Comment from the depositor
RCB3759
	PLCη2C(N8320)
		Comment	Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
		Comment from the depositor
RCB3760
	PLCη2C(N8328)
		Comment	Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
		Comment from the depositor
RCB3761
	PLCη2C(N8339)
		Comment	Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
		Comment from the depositor
RCB3762
	PLCη2C(N8346)
		Comment	Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
		Comment from the depositor
RCB3763
	PLCη2C(N8351)
		Comment	Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
		Comment from the depositor
RCB3764
	PLCη2C(N8353)
		Comment	Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
		Comment from the depositor
RCB3765
	PLCη2C(N8357)
		Comment	Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
		Comment from the depositor
RCB3766
	PLCη2C(N8360)
		Comment	Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
		Comment from the depositor
RCB3767
	PLCη2C(N8361)
		Comment	Currently not ready. Hybridoma against PLCη2C : Phospholipase Cη2 (1065-1164(100aa)) antigen.
		Comment from the depositor
RCB3768
	Prdm14-2(N8028)
		Comment	Currently not ready. Hybridoma against Prdm14-2 : PR domain containing 14 (181-280(100aa)) antigen.
		Comment from the depositor
RCB3769
	Prdm14-2(N8048)
		Comment	Currently not ready. Hybridoma against Prdm14-2 : PR domain containing 14 (181-280(100aa)) antigen.
		Comment from the depositor
RCB3770
	Prdm14-2(N8070)
		Comment	Currently not ready. Hybridoma against Prdm14-2 : PR domain containing 14 (181-280(100aa)) antigen.
		Comment from the depositor
RCB3771
	Prdm1-2(N6902)
		Comment	Currently not ready. Hybridoma against Prdm1-2+AP75: PR domain containing1 (757-856(100aa)) antigen.
		Comment from the depositor
RCB3772
	Prdm1-2(N6915)
		Comment	Currently not ready. Hybridoma against Prdm1-2+AP75: PR domain containing1 (757-856(100aa)) antigen.
		Comment from the depositor
RCB3773
	Prdm1-2(N6916)
		Comment	Currently not ready. Hybridoma against Prdm1-2+AP75: PR domain containing1 (757-856(100aa)) antigen.
		Comment from the depositor
RCB3774
	Prdm1-2(N6917)
		Comment	Currently not ready. Hybridoma against Prdm1-2+AP75: PR domain containing1 (757-856(100aa)) antigen.
		Comment from the depositor
RCB3775
	Prdm1-2(N6927)
		Comment	Currently not ready. Hybridoma against Prdm1-2+AP75: PR domain containing1 (757-856(100aa)) antigen.
		Comment from the depositor
RCB3776
	HZF2(Y3701)
		Comment	Currently not ready. Hybridoma against HZF2 : Hematopoietic zinc finger (1-50(50aa)) antigen.
		Comment from the depositor
RCB3777
	HZF2(Y3713)
		Comment	Currently not ready. Hybridoma against HZF2 : Hematopoietic zinc finger (1-50(50aa)) antigen.
		Comment from the depositor
RCB3778
	HZF2(Y3716)
		Comment	Currently not ready. Hybridoma against HZF2 : Hematopoietic zinc finger (1-50(50aa)) antigen.
		Comment from the depositor
RCB3779
	HZF3(Y3901)
		Comment	Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
		Comment from the depositor
RCB3780
	HZF3(Y3916)
		Comment	Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
		Comment from the depositor
RCB3781
	HZF3(Y3919)
		Comment	Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
		Comment from the depositor
RCB3782
	HZF3(Y3921)
		Comment	Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
		Comment from the depositor
RCB3783
	HZF3(Y3923)
		Comment	Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
		Comment from the depositor
RCB3784
	HZF3(Y3924)
		Comment	Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
		Comment from the depositor
RCB3785
	HZF3(Y3928)
		Comment	Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
		Comment from the depositor
RCB3786
	HZF3(Y3932)
		Comment	Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
		Comment from the depositor
RCB3787
	HZF3(Y3942)
		Comment	Currently not ready. Hybridoma against HZF3 : Hematopoietic zinc finger (107-157(51aa)) antigen.
		Comment from the depositor
RCB3788
	HZF4(Y4006)
		Comment	Currently not ready. Hybridoma against HZF4 : Hematopoietic zinc finger (294-365(72aa)+1amino acid [Ser]) antigen.
		Comment from the depositor
RCB3789
	HZF4(Y4019)
		Comment	Currently not ready. Hybridoma against HZF4 : Hematopoietic zinc finger (294-365(72aa)+1amino acid [Ser]) antigen.
		Comment from the depositor
RCB3790
	tead2(Y3312)
		Comment	Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
		Comment from the depositor
RCB3791
	tead2(Y3321)
		Comment	Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
		Comment from the depositor
RCB3792
	tead2(Y3324)
		Comment	Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
		Comment from the depositor
RCB3793
	tead2(Y3325)
		Comment	Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
		Comment from the depositor
RCB3794
	tead2(Y3329)
		Comment	Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
		Comment from the depositor
RCB3795
	tead2(Y3331)
		Comment	Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
		Comment from the depositor
RCB3796
	tead2(Y3336)
		Comment	Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
		Comment from the depositor
RCB3797
	tead2(Y3339)
		Comment	Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
		Comment from the depositor
RCB3798
	tead2(Y3342)
		Comment	Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
		Comment from the depositor
RCB3799
	tead2(Y3343)
		Comment	Currently not ready. Hybridoma against tead2 : TEA domain family member 2 (140-216(77aa)) antigen.
		Comment from the depositor
RCB3800
	SOCS1-1(Y9208)
		Comment	Currently not ready. Hybridoma against SOCS1-1 : Suppressor of Cytokine Signaling1 (1-60(60aa)) antigen.
		Comment from the depositor
RCB3801
	SOCS1-1(Y9213)
		Comment	Currently not ready. Hybridoma against SOCS1-1 : Suppressor of Cytokine Signaling1 (1-60(60aa)) antigen.
		Comment from the depositor
RCB3802
	SOCS1-1(Y9215)
		Comment	Currently not ready. Hybridoma against SOCS1-1 : Suppressor of Cytokine Signaling1 (1-60(60aa)) antigen.
		Comment from the depositor
RCB3803
	Prdm14-1(N8902)
		Comment	Currently not ready. Hybridoma against Prdm14-1 : PR domain containing14 (1-100(100aa)) antigen.
		Comment from the depositor
RCB3804
	CDK-11(Z0410)
		Comment	Currently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
		Comment from the depositor
RCB3805
	CDK-11(Z0418)
		Comment	Currently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
		Comment from the depositor
RCB3806
	CDK-11(Z0425)
		Comment	Currently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
		Comment from the depositor
RCB3807
	CDK-11(Z0430)
		Comment	Currently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
		Comment from the depositor
RCB3808
	CDK-11(Z0432)
		Comment	Currently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
		Comment from the depositor
RCB3809
	CDK-11(Z0441)
		Comment	Currently not ready. Hybridoma against CDK-11 : Cyclin dependent kinase-11 (378-456(79aa)) antigen.
		Comment from the depositor
RCB3810
	Neurotonin3(Z0835)
		Comment	Currently not ready. Hybridoma against Neurotonin3 : Neurotonin (409-507(99aa)) antigen.
		Comment from the depositor
RCB3811
	Neurotonin4(Z0901-265)
		Comment	Currently not ready. Hybridoma against Neurotonin4 : Neurotonin (1-77(77aa)) antigen.
		Comment from the depositor
RCB3812
	Neurotonin4(Z0937)
		Comment	Currently not ready. Hybridoma against Neurotonin4 : Neurotonin (1-77(77aa)) antigen.
		Comment from the depositor
RCB3813
	Neurotonin4(Z0953)
		Comment	Currently not ready. Hybridoma against Neurotonin4 : Neurotonin (1-77(77aa)) antigen.
		Comment from the depositor
RCB3814
	Neurotonin4(Z0956(222))
		Comment	Currently not ready. Hybridoma against Neurotonin4 : Neurotonin (1-77(77aa)) antigen.
		Comment from the depositor
RCB3815
	AKAP15(Y0319)
		Comment	Currently not ready. Hybridoma against AKAP15 : A kinase anchor protein15 (23-75(53aa)) antigen.
		Comment from the depositor
RCB3816
	AKAP15(Y0329)
		Comment	Currently not ready. Hybridoma against AKAP15 : A kinase anchor protein15 (23-75(53aa)) antigen.
		Comment from the depositor
RCB3817
	AKAP15(Y0332)
		Comment	Currently not ready. Hybridoma against AKAP15 : A kinase anchor protein15 (23-75(53aa)) antigen.
		Comment from the depositor
RCB3818
	AKAP15(Y0335)
		Comment	Currently not ready. Hybridoma against AKAP15 : A kinase anchor protein15 (23-75(53aa)) antigen.
		Comment from the depositor
RCB3819
	AKAP15(Y0348)
		Comment	Currently not ready. Hybridoma against AKAP15 : A kinase anchor protein15 (23-75(53aa)) antigen.
		Comment from the depositor
RCB3820
	mGli2-2(N9106)
		Comment	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
		Comment from the depositor
RCB3821
	mGli2-2(N9109)
		Comment	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
		Comment from the depositor
RCB3822
	mGli2-2(N9110)
		Comment	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
		Comment from the depositor
RCB3823
	mGli2-2(N9113)
		Comment	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
		Comment from the depositor
RCB3824
	mGli2-2(N9119)
		Comment	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
		Comment from the depositor
RCB3825
	mGli2-2(N9122)
		Comment	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
		Comment from the depositor
RCB3826
	mGli2-2(N9124)
		Comment	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
		Comment from the depositor
RCB3827
	mGli2-2(N9133)
		Comment	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
		Comment from the depositor
RCB3828
	mGli2-2(N9143)
		Comment	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
		Comment from the depositor
RCB3829
	mGli2-2(N9144)
		Comment	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
		Comment from the depositor
RCB3830
	mGli2-2(N9145)
		Comment	Currently not ready. Hybridoma against mGli2-2 : GLI family zinc finger 2 (327-391(65aa)) antigen.
		Comment from the depositor
RCB3831
	SMO-2(B7115B)
		Comment	Currently not ready. Hybridoma against SMO-2 : SMO (470-519 (50aa)) antigen.
		Comment from the depositor
RCB3832
	Wnt4(N0716)
		Comment	Currently not ready. Hybridoma against Wnt4 : Wnt4 (37-77 (41aa)) antigen.
		Comment from the depositor
RCB3833
	Gli1(N5510)
		Comment	Currently not ready. Hybridoma against Gli1 : GLI family zinc finger 1 (2-68 (67aa)) antigen.
		Comment from the depositor
RCB3834
	Gli1(N5516-191)
		Comment	Currently not ready. Hybridoma against Gli1 : GLI family zinc finger 1 (2-68 (67aa)) antigen.
		Comment from the depositor
RCB3835
	Gli1(N5537)
		Comment	Currently not ready. Hybridoma against Gli1 : GLI family zinc finger 1 (2-68 (67aa)) antigen.
		Comment from the depositor
RCB3836
	SMO-1(N5813)
		Comment	Currently not ready. Hybridoma against SMO-1 : SMO (90-172 (83aa)) antigen.
		Comment from the depositor
RCB3837
	Gli3(N6202)
		Comment	Currently not ready. Hybridoma against gp64 fusion Gli3 : GLI family zinc finger 3 (2-60 (59aa)) antigen expressed by baculovirus.
		Comment from the depositor
RCB3838
	Calp7-1(Y0717)
		Comment	Currently not ready. Hybridoma against Calp7-1 : Calpain7 (78-157(80aa)) antigen.
		Comment from the depositor
RCB3839
	Calp7-1(Y0737)
		Comment	Currently not ready. Hybridoma against Calp7-1 : Calpain7 (78-157(80aa)) antigen.
		Comment from the depositor
RCB3840
	PEG10-1(H1805)
		Comment	Currently not ready. Hybridoma against PEG10-1 (full length) antigen.
		Comment from the depositor
RCB3841
	PEG10-1(H1807)
		Comment	Currently not ready. Hybridoma against PEG10-1 (full length) antigen.
		Comment from the depositor
RCB3842
	PEG10-1(H1812)
		Comment	Currently not ready. Hybridoma against PEG10-1 (full length) antigen.
		Comment from the depositor
RCB3843
	PEG10-1(H1827)
		Comment	Currently not ready. Hybridoma against PEG10-1 (full length) antigen.
		Comment from the depositor
RCB3844
	PEG10-1(H1829)
		Comment	Currently not ready. Hybridoma against PEG10-1 (full length) antigen.
		Comment from the depositor
RCB3845
	PEG10-1(H1831)
		Comment	Currently not ready. Hybridoma against PEG10-1 (full length) antigen.
		Comment from the depositor
RCB3846
	TFF1deltaN(H6110)
		Comment	Currently not ready. Hybridoma against TFF1 deltaN : TFF1 (full length) antigen.
		Comment from the depositor
RCB3847
	TFF1deltaN(H6111)
		Comment	Currently not ready. Hybridoma against TFF1 deltaN : TFF1 (full length) antigen.
		Comment from the depositor
RCB3848
	TFF1deltaN(H6112)
		Comment	Currently not ready. Hybridoma against TFF1 deltaN : TFF1 (full length) antigen.
		Comment from the depositor
RCB3849
	TFF1deltaN(H6123)
		Comment	Currently not ready. Hybridoma against TFF1 deltaN : TFF1 (full length) antigen.
		Comment from the depositor
RCB3850
	TFF1deltaN(H6134)
		Comment	Currently not ready. Hybridoma against TFF1 deltaN : TFF1 (full length) antigen.
		Comment from the depositor
RCB3851
	STIP1(H3401)
		Comment	Currently not ready. Hybridoma against STIP1 (full length) antigen.
		Comment from the depositor
RCB3852
	STIP1(H3408)
		Comment	Currently not ready. Hybridoma against STIP1 (full length) antigen.
		Comment from the depositor
RCB3853
	STIP1(H3420)
		Comment	Currently not ready. Hybridoma against STIP1 (full length) antigen.
		Comment from the depositor
RCB3854
	STIP1(H3425)
		Comment	Currently not ready. Hybridoma against STIP1 (full length) antigen.
		Comment from the depositor
RCB3855
	STIP1(H3430)
		Comment	Currently not ready. Hybridoma against STIP1 (full length) antigen.
		Comment from the depositor
RCB3856
	STIP1(H3444)
		Comment	Currently not ready. Hybridoma against STIP1 (full length) antigen.
		Comment from the depositor
RCB3857
	STIP1(H3445)
		Comment	Currently not ready. Hybridoma against STIP1 (full length) antigen.
		Comment from the depositor
RCB3858
	STIP1(H3454)
		Comment	Currently not ready. Hybridoma against STIP1 (full length) antigen.
		Comment from the depositor
RCB3859
	STIP1(H3455)
		Comment	Currently not ready. Hybridoma against STIP1 (full length) antigen.
		Comment from the depositor
RCB3860
	STIP1(H3456)
		Comment	Currently not ready. Hybridoma against STIP1 (full length) antigen.
		Comment from the depositor
RCB3861
	STIP1(H1726)
		Comment	Currently not ready. Hybridoma against STIP1 (full length) antigen.
		Comment from the depositor
RCB3862
	STIP1(H1731)
		Comment	Currently not ready. Hybridoma against STIP1 (full length) antigen.
		Comment from the depositor
RCB3863
	Rab32(H3502)
		Comment	Currently not ready. Hybridoma against Rab32 (full length) antigen.
		Comment from the depositor
RCB3864
	Rab32(H3506)
		Comment	Currently not ready. Hybridoma against Rab32 (full length) antigen.
		Comment from the depositor
RCB3865
	Rab32(H3512)
		Comment	Currently not ready. Hybridoma against Rab32 (full length) antigen.
		Comment from the depositor
RCB3866
	Rab32(H3513)
		Comment	Currently not ready. Hybridoma against Rab32 (full length) antigen.
		Comment from the depositor
RCB3867
	Rab32(H3516)
		Comment	Currently not ready. Hybridoma against Rab32 (full length) antigen.
		Comment from the depositor
RCB3868
	Rab32(H3519)
		Comment	Currently not ready. Hybridoma against Rab32 (full length) antigen.
		Comment from the depositor
RCB3869
	Rab32(H3521)
		Comment	Currently not ready. Hybridoma against Rab32 (full length) antigen.
		Comment from the depositor
RCB3870
	GBR7(H4720)
		Comment	Currently not ready. Hybridoma against GBR7 (full length) antigen.
		Comment from the depositor
RCB3871
	GBR7(H4722)
		Comment	Currently not ready. Hybridoma against GBR7 (full length) antigen.
		Comment from the depositor
RCB3872
	GBR7(H4733)
		Comment	Currently not ready. Hybridoma against GBR7 (full length) antigen.
		Comment from the depositor
RCB3873
	GBR7(H4739)
		Comment	Currently not ready. Hybridoma against GBR7 (full length) antigen.
		Comment from the depositor
RCB3874
	GBR7(H4747)
		Comment	Currently not ready. Hybridoma against GBR7 (full length) antigen.
		Comment from the depositor
RCB3875
	GBR7(H4749)
		Comment	Currently not ready. Hybridoma against GBR7 (full length) antigen.
		Comment from the depositor
RCB3876
	GBR7(H4750)
		Comment	Currently not ready. Hybridoma against GBR7 (full length) antigen.
		Comment from the depositor
RCB3877
	GBR7(H4751)
		Comment	Currently not ready. Hybridoma against GBR7 (full length) antigen.
		Comment from the depositor
RCB3878
	GBR7(H4752)
		Comment	Currently not ready. Hybridoma against GBR7 (full length) antigen.
		Comment from the depositor
RCB3879
	GBR7(H4755)
		Comment	Currently not ready. Hybridoma against GBR7 (full length) antigen.
		Comment from the depositor
RCB3880
	FLJ20442(H5409)
		Comment	Currently not ready. Hybridoma against FLJ20442 (full length) antigen.
		Comment from the depositor
RCB3881
	FLJ20442(H5413)
		Comment	Currently not ready. Hybridoma against FLJ20442 (full length) antigen.
		Comment from the depositor
RCB3882
	FLJ20442(H5422)
		Comment	Currently not ready. Hybridoma against FLJ20442 (full length) antigen.
		Comment from the depositor
RCB3883
	FLJ20442(H5425)
		Comment	Currently not ready. Hybridoma against FLJ20442 (full length) antigen.
		Comment from the depositor
RCB3884
	FLJ20442(H5429)
		Comment	Currently not ready. Hybridoma against FLJ20442 (full length) antigen.
		Comment from the depositor
RCB3885
	FLJ20442(H5432)
		Comment	Currently not ready. Hybridoma against FLJ20442 (full length) antigen.
		Comment from the depositor
RCB3886
	FLJ20442(H5433)
		Comment	Currently not ready. Hybridoma against FLJ20442 (full length) antigen.
		Comment from the depositor
RCB3887
	Galectin4(H6004)
		Comment	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
		Comment from the depositor
RCB3888
	Galectin4(H6005)
		Comment	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
		Comment from the depositor
RCB3889
	Galectin4(H6006)
		Comment	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
		Comment from the depositor
RCB3890
	Galectin4(H6007)
		Comment	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
		Comment from the depositor
RCB3891
	Galectin4(H6009)
		Comment	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
		Comment from the depositor
RCB3892
	Galectin4(H6013)
		Comment	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
		Comment from the depositor
RCB3893
	Galectin4(H6015)
		Comment	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
		Comment from the depositor
RCB3894
	Galectin4(H6024)
		Comment	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
		Comment from the depositor
RCB3895
	Galectin4(H6026)
		Comment	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
		Comment from the depositor
RCB3896
	Galectin4(H6034)
		Comment	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
		Comment from the depositor
RCB3897
	Galectin4(H6038)
		Comment	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
		Comment from the depositor
RCB3898
	Galectin4(H6043)
		Comment	Currently not ready. Hybridoma against Galectin4 (full length) antigen.
		Comment from the depositor
RCB3899
	PAEP(H7001)
		Comment	Currently not ready. Hybridoma against PAEP (full length) antigen.
		Comment from the depositor
RCB3900
	PAEP(H7005)
		Comment	Currently not ready. Hybridoma against PAEP (full length) antigen.
		Comment from the depositor
RCB3901
	PAEP(H7006)
		Comment	Currently not ready. Hybridoma against PAEP (full length) antigen.
		Comment from the depositor
RCB3902
	PAEP(H7011)
		Comment	Currently not ready. Hybridoma against PAEP (full length) antigen.
		Comment from the depositor
RCB3903
	PAEP(H7015A)
		Comment	Currently not ready. Hybridoma against PAEP (full length) antigen.
		Comment from the depositor
RCB3904
	PAEP(H7020A)
		Comment	Currently not ready. Hybridoma against PAEP (full length) antigen.
		Comment from the depositor
RCB3905
	PAEP(H7026)
		Comment	Currently not ready. Hybridoma against PAEP (full length) antigen.
		Comment from the depositor
RCB3906
	PAEP(H7033)
		Comment	Currently not ready. Hybridoma against PAEP (full length) antigen.
		Comment from the depositor
RCB3907
	PGC-1(H5953)
		Comment	Currently not ready. Hybridoma against PGC-1 (2-81(80aa)) antigen.
		Comment from the depositor
RCB3908
	STK15(H5701)
		Comment	Currently not ready. Hybridoma against STK15 (full length) antigen.
		Comment from the depositor
RCB3909
	STK15(H5706)
		Comment	Currently not ready. Hybridoma against STK15 (full length) antigen.
		Comment from the depositor
RCB3910
	STK15(H5716)
		Comment	Currently not ready. Hybridoma against STK15 (full length) antigen.
		Comment from the depositor
RCB3911
	STK15(H5723)
		Comment	Currently not ready. Hybridoma against STK15 (full length) antigen.
		Comment from the depositor
RCB3912
	STK15(H5725)
		Comment	Currently not ready. Hybridoma against STK15 (full length) antigen.
		Comment from the depositor
RCB3913
	STK15(H5728)
		Comment	Currently not ready. Hybridoma against STK15 (full length) antigen.
		Comment from the depositor
RCB3914
	STK15(H5737)
		Comment	Currently not ready. Hybridoma against STK15 (full length) antigen.
		Comment from the depositor
RCB3915
	STK15(H5743)
		Comment	Currently not ready. Hybridoma against STK15 (full length) antigen.
		Comment from the depositor
RCB3916
	STK15(H5754)
		Comment	Currently not ready. Hybridoma against STK15 (full length) antigen.
		Comment from the depositor
RCB3917
	STK15(H5755)
		Comment	Currently not ready. Hybridoma against STK15 (full length) antigen.
		Comment from the depositor
RCB3918
	TOP1MT(H8602)
		Comment	Currently not ready. Hybridoma against TOP1MT (full length) antigen.
		Comment from the depositor
RCB3919
	TOP1MT(H8607)
		Comment	Currently not ready. Hybridoma against TOP1MT (full length) antigen.
		Comment from the depositor
RCB3920
	TOP1MT(H8619)
		Comment	Currently not ready. Hybridoma against TOP1MT (full length) antigen.
		Comment from the depositor
RCB3921
	TOP1MT(H8624)
		Comment	Currently not ready. Hybridoma against TOP1MT (full length) antigen.
		Comment from the depositor
RCB3922
	TOP1MT(H8629)
		Comment	Currently not ready. Hybridoma against TOP1MT (full length) antigen.
		Comment from the depositor
RCB3923
	TOP1MT(H8637)
		Comment	Currently not ready. Hybridoma against TOP1MT (full length) antigen.
		Comment from the depositor
RCB3924
	TOP1MT(H8638)
		Comment	Currently not ready. Hybridoma against TOP1MT (full length) antigen.
		Comment from the depositor
RCB3925
	TOP1MT(H8644)
		Comment	Currently not ready. Hybridoma against TOP1MT (full length) antigen.
		Comment from the depositor
RCB3926
	TOP1MT(H8650)
		Comment	Currently not ready. Hybridoma against TOP1MT (full length) antigen.
		Comment from the depositor
RCB3927
	TOP1MT(H8655)
		Comment	Currently not ready. Hybridoma against TOP1MT (full length) antigen.
		Comment from the depositor
RCB3928
	DUSP9(H8901)
		Comment	Currently not ready. Hybridoma against DUSP9 (full length) antigen.
		Comment from the depositor
RCB3929
	DUSP9(H8902)
		Comment	Currently not ready. Hybridoma against DUSP9 (full length) antigen.
		Comment from the depositor
RCB3930
	DUSP9(H8905)
		Comment	Currently not ready. Hybridoma against DUSP9 (full length) antigen.
		Comment from the depositor
RCB3931
	DUSP9(H8913)
		Comment	Currently not ready. Hybridoma against DUSP9 (full length) antigen.
		Comment from the depositor
RCB3932
	DUSP9(H8914)
		Comment	Currently not ready. Hybridoma against DUSP9 (full length) antigen.
		Comment from the depositor
RCB3933
	DUSP9(H8915)
		Comment	Currently not ready. Hybridoma against DUSP9 (full length) antigen.
		Comment from the depositor
RCB3934
	DUSP9(H8921)
		Comment	Currently not ready. Hybridoma against DUSP9 (full length) antigen.
		Comment from the depositor
RCB3935
	DUSP9(H8922)
		Comment	Currently not ready. Hybridoma against DUSP9 (full length) antigen.
		Comment from the depositor
RCB3936
	DUSP9(H8925)
		Comment	Currently not ready. Hybridoma against DUSP9 (full length) antigen.
		Comment from the depositor
RCB3937
	DUSP9(H8942)
		Comment	Currently not ready. Hybridoma against DUSP9 (full length) antigen.
		Comment from the depositor
RCB3938
	TIF2(H8403)
		Comment	Currently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
		Comment from the depositor
RCB3939
	TIF2(H8407)
		Comment	Currently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
		Comment from the depositor
RCB3940
	TIF2(H8411)
		Comment	Currently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
		Comment from the depositor
RCB3941
	TIF2(H8414)
		Comment	Currently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
		Comment from the depositor
RCB3942
	TIF2(H8424)
		Comment	Currently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
		Comment from the depositor
RCB3943
	TIF2(H8427)
		Comment	Currently not ready. Hybridoma against TIF2 (2-47 (46aa)) antigen.
		Comment from the depositor
RCB3944
	SKIP(H8514)
		Comment	Currently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
		Comment from the depositor
RCB3945
	SKIP(H8515)
		Comment	Currently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
		Comment from the depositor
RCB3946
	SKIP(H8529)
		Comment	Currently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
		Comment from the depositor
RCB3947
	SKIP(H8530)
		Comment	Currently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
		Comment from the depositor
RCB3948
	SKIP(H8524)
		Comment	Currently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
		Comment from the depositor
RCB3949
	SKIP(H8531)
		Comment	Currently not ready. Hybridoma against SKIP (2-52 (51aa)) antigen.
		Comment from the depositor
RCB3950
	TRIP13(H9319)
		Comment	Currently not ready. Hybridoma against TRIP13 (2-99 (98aa)) antigen.
		Comment from the depositor
RCB3951
	TRIP13(H9341)
		Comment	Currently not ready. Hybridoma against TRIP13 (2-99 (98aa)) antigen.
		Comment from the depositor
RCB3952
	RCN2(H9757)
		Comment	Currently not ready. Hybridoma against RCN2 (2-99 (98aa)) antigen.
		Comment from the depositor
RCB3953
	RBP2(H9807)
		Comment	Currently not ready. Hybridoma against RBP2 (2-99 (98aa)) antigen.
		Comment from the depositor
RCB3954
	PGC1b-2(N5702)
		Comment	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
		Comment from the depositor
RCB3955
	PGC1b-2(N5704)
		Comment	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
		Comment from the depositor
RCB3956
	PGC1b-2(N5708)
		Comment	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
		Comment from the depositor
RCB3957
	PGC1b-2(N5715)
		Comment	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
		Comment from the depositor
RCB3958
	PGC1b-2(N5719)
		Comment	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
		Comment from the depositor
RCB3959
	PGC1b-2(N5720)
		Comment	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
		Comment from the depositor
RCB3960
	PGC1b-2(N5722)
		Comment	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
		Comment from the depositor
RCB3961
	PGC1b-2(N5723)
		Comment	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
		Comment from the depositor
RCB3962
	PGC1b-2(N5739)
		Comment	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
		Comment from the depositor
RCB3963
	gp64(B8109B)
		Comment	Currently not ready. Hybridoma against gp64 : glycoprotein 64 (full length) antigen.
		Comment from the depositor
RCB3964
	gp64(B8121A)
		Comment	Currently not ready. Hybridoma against gp64 : glycoprotein 64 (full length) antigen.
		Comment from the depositor
RCB3965
	gp64(B8137A)
		Comment	Currently not ready. Hybridoma against gp64 : glycoprotein 64 (full length) antigen.
		Comment from the depositor
RCB3966
	gp64(B8140A)
		Comment	Currently not ready. Hybridoma against gp64 : glycoprotein 64 (full length) antigen.
		Comment from the depositor
RCB3967
	gp64(B8147A)
		Comment	Currently not ready. Hybridoma against gp64 : glycoprotein 64 (full length) antigen.
		Comment from the depositor
RCB3968
	mMTMR6(N7705)
		Comment	Currently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
		Comment from the depositor
RCB3969
	mMTMR6(N7706)
		Comment	Currently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
		Comment from the depositor
RCB3970
	mMTMR6(N7712)
		Comment	Currently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
		Comment from the depositor
RCB3971
	mMTMR6(N7715)
		Comment	Currently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
		Comment from the depositor
RCB3972
	mMTMR6(N7725)
		Comment	Currently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
		Comment from the depositor
RCB3973
	mMTMR6(N7739)
		Comment	Currently not ready. Hybridoma against mMTMR6 : Myotubularin related protein 6 (full length) antigen.
		Comment from the depositor
RCB3974
	SAV-1-N1(Z2011)
		Comment	Currently not ready. Hybridoma against SAV-1-N1 : Salvador homolog 1 (100-149(50aa)) antigen.
		Comment from the depositor
RCB3975
	SAV-1-N1(Z2020)
		Comment	Currently not ready. Hybridoma against SAV-1-N1 : Salvador homolog 1 (100-149(50aa)) antigen.
		Comment from the depositor
RCB3976
	hPPARα-1(Y1820)
		Comment	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
		Comment from the depositor
RCB3977
	hFRS2β1(Y7607)
		Comment	Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
		Comment from the depositor
RCB3978
	hPPARα-1(Y1846)
		Comment	Currently not ready. Hybridoma against PGC1b-2 : PGC1b (52-100(49aa)) antigen.
		Comment from the depositor
RCB3979
	hRev-erbα-1(Y2313)
		Comment	Currently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
		Comment from the depositor
RCB3980
	hRev-erbα-1(Y2319)
		Comment	Currently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
		Comment from the depositor
RCB3981
	hRev-erbα-1(Y2325)
		Comment	Currently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
		Comment from the depositor
RCB3982
	hRev-erbα-1(Y2336)
		Comment	Currently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
		Comment from the depositor
RCB3983
	hRev-erbα-1(Y2339)
		Comment	Currently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
		Comment from the depositor
RCB3984
	hRev-erbα-1(Y2340)
		Comment	Currently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
		Comment from the depositor
RCB3985
	hRev-erbα-1(Y2347)
		Comment	Currently not ready. Hybridoma against hRev-erbα-1 : Rev-erbα (2-49 (48)aa) antigen.
		Comment from the depositor
RCB3986
	DKK1(H2907)
		Comment	Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
		Comment from the depositor
RCB3987
	DKK1(H2910)
		Comment	Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
		Comment from the depositor
RCB3988
	DKK1(H2913)
		Comment	Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
		Comment from the depositor
RCB3989
	DKK1(H2914)
		Comment	Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
		Comment from the depositor
RCB3990
	DKK1(H2922)
		Comment	Hybridoma generated against DKK1 : Dickkopf 1 (full length) antigen.
		Comment from the depositor
RCB3991
	DKK1(H2927)
		Comment	Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
		Comment from the depositor
RCB3992
	DKK1(H2928)
		Comment	Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
		Comment from the depositor
RCB3993
	DKK1(H2933)
		Comment	Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
		Comment from the depositor
RCB3994
	DKK1(H2936)
		Comment	Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
		Comment from the depositor
RCB3995
	DKK1(H2940)
		Comment	Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
		Comment from the depositor
RCB3996
	DKK1(H2945)
		Comment	Currently not ready. Hybridoma against DKK1 : Dickkopf 1 (full length) antigen.
		Comment from the depositor
RCB3997
	hNDR2C(Z1419)
		Comment	Currently not ready. Hybridoma against hNDR2C : Nodal-related 2 (365-464(100aa)) antigen.
		Comment from the depositor
RCB3998
	hNDR2C(Z1440)
		Comment	Currently not ready. Hybridoma against hNDR2C : Nodal-related 2 (365-464(100aa)) antigen.
		Comment from the depositor
RCB3999
	hNDR2C(Y5118)
		Comment	Currently not ready. Hybridoma against hNDR2C : Nodal-related 2 (365-464(100aa)) antigen.
		Comment from the depositor
RCB4000
	NFIA1(Y2230)
		Comment	Currently not ready. Hybridoma against NFIA1 : Nuclear factor I-A1 (256-315(60aa)) antigen.
		Comment from the depositor
RCB4001
	NFIA1(Y2236)
		Comment	Currently not ready. Hybridoma against NFIA1 : Nuclear factor I-A1 (256-315(60aa)) antigen.
		Comment from the depositor
RCB4002
	NFIA1(Y2238)
		Comment	Currently not ready. Hybridoma against NFIA1 : Nuclear factor I-A1 (256-315(60aa)) antigen.
		Comment from the depositor
RCB4003
	NFIA1(Y2240)
		Comment	Currently not ready. Hybridoma against NFIA1 : Nuclear factor I-A1 (256-315(60aa)) antigen.
		Comment from the depositor
RCB4004
	NFIB3(Y2823)
		Comment	Currently not ready. Hybridoma against NFIB3 : Nuclear factor I-B3 (347-414(68aa)) antigen.
		Comment from the depositor
RCB4005
	NFIB3(Y2833)
		Comment	Currently not ready. Hybridoma against NFIB3 : Nuclear factor I-B3 (347-414(68aa)) antigen.
		Comment from the depositor
RCB4006
	NFIX1(Y4402)
		Comment	Currently not ready. Hybridoma against NFIX1 : Nuclear factor I-X1 (258-318(61aa)) antigen.
		Comment from the depositor
RCB4007
	NFIX1(Y4406)
		Comment	Currently not ready. Hybridoma against NFIX1 : Nuclear factor I-X1 (258-318(61aa)) antigen.
		Comment from the depositor
RCB4008
	NFIX1(Y4418)
		Comment	Currently not ready. Hybridoma against NFIX1 : Nuclear factor I-X1 (258-318(61aa)) antigen.
		Comment from the depositor
RCB4009
	NFIX1(Y4424)
		Comment	Currently not ready. Hybridoma against NFIX1 : Nuclear factor I-X1 (258-318(61aa)) antigen.
		Comment from the depositor
RCB4010
	hNRF2-3(Y4902)
		Comment	Currently not ready. Hybridoma against NFIX1 : hNRF2-3 : Nuclear factor erythroid2-related factor 2 (331-390(60aa)) antigen.
		Comment from the depositor
RCB4011
	Bach1-H1(N9502)
		Comment	Currently not ready. Hybridoma against NFIX1 : Bach1-H1 : BTB and CNC homology 1 (317-390(74aa)) antigen.
		Comment from the depositor
RCB4012
	Bach1-H1(N9516)
		Comment	Currently not ready. Hybridoma against NFIX1 : Bach1-H1 : BTB and CNC homology 1 (317-390(74aa)) antigen.
		Comment from the depositor
RCB4013
	Bach1-H2(Y0208)
		Comment	Currently not ready. Hybridoma against NFIX1 : Bach1-H2 : BTB and CNC homology 1 (637-725(89aa)) antigen.
		Comment from the depositor
RCB4014
	Bach1-M1(N9602)
		Comment	Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(75aa)) antigen.
		Comment from the depositor
RCB4015
	Bach1-M1(N9609)
		Comment	Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(75aa)) antigen.
		Comment from the depositor
RCB4016
	Bach1-M1(N9610)
		Comment	Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(75aa)) antigen.
		Comment from the depositor
RCB4017
	Bach1-M1(N9611)
		Comment	Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(75aa)) antigen.
		Comment from the depositor
RCB4018
	Bach1-M1(N9613)
		Comment	Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(75aa)) antigen.
		Comment from the depositor
RCB4019
	Bach1-M1(N9628)
		Comment	Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(75aa)) antigen.
		Comment from the depositor
RCB4020
	Bach1-M1(N9639)
		Comment	Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(75aa)) antigen.
		Comment from the depositor
RCB4021
	Bach1-M1(N9642)
		Comment	Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(75aa)) antigen.
		Comment from the depositor
RCB4022
	Bach1-M1(N9647)
		Comment	Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(75aa)) antigen.
		Comment from the depositor
RCB4023
	Bach1-M1(N9648)
		Comment	Currently not ready. Hybridoma against NFIX1 : Bach1-M1 : BTB and CNC homology 1 (318-392(75aa)) antigen.
		Comment from the depositor
RCB4024
	Bach1-M2(Y2103)
		Comment	Currently not ready. Hybridoma against Bach1-M2 : BTB and CNC homology 1 (640-728(89aa)) antigen.
		Comment from the depositor
RCB4025
	Bach1-M2(Y2117)
		Comment	Currently not ready. Hybridoma against Bach1-M2 : BTB and CNC homology 1 (640-728(89aa)) antigen.
		Comment from the depositor
RCB4026
	Bach1-M2(Y2133)
		Comment	Currently not ready. Hybridoma against Bach1-M2 : BTB and CNC homology 1 (640-728(89aa)) antigen.
		Comment from the depositor
RCB4027
	DRPLA-2(N9330)
		Comment	Currently not ready. Hybridoma against DRPLA-2 : Dentato-rubro-pallido-luysian atrophy (101-200(100aa)) antigen.
		Comment from the depositor
RCB4028
	DRPLA-2(N9331)
		Comment	Currently not ready. Hybridoma against DRPLA-2 : Dentato-rubro-pallido-luysian atrophy (101-200(100aa)) antigen.
		Comment from the depositor
RCB4029
	DRPLA-4(Y0435)
		Comment	Currently not ready. Hybridoma against DRPLA-4 : Dentato-rubro-pallido-luysian atrophy (1085-1184(100aa)) antigen.
		Comment from the depositor
RCB4030
	hPTK7-Cyto(Y2040)
		Comment	Currently not ready. Hybridoma against hPTK7-Cyto : Tyrosine-protein kinase-like 7 (725-795(70aa)) antigen.
		Comment from the depositor
RCB4031
	hPTK7-Extra(Y1927)
		Comment	Currently not ready. Hybridoma against hPTK7-Extra : Tyrosine-protein kinase-like 7 (31-130 (100aa)) antigen.
		Comment from the depositor
RCB4032
	hPTK7-Extra(Y1937)
		Comment	Currently not ready. Hybridoma against hPTK7-Extra : Tyrosine-protein kinase-like 7 (31-130 (100aa)) antigen.
		Comment from the depositor
RCB4033
	MEF2A-3(Y0809)
		Comment	Currently not ready. Hybridoma against MEF2A-3 : Myocyte-specific enhancer factor 2A (318-403(86aa)) antigen.
		Comment from the depositor
RCB4034
	MEF2A-3(Y0833)
		Comment	Currently not ready. Hybridoma against MEF2A-3 : Myocyte-specific enhancer factor 2A (318-403(86aa)) antigen.
		Comment from the depositor
RCB4035
	MEF2A-3(Y0834)
		Comment	Currently not ready. Hybridoma against MEF2A-3 : Myocyte-specific enhancer factor 2A (318-403(86aa)) antigen.
		Comment from the depositor
RCB4036
	MEF2A-3(Y0841)
		Comment	Currently not ready. Hybridoma against MEF2A-3 : Myocyte-specific enhancer factor 2A (318-403(86aa)) antigen.
		Comment from the depositor
RCB4037
	MEF2A-3(Y0847)
		Comment	Currently not ready. Hybridoma against MEF2A-3 : Myocyte-specific enhancer factor 2A (318-403(86aa)) antigen.
		Comment from the depositor
RCB4038
	MEF2C-2(Y1728)
		Comment	Currently not ready. Hybridoma against MEF2C-2 : Myocyte-specific enhancer factor 2C (161-248(88aa)) antigen.
		Comment from the depositor
RCB4039
	MEF2C-2(Y1740)
		Comment	Currently not ready. Hybridoma against MEF2C-2 : Myocyte-specific enhancer factor 2C (161-248(88aa)) antigen.
		Comment from the depositor
RCB4040
	AFP(B2007C)
		Comment	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
		Comment from the depositor
RCB4041
	AFP(B2011D)
		Comment	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
		Comment from the depositor
RCB4042
	AFP(B2015C)
		Comment	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
		Comment from the depositor
RCB4043
	AFP(B2117C)
		Comment	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
		Comment from the depositor
RCB4044
	AFP(B2150D)
		Comment	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
		Comment from the depositor
RCB4045
	AFP(B2151D)
		Comment	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
		Comment from the depositor
RCB4046
	TFF1(N2306)
		Comment	Currently not ready. Hybridoma against TFF1 (27-75 (49aa)) antigen.
		Comment from the depositor
RCB4047
	TFF1(N2309)
		Comment	Currently not ready. Hybridoma against TFF1 (27-75 (49aa)) antigen.
		Comment from the depositor
RCB4048
	TFF1(N2320)
		Comment	Currently not ready. Hybridoma against TFF1 (27-75 (49aa)) antigen.
		Comment from the depositor
RCB4049
	TFF1(N2325)
		Comment	Currently not ready. Hybridoma against TFF1 (27-75 (49aa)) antigen.
		Comment from the depositor
RCB4050
	mGCNF-Hinge(N6724)
		Comment	Currently not ready. Hybridoma against mGCNF-Hinge : Germ cell nuclear factor (160-263(104aa)) antigen.
		Comment from the depositor
RCB4051
	mGCNF-Hinge(N6729)
		Comment	Currently not ready. Hybridoma against mGCNF-Hinge : Germ cell nuclear factor (160-263(104aa)) antigen.
		Comment from the depositor
RCB4052
	mGCNF-Hinge(N6737)
		Comment	Currently not ready. Hybridoma against mGCNF-Hinge : Germ cell nuclear factor (160-263(104aa)) antigen.
		Comment from the depositor
RCB4053
	mGCNF-Hinge(N6760)
		Comment	Currently not ready. Hybridoma against mGCNF-Hinge : Germ cell nuclear factor (160-263(104aa)) antigen.
		Comment from the depositor
RCB4054
	mGCNF-N(N6807)
		Comment	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
		Comment from the depositor
RCB4055
	mGCNF-N(N6812)
		Comment	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
		Comment from the depositor
RCB4056
	mGCNF-N(N6813)
		Comment	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
		Comment from the depositor
RCB4057
	mGCNF-N(N6816)
		Comment	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
		Comment from the depositor
RCB4058
	mGCNF-N(N6819)
		Comment	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
		Comment from the depositor
RCB4059
	mGCNF-N(N6823)
		Comment	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
		Comment from the depositor
RCB4060
	mGCNF-N(N6824)
		Comment	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
		Comment from the depositor
RCB4061
	mGCNF-N(N6831)
		Comment	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
		Comment from the depositor
RCB4062
	mGCNF-N(N6832)
		Comment	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
		Comment from the depositor
RCB4063
	mGCNF-N(N6836)
		Comment	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
		Comment from the depositor
RCB4064
	mGCNF-N(N6839)
		Comment	Currently not ready. Hybridoma against mGCNF-N : Germ cell nuclear factor (2-70(69aa)) antigen.
		Comment from the depositor
RCB4065
	hFOXP3(B8905-6)
		Comment	Currently not ready. Hybridoma against hFOXP3 : Forkhead box P3 (105-190(86aa)) antigen.
		Comment from the depositor
RCB4066
	hFOXP3(B8916B)
		Comment	Currently not ready. Hybridoma against hFOXP3 : Forkhead box P3 (105-190(86aa)) antigen.
		Comment from the depositor
RCB4067
	PPARdelta-1(2-45)(C0309A)
		Comment	Currently not ready. Hybridoma against PPARdelta-1 (2-45) : Peroxisome proliferator-activated receptor delta (2-45(44aa)) antigen.
		Comment from the depositor
RCB4068
	PPARdelta-1(2-45)(C0309B)
		Comment	Currently not ready. Hybridoma against PPARdelta-1 (2-45) : Peroxisome proliferator-activated receptor delta (2-45(44aa)) antigen.
		Comment from the depositor
RCB4069
	PPARdelta-1(2-45)(C0309C)
		Comment	Currently not ready. Hybridoma against PPARdelta-1 (2-45) : Peroxisome proliferator-activated receptor delta (2-45(44aa)) antigen.
		Comment from the depositor
RCB4070
	hRev-erbα-2(Y2408)
		Comment	Currently not ready. Hybridoma against hRev-erbα-2 : Rev-erbα (41-80(40aa)) antigen.
		Comment from the depositor
RCB4071
	hHNF4ɤ-1(Y4602)
		Comment	Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
		Comment from the depositor
RCB4072
	hHNF4ɤ-1(Y4611)
		Comment	Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
		Comment from the depositor
RCB4073
	hHNF4ɤ-1(Y4618)
		Comment	Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
		Comment from the depositor
RCB4074
	hHNF4ɤ-1(Y4621)
		Comment	Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
		Comment from the depositor
RCB4075
	hHNF4ɤ-1(Y4623)
		Comment	Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
		Comment from the depositor
RCB4076
	hHNF4ɤ-1(Y4625)
		Comment	Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
		Comment from the depositor
RCB4077
	hHNF4ɤ-1(Y4626)
		Comment	Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
		Comment from the depositor
RCB4078
	hHNF4ɤ-1(Y4635)
		Comment	Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
		Comment from the depositor
RCB4079
	hHNF4ɤ-1(Y4643)
		Comment	Currently not ready. Hybridoma against hHNF4γ-1 : Hepatic nuclear factor 4 γ (78-127(50aa)) antigen.
		Comment from the depositor
RCB4080
	Cys-SN2(N3306)
		Comment	Hybridoma against Cys-SN2 : Cystatin (92-117 (26aa)) antigen.
		Comment from the depositor	Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4081
	Cys-SN2(N3312)
		Comment	Hybridoma against Cys-SN2 :Cystatin (92-117 (26aa)) antigen.
		Comment from the depositor	Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4082
	Cys-SN2(N3316)
		Comment	Hybridoma against Cys-SN2 :Cystatin (92-117 (26aa)) antigen.
		Comment from the depositor	Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4083
	Cys-SN2(N3323)
		Comment	Hybridoma against Cys-SN2 : Cystatin (92-117 (26aa)) antigen.
		Comment from the depositor
RCB4084
	Cys-SN2(N3331)
		Comment	Hybridoma against Cys-SN2 : Cystatin (92-117 (26aa)) antigen.
		Comment from the depositor	Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4085
	Cys-SN2(N3338)
		Comment	Hybridoma against Cys-SN2 : Cystatin (92-117 (26aa)) antigen.
		Comment from the depositor	Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4086
	Cys-SN2(N3344)
		Comment	Hybridoma against Cys-SN2 : Cystatin (92-117 (26aa)) antigen.
		Comment from the depositor	Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4087
	Cys-SN2(N3346)
		Comment	Currently not ready. Hybridoma against Cys-SN2 : Cystatin (92-117 (26aa)) antigen.
		Comment from the depositor
RCB4088
	Cys-SN2(N3349)
		Comment	Hybridoma against Cys-SN2 : Cystatin (92-117 (26aa)) antigen.
		Comment from the depositor	Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4089
	Cys-SN2(N3372)
		Comment	Hybridoma against Cys-SN2 : Cystatin (92-117 (26aa)) antigen.
		Comment from the depositor	Cystatin(92-117(26aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4090
	TRβ-CT(H9401)
		Comment	Currently not ready. Hybridoma against TRβ-CT : TRβ (199-227 (29aa)) antigen.
		Comment from the depositor
RCB4091
	TRβ-CT(H9420)
		Comment	Currently not ready. Hybridoma against TRβ-CT : TRβ (199-227 (29aa)) antigen.
		Comment from the depositor
RCB4092
	TRβ-CT(H9431)
		Comment	Currently not ready. Hybridoma against TRβ-CT : TRβ (199-227 (29aa)) antigen.
		Comment from the depositor
RCB4093
	TRβ-CT(H9437)
		Comment	Currently not ready. Hybridoma against TRβ-CT : TRβ (199-227 (29aa)) antigen.
		Comment from the depositor
RCB4094
	mGli2(N7206)
		Comment	Currently not ready. Hybridoma against mGli2 : GLI family zinc finger 2 (3-49 (47aa)) antigen.
		Comment from the depositor
RCB4095
	mGli2(N7212)
		Comment	Currently not ready. Hybridoma against mGli2 : GLI family zinc finger 2 (3-49 (47aa)) antigen.
		Comment from the depositor
RCB4096
	mGli2(N7219)
		Comment	Currently not ready. Hybridoma against mGli2 : GLI family zinc finger 2 (3-49 (47aa)) antigen.
		Comment from the depositor
RCB4097
	mGli2(N7237)
		Comment	Currently not ready. Hybridoma against mGli2 : GLI family zinc finger 2 (3-49 (47aa)) antigen.
		Comment from the depositor
RCB4098
	mTES101-RP(N6002)
		Comment	Currently not ready. Hybridoma against mTES101-RP : Testicular germ cell specific antigen101 (194-217(24aa)) antigen.
		Comment from the depositor
RCB4099
	mTES101-RP(N6022A)
		Comment	Currently not ready. Hybridoma against mTES101-RP : Testicular germ cell specific antigen101 (194-217(24aa)) antigen.
		Comment from the depositor
RCB4100
	mTES101-RP(N6022B)
		Comment	Currently not ready. Hybridoma against mTES101-RP : Testicular germ cell specific antigen101 (194-217(24aa)) antigen.
		Comment from the depositor
RCB4101
	mTES101-RP(N6035)
		Comment	Currently not ready. Hybridoma against mTES101-RP : Testicular germ cell specific antigen101 (194-217(24aa)) antigen.
		Comment from the depositor
RCB4102
	mTES101-RP(N6038)
		Comment	Currently not ready. Hybridoma against mTES101-RP : Testicular germ cell specific antigen101 (194-217(24aa)) antigen.
		Comment from the depositor
RCB4103
	TADA3(B0331A)
		Comment	Currently not ready. Hybridoma against TADA3 (3-49 (61-160 (100aa)) antigen.
		Comment from the depositor
RCB4104
	WBP2(N2617)
		Comment	Currently not ready. Hybridoma against WBP2 (3-49 (2-101(100aa)) antigen.
		Comment from the depositor
RCB4105
	WBP2(N2640)
		Comment	Currently not ready. Hybridoma against WBP2 (3-49 (2-101(100aa)) antigen.
		Comment from the depositor
RCB4106
	WBP2(N2645)
		Comment	Currently not ready. Hybridoma against WBP2 (3-49 (2-101(100aa)) antigen.
		Comment from the depositor
RCB4107
	AI-gp(Y3111)
		Comment	Currently not ready. Hybridoma against AI-gp : AI (506-555(50aa)) antigen.
		Comment from the depositor
RCB4108
	AI-gp(Y3123)
		Comment	Currently not ready. Hybridoma against AI-gp : AI (506-555(50aa)) antigen.
		Comment from the depositor
RCB4109
	AI-gp(Y3124)
		Comment	Currently not ready. Hybridoma against AI-gp : AI (506-555(50aa)) antigen.
		Comment from the depositor
RCB4110
	AI-gp(Y3127)
		Comment	Currently not ready. Hybridoma against AI-gp : AI (506-555(50aa)) antigen.
		Comment from the depositor
RCB4111
	AI-gp(Y3147)
		Comment	Currently not ready. Hybridoma against AI-gp : AI (506-555(50aa)) antigen.
		Comment from the depositor
RCB4112
	AFP(B5925A)
		Comment	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
		Comment from the depositor
RCB4113
	AFP(B5937F)
		Comment	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
		Comment from the depositor
RCB4114
	AFP(B5939D)
		Comment	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
		Comment from the depositor
RCB4115
	AFP(B5944F)
		Comment	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
		Comment from the depositor
RCB4116
	AFP(B5955D)
		Comment	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
		Comment from the depositor
RCB4117
	AFP(B5963D)
		Comment	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
		Comment from the depositor
RCB4118
	AFP(B5980D)
		Comment	Currently not ready. Hybridoma against AFP : Alpha-fetoprotein (full length) antigen.
		Comment from the depositor
RCB4119
	CCR5 SP3(Y4108)
		Comment	Currently not ready. Hybridoma against CCR5 SP3(Y sulfation) : Chemokine receptor 5 (11-19(9aa)) antigen.
		Comment from the depositor
RCB4120
	CCR5 SP3(Y4125)
		Comment	Currently not ready. Hybridoma against CCR5 SP3(Y sulfation) : Chemokine receptor 5 (11-19(9aa)) antigen.
		Comment from the depositor
RCB4121
	CCR5 SP3(Y4126)
		Comment	Currently not ready. Hybridoma against CCR5 SP3(Y sulfation) : Chemokine receptor 5 (11-19(9aa)) antigen.
		Comment from the depositor
RCB4122
	mNCoR-1(Y8110)
		Comment	Currently not ready. Hybridoma against mNCoR-1 : Nuclear receptor corepressor 1 (1817-1879(63aa)) antigen.
		Comment from the depositor
RCB4123
	mNCoR-1(Y8111)
		Comment	Hybridoma against mNCoR-1 : Nuclear receptor corepressor 1 (1817-1879(63aa)) antigen.
		Comment from the depositor	Nuclear receptor corepressor 1 (1817-1879(63aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4124
	mNCoR-1(Y8129)
		Comment	Hybridoma against mNCoR-1 : Nuclear receptor corepressor 1 (1817-1879(63aa)) antigen.
		Comment from the depositor	Nuclear receptor corepressor 1 (1817-1879(63aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4125
	mNCoR-1(Y8131(A))
		Comment	Currently not ready. Hybridoma against mNCoR-1 : Nuclear receptor corepressor 1 (1817-1879(63aa)) antigen.
		Comment from the depositor
RCB4126
	mSRC-1(Y8207)
		Comment	Currently not ready. Hybridoma against mSRC-1 (626-668(43aa)) antigen.
		Comment from the depositor
RCB4127
	mSRC-1(Y8243)
		Comment	Currently not ready. Hybridoma against mSRC-1 (626-668(43aa)) antigen.
		Comment from the depositor
RCB4128
	HSMRT(Y9017)
		Comment	Currently not ready. Hybridoma against HSMRT (1922-2043(122aa)) antigen.
		Comment from the depositor
RCB4129
	HSMRT(Y9033)
		Comment	Currently not ready. Hybridoma against HSMRT (1922-2043(122aa)) antigen.
		Comment from the depositor
RCB4130
	hRIP140(Y9140)
		Comment	Currently not ready. Hybridoma against hRIP140 (733-847(115aa)) antigen.
		Comment from the depositor
RCB4131
	hTIF2(Y8917)
		Comment	Currently not ready. Hybridoma against hTIF2 (733-847(753-804(52aa)) antigen.
		Comment from the depositor
RCB4132
	hTIF2(Y8918)
		Comment	Currently not ready. Hybridoma against hTIF2 (733-847(753-804(52aa)) antigen.
		Comment from the depositor
RCB4133
	BAP37(Z1131B)
		Comment	Currently not ready. Hybridoma against BAP37 : B-cell receptor-associated protein 37 (210-249(40aa)) antigen.
		Comment from the depositor
RCB4134
	SOX21 PepT3(Z3001)
		Comment	Currently not ready. Hybridoma against SOX21 PepT3 : SRY (sex determining region Y)-box 21 (129-176(48aa)) antigen.
		Comment from the depositor
RCB4135
	Epc1AG(Z3703)
		Comment	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
		Comment from the depositor
RCB4136
	Epc1AG(Z3705)
		Comment	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
		Comment from the depositor
RCB4137
	Epc1AG(Z3710)
		Comment	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
		Comment from the depositor
RCB4138
	Epc1AG(Z3714)
		Comment	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
		Comment from the depositor
RCB4139
	Epc1AG(Z3715)
		Comment	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
		Comment from the depositor
RCB4140
	Epc1AG(Z3716)
		Comment	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
		Comment from the depositor
RCB4141
	Epc1AG(Z3725)
		Comment	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
		Comment from the depositor
RCB4142
	Epc1AG(Z3728)
		Comment	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
		Comment from the depositor
RCB4143
	Epc1AG(Z3733)
		Comment	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
		Comment from the depositor
RCB4144
	Epc1AG(Z3741)
		Comment	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
		Comment from the depositor
RCB4145
	Epc1AG(Z3742)
		Comment	Currently not ready. Hybridoma against Epc1AG : Enhancer of polycomb homolog 1 (718-763(46aa)) antigen.
		Comment from the depositor
RCB4146
	Epc2AG(Z3901)
		Comment	Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
		Comment from the depositor
RCB4147
	Epc2AG(Z3906)
		Comment	Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
		Comment from the depositor
RCB4148
	Epc2AG(Z3908)
		Comment	Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
		Comment from the depositor
RCB4149
	Epc2AG(Z3911)
		Comment	Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
		Comment from the depositor
RCB4150
	Epc2AG(Z3921)
		Comment	Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
		Comment from the depositor
RCB4151
	Epc2AG(Z3922)
		Comment	Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
		Comment from the depositor
RCB4152
	Epc2AG(Z3925)
		Comment	Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
		Comment from the depositor
RCB4153
	Epc2AG(Z3931)
		Comment	Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
		Comment from the depositor
RCB4154
	Epc2AG(Z3934)
		Comment	Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
		Comment from the depositor
RCB4155
	Epc2AG(Z3940)
		Comment	Currently not ready. Hybridoma against Epc2AG : Enhancer of polycomb homolog 2 (701-779(79aa)) antigen.
		Comment from the depositor
RCB4156
	STK3(Z2801)
		Comment	Currently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(55aa)) antigen.
		Comment from the depositor
RCB4157
	STK3(Z2804)
		Comment	Currently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(55aa)) antigen.
		Comment from the depositor
RCB4158
	STK3(Z2814)
		Comment	Currently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(55aa)) antigen.
		Comment from the depositor
RCB4159
	STK3(Z2816)
		Comment	Currently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(55aa)) antigen.
		Comment from the depositor
RCB4160
	STK3(Z2822)
		Comment	Currently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(55aa)) antigen.
		Comment from the depositor
RCB4161
	STK3(Z2828)
		Comment	Currently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(55aa)) antigen.
		Comment from the depositor
RCB4162
	STK3(Z2829)
		Comment	Currently not ready. Hybridoma against STK3 : Serine/threonine kinase 3 (382-436(55aa)) antigen.
		Comment from the depositor
RCB4163
	mDAI-3S(Z4401)
		Comment	Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
		Comment from the depositor
RCB4164
	mDAI-3S(Z4410)
		Comment	Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
		Comment from the depositor
RCB4165
	mDAI-3S(Z4415)
		Comment	Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
		Comment from the depositor
RCB4166
	mDAI-3S(Z4420)
		Comment	Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
		Comment from the depositor
RCB4167
	mDAI-3S(Z4424)
		Comment	Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
		Comment from the depositor
RCB4168
	mDAI-3S(Z4429)
		Comment	Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
		Comment from the depositor
RCB4169
	mDAI-3S(Z4402)
		Comment	Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
		Comment from the depositor
RCB4170
	mDAI-3S(Z4418)
		Comment	Currently not ready. Hybridoma against mDAI-3S : DNA-dependent activator of IFN-regulatory factors (362-411(50aa)) antigen.
		Comment from the depositor
RCB4171
	JHDM2A-3C(Z5507)
		Comment	Currently not ready. Hybridoma against JHDM2A-3C : Jumonji domain containing gene family of histone demethylase 2A (1151-1224(74aa)) antigen.
		Comment from the depositor
RCB4172
	JHDM2A-4C(Z6316)
		Comment	Currently not ready. Hybridoma against JHDM2A-4C : Jumonji domain containing gene family of histone demethylase 2A (1089-1138(50aa)) antigen.
		Comment from the depositor
RCB4173
	HIF1(Z6413)
		Comment	Currently not ready. Hybridoma against HIF1 : Hypoxia-inducible transcription factor 1 (361-405(45aa)) antigen.
		Comment from the depositor
RCB4174
	HIF1(Z6414)
		Comment	Currently not ready. Hybridoma against HIF1 : Hypoxia-inducible transcription factor 1 (361-405(45aa)) antigen.
		Comment from the depositor
RCB4175
	HIF1(Z6417)
		Comment	Currently not ready. Hybridoma against HIF1 : Hypoxia-inducible transcription factor 1 (361-405(45aa)) antigen.
		Comment from the depositor
RCB4176
	HIF1(Z6437)
		Comment	Currently not ready. Hybridoma against HIF1 : Hypoxia-inducible transcription factor 1 (361-405(45aa)) antigen.
		Comment from the depositor
RCB4177
	HIF2(Z6502)
		Comment	Currently not ready. Hybridoma against HIF2 : Hypoxia-inducible transcription factor 2 (603-652(50aa)) antigen.
		Comment from the depositor
RCB4178
	HIF2(Z6526)
		Comment	Currently not ready. Hybridoma against HIF2 : Hypoxia-inducible transcription factor 2 (603-652(50aa)) antigen.
		Comment from the depositor
RCB4179
	p65-12(Z6635)
		Comment	Currently not ready. Hybridoma against p65-12 : p65 (116-168(53aa)) antigen.
		Comment from the depositor
RCB4180
	Mrf2-2(Z7411)
		Comment	Currently not ready. Hybridoma against Mrf2-2 : Modulator recognition factor 2 (1140-1189(50aa)) antigen.
		Comment from the depositor
RCB4181
	Mrf2-2(Z7437)
		Comment	Currently not ready. Hybridoma against Mrf2-2 : Modulator recognition factor 2 (1140-1189(50aa)) antigen.
		Comment from the depositor
RCB4182
	THRAP3(Z6803)
		Comment	Currently not ready. Hybridoma against THRAP3 : Thyroid hormone receptor associated protein 3 (457-513(57aa)) antigen.
		Comment from the depositor
RCB4183
	THRAP3(Z6824)
		Comment	Currently not ready. Hybridoma against THRAP3 : Thyroid hormone receptor associated protein 3 (457-513(57aa)) antigen.
		Comment from the depositor
RCB4184
	THRAP3(Z6832)
		Comment	Currently not ready. Hybridoma against THRAP3 : Thyroid hormone receptor associated protein 3 (457-513(57aa)) antigen.
		Comment from the depositor
RCB4185
	THRAP3(Z6840)
		Comment	Currently not ready. Hybridoma against THRAP3 : Thyroid hormone receptor associated protein 3 (457-513(57aa)) antigen.
		Comment from the depositor
RCB4186
	KLF4(Z6902)
		Comment	Currently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(65aa)) antigen.
		Comment from the depositor
RCB4187
	KLF4(Z6913)
		Comment	Currently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(65aa)) antigen.
		Comment from the depositor
RCB4188
	KLF4(Z6919)
		Comment	Currently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(65aa)) antigen.
		Comment from the depositor
RCB4189
	KLF4(Z6928)
		Comment	Currently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(65aa)) antigen.
		Comment from the depositor
RCB4190
	KLF4(Z6929)
		Comment	Currently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(65aa)) antigen.
		Comment from the depositor
RCB4191
	KLF4(Z6943)
		Comment	Currently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(65aa)) antigen.
		Comment from the depositor
RCB4192
	KLF4(Z6944)
		Comment	Currently not ready. Hybridoma against KLF4 : Kruppel-like factor 4 (26-90(65aa)) antigen.
		Comment from the depositor
RCB4193
	CCR4aN(Y6206)
		Comment	Hybridoma against CCR4aN : CCR4-NOT transcription complex, subunit 6 (141-190(50aa)) antigen.
		Comment from the depositor	CCR4aN : CCR4-NOT transcription complex, subunit 6 (141-190(50aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4194
	CCR4bC(Y5601)
		Comment	Currently not ready. Hybridoma against CCR4bC : CCR4-NOT transcription complex, subunit 6-like (501-555(55aa)) antigen.
		Comment from the depositor
RCB4195
	CCR4bC(Y5606)
		Comment	Currently not ready. Hybridoma against CCR4bC : CCR4-NOT transcription complex, subunit 6-like (501-555(55aa)) antigen.
		Comment from the depositor
RCB4196
	CCR4bC(Y5657)
		Comment	Currently not ready. Hybridoma against CCR4bC : CCR4-NOT transcription complex, subunit 6-like (501-555(55aa)) antigen.
		Comment from the depositor
RCB4197
	SETD3(Y2501)
		Comment	Currently not ready. Hybridoma against SETD3 : SET domain containing 3 (2-139(138aa)) antigen.
		Comment from the depositor
RCB4198
	SETD3(Y2537)
		Comment	Currently not ready. Hybridoma against SETD3 : SET domain containing 3 (2-139(138aa)) antigen.
		Comment from the depositor
RCB4199
	mSETDB2-1(Y7221)
		Comment	Currently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
		Comment from the depositor
RCB4200
	mSETDB2-1(Y7227)
		Comment	Currently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
		Comment from the depositor
RCB4201
	mSETDB2-1(Y7228)
		Comment	Currently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
		Comment from the depositor
RCB4202
	mSETDB2-1(Y7232)
		Comment	Currently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
		Comment from the depositor
RCB4203
	mSETDB2-1(Y7241)
		Comment	Currently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
		Comment from the depositor
RCB4204
	mSETDB2-1(Y7246)
		Comment	Currently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
		Comment from the depositor
RCB4205
	mSETDB2-1(Y7247)
		Comment	Currently not ready. Hybridoma against mSETDB2-1 : SET domain, bifurcated 2 (14-129(116aa)) antigen.
		Comment from the depositor
RCB4206
	Prdm6-2(Y7126)
		Comment	Currently not ready. Hybridoma against Prdm6-2 : PR domain containing 6 (294-392(99aa)) antigen.
		Comment from the depositor
RCB4207
	Prdm16-1(Z0311)
		Comment	Currently not ready. Hybridoma against Prdm16-1 : PR domain containing 16 (4-103(100aa)) antigen.
		Comment from the depositor
RCB4208
	Prdm16-1(Z0315)
		Comment	Currently not ready. Hybridoma against Prdm16-1 : PR domain containing 16 (4-103(100aa)) antigen.
		Comment from the depositor
RCB4209
	Prdm16-1(Z0324)
		Comment	Currently not ready. Hybridoma against Prdm16-1 : PR domain containing 16 (4-103(100aa)) antigen.
		Comment from the depositor
RCB4210
	Prdm16-1(Z0327)
		Comment	Currently not ready. Hybridoma against Prdm16-1 : PR domain containing 16 (4-103(100aa)) antigen.
		Comment from the depositor
RCB4211
	Prdm16-1(Z0346)
		Comment	Currently not ready. Hybridoma against Prdm16-1 : PR domain containing 16 (4-103(100aa)) antigen.
		Comment from the depositor
RCB4212
	Prdm16-2(Z1301)
		Comment	Hybridoma against Prdm16-2 : PR domain containing 16 (467-566(100aa)) antigen.
		Comment from the depositor	PR domain containing 16 (467-566(100aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4213
	Prdm16-2(Z1312)
		Comment	Currently not ready. Hybridoma against Prdm16-2 : PR domain containing 16 (467-566(100aa)) antigen.
		Comment from the depositor
RCB4214
	Prdm16-2(Z1322)
		Comment	Currently not ready. Hybridoma against Prdm16-2 : PR domain containing 16 (467-566(100aa)) antigen.
		Comment from the depositor
RCB4215
	Prdm2-2(Z0601)
		Comment	Currently not ready. Hybridoma against Prdm2-2 : PR domain containing 2 (210-309(100aa)) antigen.
		Comment from the depositor
RCB4216
	Prdm2-2(Z0605)
		Comment	Currently not ready. Hybridoma against Prdm2-2 : PR domain containing 2 (210-309(100aa)) antigen.
		Comment from the depositor
RCB4217
	Prdm2-2(Z0626)
		Comment	Currently not ready. Hybridoma against Prdm2-2 : PR domain containing 2 (210-309(100aa)) antigen.
		Comment from the depositor
RCB4218
	Prdm2-2(Z0631)
		Comment	Currently not ready. Hybridoma against Prdm2-2 : PR domain containing 2 (210-309(100aa)) antigen.
		Comment from the depositor
RCB4219
	Prdm2-2(Z0654)
		Comment	Currently not ready. Hybridoma against Prdm2-2 : PR domain containing 2 (210-309(100aa)) antigen.
		Comment from the depositor
RCB4220
	Prdm4-1(Y8328)
		Comment	Currently not ready. Hybridoma against Prdm4-1 : PR domain containing 4 (161-260(100aa)) antigen.
		Comment from the depositor
RCB4221
	Prdm4-1(Y8341)
		Comment	Currently not ready. Hybridoma against Prdm4-1 : PR domain containing 4 (161-260(100aa)) antigen.
		Comment from the depositor
RCB4222
	COUP TFII-2(Z0504)
		Comment	Currently not ready. Hybridoma against COUP TFII-2 : Chicken Ovalbumin Upstream Promoter-Transcription Factor II (1-50(50aa)) antigen.
		Comment from the depositor
RCB4223
	COUP TFII-2(Z0523)
		Comment	Currently not ready. Hybridoma against COUP TFII-2 : Chicken Ovalbumin Upstream Promoter-Transcription Factor II (1-50(50aa)) antigen.
		Comment from the depositor
RCB4224
	COUP TFII-2(Z0533)
		Comment	Currently not ready. Hybridoma against COUP TFII-2 : Chicken Ovalbumin Upstream Promoter-Transcription Factor II (1-50(50aa)) antigen.
		Comment from the depositor
RCB4225
	methylated budded baculovirus(C4914-2)
		Comment	Currently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
		Comment from the depositor
RCB4226
	methylated budded baculovirus(C4930-101)
		Comment	Currently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
		Comment from the depositor
RCB4227
	methylated budded baculovirus(C5006-9)
		Comment	Currently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
		Comment from the depositor
RCB4228
	methylated budded baculovirus(C5009-33)
		Comment	Currently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
		Comment from the depositor
RCB4229
	methylated budded baculovirus(C5032-60)
		Comment	Currently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
		Comment from the depositor
RCB4230
	methylated budded baculovirus(C5123-70)
		Comment	Currently not ready. Hybridoma against methylated budded baculovirus (1K,2K,3K) antigen.
		Comment from the depositor
RCB4231
	ATIP-CT(N4204)
		Comment	Currently not ready. Hybridoma against ATIP-CT : Angiotensin II receptor type 2-interacting proteins (327-426(100aa)) antigen.
		Comment from the depositor
RCB4232
	ATIP-CT(N4207)
		Comment	Currently not ready. Hybridoma against ATIP-CT : Angiotensin II receptor type 2-interacting proteins (327-426(100aa)) antigen.
		Comment from the depositor
RCB4233
	ATIP-CT(N4235)
		Comment	Currently not ready. Hybridoma against ATIP-CT : Angiotensin II receptor type 2-interacting proteins (327-426(100aa)) antigen.
		Comment from the depositor
RCB4234
	ROBO1 Ag1(Y4314)
		Comment	Currently not ready. Hybridoma against ROBO1 Ag1 : Roundabout 1 (946-1034(89aa)) antigen.
		Comment from the depositor
RCB4235
	ROBO1 Ag2(Y7002)
		Comment	Currently not ready. Hybridoma against ROBO1 Ag2 : Roundabout 1 (1062-1148(87aa)) antigen.
		Comment from the depositor
RCB4236
	ROBO1 Ag6(Y8411)
		Comment	Currently not ready. Hybridoma against ROBO1 Ag6 : Roundabout 1 (1458-1555(98aa)) antigen.
		Comment from the depositor
RCB4237
	APE-C(Y1202)
		Comment	Currently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
		Comment from the depositor
RCB4238
	APE-C(Y1209)
		Comment	Currently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
		Comment from the depositor
RCB4239
	APE-C(Y1215)
		Comment	Currently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
		Comment from the depositor
RCB4240
	APE-C(Y1220)
		Comment	Currently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
		Comment from the depositor
RCB4241
	APE-C(Y1221)
		Comment	Currently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
		Comment from the depositor
RCB4242
	APE-C(Y1244)
		Comment	Currently not ready. Hybridoma against APE-C : Akt-phosphorylation enhancer (1786-1845(60aa)) antigen.
		Comment from the depositor
RCB4243
	APE-N1(N9406)
		Comment	Currently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
		Comment from the depositor
RCB4244
	APE-N1(N9407)
		Comment	Currently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
		Comment from the depositor
RCB4245
	APE-N1(N9426)
		Comment	Currently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
		Comment from the depositor
RCB4246
	APE-N1(N9436A)
		Comment	Currently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
		Comment from the depositor
RCB4247
	APE-N1(N9436B)
		Comment	Currently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
		Comment from the depositor
RCB4248
	APE-N1(N9442)
		Comment	Currently not ready. Hybridoma against APE-N1 : Akt-phosphorylation enhancer (322-372(51aa)) antigen.
		Comment from the depositor
RCB4249
	APE-N3(Y0013)
		Comment	Currently not ready. Hybridoma against APE-N3 : Akt-phosphorylation enhancer (551-601(51aa)) antigen.
		Comment from the depositor
RCB4250
	APE-N3(Y0026)
		Comment	Currently not ready. Hybridoma against APE-N3 : Akt-phosphorylation enhancer (551-601(51aa)) antigen.
		Comment from the depositor
RCB4251
	APE-N3(Y0028)
		Comment	Currently not ready. Hybridoma against APE-N3 : Akt-phosphorylation enhancer (551-601(51aa)) antigen.
		Comment from the depositor
RCB4252
	APE-N3(Y0038)
		Comment	Currently not ready. Hybridoma against APE-N3 : Akt-phosphorylation enhancer (551-601(51aa)) antigen.
		Comment from the depositor
RCB4253
	hTobC(Y5432)
		Comment	Hybridoma against hTobC : Transducer of ERBB2, 1 (263-345(83aa)) antigen.
		Comment from the depositor	hTobC : Transducer of ERBB2, 1 (263-345(83aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4254
	hTobC(Y5443)
		Comment	Hybridoma against hTobC : Transducer of ERBB2, 1 (263-345(83aa)) antigen.
		Comment from the depositor	hTobC : Transducer of ERBB2, 1 (263-345(83aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4255
	hTobC(Y5444)
		Comment	Hybridoma against hTobC : Transducer of ERBB2, 1 (263-345(83aa)) antigen.
		Comment from the depositor	hTobC : Transducer of ERBB2, 1 (263-345(83aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4256
	hTobC(Y5452)
		Comment	Hybridoma against hTobC : Transducer of ERBB2, 1 (263-345(83aa)) antigen.
		Comment from the depositor	hTobC : Transducer of ERBB2, 1 (263-345(83aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4257
	hTobM(Y5807)
		Comment	Currently not ready. Hybridoma against hTobM : Transducer of ERBB2, 1 (136-236(101aa)) antigen.
		Comment from the depositor
RCB4258
	hTobM(Y5815)
		Comment	Currently not ready. Hybridoma against hTobM : Transducer of ERBB2, 1 (136-236(101aa)) antigen.
		Comment from the depositor
RCB4259
	p115-C(Y0902)
		Comment	Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
		Comment from the depositor
RCB4260
	p115-C(Y0912)
		Comment	Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
		Comment from the depositor
RCB4261
	p115-C(Y0915)
		Comment	Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
		Comment from the depositor
RCB4262
	p115-C(Y0920)
		Comment	Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
		Comment from the depositor
RCB4263
	p115-C(Y0921)
		Comment	Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
		Comment from the depositor
RCB4264
	p115-C(Y0924)
		Comment	Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
		Comment from the depositor
RCB4265
	p115-C(Y0931)
		Comment	Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
		Comment from the depositor
RCB4266
	p115-C(Y0945)
		Comment	Currently not ready. Hybridoma against p115-C : p115phoGEF(guanine nucleotide exchange factor) (814-913(100aa)) antigen.
		Comment from the depositor
RCB4267
	LARG-C term(Y9601)
		Comment	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
		Comment from the depositor
RCB4268
	LARG-C term(Y9614)
		Comment	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
		Comment from the depositor
RCB4269
	LARG-C term(Y9618)
		Comment	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
		Comment from the depositor
RCB4270
	LARG-C term(Y9619)
		Comment	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
		Comment from the depositor
RCB4271
	LARG-C term(Y9625)
		Comment	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
		Comment from the depositor
RCB4272
	LARG-C term(Y9626)
		Comment	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
		Comment from the depositor
RCB4273
	LARG-C term(Y9627)
		Comment	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
		Comment from the depositor
RCB4274
	LARG-C term(Y9637)
		Comment	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1466-1565(100aa)) antigen.
		Comment from the depositor
RCB4276
	ATIP-CT(C1708-1)
		Comment	Currently not ready. Hybridoma against ATIP-CT : Angiotensin II receptor type 2-interacting proteins (327-426 (100aa)) antigen.
		Comment from the depositor
RCB4277
	ATIP-CT(C1717-5)
		Comment	Currently not ready. Hybridoma against ATIP-CT : Angiotensin II receptor type 2-interacting proteins (327-426 (100aa)) antigen.
		Comment from the depositor
RCB4278
	NM6(Y0620)
		Comment	Currently not ready. Hybridoma against NM6 : Myotubularin related protein 6 (1-100(100aa)) antigen.
		Comment from the depositor
RCB4279
	NM6s(Y67002)
		Comment	Currently not ready. Hybridoma against NM6s : Myotubularin related protein 6 (1-100(100aa)) antigen.
		Comment from the depositor
RCB4280
	NM6s(Y67003)
		Comment	Currently not ready. Hybridoma against NM6s : Myotubularin related protein 6 (1-100(100aa)) antigen.
		Comment from the depositor
RCB4281
	NM6s(Y67057)
		Comment	Currently not ready. Hybridoma against NM6s : Myotubularin related protein 6 (1-100(100aa)) antigen.
		Comment from the depositor
RCB4282
	NM6s(Y67081)
		Comment	Currently not ready. Hybridoma against NM6s : Myotubularin related protein 6 (1-100(100aa)) antigen.
		Comment from the depositor
RCB4283
	NM6s(Y67109)
		Comment	Currently not ready. Hybridoma against NM6s : Myotubularin related protein 6 (1-100(100aa)) antigen.
		Comment from the depositor
RCB4284
	CM1s(Z1001)
		Comment	Currently not ready. Hybridoma against CM1s : Myotubular myopathy 1 (555-604(50aa)) antigen.
		Comment from the depositor
RCB4285
	CM1s(Z1002)
		Comment	Currently not ready. Hybridoma against CM1s : Myotubular myopathy 1 (555-604(50aa)) antigen.
		Comment from the depositor
RCB4286
	CM1s(Z1014)
		Comment	Currently not ready. Hybridoma against CM1s : Myotubular myopathy 1 (555-604(50aa)) antigen.
		Comment from the depositor
RCB4287
	CM1s(Z1016)
		Comment	Currently not ready. Hybridoma against CM1s : Myotubular myopathy 1 (555-604(50aa)) antigen.
		Comment from the depositor
RCB4288
	CM1s(Z1057)
		Comment	Currently not ready. Hybridoma against CM1s : Myotubular myopathy 1 (555-604(50aa)) antigen.
		Comment from the depositor
RCB4289
	CM6(Y9506)
		Comment	Currently not ready. Hybridoma against CM6 : Myotubularin related protein 6 (519-618(100aa)) antigen.
		Comment from the depositor
RCB4290
	CM6(Y9512)
		Comment	Currently not ready. Hybridoma against CM6 : Myotubularin related protein 6 (519-618(100aa)) antigen.
		Comment from the depositor
RCB4291
	CM6(Y9515)
		Comment	Currently not ready. Hybridoma against CM6 : Myotubularin related protein 6 (519-618(100aa)) antigen.
		Comment from the depositor
RCB4292
	CM6(Y9517)
		Comment	Currently not ready. Hybridoma against CM6 : Myotubularin related protein 6 (519-618(100aa)) antigen.
		Comment from the depositor
RCB4293
	hVir-2(Y1503)
		Comment	Currently not ready. Hybridoma against hVir-2 : Virilizer (561-611(51aa)) antigen.
		Comment from the depositor
RCB4294
	hVir-2(Y1513)
		Comment	Currently not ready. Hybridoma against hVir-2 : Virilizer (561-611(51aa)) antigen.
		Comment from the depositor
RCB4295
	hVir-2(Y1523)
		Comment	Currently not ready. Hybridoma against hVir-2 : Virilizer (561-611(51aa)) antigen.
		Comment from the depositor
RCB4296
	hVir-3(Y1613)
		Comment	Currently not ready. Hybridoma against hVir-3 : Virilizer (1421-1480(60aa)) antigen.
		Comment from the depositor
RCB4297
	hVir-3(Y1625(4C3))
		Comment	Currently not ready. Hybridoma against hVir-3 : Virilizer (1421-1480(60aa)) antigen.
		Comment from the depositor
RCB4298
	hVir-3(Y1639)
		Comment	Currently not ready. Hybridoma against hVir-3 : Virilizer (1421-1480(60aa)) antigen.
		Comment from the depositor
RCB4299
	WTAP(Y6809)
		Comment	Currently not ready. Hybridoma against WTAP : Wilms tumor 1 associated protein (6-76(71aa)) antigen.
		Comment from the depositor
RCB4300
	WTAP(Y6828)
		Comment	Currently not ready. Hybridoma against WTAP : Wilms tumor 1 associated protein (6-76(71aa)) antigen.
		Comment from the depositor
RCB4301
	hFRS2β1(Y7610)
		Comment	Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
		Comment from the depositor
RCB4302
	hFRS2β1(Y7612)
		Comment	Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
		Comment from the depositor
RCB4303
	hFRS2β1(Y7624)
		Comment	Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
		Comment from the depositor
RCB4304
	hFRS2β1(Y7632)
		Comment	Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
		Comment from the depositor
RCB4305
	hFRS2β1(Y7641)
		Comment	Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
		Comment from the depositor
RCB4306
	hFRS2β1(Y7642)
		Comment	Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
		Comment from the depositor
RCB4307
	hFRS2β1(Y7643)
		Comment	Currently not ready. Hybridoma against hFRS2β1 : Fibroblast growth factor receptor substrate 2β (342-392(51aa)) antigen.
		Comment from the depositor
RCB4308
	mNFATC-N(Y7402)
		Comment	Currently not ready. Hybridoma against mNFATC-N : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (43-143(101aa)) antigen.
		Comment from the depositor
RCB4309
	mNFATC-N(Y7405)
		Comment	Currently not ready. Hybridoma against mNFATC-N : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (43-143(101aa)) antigen.
		Comment from the depositor
RCB4310
	mNFATC-N(Y7428)
		Comment	Currently not ready. Hybridoma against mNFATC-N : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (43-143(101aa)) antigen.
		Comment from the depositor
RCB4311
	mNFATC-N(Y7445)
		Comment	Currently not ready. Hybridoma against mNFATC-N : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (43-143(101aa)) antigen.
		Comment from the depositor
RCB4312
	hEgr1(N8605)
		Comment	Currently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
		Comment from the depositor
RCB4313
	hEgr1(N8611)
		Comment	Currently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
		Comment from the depositor
RCB4314
	hEgr1(N8614)
		Comment	Currently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
		Comment from the depositor
RCB4315
	hEgr1(N8616)
		Comment	Currently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
		Comment from the depositor
RCB4316
	hEgr1(N8637)
		Comment	Currently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
		Comment from the depositor
RCB4317
	hEgr1(N8640)
		Comment	Currently not ready. Hybridoma against hEgr1 : Early growth response 1 (1-99(99aa)) antigen.
		Comment from the depositor
RCB4318
	hEgr3(N8701)
		Comment	Currently not ready. Hybridoma against hEgr3 : Early growth response 3 (27-82(56aa)) antigen.
		Comment from the depositor
RCB4319
	hEgr3(N8730)
		Comment	Currently not ready. Hybridoma against hEgr3 : Early growth response 3 (27-82(56aa)) antigen.
		Comment from the depositor
RCB4320
	Prdm8-2(N8501)
		Comment	Currently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
		Comment from the depositor
RCB4321
	Prdm8-2(N8506)
		Comment	Currently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
		Comment from the depositor
RCB4322
	Prdm8-2(N8508)
		Comment	Currently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
		Comment from the depositor
RCB4323
	Prdm8-2(N8513)
		Comment	Currently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
		Comment from the depositor
RCB4324
	Prdm8-2(N8520)
		Comment	Currently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
		Comment from the depositor
RCB4325
	Prdm8-2(N8526)
		Comment	Currently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
		Comment from the depositor
RCB4326
	Prdm8-2(N8533)
		Comment	Currently not ready. Hybridoma against Prdm8-2 : PR domain containing 8 (265-364(100aa)) antigen.
		Comment from the depositor
RCB4327
	Aggrecan-1(Y3416)
		Comment	Currently not ready. Hybridoma against Aggrecan-1 : Aggrecan (2168-2223(56aa)) antigen.
		Comment from the depositor
RCB4328
	Aggrecan-1(Y3428)
		Comment	Currently not ready. Hybridoma against Aggrecan-1 : Aggrecan (2168-2223(56aa)) antigen.
		Comment from the depositor
RCB4329
	Aggrecan-1(Y3431)
		Comment	Currently not ready. Hybridoma against Aggrecan-1 : Aggrecan (2168-2223(56aa)) antigen.
		Comment from the depositor
RCB4330
	Aggrecan-1(Y3441)
		Comment	Currently not ready. Hybridoma against Aggrecan-1 : Aggrecan (2168-2223(56aa)) antigen.
		Comment from the depositor
RCB4331
	Aggrecan-1(Y3446)
		Comment	Currently not ready. Hybridoma against Aggrecan-1 : Aggrecan (2168-2223(56aa)) antigen.
		Comment from the depositor
RCB4332
	PTX3N46(Z3805(421))
		Comment	Currently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
		Comment from the depositor
RCB4333
	PTX3N46(Z3818-1-19)
		Comment	Currently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
		Comment from the depositor
RCB4334
	PTX3N46(Z3821(100))
		Comment	Currently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
		Comment from the depositor
RCB4335
	PTX3N46(Z3825(125))
		Comment	Currently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
		Comment from the depositor
RCB4336
	PTX3N46(Z3829-156)
		Comment	Currently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
		Comment from the depositor
RCB4337
	PTX3N46(Z3835-467)
		Comment	Currently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
		Comment from the depositor
RCB4338
	PTX3N46(Z3839-590)
		Comment	Currently not ready. Hybridoma against PTX3N46 : Pentraxin3 (18-46(29aa)) antigen.
		Comment from the depositor
RCB4339
	CBLL1-2(Y6018)
		Comment	Currently not ready. Hybridoma against CBLL1-2 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (430-491(62aa)) antigen.
		Comment from the depositor
RCB4340
	CBLL1-2(Y6026)
		Comment	Currently not ready. Hybridoma against CBLL1-2 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (430-491(62aa)) antigen.
		Comment from the depositor
RCB4341
	CBLL1-2(Y6037)
		Comment	Currently not ready. Hybridoma against CBLL1-2 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (430-491(62aa)) antigen.
		Comment from the depositor
RCB4342
	CBLL1-2(Y6047)
		Comment	Currently not ready. Hybridoma against CBLL1-2 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (430-491(62aa)) antigen.
		Comment from the depositor
RCB4343
	CBLL1-2(Y6048)
		Comment	Currently not ready. Hybridoma against CBLL1-2 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (430-491(62aa)) antigen.
		Comment from the depositor
RCB4344
	CBLL1-1(Y6610)
		Comment	Currently not ready. Hybridoma against CBLL1-1 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (5-70(66aa)) antigen.
		Comment from the depositor
RCB4345
	CBLL1-1(Y6621)
		Comment	Currently not ready. Hybridoma against CBLL1-1 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (5-70(66aa)) antigen.
		Comment from the depositor
RCB4346
	CBLL1-1(Y6641)
		Comment	Currently not ready. Hybridoma against CBLL1-1 : Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1 (5-70(66aa)) antigen.
		Comment from the depositor
RCB4347
	PDZ-CS(Y7501)
		Comment	Currently not ready. Hybridoma against PDZ-CS : Rho guanine nucleotide exchange factor (GEF) 11 (1423-1522(100aa)) antigen.
		Comment from the depositor
RCB4348
	PDZ-CS(Y7504)
		Comment	Currently not ready. Hybridoma against PDZ-CS : Rho guanine nucleotide exchange factor (GEF) 11 (1423-1522(100aa)) antigen.
		Comment from the depositor
RCB4349
	PDZ-CS(Y7505)
		Comment	Currently not ready. Hybridoma against PDZ-CS : Rho guanine nucleotide exchange factor (GEF) 11 (1423-1522(100aa)) antigen.
		Comment from the depositor
RCB4350
	PDZ-CS(Y7534)
		Comment	Currently not ready. Hybridoma against PDZ-CS : Rho guanine nucleotide exchange factor (GEF) 11 (1423-1522(100aa)) antigen.
		Comment from the depositor
RCB4351
	PDZ-CS(Y7537)
		Comment	Currently not ready. Hybridoma against PDZ-CS : Rho guanine nucleotide exchange factor (GEF) 11 (1423-1522(100aa)) antigen.
		Comment from the depositor
RCB4352
	Ets-1 Mid(Y8012)
		Comment	Currently not ready. Hybridoma against Ets-1 Mid : v-ets erythroblastosis virus E26 oncogene homolog 1 (220-304(85aa)) antigen.
		Comment from the depositor
RCB4353
	Ets-1 Mid(Y8020)
		Comment	Currently not ready. Hybridoma against Ets-1 Mid : v-ets erythroblastosis virus E26 oncogene homolog 1 (220-304(85aa)) antigen.
		Comment from the depositor
RCB4354
	Ets-1 Mid(Y8029)
		Comment	Currently not ready. Hybridoma against Ets-1 Mid : v-ets erythroblastosis virus E26 oncogene homolog 1 (220-304(85aa)) antigen.
		Comment from the depositor
RCB4355
	prdm 5(C2518A)
		Comment	Currently not ready. Hybridoma against gp64 fusion prdm 5 : PR domain containing 5 (10-110(101aa)) antigen expressed by baculovirus.
		Comment from the depositor
RCB4356
	RGS3T(C6501-4)
		Comment	Currently not ready. Hybridoma against RGS3T : regular of G protein signaling 3 (full length) antigen.
		Comment from the depositor
RCB4357
	Gq(C6604-5)
		Comment	Currently not ready. Hybridoma against Gq : GNAQ (full length) antigen.
		Comment from the depositor
RCB4358
	Gq(C6611A-11-A2)
		Comment	Currently not ready. Hybridoma against Gq : GNAQ (full length) antigen.
		Comment from the depositor
RCB4359
	Gq(C6611B-35-18)
		Comment	Currently not ready. Hybridoma against Gq : GNAQ (full length) antigen.
		Comment from the depositor
RCB4360
	Gq(C6618-81)
		Comment	Currently not ready. Hybridoma against Gq : GNAQ (full length) antigen.
		Comment from the depositor
RCB4361
	Gq(C6623-18)
		Comment	Currently not ready. Hybridoma against Gq : GNAQ (full length) antigen.
		Comment from the depositor
RCB4362
	Gα13(C9101-F5-1)
		Comment	Currently not ready. Hybridoma against Gα13 : GNA12 (full length) antigen.
		Comment from the depositor
RCB4363
	Gα13(C9201-B5-4)
		Comment	Currently not ready. Hybridoma against Gα13 : GNA13 (full length) antigen.
		Comment from the depositor
RCB4364
	Gα13(C9202-F9-1)
		Comment	Currently not ready. Hybridoma against Gα13 : GNA13 (full length) antigen.
		Comment from the depositor
RCB4365
	Gα13(C9204-D4-1)
		Comment	Currently not ready. Hybridoma against Gα13 : GNA13 (full length) antigen.
		Comment from the depositor
RCB4366
	Gα13(C9205-F6-4)
		Comment	Currently not ready. Hybridoma against Gα13 : GNA13 (full length) antigen.
		Comment from the depositor
RCB4367
	Gα12(D0901-A1-E11)
		Comment	Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
		Comment from the depositor
RCB4368
	Gα12(D0902-B12-G11)
		Comment	Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
		Comment from the depositor
RCB4369
	Gα12(D0904-A6-H2)
		Comment	Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
		Comment from the depositor
RCB4370
	Gα12(D0906-B10-D6)
		Comment	Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
		Comment from the depositor
RCB4371
	Gα12(D0907-E2-E8)
		Comment	Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
		Comment from the depositor
RCB4372
	Gα12(D0908-G5-A6)
		Comment	Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
		Comment from the depositor
RCB4373
	Gα12(D0910-G5-D10)
		Comment	Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
		Comment from the depositor
RCB4374
	Gα12(D0911-E6-G1)
		Comment	Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
		Comment from the depositor
RCB4375
	Gα12(D0912-B5-C9)
		Comment	Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
		Comment from the depositor
RCB4376
	Gα12(D0914-D5-D4)
		Comment	Currently not ready. Hybridoma against Gα12 : GNA12 (full length) antigen.
		Comment from the depositor
RCB4377
	NFATC-3(Z2705)
		Comment	Currently not ready. Hybridoma against NFATC-3 : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (35-107(73aa)) antigen.
		Comment from the depositor
RCB4378
	mOSR-2(Z2914)
		Comment	Currently not ready. Hybridoma against mOSR-2 : Odd-skipped related 2 (59-157(99aa) antigen.
		Comment from the depositor
RCB4379
	ATOX1(Z3101)
		Comment	Currently not ready. Hybridoma against ATOX1 : ATX1 antioxidant protein 1 homolog (68AA) antigen.
		Comment from the depositor
RCB4380
	ATOX1(Z3112)
		Comment	Hybridoma against ATOX1 : ATX1 antioxidant protein 1 homolog (68AA) antigen.
		Comment from the depositor	ATX1 antioxidant protein 1 homolog (68AA) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4381
	ATOX1(Z3138)
		Comment	Currently not ready. Hybridoma against ATOX1 : ATX1 antioxidant protein 1 homolog (68AA) antigen.
		Comment from the depositor
RCB4382
	ATOX1(Z3140)
		Comment	Currently not ready. Hybridoma against ATOX1 : ATX1 antioxidant protein 1 homolog (68AA) antigen.
		Comment from the depositor
RCB4383
	ATOX1(Z3144)
		Comment	Currently not ready. Hybridoma against ATOX1 : ATX1 antioxidant protein 1 homolog (68AA) antigen.
		Comment from the depositor
RCB4384
	MAN-1(Z4201)
		Comment	Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
		Comment from the depositor
RCB4385
	MAN-1(Z4202)
		Comment	Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
		Comment from the depositor
RCB4386
	MAN-1(Z4205)
		Comment	Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
		Comment from the depositor
RCB4387
	MAN-1(Z4209)
		Comment	Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
		Comment from the depositor
RCB4388
	MAN-1(Z4221)
		Comment	Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
		Comment from the depositor
RCB4389
	MAN-1(Z4222)
		Comment	Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
		Comment from the depositor
RCB4390
	MAN-1(Z4223)
		Comment	Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
		Comment from the depositor
RCB4391
	MAN-1(Z4237)
		Comment	Currently not ready. Hybridoma against MAN-1 : MAN1 (734-807(74aa)) antigen.
		Comment from the depositor
RCB4392
	SETDB-1(Z4601)
		Comment	Hybridoma against SETDB-1 : SET domain, bifurcated 1 (1025-1080(56aa)) antigen.
		Comment from the depositor	SET domain, bifurcated 1 (1025-1080(56aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4393
	SETDB-1(Z4606)
		Comment	Hybridoma against SETDB-1 : SET domain, bifurcated 1 (1025-1080(56aa)) antigen.
		Comment from the depositor	SET domain, bifurcated 1 (1025-1080(56aa)) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4394
	SETDB-1(Z4613)
		Comment	Currently not ready. Hybridoma against SETDB-1 : SET domain, bifurcated 1 (1025-1080(56aa)) antigen.
		Comment from the depositor
RCB4395
	SETDB-1(Z4630)
		Comment	Currently not ready. Hybridoma against SETDB-1 : SET domain, bifurcated 1 (1025-1080(56aa)) antigen.
		Comment from the depositor
RCB4396
	mp250GAP(Z4906)
		Comment	Currently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
		Comment from the depositor
RCB4397
	mp250GAP(Z4932)
		Comment	Currently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
		Comment from the depositor
RCB4398
	mp250GAP(Z4937)
		Comment	Currently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
		Comment from the depositor
RCB4399
	mp250GAP(Z4942)
		Comment	Currently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
		Comment from the depositor
RCB4400
	mp250GAP(Z4946)
		Comment	Currently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
		Comment from the depositor
RCB4401
	mp250GAP(Z4947)
		Comment	Currently not ready. Hybridoma against mp250GAP : Rho GTPase activating protein 32 (1660-1727(68aa)) antigen.
		Comment from the depositor
RCB4402
	SETD5-1(Z5235-36)
		Comment	Currently not ready. Hybridoma against SETD5-1 : SET domain containing 5 (43-93(51aa)) antigen.
		Comment from the depositor
RCB4403
	SETD5-1(Z5235-42)
		Comment	Currently not ready. Hybridoma against SETD5-1 : SET domain containing 5 (43-93(51aa)) antigen.
		Comment from the depositor
RCB4404
	NFATC1-2(Z5302)
		Comment	Currently not ready. Hybridoma against NFATC1-2 : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (134-223(90aa)) antigen.
		Comment from the depositor
RCB4405
	NFATC1-2(Z5321)
		Comment	Currently not ready. Hybridoma against NFATC1-2 : Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (134-223(90aa)) antigen.
		Comment from the depositor
RCB4406
	GluR1-1(Z6114)
		Comment	Currently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
		Comment from the depositor
RCB4407
	GluR1-1(Z6119)
		Comment	Currently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
		Comment from the depositor
RCB4408
	GluR1-1(Z6123)
		Comment	Currently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
		Comment from the depositor
RCB4409
	GluR1-1(Z6135)
		Comment	Currently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
		Comment from the depositor
RCB4410
	GluR1-1(Z6141)
		Comment	Currently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
		Comment from the depositor
RCB4411
	GluR1-1(Z6143)
		Comment	Currently not ready. Hybridoma against GluR1-1 : Glutamate receptor, ionotropic, AMPA 1 (19-68(50aa)) antigen.
		Comment from the depositor
RCB4412
	SETD5-4(Z5702-3)
		Comment	Currently not ready. Hybridoma against SETD5-4 : SET domain containing 5 (1241-1291(51aa)) antigen.
		Comment from the depositor
RCB4413
	SETD5-4(Z5704-209)
		Comment	Currently not ready. Hybridoma against SETD5-4 : SET domain containing 5 (1241-1291(51aa)) antigen.
		Comment from the depositor
RCB4414
	SETD5-4(Z5708-71)
		Comment	Currently not ready. Hybridoma against SETD5-4 : SET domain containing 5 (1241-1291(51aa)) antigen.
		Comment from the depositor
RCB4415
	SETD5-4(Z5714-114)
		Comment	Currently not ready. Hybridoma against SETD5-4 : SET domain containing 5 (1241-1291(51aa)) antigen.
		Comment from the depositor
RCB4416
	SETD5-4(Z5721-234)
		Comment	Currently not ready. Hybridoma against SETD5-4 : SET domain containing 5 (1241-1291(51aa)) antigen.
		Comment from the depositor
RCB4417
	PRMT1-N(Z5017)
		Comment	Currently not ready. Hybridoma against PRMT1-N : Protein arginine methyltransferase 1 (7-56(50aa)) antigen.
		Comment from the depositor
RCB4418
	PRMT1-N(Z5018)
		Comment	Currently not ready. Hybridoma against PRMT1-N : Protein arginine methyltransferase 1 (7-56(50aa)) antigen.
		Comment from the depositor
RCB4419
	PRMT1-N(Z5026)
		Comment	Currently not ready. Hybridoma against PRMT1-N : Protein arginine methyltransferase 1 (7-56(50aa)) antigen.
		Comment from the depositor
RCB4420
	NM1S/Tg(Z7332)
		Comment	Currently not ready. Hybridoma against NM1S/Tg : Myotubular myopathy 1 (1-50(50aa)) antigen.
		Comment from the depositor
RCB4421
	NM1S/Tg(Z7342)
		Comment	Currently not ready. Hybridoma against NM1S/Tg : Myotubular myopathy 1 (1-50(50aa)) antigen.
		Comment from the depositor
RCB4422
	CM3(Z7511)
		Comment	Currently not ready. Hybridoma against CM3 : Myotubularin related protein 3 (1111-1161(51aa)) antigen.
		Comment from the depositor
RCB4423
	CM3(Z7528)
		Comment	Currently not ready. Hybridoma against CM3 : Myotubularin related protein 3 (1111-1161(51aa)) antigen.
		Comment from the depositor
RCB4424
	CM3(Z7536)
		Comment	Currently not ready. Hybridoma against CM3 : Myotubularin related protein 3 (1111-1161(51aa)) antigen.
		Comment from the depositor
RCB4425
	NM3(Z8021)
		Comment	Currently not ready. Hybridoma against NM3 : Myotubularin related protein 3 (1-50(50aa)) antigen.
		Comment from the depositor
RCB4426
	CM4/Tg(Z8214)
		Comment	Currently not ready. Hybridoma against CM4/Tg : Myotubularin related protein 4 (909-959(51aa)) antigen.
		Comment from the depositor
RCB4427
	CM4/Tg(Z8217)
		Comment	Currently not ready. Hybridoma against CM4/Tg : Myotubularin related protein 4 (909-959(51aa)) antigen.
		Comment from the depositor
RCB4428
	CM4/Tg(Z8245B)
		Comment	Currently not ready. Hybridoma against CM4/Tg : Myotubularin related protein 4 (909-959(51aa)) antigen.
		Comment from the depositor
RCB4429
	Fbxl 10-N(Z8310)
		Comment	Currently not ready. Hybridoma against Fbxl 10-N : F-box and leucine-rich repeat protein 10 (45-92(48aa)) antigen.
		Comment from the depositor
RCB4430
	Fbxl 10-N(Z8312)
		Comment	Currently not ready. Hybridoma against Fbxl 10-N : F-box and leucine-rich repeat protein 10 (45-92(48aa)) antigen.
		Comment from the depositor
RCB4431
	Fbxl 10-N(Z8320)
		Comment	Currently not ready. Hybridoma against Fbxl 10-N : F-box and leucine-rich repeat protein 10 (45-92(48aa)) antigen.
		Comment from the depositor
RCB4432
	Fbxl 10-N(Z8327)
		Comment	Currently not ready. Hybridoma against Fbxl 10-N : F-box and leucine-rich repeat protein 10 (45-92(48aa)) antigen.
		Comment from the depositor
RCB4433
	Fbxl 10-N(Z8345)
		Comment	Currently not ready. Hybridoma against Fbxl 10-N : F-box and leucine-rich repeat protein 10 (45-92(48aa)) antigen.
		Comment from the depositor
RCB4434
	LARG-C term(D4004-4E2-6)
		Comment	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
		Comment from the depositor
RCB4435
	LARG-C term(D4005-6A6-29)
		Comment	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
		Comment from the depositor
RCB4436
	LARG-C term(D4101-2G11-41)
		Comment	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
		Comment from the depositor
RCB4437
	LARG-C term(D4106-5G1-67)
		Comment	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
		Comment from the depositor
RCB4438
	LARG-C term(D4107-5H2-110)
		Comment	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
		Comment from the depositor
RCB4439
	LARG-C term(D4202-2E6-130)
		Comment	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
		Comment from the depositor
RCB4440
	LARG-C term(D4204-1A10-163)
		Comment	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
		Comment from the depositor
RCB4441
	LARG-C term(D4205-2A9-213)
		Comment	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
		Comment from the depositor
RCB4442
	LARG-C term(D4206-2B8-221)
		Comment	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
		Comment from the depositor
RCB4443
	LARG-C term(D4207-2D10-262)
		Comment	Currently not ready. Hybridoma against LARG-C-terminal : Leukemia associated Rho guanine nucleotide exchange factor (1304-1544(241aa)) antigen.
		Comment from the depositor
RCB4444
	Emerin Ab-3(D2702-12)
		Comment	Currently not ready. Hybridoma against Emerin Ab-3 : Emerin (48-110(63aa)) antigen.
		Comment from the depositor
RCB4445
	Emerin Ab-3(D2703-2)
		Comment	Currently not ready. Hybridoma against Emerin Ab-3 : Emerin (48-110(63aa)) antigen.
		Comment from the depositor
RCB4446
	Emerin Ab-3(D2704-5)
		Comment	Currently not ready. Hybridoma against Emerin Ab-3 : Emerin (48-110(63aa)) antigen.
		Comment from the depositor
RCB4447
	Emerin Ab-3(D2705-2)
		Comment	Currently not ready. Hybridoma against Emerin Ab-3 : Emerin (48-110(63aa)) antigen.
		Comment from the depositor
RCB4448
	Emerin Ab-3(D2738-2)
		Comment	Currently not ready. Hybridoma against Emerin Ab-3 : Emerin (48-110(63aa)) antigen.
		Comment from the depositor
RCB4449
	SR-C3H/He
		Comment	Ascites sarcoma induced with Rous sarcom.
		Comment from the depositor
RCB4450
	SR-DDD
		Comment	Ascites sarcoma induced with Rous sarcom.
		Comment from the depositor
RCB4451
	UPS-1
		Comment	Sub-line of CHO-K1 which is defective in the non-endocytic uptake of fluorescent analogs of phosphatidylserine (C6-NBD-PS).
		Comment from the depositor
RCB4452
	FL-YB
		Comment	Mouse follicular dendritic cell line
		Comment from the depositor
RCB4454
	SR-CDF1DBT
		Comment	Mouse brain tumors induced with Rous sarcom.
		Comment from the depositor
RCB4455
	PC-9
		Comment	Human cell line derived from lung adenocarcinoma cells. Differentiated type. Previous name:PC-14(RCB0446)
		Comment from the depositor
RCB4466
	HANK1
		Comment	NK/T-cell lymphoma.
		Comment from the depositor
RCB4467
	TIG-1
		Comment	Human lung-derived adherent cells. The origin is not cancer. 25-35PDL.
		Comment from the depositor
RCB4468
	TIG-3
		Comment	Human lung-derived adherent cells. The origin is not cancer. 25-35PDL.
		Comment from the depositor
RCB4469
	TIG-7
		Comment	Human lung-derived adherent cells. The origin is not cancer. 25-35PDL.
		Comment from the depositor
RCB4472
	IN-IC
		Comment	Rat cell line derived from kidney.
		Comment from the depositor
RCB4473
	F6B3
		Comment	Mouse brain tumors induced with Rous sarcom.
		Comment from the depositor
RCB4474
	Ba/F3-CL1
		Comment	Mouse pro-B cell line derived from C3H strain. IL-3 dependent. After cloning (RCB0805 Ba/F3). Information
		Comment from the depositor
RCB4475
	SMP30/GNL-KO
		Comment
		Comment from the depositor	Deletion of the ascorbic acid synthesis enzyme gluconolactonase gene, and introduction of the temperature-sensitive SV40T antigen tsA58 gene.
RCB4476
	Ba/F3
		Comment	Mouse pro-B cell line derived from C3H strain. IL-3 dependent. Information
		Comment from the depositor
RCB4477
	ACK2
		Comment	Hybridoma cell line producing anti-mouse c-kit (CD117) antibody.
		Comment from the depositor
RCB4478
	ACK4
		Comment	Hybridoma cell line producing anti-mouse c-kit (CD117) antibody.
		Comment from the depositor
RCB4479
	ACK30
		Comment	Hybridoma cell line producing anti-mouse c-kit (CD117) antibody.
		Comment from the depositor
RCB4480
	ACK45
		Comment	Hybridoma cell line producing anti-mouse c-kit (CD117) antibody.
		Comment from the depositor
RCB4481
	A7R34
		Comment	Hybridoma cell line producing anti-mouse IL-7 Receptor alpha (CD127) antibody.
		Comment from the depositor
RCB4482
	APA5
		Comment	Hybridoma cell line producing anti-mouse PDGF Receptor alpha (CD140a) antibody.
		Comment from the depositor
RCB4483
	APB5
		Comment	Hybridoma cell line producing anti-mouse PDGF Receptor beta (CD140b) antibody.
		Comment from the depositor
RCB4484
	Avas12
		Comment	Hybridoma cell line producing anti-mouse Flk-1/VEGF-Receptor 2 (CD309) antibody.
		Comment from the depositor
RCB4485
	A2F10
		Comment	Hybridoma cell line producing anti-mouse Flk-2/Flt-3 (CD135) antibody.
		Comment from the depositor
RCB4486
	AFS98
		Comment	Hybridoma cell line producing anti-mouse c-fms (CD115) antibody.
		Comment from the depositor
RCB4487
	ACD1
		Comment	Hybridoma cell line producing anti-mouse CDK4 antibody.
		Comment from the depositor
RCB4488
	AFL4
		Comment	Hybridoma cell line producing anti-mouse VEGF-Receptor 3 antibody.Application consideration
		Comment from the depositor
RCB4489
	MB86
		Comment	Hybridoma cell line producing anti-mouse IgM(b)/Igh6b antibody.
		Comment from the depositor
RCB4495
	BL2-5-8
		Comment
		Comment from the depositor	A reporter cell line derived from a mouse hematopoietic cell line, Ba/F3, for identification of proteins that are translocated into or out of the nucleus in response to an extracellular stimulus and other changes in cell status using the inducible translocation trap (ITT) technology. The cell line can also be used for screening of compounds affecting inducible nuclear translocation and nuclear export by ITT. The human CD2 (hCD2) gene is used as reporter gene.
RCB4496
	BLG-139-3
		Comment
		Comment from the depositor	A reporter cell line derived from a mouse hematopoietic cell line, Ba/F3, for identification of proteins that are translocated into or out of the nucleus in response to an extracellular stimulus and other changes in cell status using the inducible translocation trap (ITT) technology. The cell line can also be used for screening of compounds affecting inducible nuclear translocation and nuclear export by ITT. The green fluorescent protein (GFP) gene is used as reporter gene.
RCB4497
	BBLG-50-1
		Comment
		Comment from the depositor	A reporter cell line derived from the BB13 cell line for identification of proteins that are translocated into or out of the nucleus in response to an extracellular stimulus and other changes in cell status using the inducible translocation trap (ITT) technology. The cell line can also be used for screening of compounds affecting inducible nuclear translocation and nuclear export by ITT. BB13 is derived from a mouse hematopoietic cell line, Ba/F3, and ectopically expresses epidermal growth factor receptor (EGFR) and the anti-apoptotic Bcl-2 protein. BB13 can survive in the absence of IL-3 if EGF is present. The green fluorescent protein (GFP) gene is used as reporter gene.
RCB4498
	NP 2
		Comment	Human cell line derived from anaplastic glioma.
		Comment from the depositor
RCB4499
	Onda 10
		Comment	Human cell line derived from anaplastic glioma.
		Comment from the depositor
RCB4500
	Onda 11
		Comment	Human cell line derived from glioblastoma.
		Comment from the depositor
RCB4504
	NP 3
		Comment	Human cell line derived from anaplastic glioma.
		Comment from the depositor
RCB4505
	NP 5
		Comment	Human cell line derived from anaplastic glioma.
		Comment from the depositor
RCB4515
	YACUT
		Comment	Currently not ready.
		Comment from the depositor
RCB4516
	STIM2^(-/-)DT40
		Comment	A subline of avian cell line, DT40, lacking STIM2 gene.
		Comment from the depositor
RCB4517
	STIM1^(-/-)STIM2^(-/-)DT40
		Comment	A subline of avian cell line, DT40, lacking both STIM1 and STIM2 genes.
		Comment from the depositor
RCB4518
	Orai1^(-/-)DT40
		Comment	A subline of avian cell line, DT40, lacking Orai1 gene.
		Comment from the depositor
RCB4519
	Orai2^(-/-)DT40
		Comment	A subline of avian cell line, DT40, lacking Orai2 gene.
		Comment from the depositor
RCB4520
	Orai1^(-/-)Orai2^(-/-)DT40
		Comment	A subline of avian cell line, DT40, lacking both Orai1 and Orai2 genes.
		Comment from the depositor
RCB4539
	MCS-1
		Comment	Currently not ready.
		Comment from the depositor
RCB4540
	MCS-8
		Comment	Currently not ready.
		Comment from the depositor
RCB4548
	PT-r
		Comment	Rat cell line derived from parathyroid gland.
		Comment from the depositor
RCB4549
	RSV-M
		Comment	Mouse brain tumors induced with Rous sarcom.
		Comment from the depositor
RCB4554
	HiDEP-1
		Comment	Human erythroid progenitor cell line derived from iPS cells. Expressing fetal type hemoglobin.
		Comment from the depositor
RCB4555
	HiDEP-2
		Comment	Human erythroid progenitor cell line derived from iPS cells. Expressing fetal type hemoglobin.
		Comment from the depositor
RCB4556
	HUDEP-1
		Comment	Human erythroid progenitor cell line derived from umbilical cord blood cells. Expressing fetal type hemoglobin.
		Comment from the depositor
RCB4557
	HUDEP-2
		Comment	Human erythroid progenitor cell line derived from umbilical cord blood cells. Expressing adult type hemoglobin.
		Comment from the depositor
RCB4560
	Ham-1
		Comment
		Comment from the depositor	Screening of anticancer drug, Transplantable in immunodeficient mice, In vivo model of cholangiocarcinoma.
RCB4561
	MOLT-17
		Comment	Human cell line derived from T cell leukemia (T-ALL). Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to DSMZ no.: ACC 36 prior to order.
		Comment from the depositor
RCB4562
	HUDEP-3
		Comment	Human erythroid progenitor cell line derived from umbilical cord blood cells. Expressing fetal type hemoglobin.
		Comment from the depositor
RCB4563
	TSt-4/N-DLL4
		Comment	Original murine mesenchymal cell line was derived from fetal thymus tissue. A line Expressing DLL4 gene.
		Comment from the depositor
RCB4566
	TEC1C8
		Comment	Culture of Thymic Epithelial Cell Lines., Protocol (pdf：120KB)
		Comment from the depositor	A mouse thymic cortical epithelial cell. It does not have the ability to present soluble antigen to its antigen specific helper T cells. This cell line is available to analyze the functions of cortical epithelial cells and medullary epithelial cells that control the differentiation and selection of intrathymic T cells. It is also useful for attempts such as thymus reconstruction using these cell lines, aiming at such functional recovery.
RCB4568
	TEC2-3
		Comment	Culture of Thymic Epithelial Cell Lines., Protocol (pdf：120KB)
		Comment from the depositor	A mouse thymic medullary epithelial cell line. It has the ability to present soluble antigen to its antigen specific helper T cells. This cell line is available to analyze the functions of cortical epithelial cells and medullary epithelial cells that control the differentiation and selection of intrathymic T cells. It is also useful for attempts such as thymus reconstruction using these cell lines, aiming at such functional recovery.
RCB4569
	TEC3-10
		Comment	Culture of Thymic Epithelial Cell Lines., Protocol (pdf：120KB)
		Comment from the depositor	A mouse thymic medullary epithelial cell line. It has the ability to present soluble antigen to its antigen specific helper T cells. This cell line is available to analyze the functions of cortical epithelial cells and medullary epithelial cells that control the differentiation and selection of intrathymic T cells. It is also useful for attempts such as thymus reconstruction using these cell lines, aiming at such functional recovery.
RCB4570
	MEF(WT)
		Comment
		Comment from the depositor	The cells are fibroblasts prepared from embryos of the wild type mice (congenic (>96%) to C57BL/6J mice). They were immortalized by transfection with a plasmid encoding the SV40 large T antigen.
RCB4571
	MEF(Ngly1-/-)
		Comment
		Comment from the depositor	The cells are fibroblasts prepared from embryos of the Ngly1-knockout mice (congenic (>96%) to C57BL/6J mice). They were immortalized by transfection with a plasmid encoding the SV40 large T antigen.
RCB4572
	MEF(Engase-/-)
		Comment
		Comment from the depositor	The cells are fibroblasts prepared from embryos of the Engase -knockout mice (congenic (>96%) to C57BL/6J mice). They were immortalized by transfection with a plasmid encoding the SV40 large T antigen.
RCB4573
	MEF(Ngly1-/-Engase-/-)
		Comment
		Comment from the depositor	The cells are fibroblasts prepared from embryos of the Ngly1 Engase-double knockout mice (congenic (>96%) to C57BL/6J mice). They were immortalized by transfection with a plasmid encoding the SV40 large T antigen.
RCB4582
	SEAP/HeLa
		Comment
		Comment from the depositor	The cell line expresses human secretory alkaline phosphatase. By collecting their culture media, you can measure secretory actlvlty by sensitive enzymatic assay, using Phospha-Light.
RCB4591
	Siglec-14/THP-1
		Comment
		Comment from the depositor	The cell line was generated by retroviral transduction of human Siglec-14 cDNA into the THP-1 cell line (JCRB0112). Basic properties are similar to those of THP-1.
RCB4592
	r/mHM-SFME-1
		Comment
		Comment from the depositor	In 1987, D.Loo et al at D.Barnes lab established a pre-glial cell line SFME from Balb/c mouse embryo in serum free condition. C.Rawson et al established a tumorigenic but non-metastatic transformed cell line, ras/mycSFME, by introducing active human cH-ras and mouse c-myc into SFME cells in 1992. T.Nomura et al introduced pSV2neo into ras/mycSFME cells and discovered metastatic cells in syngeneic host lungs. Obtained mtastatic cells no longer showed neomycin resistancy. The r/mHM-SFME-1 cell line, an experimental tumor cell line carrying metastatic ability in immuno-competent Balb/c mouse, was established from the mtastasized lung in 1993 by cloning from soft agar colony,.
RCB4593
	CALM WT MEF
		Comment	CALM non-deficient MEF cells. Tranformed with SV40 large T antigen gene.
		Comment from the depositor
RCB4594
	CALM KO MEF
		Comment	CALM deficient MEF cells. Tranformed with SV40 large T antigen gene.
		Comment from the depositor
RCB4623
	Ba/ER
		Comment	Ba/ER was created by stable transfection of murine pro-B Ba/F3 cells with a murine erythropoietin receptor gene. Ba/ER proliferates dependent on erythropoietin or interleukin-3.
		Comment from the depositor
RCB4624
	CHO-DR1000L-4N
		Comment
		Comment from the depositor	CHO DG44 based recombinant cell line which produce human GM-CSF. Cell line was constructed via gene amplification by transfection of dhfr and GM-CSF genes.
RCB4627
	KUP5
		Comment
		Comment from the depositor	An immortalized mouse Kupffer cell line established from C57BL/6 strain. The Kupffer cells were proliferated in the mixed primary culture of C57BL/6 adult mouse liver cells, then infected with a replication-deficient retroviral vector containing the human c-myc oncogene and neomycin resistance gene, isolated and selected with G418 (cloned by a limited dilution). No significant production of infectious viral particles from KUP5 cells was confirmed by bioassay using SC-1 cells.
RCB4635
	#16-15
		Comment	Hybridoma cell line producing anti-human BEND3 antibody (rat IgM).
		Comment from the depositor
RCB4661
	Hepa/8F5
		Comment
		Comment from the depositor	Hepa/8F5 derived from mouse hepatoma Hepa1-6 [RCB1638] cells was established by introducing doxycycline (Dox)-inducible eight liver-enriched transcription factor (LETF) genes. Upon overexpression of LETF genes by Dox addition, cell proliferation ceases and the cells change the morphology expressing high liver functions.
RCB4662
	HCT116 CMV-OsTIR1
		Comment	cf.： Kanemaki's Auxin Inducible Degron (AID) System
		Comment from the depositor	This is an HCT116 cell line in which CMV-OsTIR1 (pMK232, PURO) was introduced at the both alleles of the AAVS1 locus by using CRISPR/Cas.This parental cell line consitutively express OsTIR1 and can be used for generation of AID mutants.
RCB4664
	d5P
		Comment
		Comment from the depositor	Renal cell carcinoma cell line d5P has established from renal tubule cells of Crlj:WI rat. Moreover this cell line is able to do transplantation for wild type Crlj:WI rat.
RCB4665
	d5krm7
		Comment
		Comment from the depositor	d5krm7 cell line has established from d5P cell line. Moreover this cell line has highly metastatic activity to lung by intracapsular transplantation.
RCB4666
	d5krm3
		Comment
		Comment from the depositor	d5krm3 cell line has established from d5P cell line. Moreover this cell line has highly metastatic activity to lung by intracapsular transplantation.
RCB4667
	id5P
		Comment
		Comment from the depositor	Renal cell carcinoma cell line d5P has established from renal tubule cells of Crli:WI rat. Moreover this cell line is able to do transplantation for wild type CrlJ:WI rat.
RCB4668
	id5krm7
		Comment
		Comment from the depositor	id5krm7 cell line has established from d5P cell line. Moreover this cell line has highly metastatic activity to lung by intracapsular transplantation.
RCB4669
	id5krm3
		Comment
		Comment from the depositor	id5krm3 cell line has established from d5P cell line. Moreover this cell line has highly metastatic activity to lung by intracapsular transplantation.
RCB4670
	KN7
		Comment
		Comment from the depositor	KN7 is an anti-idiyotypic antibody for TCRVα5Vβ11 on CD4 T celIs wihich recognize Peptide-25 of A285B from Mycobacterium tuberculosis.
RCB4674
	ICH-ERMS-1
		Comment
		Comment from the depositor	The cell line has been established from a biopsied sample with an aplastic embryonal rhabdomyosarcoma originating in the pelvis of 5-year-old female. The biopsy revealed TP53 c.733G>A; however, the autopsy and established cell line showed TP53 c.743G>T.
RCB4675
	NMuMG/Fucci(CA)2.1
		Comment	Important notice regarding nomenclature of Fucci. Research tools : Fucci – Fluorescent Ubiquitination-based Cell Cycle Indicator.
		Comment from the depositor	A subline of the NMuMG cell line expressing Fucci(CA)2.1, a cell cycle marker. Cell line name : NMuMG/Fucci(CA)2.1 #2.
RCB4676
	HeLa/Fucci(CA)2
		Comment	Important notice regarding nomenclature of Fucci. Research tools : Fucci – Fluorescent Ubiquitination-based Cell Cycle Indicator.
		Comment from the depositor	A subline of the HeLa cell line expressing Fucci(CA)2, a cell cycle marker. Cell line name : HeLa/Fucci(CA)2 #3.
RCB4679
	HepG2-NIAS
		Comment	A subline of Hep G2 cells that can not only rapidly activate hepatic functions such as albumin secretion, urea synthesis and CYP3A4 activity but also induce the formation of bile canaliculus-like structures by utilizing a collagen vitrigel membrane as a culture substratum.
		Comment from the depositor	Hep G2 cells (RCB1648) described as a backup of ECACC 2870 derived from ECACC were conditioned in culture using a DMEM containing 10% heat-inactivated FBS, 20mM HEPES 100U/ml penicillin and 100μg/ml streptomycin. By the use of collagen vitrigel membrane as a culture substratum, hepatic functions such as albumin secretion, urea synthesis and CYP3A4 activity were rapidly activated, and also the formation of bile canaliculus-like structures were induced.
RCB4680
	MS-5
		Comment	Mouse stromal cell line which supports hematopoietic cells.
		Comment from the depositor
RCB4681
	MS-K
		Comment	Murine cell line derived from sarcoma.
		Comment from the depositor
RCB4683
	6330403Rik
		Comment
		Comment from the depositor	Anti-6330403k07Rik antibody production hybridoma cell
RCB4684
	celf3
		Comment
		Comment from the depositor	Anti-Celf3 antibody production hybridoma cell
RCB4685
	Dgcr14
		Comment
		Comment from the depositor	Anti-Dgcr14 antibody production hybridoma cell
RCB4687
	HEK-Dsup
		Comment
		Comment from the depositor	A subline of the HEK293(RCB1637) cells. Stably expressing Damage suppressor (Dsup). Radio-resistance. Dsup is a tardigrade-unique DNA protection protein.
RCB4688
	HEK-DsupKD
		Comment
		Comment from the depositor	A subline of the HEK293(RCB1637) cells. Expressing shRNA against Dsup in HEK-Dsup celIs. Dsup is a tardigrade-unique DNA protection protein.
RCB4689
	HEK-DsupΔC
		Comment
		Comment from the depositor	A subline of the HEK293(RCB1637) cells. Stably expressing Damage suppressor (Dsup) mutant lacking the C-terminal region. Dsup is a tardigrade-unique DNA protection protein.
RCB4692
	HCT116-vim
		Comment
		Comment from the depositor	Transgenic human cell line derived from colon cancer. This cell line is suitable to observe epithelial- mesenchymal transformation.
RCB4693
	ChR2-C2C12
		Comment	A subline of the murine C2C12 cell line　(RCB0987) which stably expresses　channelrhodopsin 2-Venus (ChR2-Venus), one of light-gated cation channels derived from a green alga Chlamydomonas reinhardtii, tagged with a fluorescent protein, Venus.
		Comment from the depositor
RCB4695
	GFP-LC3-RFP-LC3ΔG HeLa
		Comment
		Comment from the depositor	This cell line stablly expresses EGFP-LC3-mRFP-LC3Δ, an autophagic flux probe. Cellular autophagic flux can be evaluated by calculating the ratio of GFP against RFP fluorescent intensity.
RCB4696
	GFP-LC3-RFP-LC3ΔG MEF
		Comment
		Comment from the depositor	This cell line stablly expresses EGFP-LC3-mRFP-LC3Δ, an autophagic flux probe. Cellular autophagic flux can be evaluated by calculating the ratio of GFP against RFP fluorescent intensity.
RCB4699
	S-TFE
		Comment
		Comment from the depositor	S-TFE is established from a rare subtype of Xp11 translocation renal cell carcinoma. The cell line demonstrated definite gene fusion including TFE3 gene located on chromosome X. It showed ASPL-TFE3 type 1 fusion.
RCB4700
	A2A12
		Comment
		Comment from the depositor	Hybridoma cells producing a monoclonal antibody against plexin-A2.
RCB4701
	A4F5
		Comment
		Comment from the depositor	Hybridoma cells producing a monoclonal antibody against plexin-A4.
RCB4702
	3A12
		Comment	Currently not ready.
		Comment from the depositor	Hybridoma cells producing a monoclonal antibody against plexin-A2.
RCB4703
	5H1
		Comment	Currently not ready.
		Comment from the depositor	Hybridoma cells producing a monoclonal antibody against plexin-A2.
RCB4704
	6B12
		Comment	Currently not ready.
		Comment from the depositor	Hybridoma cells producing a monoclonal antibody against plexin-A2.
RCB4705
	1D2B
		Comment	Currently not ready.
		Comment from the depositor	Hybridoma cells producing a monoclonal antibody against plexin-A4.
RCB4706
	4F83
		Comment	Currently not ready.
		Comment from the depositor	Hybridoma cells producing a monoclonal antibody against plexin-A4.
RCB4707
	5D83
		Comment	Currently not ready.
		Comment from the depositor	Hybridoma cells producing a monoclonal antibody against plexin-A4.
RCB4708
	5H8B
		Comment	Currently not ready.
		Comment from the depositor	Hybridoma cells producing a monoclonal antibody against plexin-A4.
RCB4709
	THL98
		Comment	Currently not ready.
		Comment from the depositor	Hybridoma producing a monoclonal antibody against themolabail hemolysin (TLH) of V. parahaemolyticus.
RCB4710
	VP109
		Comment	Currently not ready.
		Comment from the depositor	Hybridoma producing a monoclonal antibody against F0F1 ATP synthase　δ-subunit of V. parahaemolyticus.
RCB4711
	TRH81
		Comment	Currently not ready.
		Comment from the depositor	Hybridoma producing a monoclonal antibody against thermostable direct hemolysin (TDH)-related hemolysin(TRH) of V. parahaemolyticus.
RCB4712
	TRH96
		Comment	Currently not ready.
		Comment from the depositor	Hybridoma producing a monoclonal antibody against thermostable direct hemolysin(TDH)-related hemolysin(TRH) of V. parahaemolyticus.
RCB4713
	TRH137
		Comment	Currently not ready.
		Comment from the depositor	Hybridoma producing a monoclonal antibody against thermostable direct hemolysin(TDH)-related hemolysin(TRH) of V. parahaemolyticus.
RCB4714
	Betv2-3
		Comment	Currently not ready.
		Comment from the depositor	Hybridoma producing a monoclonal antibody against birch pollen allergen profilin (Bet v 2).
RCB4715
	Cits2-38
		Comment	Currently not ready.
		Comment from the depositor	Hybridoma producing a monoclonal antibody against orange allergen profilin (Cit s 2).
RCB4716
	Cits2-47
		Comment	Currently not ready.
		Comment from the depositor	Hybridoma producing a monoclonal antibody against orange allergen profilin (Cit s 2).
RCB4717
	WT(MEF)
		Comment
		Comment from the depositor	Mouse embryonic fibroblasts immortalized by transfection of SV40 large T antigen in Oyadomari laboratory.
RCB4718
	eIF2ak(4KO)
		Comment
		Comment from the depositor	The eIF2α kinase quadruple knockout cells in which the four known eIF2α kinase genes (Hri, Pkr, Perk, Gcn2) were deleted using the CRISPR/Cas9-mediated genome editing. The parental cell line is the immortalized mouse embryonic fibroblasts established in Oyadomari laboratory.
RCB4719
	eIF2ak(4KO+HRI)
		Comment
		Comment from the depositor	This is an eIF2ak(4KO) RCB4718 MEF cell line in which flag-tagged mouse HRI was reintroduced by retrovirus.
RCB4720
	eIF2ak(4KO+PERK)
		Comment
		Comment from the depositor	This is an eIF2ak(4KO) RCB4718 MEF cell line in which flag-tagged mouse PERK was reintroduced by retrovirus.
RCB4721
	eIF2ak(4KO+PKR)
		Comment
		Comment from the depositor	This is an eIF2ak(4KO) RCB4718 MEF cell line in which flag-tagged mouse PKR was reintroduced by retrovirus.
RCB4722
	eIF2ak(4KO+GCN2)
		Comment
		Comment from the depositor	This is an eIF2ak(4KO) RCB4718 MEF cell line in which flag-tagged mouse GCN2 was reintroduced by retrovirus.
RCB4724
	A2A(C2702-B05-52)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4725
	A2A(C2704-C07-89)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4726
	A2A(C2831-104)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4727
	A2A(C2838-190)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4728
	A2A(C3007-E6)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4729
	A2A(C3019-B-203-B3)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4730
	A2A(C3024-43)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4731
	A2A(C3025-95)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4732
	A2A(C3029A-236)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4733
	A2A(C3044-10)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4734
	A2A(C3080-145)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4735
	A2A(C3138G3(A))
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4736
	A2A(C3160-79)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4737
	A2A(C3169-214)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4738
	A2A(C3978B-D4)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4739
	A2A(C3938B-F6)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4740
	A2A(C3943B-E3)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4741
	A2A(C40006-123)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4742
	A2A(C40010-A6)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4743
	A2A(C40011-G11)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4744
	A2A(C40037-A5)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4745
	A2A(C40040-A12)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4746
	A2A(C40056-G6)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4747
	A2A(C40076-173)
		Comment	Currently not ready. Hybridoma against A2A (human) : adenosine A2A receptor (1~316 aa) antigen.
		Comment from the depositor
RCB4748
	M2(C1801-A9-16)
		Comment	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
		Comment from the depositor
RCB4749
	M2(C1802-B4-42)
		Comment	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
		Comment from the depositor
RCB4750
	M2(C1803-C2-74)
		Comment	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
		Comment from the depositor
RCB4751
	M2(C1805-E5-95)
		Comment	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
		Comment from the depositor
RCB4752
	M2(C1901-C4-152)
		Comment	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
		Comment from the depositor
RCB4753
	M2(C3603-D10-1)
		Comment	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
		Comment from the depositor
RCB4754
	M2(C4729-H1-3)
		Comment	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
		Comment from the depositor
RCB4755
	M2(C4804-3)
		Comment	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
		Comment from the depositor
RCB4756
	M2(C4817-1)
		Comment	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
		Comment from the depositor
RCB4757
	M2(C4814-E10-3)
		Comment	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
		Comment from the depositor
RCB4758
	M2(C5708-1)
		Comment	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
		Comment from the depositor
RCB4759
	M2(C5801-3)
		Comment	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
		Comment from the depositor
RCB4760
	M2(C5903-1)
		Comment	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
		Comment from the depositor
RCB4761
	M2(D0303-12)
		Comment	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
		Comment from the depositor
RCB4762
	M2(D0368-63-A1-16)
		Comment	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
		Comment from the depositor
RCB4763
	M2(D0403-13)
		Comment	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
		Comment from the depositor
RCB4764
	M2(D0423-15)
		Comment	Currently not ready. Hybridoma against M2 (human) : muscarinic acetylcholine receptor (delta 224~381 aa) antigen.
		Comment from the depositor
RCB4765
	Band3(C4201-A1-10)
		Comment	Currently not ready. Hybridoma against Band 3 (human) : Band 3 (anion exchanger 1) (full length) antigen.
		Comment from the depositor
RCB4766
	Band3(C4203-D3-26)
		Comment	Currently not ready. Hybridoma against Band 3 (human) : Band 3 (anion exchanger 1) (full length) antigen.
		Comment from the depositor
RCB4767
	Band3(C4204-C3-48)
		Comment	Currently not ready. Hybridoma against Band 3 (human) : Band 3 (anion exchanger 1) (full length) antigen.
		Comment from the depositor
RCB4768
	Band3(C4206-G7-90)
		Comment	Currently not ready. Hybridoma against Band 3 (human) : Band 3 (anion exchanger 1) (full length) antigen.
		Comment from the depositor
RCB4769
	Glut5(C45053-H4)
		Comment	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
		Comment from the depositor
RCB4770
	Glut5(C45085-F2)
		Comment	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
		Comment from the depositor
RCB4771
	Glut5(C45107-102)
		Comment	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
		Comment from the depositor
RCB4772
	Glut5(C45019-3)
		Comment	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
		Comment from the depositor
RCB4773
	Glut5(C45077-49)
		Comment	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
		Comment from the depositor
RCB4774
	Glut5(C45106-78)
		Comment	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
		Comment from the depositor
RCB4775
	Glut5(C45021-34)
		Comment	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
		Comment from the depositor
RCB4776
	Glut5(C45004-016)
		Comment	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
		Comment from the depositor
RCB4777
	Glut5(C45008-054)
		Comment	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
		Comment from the depositor
RCB4778
	Glut5(C45037-101)
		Comment	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
		Comment from the depositor
RCB4779
	Glut5(C45080-134)
		Comment	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
		Comment from the depositor
RCB4780
	Glut5(C45081-146)
		Comment	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
		Comment from the depositor
RCB4781
	Glut5(C45119-160)
		Comment	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
		Comment from the depositor
RCB4782
	Glut5(C45124-214)
		Comment	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
		Comment from the depositor
RCB4783
	Glut5(C45125-237)
		Comment	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
		Comment from the depositor
RCB4784
	Glut5(C45032-73)
		Comment	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
		Comment from the depositor
RCB4785
	Glut5(C45120-263-A4)
		Comment	Currently not ready. Hybridoma against Glut 5 (rat) : glucose transporter 5 (full length) antigen.
		Comment from the depositor
RCB4786
	v-ATP ase VoV1(C87076-007)
		Comment	Currently not ready. Hybridoma against v-ATP ase CL : v-ATP ase (CL domain) antigen.
		Comment from the depositor
RCB4787
	v-ATP ase VoV1(C87076-014)
		Comment	Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
		Comment from the depositor
RCB4788
	v-ATP ase VoV1(C87079-067)
		Comment	Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
		Comment from the depositor
RCB4789
	v-ATP ase VoV1(C87119-130)
		Comment	Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
		Comment from the depositor
RCB4790
	v-ATP ase VoV1(C87119-132)
		Comment	Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
		Comment from the depositor
RCB4791
	v-ATP ase VoV1(C87119-148)
		Comment	Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
		Comment from the depositor
RCB4792
	v-ATP ase VoV1(C87160-164)
		Comment	Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
		Comment from the depositor
RCB4793
	v-ATP ase VoV1(C87187-276)
		Comment	Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
		Comment from the depositor
RCB4794
	v-ATP ase VoV1(C87159B-111)
		Comment	Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
		Comment from the depositor
RCB4795
	v-ATP ase VoV1(C9017-349)
		Comment	Currently not ready. Hybridoma against v-ATP ase VoV1(E. coli) : v-ATP ase (VoV1 domain) antigen.
		Comment from the depositor
RCB4796
	v-ATP ase CL(E72013-2C2-94)
		Comment	Currently not ready. Hybridoma against v-ATP ase CL : v-ATP ase (CL domain) antigen.
		Comment from the depositor
RCB4797
	HRH1(D2205-A8)
		Comment	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
		Comment from the depositor
RCB4798
	HRH1(D2210-C9)
		Comment	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
		Comment from the depositor
RCB4799
	HRH1(D2201-D7)
		Comment	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
		Comment from the depositor
RCB4800
	HRH1(D2315-H6)
		Comment	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
		Comment from the depositor
RCB4801
	HRH1(D2335-A10)
		Comment	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
		Comment from the depositor
RCB4802
	HRH1(D2351-H7)
		Comment	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
		Comment from the depositor
RCB4803
	HRH1(D2335-F8)
		Comment	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
		Comment from the depositor
RCB4804
	HRH1(D2363-H11)
		Comment	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
		Comment from the depositor
RCB4805
	HRH1(D2326-G6-F12)
		Comment	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
		Comment from the depositor
RCB4806
	HRH1(D2323-H5)
		Comment	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
		Comment from the depositor
RCB4807
	HRH1(D2340-67)
		Comment	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
		Comment from the depositor
RCB4808
	HRH1(D2401-E6)
		Comment	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
		Comment from the depositor
RCB4809
	HRH1(D2503-B5)
		Comment	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
		Comment from the depositor
RCB4810
	HRH1(D2510-110)
		Comment	Currently not ready. Hybridoma against HRH1 (human) : histamine receptor H1 (full length) antigen.
		Comment from the depositor
RCB4811
	Glut1(D3638-22)
		Comment	Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
		Comment from the depositor	Purified full length of human glucose transporter (hGlut1) expressed in the Saccharomyces cerevisiae. was reconstituted into liposomes. This hybridoma was generated using the hGlut1 liposome as an immunogen.
RCB4812
	Glut1(D3643-9)
		Comment	Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
		Comment from the depositor	Purified full length of human glucose transporter (hGlut1) expressed in the Saccharomyces cerevisiae. was reconstituted into liposomes. This hybridoma was generated using the hGlut1 liposome as an immunogen.
RCB4813
	Glut1(D4425-2)
		Comment	Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
		Comment from the depositor	Purified full length of human glucose transporter (hGlut1) expressed in the Saccharomyces cerevisiae. was reconstituted into liposomes. This hybridoma was generated using the hGlut1 liposome as an immunogen.
RCB4814
	Glut1(D4416-3)
		Comment	Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
		Comment from the depositor	Purified full length of human glucose transporter (hGlut1) expressed in the Saccharomyces cerevisiae. was reconstituted into liposomes. This hybridoma was generated using the hGlut1 liposome as an immunogen.
RCB4815
	Glut1(D4417-14)
		Comment	Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
		Comment from the depositor	Purified full length of human glucose transporter (hGlut1) expressed in the Saccharomyces cerevisiae. was reconstituted into liposomes. This hybridoma was generated using the hGlut1 liposome as an immunogen.
RCB4816
	Glut1(D4402-6)
		Comment	Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
		Comment from the depositor	Purified full length of human glucose transporter (hGlut1) expressed in the Saccharomyces cerevisiae. was reconstituted into liposomes. This hybridoma was generated using the hGlut1 liposome as an immunogen.
RCB4817
	Glut1(D4418-30)
		Comment	Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
		Comment from the depositor	Purified full length of human glucose transporter (hGlut1) expressed in the Saccharomyces cerevisiae. was reconstituted into liposomes. This hybridoma was generated using the hGlut1 liposome as an immunogen.
RCB4818
	Glut1(D4404-9)
		Comment	Hybridoma against Glut 1 (human) : glucose transporter 1 (full length) antigen.
		Comment from the depositor	Purified full length of human glucose transporter (hGlut1) expressed in the Saccharomyces cerevisiae. was reconstituted into liposomes. This hybridoma was generated using the hGlut1 liposome as an immunogen.
RCB4819
	OxlT(D5901-1A08)
		Comment	Currently not ready. Hybridoma against OxlT(E. coli) : oxalate transport (full length) antigen.
		Comment from the depositor
RCB4820
	OxlT(D5901-1B08)
		Comment	Currently not ready. Hybridoma against OxlT(E. coli) : oxalate transport (full length) antigen.
		Comment from the depositor
RCB4821
	OxlT(D5904-1D08)
		Comment	Currently not ready. Hybridoma against OxlT(E. coli) : oxalate transport (full length) antigen.
		Comment from the depositor
RCB4822
	OxlT(D5906-1F04)
		Comment	Currently not ready. Hybridoma against OxlT(E. coli) : oxalate transport (full length) antigen.
		Comment from the depositor
RCB4823
	OxlT(D5907-1H07)
		Comment	Currently not ready. Hybridoma against OxlT(E. coli) : oxalate transport (full length) antigen.
		Comment from the depositor
RCB4824
	OxlT(D5908-2B09)
		Comment	Currently not ready. Hybridoma against OxlT(E. coli) : oxalate transport (full length) antigen.
		Comment from the depositor
RCB4825
	OxlT(D5921-2E03)
		Comment	Currently not ready. Hybridoma against OxlT(E. coli) : oxalate transport (full length) antigen.
		Comment from the depositor
RCB4826
	OxlT(D5924-2H06)
		Comment	Currently not ready. Hybridoma against OxlT(E. coli) : oxalate transport (full length) antigen.
		Comment from the depositor
RCB4827
	OxlT(D6205-3B02)
		Comment	Currently not ready. Hybridoma against OxlT(E. coli) : oxalate transport (full length) antigen.
		Comment from the depositor
RCB4828
	OxlT(D6206-3B05)
		Comment	Currently not ready. Hybridoma against OxlT(E. coli) : oxalate transport (full length) antigen.
		Comment from the depositor
RCB4829
	OxlT(D6538-3F03)
		Comment	Currently not ready. Hybridoma against OxlT(E. coli) : oxalate transport (full length) antigen.
		Comment from the depositor
RCB4830
	OxlT(D6541-3G02)
		Comment	Currently not ready. Hybridoma against OxlT(E. coli) : oxalate transport (full length) antigen.
		Comment from the depositor
RCB4831
	AT2(D5604-006)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4832
	AT2(D5614-054)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4833
	AT2(D5608-040)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4834
	AT2(D5647-129)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4835
	AT2(D5655-150)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4836
	AT2(D5630-095)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4837
	AT2(D5605-011)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4838
	AT2(D5640-072)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4839
	AT2(D5620-032)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4840
	AT2(D5626-060)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4841
	AT2(D5711-4A03-B03)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4842
	AT2(D5713-4C10-290)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4843
	AT2(D5725-3B08-369)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4844
	AT2(D5702-1A09-173)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4845
	AT2(D5705-1E10-208)
		Comment	Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor	AT2-null mice crossed with gp64 transgenic mice. AT２-null mice were prepared according to the previously described procedure (Nature, 377. 748-750, 1995). Gp64 transgenic mice were prepared according to the previously described procedure ( J.Immunol,Methods. 30: 322(1-2), 114-117, 2007.).
RCB4846
	AT2(D5711-2H02-A01)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4847
	AT2(D5714A-4D07-334)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4848
	AT2(D5706-1F03-149)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4849
	AT2(D5709-1H06-187)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4850
	AT2(D5711-2H05-229)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4851
	AT2(D5701-1A07-116)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4852
	AT2(D5712-4A08-236)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4853
	AT2(D5707-1G02-158)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4854
	AT2(D5722-2D12-202)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4855
	AT2(D5701-1A06-100)
		Comment	Currently not ready. Hybridoma against AT2 ( human) : angiotensin type II receptor (full length) antigen.
		Comment from the depositor
RCB4856
	TACR2(D8116-4C1-1)
		Comment	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
		Comment from the depositor
RCB4857
	TACR2(D8103-3F12-1)
		Comment	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
		Comment from the depositor
RCB4858
	TACR2(D8210-5D5-1)
		Comment	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
		Comment from the depositor
RCB4859
	TACR2(D8213-5A1-3)
		Comment	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
		Comment from the depositor
RCB4860
	TACR2(D83007-3)
		Comment	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
		Comment from the depositor
RCB4861
	TACR2(D83010-1)
		Comment	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
		Comment from the depositor
RCB4862
	TACR2(D83008-1)
		Comment	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
		Comment from the depositor
RCB4863
	TACR2(D84042-1)
		Comment	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
		Comment from the depositor
RCB4864
	TACR2(D84048-1)
		Comment	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
		Comment from the depositor
RCB4865
	TACR2(D84072-1)
		Comment	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
		Comment from the depositor
RCB4866
	TACR2(D84026-1)
		Comment	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
		Comment from the depositor
RCB4867
	TACR2(D84083-1)
		Comment	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
		Comment from the depositor
RCB4868
	TACR2(D84112-1)
		Comment	Currently not ready. Hybridoma against TACR2 (human) : tachykinin receptor II (full length) antigen.
		Comment from the depositor
RCB4869
	GluR1-2(Z9139)
		Comment	Currently not ready. Hybridoma against GluR1-2 (mouse) : GluA1 AMPA (a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptor (236~286 aa) antigen.
		Comment from the depositor
RCB4870
	AQP4(C9401-A3-29)
		Comment	Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
		Comment from the depositor
RCB4871
	AQP4(D12092-1C3-02)
		Comment	Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
		Comment from the depositor
RCB4872
	AQP4(D15107-3D7-33)
		Comment	Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
		Comment from the depositor	Full length of human aquaporin 4 (hAQP4) M23 isoform was expressed on the surface of baculovirus according to the previously described procedure ( J.Immunol,Methods. 30: 322(1-2), 114-117, 2007). This hybridoma was generated using the recombinant budded virus as an immunogen.
RCB4873
	AQP4(E3634-13)
		Comment	Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
		Comment from the depositor
RCB4874
	AQP4(E3641-70)
		Comment	Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
		Comment from the depositor
RCB4875
	AQP4(E3635-60-A7)
		Comment	Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
		Comment from the depositor
RCB4876
	AQP4(E3726A-122)
		Comment	Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
		Comment from the depositor
RCB4877
	AQP4(E3716-94)
		Comment	Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
		Comment from the depositor
RCB4878
	AQP4(E3726B-130)
		Comment	Currently not ready. Hybridoma against AQP4 (human) : aquaporin (full length) antigen.
		Comment from the depositor
RCB4879
	AQP4(E5206-1B10-8)
		Comment	Currently not ready. Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
		Comment from the depositor
RCB4880
	AQP4(E5209-1C8-22)
		Comment	Currently not ready. Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
		Comment from the depositor
RCB4881
	AQP4(E5407-1E6-32)
		Comment	Currently not ready. Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
		Comment from the depositor
RCB4882
	AQP4(E5413-1G11-49)
		Comment	Currently not ready. Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
		Comment from the depositor
RCB4883
	AQP4(E5415A-1H6-68)
		Comment	Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
		Comment from the depositor	Full length of mouse aquaporin 4 (ｍAQP4) M23 isoform was expressed on the surface of baculovirus according to the previously described procedure ( J.Immunol,Methods. 30: 322(1-2), 114-117, 2007). This hybridoma was generated using the recombinant budded virus as an immunogen.
RCB4884
	AQP4(E5415B-1H7-79)
		Comment	Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
		Comment from the depositor	Full length of mouse aquaporin 4 (ｍAQP4) M23 isoform was expressed on the surface of baculovirus according to the previously described procedure ( J.Immunol,Methods. 30: 322(1-2), 114-117, 2007). This hybridoma was generated using the recombinant budded virus as an immunogen.
RCB4885
	AQP4(E5507-3A1-113)
		Comment	Currently not ready. Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
		Comment from the depositor
RCB4886
	AQP4(E5505-3D12-129)
		Comment	Currently not ready. Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
		Comment from the depositor
RCB4887
	AQP4(E5504-2G2-105)
		Comment	Currently not ready. Hybridoma against AQP4 (mouse) : aquaporin (full length) antigen.
		Comment from the depositor
RCB4888
	DP2(D5201-1A5-6)
		Comment	Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
		Comment from the depositor
RCB4889
	DP2(D5203-1D8-31)
		Comment	Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
		Comment from the depositor	Full length of mouse Prostaglandin D2 receptor DP2 was expressed on the surface of BaF3 cells according to the previously described procedure（Nagata et al. PLos One 2017 Apr 10;12(4):e0175452. doi:10.1371/journal.pone.0175452. eCollection 2017. ). This hybridoma was generated using the recombinant mouse DP2 expressed BaF3 cells as an immunogen.
RCB4890
	DP2(D5302-3A4-82)
		Comment	Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
		Comment from the depositor
RCB4891
	DP2(D5305-3B3-103)
		Comment	Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
		Comment from the depositor
RCB4892
	DP2(D5502-135)
		Comment	Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
		Comment from the depositor
RCB4893
	DP2(D5513-2-B1)
		Comment	Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
		Comment from the depositor
RCB4894
	DP2(D5516-176)
		Comment	Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
		Comment from the depositor
RCB4895
	DP2(D5517-208-A2)
		Comment	Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
		Comment from the depositor
RCB4896
	DP2(D5524-228)
		Comment	Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
		Comment from the depositor
RCB4897
	DP2(D5531-258)
		Comment	Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
		Comment from the depositor
RCB4898
	DP2(D5534-265)
		Comment	Currently not ready. Hybridoma against DP2 (mouse) : prostaglandin receptor DP2 (full length) antigen.
		Comment from the depositor
RCB4899
	NRF3-2(E9403-D3-A5-1)
		Comment	Currently not ready. Hybridoma against NRF3-2 (human) : NRF3 (363~415 aa) antigen.
		Comment from the depositor
RCB4900
	NRF3-2(E9405-1)
		Comment	Currently not ready. Hybridoma against NRF3-2 (human) : NRF3 (363~415 aa) antigen.
		Comment from the depositor
RCB4901
	NRF3-2(E9408-1)
		Comment	Hybridoma against NRF3-2 (human) : NRF3 (363~415 aa) antigen.
		Comment from the depositor	NRF3 (363~415 aa) was expressed on the surface of baculovirus as the gp64 fusion protein according to the previously described procedure (J Atheroscler Thromb. 2002;9:233-242).
RCB4902
	NRF3-2(E9413-G1-A3-1)
		Comment	Currently not ready. Hybridoma against NRF3-2 (human) : NRF3 (363~415 aa) antigen.
		Comment from the depositor
RCB4903
	NRF3-2(E9422-D2-B9-1)
		Comment	Currently not ready. Hybridoma against NRF3-2 (human) : NRF3 (363~415 aa) antigen.
		Comment from the depositor
RCB4904
	RhoA(E2004-A9-1)
		Comment	Currently not ready. Hybridoma against Rho A (human) : Rho A (full length) antigen.
		Comment from the depositor
RCB4905
	RhoA(E4402-3A1-12)
		Comment	Currently not ready. Hybridoma against Rho A (human) : Rho A (full length) antigen.
		Comment from the depositor
RCB4906
	RhoA(E4614-4C9-41)
		Comment	Currently not ready. Hybridoma against Rho A (human) : Rho A (full length) antigen.
		Comment from the depositor
RCB4907
	DHHC1(D8013-1C11-6)
		Comment	Currently not ready. Hybridoma against DHHC1 (mouse) : Asp-His-His-Cys motif containing protein 1 (full length) antigen.
		Comment from the depositor
RCB4908
	DHHC1(D8018-1D10-26)
		Comment	Currently not ready. Hybridoma against DHHC1 (mouse) : Asp-His-His-Cys motif containing protein 1 (full length) antigen.
		Comment from the depositor
RCB4909
	DHHC1(D8018-1D10-35)
		Comment	Currently not ready. Hybridoma against DHHC1 (mouse) : Asp-His-His-Cys motif containing protein 1 (full length) antigen.
		Comment from the depositor
RCB4910
	DHHC10(E2601-1C3-2)
		Comment	Currently not ready. Hybridoma against DHHC10 (mouse) : Asp-His-His-Cys motif containing protein 10 (full length) antigen.
		Comment from the depositor
RCB4911
	DHHC10(E2607-1F6-23)
		Comment	Currently not ready. Hybridoma against DHHC10 (mouse) : Asp-His-His-Cys motif containing protein 10 (full length) antigen.
		Comment from the depositor
RCB4912
	DHHC10(E2611-1H2-49)
		Comment	Currently not ready. Hybridoma against DHHC10 (mouse) : Asp-His-His-Cys motif containing protein 10 (full length) antigen.
		Comment from the depositor
RCB4913
	DHHC10(E2614-3B1-69)
		Comment	Currently not ready. Hybridoma against DHHC10 (mouse) : Asp-His-His-Cys motif containing protein 10 (full length) antigen.
		Comment from the depositor
RCB4914
	DHHC10(E2701-2B3-97)
		Comment	Currently not ready. Hybridoma against DHHC10 (mouse) : Asp-His-His-Cys motif containing protein 10 (full length) antigen.
		Comment from the depositor
RCB4915
	DHHC10(E2706-2F7-135)
		Comment	Currently not ready. Hybridoma against DHHC10 (mouse) : Asp-His-His-Cys motif containing protein 10 (full length) antigen.
		Comment from the depositor
RCB4917
	HeLa/Fucci(SA)5#16
		Comment	Important notice regarding nomenclature of Fucci. Research tools : Fucci – Fluorescent Ubiquitination-based Cell Cycle Indicator.
		Comment from the depositor	a subclone of HeLa.S3 cells provided by Dr. Mikoshiba in 2009.
RCB4919
	HeLa/Fucci(CA)5#16
		Comment	Important notice regarding nomenclature of Fucci. Research tools : Fucci – Fluorescent Ubiquitination-based Cell Cycle Indicator.
		Comment from the depositor	a subclone of HeLa.S3 cells provided by Dr. Mikoshiba in 2009.
RCB4920
	PSPA
		Comment
		Comment from the depositor	A preadipocyte clonal line established from porcine subcutaneous tissue of 85-day fetuses. When appropriately induced by the stimulants, fibroblast-like preadipocytes can differentiate into lipid-filled adipocytes.
RCB4936
	CT27
		Comment	TS culture protocol, TS culture protocol_V2
		Comment from the depositor	Human trophoblast stem cells were derived from blastocysts or placental cytotrophoblast cells. Human trophoblast stem cells have the potential to differentiate into extravillous cytotrophoblast and syncytiotrophoblast cells.
RCB4937
	CT29
		Comment	TS culture protocol, TS culture protocol_V2
		Comment from the depositor	Human trophoblast stem cells were derived from blastocysts or placental cytotrophoblast cells. Human trophoblast stem cells have the potential to differentiate into extravillous cytotrophoblast and syncytiotrophoblast cells.
RCB4938
	CT30
		Comment	TS culture protocol, TS culture protocol_V2
		Comment from the depositor	Human trophoblast stem cells were derived from blastocysts or placental cytotrophoblast cells. Human trophoblast stem cells have the potential to differentiate into extravillous cytotrophoblast and syncytiotrophoblast cells.
RCB4940
	bTS5
		Comment	TS culture protocol, TS culture protocol_V2
		Comment from the depositor	Human trophoblast stem cells were derived from blastocysts or placental cytotrophoblast cells. Human trophoblast stem cells have the potential to differentiate into extravillous cytotrophoblast and syncytiotrophoblast cells.
RCB4941
	bTS11
		Comment	TS culture protocol, TS culture protocol_V2
		Comment from the depositor	Human trophoblast stem cells were derived from blastocysts or placental cytotrophoblast cells. Human trophoblast stem cells have the potential to differentiate into extravillous cytotrophoblast and syncytiotrophoblast cells.
RCB4942
	BHK/T7-9
		Comment
		Comment from the depositor	A hamster kidney-derived BHK cell clone stably expressing T7 RNA polymerase.
RCB4943
	NU-RMESO-2
		Comment
		Comment from the depositor	Rat malignant mesothelioma induced by crocidolite peritoneal injection. Histology (tissue): epithelioid subtype, tubulopapillary variant. Histology (cell culture on the dish): solid-like. Immunohistochemistry: Podoplanin (-), Mesothelin (+), AE1/AE3 (+).
RCB4944
	NU-RMESO-9
		Comment	Currently not ready.
		Comment from the depositor	Rat malignant mesothelioma induced by crocidolite peritoneal injection. Histology (tissue): sarcomatoid subtype, fibrosarcomatoid variant with sclerosing. Histology (cell culture on the dish): spindle shape. Immunohistochemistry: Podoplanin (+), Mesothelin (+), AE1/AE3 (-).
RCB4945
	NU-RMESO-14
		Comment	Currently not ready.
		Comment from the depositor	Rat malignant mesothelioma induced by crocidolite peritoneal injection. Histology (tissue): sarcomatoid subtype, fibrosarcomatoid variant. Histology (cell culture on the dish): spindle shape. Immunohistochemistry: Podoplanin (+), Mesothelin (+), AE1/AE3 (-).
RCB4946
	NU-RMESO-20
		Comment	Currently not ready.
		Comment from the depositor	Rat malignant mesothelioma induced by crocidolite peritoneal injection. Histology (tissue): subtype, biphasic; variant, adenomatoid (microcystic) 50% + fibrosarcomatoid 50%. Histology (cell culture on the dish): fibroblast-like. Immunohistochemistry: Podoplanin (+), Mesothelin (+), AE1/AE3 (+).
RCB4947
	NU-RMESO-40
		Comment	Currently not ready.
		Comment from the depositor	Rat malignant mesothelioma induced by crocidolite peritoneal injection. Histology (tissue): sarcomatoid subtype, osteosarcomatoid variant. Histology (cell culture on the dish): spindle shape. Immunohistochemistry: Podoplanin (+), Mesothelin (+), AE1/AE3 (-).
RCB4948
	NU-RMESO-26
		Comment	Currently not ready.
		Comment from the depositor	Rat malignant mesothelioma induced by crocidolite peritoneal injection. Histology (tissue): subtype, biphasic; variant, deciduoid 30% + fibrosarcomatoid 70%. Histology (cell culture on the dish): short spindle shape . Immunohistochemistry: Podoplanin (+), Mesothelin (+), AE1/AE3 (-).
RCB4949
	NU-RMESO-79
		Comment	Currently not ready.
		Comment from the depositor	Rat malignant mesothelioma induced by crocidolite peritoneal injection. Histology (tissue): epithelioid subtype, well differentiated variant. Histology (cell culture on the dish): solid-like. Immunohistochemistry: Podoplanin (+), Mesothelin (+), AE1/AE3 (-).
RCB4965
	FBD-102b
		Comment
		Comment from the depositor	Clonal oligodendroglial progenitor cell line established from brain of fetal p53-/- mice.
RCB5003
	IWT-1
		Comment
		Comment from the depositor	This cell line was established from gastric adenocarcinoma cells in peritonitis carcinomatosa ascites.
RCB5004
	CHL-YN
		Comment	Application consideration
		Comment from the depositor	Novel cells derived from female Chinese hamster lung. Cells were immortalized by spontaneous transformation. Cells were adapted in animal component-free chemically defined media and subjected to biosafety testing (BioReliance), in which safety was confirmed by an in vitro assay to detect viral contaminants using 3 detector cell lines, a mycoplasma detection test by real-time PCR, and sterility testing by direct inoculation.
RCB5005
	FKH-1
		Comment	Acute myeloid leukemia with dek/can chimera mRNA expression. Responding to G-CSF and differentiate.
		Comment from the depositor
RCB5007
	MCC138c
		Comment
		Comment from the depositor	Human cell line derived from poor differentiated lung squamous carcinoma.　Transplantable to NOG mice.
RCB5008
	MCC148c
		Comment
		Comment from the depositor	Human cell line derived from poor differentiated lung squamous carcinoma.　Transplantable to NOG mice.
RCB5010
	D4-ChAT
		Comment
		Comment from the depositor	Hybridoma cell line producing anti-chicken ChAT antibody (mouse IgG).
RCB5029
	NIH3T3 Flp Arl13bCerulean-Fucci2a
		Comment	Currently not ready.
		Comment from the depositor	NIH/3T3 is a fibroblast cell line that was isolated from a mouse NIH/Swiss embryo. These cells were generated by a stable integration of pCDNA5-CAG-Arl13bFucci2a using the Flp-in system they were not cloned but are isogenic.
RCB5030
	NIH3T3 Flp Fucci2a
		Comment	Currently not ready.
		Comment from the depositor	NIH/3T3 is a fibroblast cell line that was isolated from a mouse NIH/Swiss embryo. These cells were generated by a stable integration of pCDNA5-Fucci2a using the Flp-in system they were not cloned but are isogenic.
RCB5036
	CMG14-12
		Comment
		Comment from the depositor	Mouse M-CSF producing Ltk- cell line, CMG14-12. The mouse M-CSF expression vector was transfected into mouse Ltk- cells, M-CSF high producing cel l line was selected and named ''CMG14-12''. CMG14-12: M-CSF producing cell line
RCB5043
	DP002
		Comment
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5044
	DP005
		Comment
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5045
	DP006
		Comment
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5046
	DP007
		Comment
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5047
	DP010
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5048
	DP011
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5049
	DP012
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5050
	DP014
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5051
	DP015
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5052
	DP017
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5053
	DP018
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5054
	DP025
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5055
	DP026
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5056
	DP028
		Comment
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5057
	DP030
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5058
	DP031
		Comment
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5059
	DP032
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5060
	DP035
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5061
	DP038
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5062
	DP039
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5063
	DP040
		Comment
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5064
	DP041
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5065
	DP042
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5066
	DP044
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5067
	DP046
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5068
	DP048
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5069
	DP049
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5070
	DP052
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5071
	DP053
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5072
	DP054
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5073
	DP056
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5074
	DP057
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5075
	DP060
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5076
	DP062
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5077
	DP064
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5078
	DP065
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5079
	DP066
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5080
	DP068
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5081
	DP069
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5082
	DP072
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5083
	DP073
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5084
	DP083
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5085
	DP086
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5086
	DP087
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5087
	DP092
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5088
	DP094
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5089
	DP099
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5090
	DP100
		Comment	Currently not ready.
		Comment from the depositor	Dental pulp cells are derived from human dental pulp. They are characterized with fibroblastic morphology, and contamination of hematopoetic cells is minimal.
RCB5093
	KIF13A-KO HeLaM
		Comment
		Comment from the depositor	KIF13A knockout (KO) HeLaM cells.
RCB5094
	KIF13B-KO HeLaM
		Comment
		Comment from the depositor	KIF13B knockout (KO) HeLaM cells.
RCB5095
	KIF13-DKO HeLaM
		Comment
		Comment from the depositor	KIF13A and KIF13B double knockout (DKO) HeLaM cells.
RCB5096
	Rab8-DKO HeLaM
		Comment
		Comment from the depositor	Rab8A and Rab8B double knockout (DKO) HeLaM cells.
RCB5097
	Rab10-KO HeLaM
		Comment
		Comment from the depositor	Rab10 knockout (KO) HeLaM cells.
RCB5098
	Rab22-DKO HeLaM
		Comment
		Comment from the depositor	Rab22A and Rab22B double knockout (DKO) HeLaM cells.
RCB5099
	Rab1A-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5100
	Rab1B-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5101
	Rab2-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockoutclone ).J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5102
	Rab3-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5103
	Rab4-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5104
	Rab5AB-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5105
	Rab5C-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5106
	Rab6-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5107
	Rab7A-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5108
	Rab7B-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5109
	Rab8-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5110
	Rab9-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5111
	Rab10-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5112
	Rab11-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5113
	Rab12-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-ll cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5114
	Rab13-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5115
	Rab14-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5116
	Rab15-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5117
	Rab17-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5118
	Rab18-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5119
	Rab19-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5120
	Rab20-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5121
	Rab21-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5122
	Rab22-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5123
	Rab23-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5124
	Rab24-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5125
	Rab25-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5126
	Rab26-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5127
	Rab27-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5128
	Rab28-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5129
	Rab29-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5130
	Rab30-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5131
	Rab32/38-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5132
	Rab33-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5133
	Rab34-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5134
	Rab35-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5135
	Rab36-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5136
	Rab37-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5137
	Rab39-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5138
	Rab40-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5139
	Rab42-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5140
	Rab43-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5141
	Rab7AB-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5142
	Rab7A/9-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5143
	Rab11/25-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5144
	Rab19/43-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5145
	Rab26/37-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5146
	Rab34/36-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5147
	Rab39/42-KO MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (Rab-knockout clone ). J Cell Biol. 2019; 218(6): 2035-2050, Tables S1-S3 (ZIP)
RCB5148
	MDCK-II
		Comment
		Comment from the depositor	MDCK-II cells (parental cells). Rab-knockout clone (RCB5099 - RCB5147).
RCB5257
	AS-E2
		Comment
		Comment from the depositor	An erythropoietin-dependent human leukemia cell line AS-E2 has been established from bone marrow of pure erythroid leukemia (PEL) patient. AS-E2 cells are strictly dependent on erythropoietin (EPO) for their growth and survival.
RCB5259
	ECCD-2
		Comment
		Comment from the depositor	Hybridoma which produces the rat monoclonal antibody ECCD-2 that recognizes E-cadherin.
RCB5261
	NCD-2
		Comment
		Comment from the depositor	Hybridoma which produces the rat monoclonal antibody NCD-2 that recognizes chicken N-cadherin.
RCB5262
	PCD-1
		Comment
		Comment from the depositor	Hybridoma which produces the rat monoclonal antibody PCD-1 that recognizes mouse P-cadherin.
RCB5263
	ATL-1K
		Comment
		Comment from the depositor	ATL-1K is a cell line established from peripheral blood of a patient with adult T-cell leukemia (ATL) and can grow without IL-2. ATL-1K cells contain one copy of HTLV-1 proviral DNA per cell. The expression of HTLV-1 antigen is not detected.
RCB5264
	ATL-3I
		Comment
		Comment from the depositor	ATL-3I is a cell line established from peripheral blood of a patient with adult T-cell leukemia (ATL) and can grow without IL-2. ATL-3I cells are positive for HTLV-1 antigens.
RCB5265
	ATL-5S
		Comment
		Comment from the depositor	ATL-5S is a cell line established from peripheral blood of a patient with adult T-cell leukemia (ATL) and can grow without IL-2. ATL-5S cells are positive for HTLV-1 antigens.
RCB5290
	BD1B
		Comment	Currently not ready.
		Comment from the depositor	Rat/mouse-hybridoma producing anti-mouse-cadherin-17 (BILL-cadherin).
RCB5291
	MEF_Hsp47 WT-18
		Comment
		Comment from the depositor	Mouse embryonic fibroblasts. Wild type control for Hsp47-deficient cell.
RCB5292
	MEF_Hsp47 KO-11
		Comment
		Comment from the depositor	Mouse embryonic fibroblasts derived from Hsp47-deficient mouse.
RCB5293
	MEF_Hsp47 KO-13
		Comment
		Comment from the depositor	Mouse embryonic fibroblasts derived from Hsp47-deficient mouse.
RCB5294
	RMM-C
		Comment	Currently not ready.
		Comment from the depositor	Cell line established from a rat spontaneous malignant amelanotic melanoma.
RCB5295
	RMM-A1
		Comment	Currently not ready.
		Comment from the depositor	Neoplastic cloned cell line established from a rat spontaneous malignant amelanotic melanoma.
RCB5296
	RMM-CAF
		Comment	Currently not ready.
		Comment from the depositor	Non-neoplastic cloned cell line established from a rat spontaneous malignant amelanotic melanoma.
RCB5297
	TSD-B4S
		Comment	Currently not ready.
		Comment from the depositor	Cloned cell line established from a rat spontaneous malignant teratoma, showing mesenchymal differentiation.
RCB5298
	TSD-F9R
		Comment	Currently not ready.
		Comment from the depositor	Cloned cell line established from a rat spontaneous malignant teratoma, showing mesenchymal differentiation.
RCB5299
	RAP80-TK6
		Comment
		Comment from the depositor	RAP80- disrupted TK6 cells ,one of the most commonly used human B lymphocyte-derived cell for cancer research.
RCB5300
	RNF8-TK6
		Comment	Currently not ready.
		Comment from the depositor	RNF8- disrupted TK6 cells ,one of the most commonly used human B lymphocyte-derived cell for cancer research.
RCB5301
	POLβ-TK6
		Comment	Currently not ready.
		Comment from the depositor	POLβ- disrupted TK6 cells ,one of the most commonly used human B lymphocyte-derived cell for cancer research.
RCB5302
	POLθ-TK6
		Comment	Currently not ready.
		Comment from the depositor	POLθ- disrupted TK6 cells ,one of the most commonly used human B lymphocyte-derived cell for cancer research.
RCB5303
	PARP1-TK6
		Comment	Currently not ready.
		Comment from the depositor	PARP1- disrupted TK6 cells ,one of the most commonly used human B lymphocyte-derived cell for cancer research.
RCB5304
	40LB
		Comment
		Comment from the depositor	A fibroblast cell line, BALB/3T3 A31, stably transfected with expression vectors encoding mouse CD40-ligand (CD40L) and BAFF. Used as feeder cells for B cell culture, they support efficient proliferation and survival of B cells.
RCB5305
	NP-2/CD4/EcoVR
		Comment
		Comment from the depositor	NP-2 is derived from a human glioma cell line. A CD4 and an ecotropic mouse retrovirus receptor (EcoVR) gene are transduced to NP-2 cells. This NP-2/CD4/EcoVR (NP-2/CD4) is resistant to the HIV strains tested. When transduced several HIV co-receptors using an ecotropic mouse retrovirus vector, this cell line become susceptible to HIVs.
RCB5306
	NP-2/CD4/EcoVR/CXCR4
		Comment
		Comment from the depositor	NP-2 is derived from a human glioma cell line. NP-2/CD4/EcoVR/CXCR4 (NP-2/CD4/CXCR4) cells are transduced with human CD4, ecotropic mouse retrovirus receptor and human CXCR4 genes and expressing cells were cloned. Although NP-2/CD4/EcoVR cell is resistant to HIVs, NP-2/CD4/EcoVR/CXCR4 cells become highly susceptible to HIVs that use CXCR4 as a coreceptor.
RCB5307
	NP-2/CD4/EcoVR/CCR5
		Comment	Currently not ready.
		Comment from the depositor	NP-2 is derived from a human glioma cell line. NP-2/CD4/EcoVR/CCR5 (NP-2/CD4/CCR5) cells are transduced with human CD4, ecotropic mouse retrovirus receptor and human CCR5 genes and expressing cells were cloned. Although NP-2/CD4/EcoVR cell is resistant to HIVs, NP-2/CD4/EcoVR/CCR5 cells become highly susceptible to HIVs that use CCR5 as a coreceptor.
RCB5308
	NP-2/CD4/EcoVR/APJ
		Comment	Currently not ready.
		Comment from the depositor	NP-2 is derived from a human glioma cell line. NP-2/CD4/EcoVR/APJ (NP-2/CD4/APJ) cells are transduced with human CD4, ecotropic mouse retrovirus receptor and human APJ genes and expressing cells were cloned. Although NP-2/CD4/EcoVR cell is resistant to HIVs, NP-2/CD4/EcoVR/APJ cells become highly susceptible to HIVs that use APJ as a coreceptor.
RCB5309
	NP-2/CD4/EcoVR/CCR6
		Comment	Currently not ready.
		Comment from the depositor	NP-2 is derived from a human glioma cell line. NP-2/CD4/EcoVR/CCR6 (NP-2/CD4/CCR6) cells are transduced with human CD4, ecotropic mouse retrovirus receptor and human CCR6 genes and expressing cells were cloned. Although NP-2/CD4/EcoVR cell is resistant to HIVs, NP-2/CD4/EcoVR/CCR6 cells become highly susceptible to HIVs that use CCR6 as a coreceptor.
RCB5310
	NP-2/CD4/EcoVR/CCR8
		Comment	Currently not ready.
		Comment from the depositor	NP-2 is derived from a human glioma cell line. NP-2/CD4/EcoVR/CCR8 (NP-2/CD4/CCR8) cells are transduced with human CD4, ecotropic mouse retrovirus receptor and human CCR8 genes and expressing cells were cloned. Although NP-2/CD4/EcoVR cell is resistant to HIVs, NP-2/CD4/EcoVR/CCR8 cells become highly susceptible to HIVs that use CCR8 as a coreceptor.
RCB5311
	NP-2/CD4/EcoVR/FPRL1
		Comment	Currently not ready.
		Comment from the depositor	NP-2 is derived from a human glioma cell line. NP-2/CD4/EcoVR/FPRL1 (NP-2/CD4/FPRL1) cells are transduced with human CD4, ecotropic mouse retrovirus receptor and human FPRL1 genes and expressing cells were cloned. Although NP-2/CD4/EcoVR cell is resistant to HIVs, NP-2/CD4/EcoVR/FPRL1 cells become highly susceptible to HIVs that use FPRL1 as a coreceptor.
RCB5312
	NP-2/CD4/EcoVR/GPR1
		Comment	Currently not ready.
		Comment from the depositor	NP-2 is derived from a human glioma cell line. NP-2/CD4/EcoVR/GPR1 (NP-2/CD4/GPR1) cells are transduced with human CD4, ecotropic mouse retrovirus receptor and human GPR1 genes and expressing cells were cloned. Although NP-2/CD4/EcoVR cell is resistant to HIVs, NP-2/CD4/EcoVR/GPR1 cells become highly susceptible to HIVs that use GPR1 as a coreceptor.
RCB5313
	NP-2/CD4/EcoVR/RDC1
		Comment	Currently not ready.
		Comment from the depositor	NP-2 is derived from a human glioma cell line. NP-2/CD4/EcoVR/RDC1 (NP-2/CD4/RDC1) cells are transduced with human CD4, ecotropic mouse retrovirus receptor and humanRDC1 genes and expressing cells were cloned. Although NP-2/CD4/EcoVR cell is resistant to HIVs, NP-2/CD4/EcoVR/RDC1 cells become highly susceptible to HIVs that use RDC1 as a coreceptor.
RCB5314
	53BP1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. 53BP1- disrupted TK6 cells.
RCB5315
	53BP1,BRCA1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. 53BP1, BRCA1- disrupted TK6 cells.
RCB5316
	Abraxas-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. Abraxas- disrupted TK6 cells.
RCB5317
	ALC1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. ALC1- disrupted TK6 cells.
RCB5318
	ALC1,PARP1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. ALC1, PARP1- disrupted TK6 cells.
RCB5319
	BLM-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. BLM- disrupted TK6 cells.
RCB5320
	CtIP-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. CtIP- disrupted TK6 cells.
RCB5321
	DNA-PKcs-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. DNA-PKcs- disrupted TK6 cells.
RCB5322
	DNA-PKcs,SMARCAL1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. DNA-PKcs, SMARCAL1- disrupted TK6 cells.
RCB5323
	FANCD2-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. FANCD2- disrupted TK6 cells.
RCB5324
	LIG4-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. LIG4- disrupted TK6 cells.
RCB5325
	LIG4,SMARCAL1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. LIG4, SMARCAL1- disrupted TK6 cells.
RCB5326
	MRE11-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. MRE11- disrupted TK6 cells.
RCB5327
	MRE11,P53-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. MRE11, P53- disrupted TK6 cells.
RCB5328
	MRE11,TDP1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. MRE11, TDP1- disrupted TK6 cells.
RCB5329
	MRE11,TDP2-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. MRE11, TDP2- disrupted TK6 cells.
RCB5330
	MUS81-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. MUS81- disrupted TK6 cells.
RCB5331
	PDIP38-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. PDIP38- disrupted TK6 cells.
RCB5332
	PDIP38,POLH-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. PDIP38, POLH- disrupted TK6 cells.
RCB5333
	PDIP38,POLH,XPA-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. PDIP38, POLH, XPA- disrupted TK6 cells.
RCB5334
	PDIP38,PrimPol-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. PDIP38, PrimPol- disrupted TK6 cells.
RCB5335
	PIAS1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. PIAS1- disrupted TK6 cells.
RCB5336
	PIAS1,PIAS4-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. PIAS1, PIAS4- disrupted TK6 cells.
RCB5337
	PIAS1,PIAS4,POLH-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. PIAS1, PIAS4, POLH- disrupted TK6 cells.
RCB5338
	PIAS1,PIAS4,POLH,XPA-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. PIAS1, PIAS4, POLH, XPA- disrupted TK6 cells.
RCB5339
	PIAS1,PIAS4,XPA-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. PIAS1, PIAS4, XPA- disrupted TK6 cells.
RCB5340
	PIAS4,XPA-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. PIAS4, XPA- disrupted TK6 cells.
RCB5341
	RAD54-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. RAD54- disrupted TK6 cells.
RCB5342
	RNF168-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. RNF168- disrupted TK6 cells.
RCB5343
	SMARCAL1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. SMARCAL1- disrupted TK6 cells.
RCB5344
	SMARCAL1,RAD54-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. SMARCAL1, RAD54- disrupted TK6 cells.
RCB5345
	TDP1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. TDP1- disrupted TK6 cells.
RCB5346
	TDP1,TDP2-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. TDP1, TDP2- disrupted TK6 cells.
RCB5347
	TDP2-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. TDP2- disrupted TK6 cells.
RCB5348
	XPA-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research.XPA- disrupted TK6 cells.
RCB5349
	XRCC1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. XRCC1- disrupted TK6 cells.
RCB5350
	XRCC1,XPA-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. XRCC1, XPA- disrupted TK6 cells.
RCB5378
	P3-X63-Ag8-U/hEphB6-T49-25
		Comment
		Comment from the depositor	Mouse hybridoma cell line producing anti-human Ehph B6 monoclonal antibody.
RCB5379
	P3-X63-Ag8-U/hZC3H12D･TFL-21-7G
		Comment
		Comment from the depositor	Mouse hybridoma cell line producing anti-human ZC3H12D(TFL) monoclonal antibody.
RCB5381
	COLO 320DM#3 SIRT1 KO cl.1
		Comment
		Comment from the depositor	Human colorectal carcinoma COLO 320DM #3 strain was cloned from the ATCC strain by Von Hoff Laboratory at Texas University around 1990. The strain was used by Shimizu Laboratory at Hiroshima University for development and application of the IR/MAR gene amplification methodology. The strain was further delivered to Mirit I Aladjem Laboratory at US NIH, where the SIRT1 knocked-out clones were isolated. Shimizu Lab in collaboration with Aladjem lab found that the genes amplified in these clones were expressed at very high level.
RCB5382
	COLO 320DM#3 SIRT1 KO cl.2
		Comment
		Comment from the depositor	Human colorectal carcinoma COLO 320DM #3 strain was cloned from the ATCC strain by Von Hoff Laboratory at Texas University around 1990. The strain was used by Shimizu Laboratory at Hiroshima University for development and application of the IR/MAR gene amplification methodology. The strain was further delivered to Mirit I Aladjem Laboratory at US NIH, where the SIRT1 knocked-out clones were isolated. Shimizu Lab in collaboration with Aladjem lab found that the genes amplified in these clones were expressed at very high level.
RCB5383
	COLO 320DM#3 SIRT1 KO cl.3
		Comment
		Comment from the depositor	Human colorectal carcinoma COLO 320DM #3 strain was cloned from the ATCC strain by Von Hoff Laboratory at Texas University around 1990. The strain was used by Shimizu Laboratory at Hiroshima University for development and application of the IR/MAR gene amplification methodology. The strain was further delivered to Mirit I Aladjem Laboratory at US NIH, where the SIRT1 knocked-out clones were isolated. Shimizu Lab in collaboration with Aladjem lab found that the genes amplified in these clones were expressed at very high level.
RCB5384
	COLO 320DM#3 SIRT1 KO cl.4
		Comment
		Comment from the depositor	Human colorectal carcinoma COLO 320DM #3 strain was cloned from the ATCC strain by Von Hoff Laboratory at Texas University around 1990. The strain was used by Shimizu Laboratory at Hiroshima University for development and application of the IR/MAR gene amplification methodology. The strain was further delivered to Mirit I Aladjem Laboratory at US NIH, where the SIRT1 knocked-out clones were isolated. Shimizu Lab in collaboration with Aladjem lab found that the genes amplified in these clones were expressed at very high level.
RCB5385
	COLO 320DM#3 SIRT1 KO cl.5
		Comment
		Comment from the depositor	Human colorectal carcinoma COLO 320DM #3 strain was cloned from the ATCC strain by Von Hoff Laboratory at Texas University around 1990. The strain was used by Shimizu Laboratory at Hiroshima University for development and application of the IR/MAR gene amplification methodology. The strain was further delivered to Mirit I Aladjem Laboratory at US NIH, where the SIRT1 knocked-out clones were isolated. Shimizu Lab in collaboration with Aladjem lab found that the genes amplified in these clones were expressed at very high level.
RCB5386
	COLO 320DM#3 SIRT1 KO cl.6
		Comment
		Comment from the depositor	Human colorectal carcinoma COLO 320DM #3 strain was cloned from the ATCC strain by Von Hoff Laboratory at Texas University around 1990. The strain was used by Shimizu Laboratory at Hiroshima University for development and application of the IR/MAR gene amplification methodology. The strain was further delivered to Mirit I Aladjem Laboratory at US NIH, where the SIRT1 knocked-out clones were isolated. Shimizu Lab in collaboration with Aladjem lab found that the genes amplified in these clones were expressed at very high level.
RCB5388
	HeLaM
		Comment
		Comment from the depositor	Human cervical cancer cell line HeLaM (substrain of HeLa).
RCB5389
	Rab1-CKO MDCK-II
		Comment
		Comment from the depositor	Rab1 conditional KO MDCK-II cell line.
RCB5390
	Rab5-CKO MDCK-II
		Comment
		Comment from the depositor	Rab5 conditional KO MDCK-II cell line.
RCB5391
	R52_Spike
		Comment
		Comment from the depositor	This cell line is a hybridoma producing anti-SARS-CoV-2 Spike antibody (Clone R52).
RCB5392
	S1D7_Spike
		Comment
		Comment from the depositor	This cell line is a hybridoma producing anti-SARS-CoV-2 Spike antibody (Clone S1D7).
RCB5393
	S3D8_Spike
		Comment
		Comment from the depositor	This cell line is a hybridoma producing anti-SARS-CoV-2 Spike antibody (Clone S3D8).
RCB5394
	Y-ML-1B
		Comment
		Comment from the depositor	Large-cell lung cancer cell line producing granulocyte colony-stimulating factor.
RCB5396
	KM1978
		Comment	Currently not ready.
		Comment from the depositor	Anti human EphB6 monoclonal antibody producing rat hybridoma.
RCB5397
	KM2048
		Comment	Currently not ready.
		Comment from the depositor	Anti human EphB6 monoclonal antibody producing rat hybridoma.
RCB5398
	KM2051
		Comment	Currently not ready.
		Comment from the depositor	Anti human EphB6 monoclonal antibody producing rat hybridoma.
RCB5399
	PL16B
		Comment	Currently not ready.
		Comment from the depositor	Immortalized AAH cell line (RCB5400 PL16T) and human non-neoplastic bronchial epithelial cell line (RCB5399 PL16B) from the same patient by transfection with the gene for SV40 large T antigen.
RCB5400
	PL16T
		Comment	Currently not ready.
		Comment from the depositor	Immortalized AAH cell line (RCB5400 PL16T) and human non-neoplastic bronchial epithelial cell line (RCB5399 PL16B) from the same patient by transfection with the gene for SV40 large T antigen.
RCB5401
	53BP1,MRE11-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. 53BP1, MRE11- disrupted TK6 cells.
RCB5402
	ATM-TK6
		Comment
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. ATM- disrupted TK6 cells.
RCB5403
	ATRX-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. ATRX- disrupted TK6 cells.
RCB5404
	BLM,MLH1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. BLM, MLH1- disrupted TK6 cells.
RCB5405
	BLM,MLH3-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. BLM, MLH3- disrupted TK6 cells.
RCB5406
	BLM,MUS81-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. BLM, MUS81- disrupted TK6 cells.
RCB5407
	BLM,SMARCAL1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. BLM, SMARCAL1- disrupted TK6 cells.
RCB5408
	BLM,XPF-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. BLM, XPF- disrupted TK6 cells.
RCB5409
	BRCA1,REV7-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. BRCA1, REV7- disrupted TK6 cells.
RCB5410
	CtIP,MRE11-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. CtIP, MRE11- disrupted TK6 cells.
RCB5411
	DNA2+/--TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. CtIP, DNA2 +/-- disrupted TK6 cells.
RCB5412
	EXO1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. EXO1- disrupted TK6 cells.
RCB5413
	EXO1,FAN1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. XO1, FAN1- disrupted TK6 cells.
RCB5414
	FAN1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. FAN1- disrupted TK6 cells.
RCB5415
	FANCC-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. FANCC- disrupted TK6 cells.
RCB5416
	GEN1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. GEN1- disrupted TK6 cells.
RCB5417
	GEN1,MLH3-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. GEN1, MLH3- disrupted TK6 cells.
RCB5418
	GEN1,MLH3,PMS2-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. GEN1, MLH3, PMS2- disrupted TK6 cells.
RCB5419
	GEN1,MUS81-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. GEN1, MUS81- disrupted TK6 cells.
RCB5420
	GEN1,RAD54-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. GEN1, RAD54- disrupted TK6 cells.
RCB5421
	LIG4,POLQ-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. LIG4, POLQ- disrupted TK6 cells.
RCB5422
	LIG4,POLQ,RAD54-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. LIG4, POLQ, RAD54- disrupted TK6 cells.
RCB5423
	LIG4,RAD54-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. LIG4, RAD54- disrupted TK6 cells.
RCB5424
	LIG4,RNF8-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. LIG4, RNF8- disrupted TK6 cells.
RCB5425
	MLH1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. MLH1- disrupted TK6 cells.
RCB5426
	MLH1,MLH3-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. MLH1, MLH3- disrupted TK6 cells.
RCB5427
	MLH1,MLH3,PMS2-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. MLH1, MLH3, PMS2- disrupted TK6 cells.
RCB5428
	MLH1,MUS81-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. MLH1, MUS81- disrupted TK6 cells.
RCB5429
	MLH1,PMS2-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. MLH1, PMS2- disrupted TK6 cells.
RCB5430
	MLH3-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. MLH3- disrupted TK6 cells.
RCB5431
	MLH3,PMS2-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. MLH3, PMS2- disrupted TK6 cells.
RCB5432
	MSH2-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. MSH2- disrupted TK6 cells.
RCB5433
	MUS81,PMS2-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. MUS81, PMS2- disrupted TK6 cells.
RCB5434
	P53-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. P53- disrupted TK6 cells.
RCB5435
	P53,PDIP38-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. P53, PDIP38- disrupted TK6 cells.
RCB5436
	P53,POLH-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. P53, POLH- disrupted TK6 cells.
RCB5437
	P53,RAD54B-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. P53, RAD54B- disrupted TK6 cells.
RCB5438
	PALB2-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. PALB2- disrupted TK6 cells.
RCB5439
	PARP1,POLB-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. PARP1, POLB- disrupted TK6 cells.
RCB5440
	PARP1,XRCC1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. PARP1, XRCC1- disrupted TK6 cells.
RCB5441
	PARP1,XRCC1,ALC1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. PARP1, XRCC1, ALC1- disrupted TK6 cells.
RCB5442
	PARP2-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. PARP2- disrupted TK6 cells.
RCB5443
	PMS2-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. PMS2- disrupted TK6 cells.
RCB5444
	POLD1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. POLD1- disrupted TK6 cells.
RCB5445
	POLE-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. POLE- disrupted TK6 cells.
RCB5446
	POLH-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. POLH- disrupted TK6 cells.
RCB5447
	POLH,PrimPol-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. POLH, PrimPol- disrupted TK6 cells.
RCB5448
	POLH,RAD18,XPA-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. POLH, RAD18, XPA- disrupted TK6 cells.
RCB5449
	POLH,XPA-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. POLH, XPA- disrupted TK6 cells.
RCB5450
	POLL-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. POLL- disrupted TK6 cells.
RCB5451
	PrimPol-TK6
		Comment
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. PrimPol- disrupted TK6 cells.
RCB5452
	RAD18-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. RAD18- disrupted TK6 cells.
RCB5453
	RAD51AP1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. RAD51AP1- disrupted TK6 cells.
RCB5454
	RAD51AP1,RAD54-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. RAD51AP1, RAD54- disrupted TK6 cells.
RCB5455
	RAD54B-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. RAD54B- disrupted TK6 cells.
RCB5456
	REV3-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. REV3- disrupted TK6 cells.
RCB5457
	REV7-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. REV7- disrupted TK6 cells.
RCB5458
	RNASEH2A-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. RNASEH2A- disrupted TK6 cells.
RCB5459
	RPA,SMARCAL1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. RPA, SMARCAL1- disrupted TK6 cells.
RCB5460
	SLFN11-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. SLFN11- disrupted TK6 cells.
RCB5461
	SLX1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. SLX1- disrupted TK6 cells.
RCB5462
	SMARCAD1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. SMARCAD1- disrupted TK6 cells.
RCB5463
	SPRTAN-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. SPRTAN- disrupted TK6 cells.
RCB5464
	SPRTAN,TDP1,TDP2-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. SPRTAN, TDP1, TDP2- disrupted TK6 cells.
RCB5465
	TIR1-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. TIR1- disrupted TK6 cells.
RCB5466
	XRCC1,POLB-TK6
		Comment	Currently not ready.
		Comment from the depositor	TK6 cells are one of the most commonly used human B lymphocyte-derived cell for cancer research. XRCC1, POLB- disrupted TK6 cells.
RCB5467
	TTA-1
		Comment	Currently not ready.
		Comment from the depositor	Anaplastic thyroid carcinoma.
RCB5468
	TTA-2
		Comment	Currently not ready.
		Comment from the depositor	Anaplastic Thyroid carcinoma.
RCB5469
	TTA-3
		Comment	Currently not ready.
		Comment from the depositor	Anaplastic Thyroid carcinoma.
RCB5470
	KTA-1
		Comment	Currently not ready.
		Comment from the depositor	Anaplastic Thyroid Carcinoma.
RCB5471
	KTA-2
		Comment	Currently not ready.
		Comment from the depositor	Anaplastic Thyroid Carcinoma.
RCB5472
	KTA-3
		Comment	Currently not ready.
		Comment from the depositor	Undifferentiated Thyroid Carcinoma.
RCB5473
	KTA-4
		Comment	Currently not ready.
		Comment from the depositor	Undifferentiated Thyroid Carcinoma.
RCB5476
	hFGFR1b/BaF3
		Comment	Currently not ready.
		Comment from the depositor	The FGF receptor-overexpressing cells to be used for the analyses of receptor specificity of the various FGF ligands. These cells are engineered from Ba/F3 cells and stably overexpress one of seven subtypes, as defined in the cell name, of FGF receptors. When a cognate (specific) FGF ligand is added, together with heparin, to the medium of these cells, cell growth is stimulated that can be detected by cell number and/or DNA synthesis. While the parent Ba/F3 cells proliferate only by the stimulation with IL-3.
RCB5477
	hFGFR1c/BaF3
		Comment	Currently not ready.
		Comment from the depositor	The FGF receptor-overexpressing cells to be used for the analyses of receptor specificity of the various FGF ligands. These cells are engineered from Ba/F3 cells and stably overexpress one of seven subtypes, as defined in the cell name, of FGF receptors. When a cognate (specific) FGF ligand is added, together with heparin, to the medium of these cells, cell growth is stimulated that can be detected by cell number and/or DNA synthesis. While the parent Ba/F3 cells proliferate only by the stimulation with IL-3.
RCB5478
	hFGFR2b/BaF3
		Comment
		Comment from the depositor	The FGF receptor-overexpressing cells to be used for the analyses of receptor specificity of the various FGF ligands. These cells are engineered from Ba/F3 cells and stably overexpress one of seven subtypes, as defined in the cell name, of FGF receptors. When a cognate (specific) FGF ligand is added, together with heparin, to the medium of these cells, cell growth is stimulated that can be detected by cell number and/or DNA synthesis. While the parent Ba/F3 cells proliferate only by the stimulation with IL-3.
RCB5479
	hFGFR2c/BaF3
		Comment	Currently not ready.
		Comment from the depositor	The FGF receptor-overexpressing cells to be used for the analyses of receptor specificity of the various FGF ligands. These cells are engineered from Ba/F3 cells and stably overexpress one of seven subtypes, as defined in the cell name, of FGF receptors. When a cognate (specific) FGF ligand is added, together with heparin, to the medium of these cells, cell growth is stimulated that can be detected by cell number and/or DNA synthesis. While the parent Ba/F3 cells proliferate only by the stimulation with IL-3.
RCB5480
	hFGFR3b/BaF3
		Comment	Currently not ready.
		Comment from the depositor	The FGF receptor-overexpressing cells to be used for the analyses of receptor specificity of the various FGF ligands. These cells are engineered from Ba/F3 cells and stably overexpress one of seven subtypes, as defined in the cell name, of FGF receptors. When a cognate (specific) FGF ligand is added, together with heparin, to the medium of these cells, cell growth is stimulated that can be detected by cell number and/or DNA synthesis. While the parent Ba/F3 cells proliferate only by the stimulation with IL-3.
RCB5481
	hFGFR3c/BaF3
		Comment	Currently not ready.
		Comment from the depositor	The FGF receptor-overexpressing cells to be used for the analyses of receptor specificity of the various FGF ligands. These cells are engineered from Ba/F3 cells and stably overexpress one of seven subtypes, as defined in the cell name, of FGF receptors. When a cognate (specific) FGF ligand is added, together with heparin, to the medium of these cells, cell growth is stimulated that can be detected by cell number and/or DNA synthesis. While the parent Ba/F3 cells proliferate only by the stimulation with IL-3.
RCB5482
	hFGFR4/BaF3
		Comment	Currently not ready.
		Comment from the depositor	The FGF receptor-overexpressing cells to be used for the analyses of receptor specificity of the various FGF ligands. These cells are engineered from Ba/F3 cells and stably overexpress one of seven subtypes, as defined in the cell name, of FGF receptors. When a cognate (specific) FGF ligand is added, together with heparin, to the medium of these cells, cell growth is stimulated that can be detected by cell number and/or DNA synthesis. While the parent Ba/F3 cells proliferate only by the stimulation with IL-3.
RCB5483
	mFGFR1c/BaF3
		Comment	Currently not ready.
		Comment from the depositor	The FGF receptor-overexpressing cells to be used for the analyses of receptor specificity of the various FGF ligands. These cells are engineered from Ba/F3 cells and stably overexpress one of seven subtypes, as defined in the cell name, of FGF receptors. When a cognate (specific) FGF ligand is added, together with heparin, to the medium of these cells, cell growth is stimulated that can be detected by cell number and/or DNA synthesis. While the parent Ba/F3 cells proliferate only by the stimulation with IL-3.
RCB5484
	mFGFR2c/BaF3
		Comment	Currently not ready.
		Comment from the depositor	The FGF receptor-overexpressing cells to be used for the analyses of receptor specificity of the various FGF ligands. These cells are engineered from Ba/F3 cells and stably overexpress one of seven subtypes, as defined in the cell name, of FGF receptors. When a cognate (specific) FGF ligand is added, together with heparin, to the medium of these cells, cell growth is stimulated that can be detected by cell number and/or DNA synthesis. While the parent Ba/F3 cells proliferate only by the stimulation with IL-3.
RCB5485
	mFGFR3b/BaF3
		Comment	Currently not ready.
		Comment from the depositor	The FGF receptor-overexpressing cells to be used for the analyses of receptor specificity of the various FGF ligands. These cells are engineered from Ba/F3 cells and stably overexpress one of seven subtypes, as defined in the cell name, of FGF receptors. When a cognate (specific) FGF ligand is added, together with heparin, to the medium of these cells, cell growth is stimulated that can be detected by cell number and/or DNA synthesis. While the parent Ba/F3 cells proliferate only by the stimulation with IL-3.
RCB5486
	mFGFR3c/BaF3
		Comment	Currently not ready.
		Comment from the depositor	The FGF receptor-overexpressing cells to be used for the analyses of receptor specificity of the various FGF ligands. These cells are engineered from Ba/F3 cells and stably overexpress one of seven subtypes, as defined in the cell name, of FGF receptors. When a cognate (specific) FGF ligand is added, together with heparin, to the medium of these cells, cell growth is stimulated that can be detected by cell number and/or DNA synthesis. While the parent Ba/F3 cells proliferate only by the stimulation with IL-3.
RCB5487
	mFGFR4/BaF3
		Comment	Currently not ready.
		Comment from the depositor	The FGF receptor-overexpressing cells to be used for the analyses of receptor specificity of the various FGF ligands. These cells are engineered from Ba/F3 cells and stably overexpress one of seven subtypes, as defined in the cell name, of FGF receptors. When a cognate (specific) FGF ligand is added, together with heparin, to the medium of these cells, cell growth is stimulated that can be detected by cell number and/or DNA synthesis. While the parent Ba/F3 cells proliferate only by the stimulation with IL-3.
RCB5503
	RAW-D cell
		Comment
		Comment from the depositor	Sub-clone of RAW-264 cells: Osteoclast precursor cell line efficiently differentiates into multinucleated osteoclasts by the stimulation with RANKL.
RCB5504
	Kat1
		Comment	Currently not ready.
		Comment from the depositor	Hybridoma producing Monoclonal antibody against rat osteoclast-specific cell-surface antigen Kat1 antigen.
RCB5505
	iKat1-A37
		Comment	Currently not ready.
		Comment from the depositor	Hybridoma producing Monoclonal antibody against rat osteoclast-selective cell-surface antigen iKat1-A37 antigen.
RCB5506
	iKat1-C71
		Comment	Currently not ready.
		Comment from the depositor	Hybridoma producing Monoclonal antibody against rat osteoclast-specific cell-surface antigen iKat1-C71 antigen.
RCB5507
	iKat1-D34
		Comment	Currently not ready.
		Comment from the depositor	Hybridoma producing Monoclonal antibody against rat osteoclast-specific cell-surface antigen iKat1-D34 antigen.
RCB5509
	Nav1.2(466-485)1B6-1C1
		Comment	Currently not ready.
		Comment from the depositor	Hybridoma cell line producing rat monoclonal antibody against Nav1.2 (epitope： 466-485aa, clone： 1B6-1C1).
RCB5510
	Navbeta4(209-228)7D7F10
		Comment	Currently not ready.
		Comment from the depositor	Hybridoma cell line producing rat monoclonal antibody against Navbeta4 (epitope： 209-228aa, clone： 7D7F10).
RCB5511
	Neuro2a-RXR
		Comment	Currently not ready.
		Comment from the depositor	Stably transfected neuro2a cells, which inducibly express N-terminal Htt (exon 1) containing 16Q, 60Q or 150Q fusing EGFP (Neuro2a-tNhtt-EGFP-16Q, Neuro2a-tNhtt-EGFP-60Q, Neuro2a-tNhtt-EGFP-150Q) under control of ponasterone A. Neuro2a-RXR is the parental cell line of Neuro2a-tNhtt-EGFP cell lines before transfection of their expression vectors.
RCB5512
	Neuro2a-tNhtt-EGFP-16Q
		Comment	Currently not ready.
		Comment from the depositor	Stably transfected neuro2a cells, which inducibly express N-terminal Htt (exon 1) containing 16Q, 60Q or 150Q fusing EGFP (Neuro2a-tNhtt-EGFP-16Q, Neuro2a-tNhtt-EGFP-60Q, Neuro2a-tNhtt-EGFP-150Q) under control of ponasterone A. Neuro2a-RXR is the parental cell line of Neuro2a-tNhtt-EGFP cell lines before transfection of their expression vectors.
RCB5513
	Neuro2a-tNhtt-EGFP-60Q
		Comment	Currently not ready.
		Comment from the depositor	Stably transfected neuro2a cells, which inducibly express N-terminal Htt (exon 1) containing 16Q, 60Q or 150Q fusing EGFP (Neuro2a-tNhtt-EGFP-16Q, Neuro2a-tNhtt-EGFP-60Q, Neuro2a-tNhtt-EGFP-150Q) under control of ponasterone A. Neuro2a-RXR is the parental cell line of Neuro2a-tNhtt-EGFP cell lines before transfection of their expression vectors.
RCB5514
	Neuro2a-tNhtt-EGFP-150Q
		Comment	Currently not ready.
		Comment from the depositor	Stably transfected neuro2a cells, which inducibly express N-terminal Htt (exon 1) containing 16Q, 60Q or 150Q fusing EGFP (Neuro2a-tNhtt-EGFP-16Q, Neuro2a-tNhtt-EGFP-60Q, Neuro2a-tNhtt-EGFP-150Q) under control of ponasterone A. Neuro2a-RXR is the parental cell line of Neuro2a-tNhtt-EGFP cell lines before transfection of their expression vectors.
RCB5515
	SCEACono2
		Comment	Currently not ready.
		Comment from the depositor	Human cell line derived from external auditory canal squamous cell carcinomas.
RCB5649
	GM95-CD4
		Comment	Currently not ready.
		Comment from the depositor
RCB5650
	GM95-CXCR4
		Comment	Currently not ready.
		Comment from the depositor
RCB5651
	GM95-CCR5
		Comment	Currently not ready.
		Comment from the depositor
RCB5652
	GM95-CD4-CXCR4
		Comment	Currently not ready.
		Comment from the depositor
RCB5653
	GM95-CD4-CCR5
		Comment	Currently not ready.
		Comment from the depositor
RCB5654
	HOMC-A4
		Comment	RCB5654 HOMC-A4, RCB5655 HOMC-B1, RCB5656 HOMC-D4 were derived from the same patient.
		Comment from the depositor	Human immortalized mesothelial cell line: Established from mesothelial cells derived from the greater omentum of a human male gastric cancer patient, and immortalized by transfection with human papilloma virus 16 E6/E7 gene and hTERT gene. The HOMC-A4 cell line exhibits an "sarcomatoid" morphology by subcloning.
RCB5655
	HOMC-B1
		Comment	RCB5654 HOMC-A4, RCB5655 HOMC-B1, RCB5656 HOMC-D4 were derived from the same patient.
		Comment from the depositor	Human immortalized mesothelial cell line: Established from mesothelial cells derived from the greater omentum of a human male gastric cancer patient, and immortalized by transfection with human papilloma virus 16 E6/E7 gene and hTERT gene. The HOMC-B1 cell line exhibits an "epithelioid" morphology by subcloning.
RCB5656
	HOMC-D4
		Comment	RCB5654 HOMC-A4, RCB5655 HOMC-B1, RCB5656 HOMC-D4 were derived from the same patient.
		Comment from the depositor	Human immortalized mesothelial cell line: Established from mesothelial cells derived from the greater omentum of a human male gastric cancer patient, and immortalized by transfection with human papilloma virus 16 E6/E7 gene and hTERT gene. The HOMC-D4 cell line exhibits an "intermediate" morphology by subcloning.
RCB5657
	2G11
		Comment	Currently not ready.
		Comment from the depositor	Mesenchymal progenitor cells derived from rat skeletal muscle, with the ability to differentiate into adipocytes and fibroblasts.
RCB5658
	HeLa PMP2 KO
		Comment
		Comment from the depositor	PMP2-knockout HeLa cells were generated with CRISPR/Cas9 gene editing.
RCB5659
	HeLa GGA1 KO
		Comment
		Comment from the depositor	GGA1-knockout HeLa cells were generated with CRISPR/Cas9 gene editing.
RCB5660
	HeLa SLC40A1 KO
		Comment
		Comment from the depositor	SLC40A1-knockout HeLa cells were generated with CRISPR/Cas9 gene editing.
RCB5661
	HPL1A
		Comment	RCB5661 HPL1A、RCB5662 HPL1D were derived from the same patient.
		Comment from the depositor	Immortalized human peripheral lung epithelial cell line.The HPL1A and HPL1D lines were established by transfecting the SV40 large T antigen gene from the normal lung of a 74-year-old female donor, who had never smoked and underwent surgery for a small well-demarcated squamous cell carcinoma of the earliest disease stage (pT1N0M0, stage I). Precancerous regions of peripheral lung such as atypical adenomatous hyperplasia were not noted in the lung specimen by the conventional pathological examination. Considering the uniform integration pattern observed for the SV40 large T antigen gene, the HPL1A and HPL1D lines appear to have arisen from a single immortalized cell.
RCB5662
	HPL1D
		Comment	RCB5661 HPL1A、RCB5662 HPL1D were derived from the same patient.
		Comment from the depositor	Immortalized human peripheral lung epithelial cell line.The HPL1A and HPL1D lines were established by transfecting the SV40 large T antigen gene from the normal lung of a 74-year-old female donor, who had never smoked and underwent surgery for a small well-demarcated squamous cell carcinoma of the earliest disease stage (pT1N0M0, stage I). Precancerous regions of peripheral lung such as atypical adenomatous hyperplasia were not noted in the lung specimen by the conventional pathological examination. Considering the uniform integration pattern observed for the SV40 large T antigen gene, the HPL1A and HPL1D lines appear to have arisen from a single immortalized cell.
RCB5663
	SS-2
		Comment
		Comment from the depositor	Neuroendocrine carcinoma cell line derived from a human ascending colon tumor.
RCB5664
	Y-MESO-8A
		Comment	RCB5664 Y-MESO-8A, RCB5665 Y-MESO-8D were derived from the same patient.
		Comment from the depositor	Human malignant pleural mesothelioma cell line. The primary tumor is a biphasic (predominantly sarcomatoid) tumor tissue. Subcloned from patient's pleural fluid and shows epithelioid morphology.
RCB5665
	Y-MESO-8D
		Comment	RCB5664 Y-MESO-8A, RCB5665 Y-MESO-8D were derived from the same patient.
		Comment from the depositor	Human malignant pleural mesothelioma cell line. The primary tumor is a biphasic (predominantly sarcomatoid) tumor tissue. Subcloned from patient's pleural fluid and shows sarcomatoid morphology.
RCB5666
	Y-MESO-9
		Comment
		Comment from the depositor	Human malignant pleural mesothelioma cell line. The tumor tissue was epithelial malignant mesothelioma and this cell line was established from the pleural fluid of a patient. This cell line has NF2 and BAP1 gene mutations.
RCB5667
	Y-MESO-12
		Comment
		Comment from the depositor	Human malignant pleural mesothelioma cell line. This cell line was established from the tumor tissue (epithelioid type MPM) of a patient. This cell line has a homozogous deletion of the NF2 gene.
RCB5668
	Y-MESO-14
		Comment
		Comment from the depositor	Human malignant pleural mesothelioma cell line. This cell line was established from the tumor tissue (biphasic MPM susp.) of a patient. This cell line has NF2, LATS2 and BAP1 gene mutations.
RCB5669
	Y-MESO-22
		Comment	Currently not ready.
		Comment from the depositor	Human malignant pleural mesothelioma cell line. This cell line was established from the tumor tissue (sarcomatoid MPM) of a patient. This cell line has a homozogous deletion of the NF2 gene.
RCB5670
	Y-MESO-25
		Comment
		Comment from the depositor	Human malignant pleural mesothelioma cell line. This cell line was established from the pleural effusion of epithelioid type MPM of a patient. This cell line has the NF2 gene mutation and the BAP gene homozygous deletion.
RCB5671
	Y-MESO-26B
		Comment	Currently not ready.
		Comment from the depositor	Human malignant pleural mesothelioma cell line. This cell line was established from the pleural effusion of lymphohistiocytoid type MPM of a patient. This cell line has the NF2 gene homozygous deletion and the NF2 gene mutation.
RCB5672
	Y-MESO-27
		Comment
		Comment from the depositor	Human malignant pleural mesothelioma cell line. This cell line was established from the pleural effusion of epithelioid type MPM of a patient.
RCB5673
	Y-MESO-28
		Comment
		Comment from the depositor	Human malignant pleural mesothelioma cell line. This cell line was established from the pleural effusion of epithelioid type MPM of a patient.
RCB5674
	Y-MESO-29
		Comment	Currently not ready.
		Comment from the depositor	Human malignant pleural mesothelioma cell line. This cell line was established from the pleural effusion of epithelioid type MPM of a patient.
RCB5675
	Y-MESO-30
		Comment
		Comment from the depositor	Human malignant pleural mesothelioma cell line. The primary tumor shows epithelioid morphology.
RCB5676
	CHK-Q
		Comment
		Comment from the depositor	A spontaneously immortalized cell line from primary culture of kidney tissue of Chinese hamsters bred as experimental animals.
RCB5677
	HepG2/8F_HS
		Comment	Currently not ready.
		Comment from the depositor	A genetically modified human hepatoma cell line in which eight liver-specific transcription factor genes are introduced into human hepatoblastoma HepG2 (RCB1648) cells so as to be expressed by heat stimulation, and many liver functions are induced upon heat treatment (43°C, 30 minutes).
RCB5678
	P44D9(1)G4(1)B1#8
		Comment	Currently not ready.
		Comment from the depositor	A hybridoma producing anti-CD271 antibody.
RCB5679
	P39G8(1)E1(1)C11#13
		Comment	Currently not ready.
		Comment from the depositor	A hybridoma producing anti-CD271 antibody.
RCB5680
	Ba/F3/mIL-31RA/mOSMR
		Comment	Currently not ready.
		Comment from the depositor	Ba/F3/mIL-31RA/mOSMR cells were created by transducing mouse IL-31 receptor α (NR10) and mouse OSMR genes. Ba/F3/mIL-31RA/mOSMR cells have acquired mouse IL-31-dependent proliferative response.
RCB5681
	Astrocyte(AWT)
		Comment
		Comment from the depositor	A cultured cell line derived from a strain of primary astrocyte cells isolated from C57BL/6 brain (cerebrum).
RCB5682
	Astrocyte(ASD)
		Comment
		Comment from the depositor	A cultured cell line derived from a strain of primary astrocyte cells isolated from C57BL/6x129sv brain (cerebrum).
RCB5683
	ASPS-KY
		Comment
		Comment from the depositor	Human cell line derived from alveolar soft part sarcoma.
RCB5684
	MDS92
		Comment	Currently not ready.
		Comment from the depositor	This cell line was established from the bone marrow of a patient with MDS. MDS92 cells proliferate slowly in the presence of IL-3 and the whole cells consist of immature blastic cell fraction and dysplastic neutrophil-like or macrophage-like differentiated cell fractions. MDS92 is a parental cell line of MDS-L, MDS-L-2007 and MDS-LGF. After a long -term culture, most cells may differentiate into mature cells and proliferate no longer in some cases, while immature cells may begin to expand like as leukemic transition in the other cases.
RCB5685
	MDS-L
		Comment
		Comment from the depositor	MDS-L cell line is a blastic subline originated from MDS92 which was established from the bone marrow of a patient with MDS. MDS-L cells proliferate in the presence of IL-3 and have lost maturing capacity unlike the parental MDS92. MDS-L is a parental cell line of MDS-L-2007 and MDS-LGF.
RCB5686
	MDS-L-2007
		Comment
		Comment from the depositor	MDS-L-2007 cell line is a blastic subline originated from MDS-L. (MDS-L cell line is a blastic subline derived from MDS92 which was established from the bone marrow of a patient with MDS.) MDS-L-2007 cells proliferate in the presence of IL-3 and have lost maturing capacity.
RCB5687
	MDS-LGF
		Comment
		Comment from the depositor	MDS-LGF cell line is a blastic subline originated from MDS-L. (MDS-L cell line is a blastic subline derived from MDS92 which was established from the bone marrow of a patient with MDS.) MDS-LGF cells proliferate without IL-3 and have lost maturing capacity.
RCB5688
	ATG13 WT MEF
		Comment	Currently not ready.
		Comment from the depositor	Mouse embryonic fibroblasts. Wild type control for Atg13KO MEF.
RCB5689
	ATG13 KO MEF
		Comment	Currently not ready.
		Comment from the depositor	Atg13-knockout mouse embryonic fibroblast.
RCB5690
	ATG2A/B WT MEF
		Comment	Currently not ready.
		Comment from the depositor	Mouse embryonic fibroblasts. Wild type control for Atg2A/B-ＤKO MEF.
RCB5691
	ATG2A/B double KO MEF
		Comment	Currently not ready.
		Comment from the depositor	Mouse embryonic fibroblast in which Atg2A/B genes were deleted using CRISPR/Cas9-mediated genome editing.
RCB5692
	ATGs Parental HeLa
		Comment
		Comment from the depositor	Autophagy related gene knockout HeLa.
RCB5693
	ATG5 KO HeLa
		Comment
		Comment from the depositor	HeLa in which ATG5 gene was deleted using CRISPR/Cas9-mediated genome editing.
RCB5694
	ATG3 KO HeLa
		Comment	Currently not ready.
		Comment from the depositor	HeLa in which ATG3 gene was deleted using CRISPR/Cas9-mediated genome editing.
RCB5695
	ATG9A KO HeLa
		Comment
		Comment from the depositor	HeLa in which ATG9A gene was deleted using CRISPR/Cas9-mediated genome editing.
RCB5696
	FIP200 KO HeLa
		Comment
		Comment from the depositor	HeLa in which FIP200 gene was deleted using CRISPR/Cas9-mediated genome editing.
RCB5697
	ATG3 and FIP200 double KO HeLa
		Comment	Currently not ready.
		Comment from the depositor	HeLa in which ATG3 and FIP200 genes were deleted using CRISPR/Cas9-mediated genome editing.
RCB5698
	ATG3 and ATG14L double KO HeLa
		Comment	Currently not ready.
		Comment from the depositor	HeLa in which ATG3 and ATG14L genes were deleted using CRISPR/Cas9-mediated genome editing.
RCB5699
	ATG2A/B double KO HeLa
		Comment
		Comment from the depositor	HeLa in which ATG2A/B genes were deleted using CRISPR/Cas9-mediated genome editing.
RCB5700
	ATG2A KO HeLa
		Comment	Currently not ready.
		Comment from the depositor	HeLa in which ATG2A gene was deleted using CRISPR/Cas9-mediated genome editing.
RCB5701
	ATG2B KO HeLa
		Comment	Currently not ready.
		Comment from the depositor	HeLa in which ATG2B gene was deleted using CRISPR/Cas9-mediated genome editing.
RCB5702
	TMEM41A KO HeLa
		Comment	Currently not ready.
		Comment from the depositor	HeLa in which TMEM41A gene was deleted using CRISPR/Cas9-mediated genome editing.
RCB5703
	TMEM41B KO HeLa
		Comment	Currently not ready.
		Comment from the depositor	HeLa in which TMEM41B gene was deleted using CRISPR/Cas9-mediated genome editing.
RCB5704
	TMEM64 KO HeLa
		Comment	Currently not ready.
		Comment from the depositor	HeLa in which TMEM64 gene was deleted using CRISPR/Cas9-mediated genome editing.
RCB5705
	VMP1 KO HeLa
		Comment	Currently not ready.
		Comment from the depositor	HeLa in which VMP1 gene was deleted using CRISPR/Cas9-mediated genome editing.
RCB5706
	SS-GFP-RFP-KDEL HeLa
		Comment	Currently not ready.
		Comment from the depositor	HeLa stably expressing GFP-RFP-KDEL.
RCB5707
	Parental HEK293T of TMEM41B-KO and VMP1-KO
		Comment	Currently not ready.
		Comment from the depositor	Parental cells of TMEM41B-KO and VMP1-KO HEK293T cells.
RCB5708
	TMEM41B KO HEK293T
		Comment	Currently not ready.
		Comment from the depositor	HEK293T in which TMEM41B gene was deleted using CRISPR/Cas9-mediated genome editing.
RCB5709
	VMP1 KO HEK293T
		Comment	Currently not ready.
		Comment from the depositor	HEK293T in which VMP1 gene was deleted using CRISPR/Cas9-mediated genome editing.
RCB5710
	Y-MESO-37
		Comment	Currently not ready.
		Comment from the depositor	Human malignant peritoneal mesothelioma cell line.
RCB5711
	Y-MESO-43
		Comment	Currently not ready.
		Comment from the depositor	Human malignant pleural mesothelioma cell line, which was initially diagnosed biphasic type.
RCB5712
	Y-MESO-45
		Comment	Currently not ready.
		Comment from the depositor	Human malignant pleural mesothelioma cell line.
RCB5713
	Y-MESO-48
		Comment	Currently not ready.
		Comment from the depositor	Human malignant pleural mesothelioma cell line.
RCB5714
	Y-MESO-61
		Comment	Currently not ready.
		Comment from the depositor	Human malignant pleural mesothelioma cell line.　Epithelioid type.
RCB5715
	Y-MESO-72
		Comment	Currently not ready.
		Comment from the depositor	Human malignant pleural mesothelioma cell line.　Epithelioid type.
RCB5716
	Y-MESO-76
		Comment	Currently not ready.
		Comment from the depositor	Human malignant pleural mesothelioma cell line.　Epithelioid type.
RCB5717
	HEK-Q37C-798
		Comment	Currently not ready.
		Comment from the depositor	293T cells (ATCC, CRL-3216) expressing QUEEN-37C, an ATP sensor fluorescent protein.
RCB5718
	HL-Q37C-393H8
		Comment
		Comment from the depositor	HeLa cells (RIKEN BRC, RCB0007) expressing QUEEN-37C, an ATP sensor fluorescent protein.
RCB5719
	HL-Q37C-701G7
		Comment
		Comment from the depositor	HeLa cells (RIKEN BRC, RCB0007) expressing QUEEN-37C, an ATP sensor fluorescent protein.
RCB5720
	HL-Q37C/GemRFP-801A1
		Comment	Currently not ready.
		Comment from the depositor	HeLa cells (RIKEN BRC, RCB0007) expressing QUEEN-37C, an ATP sensor fluorescent protein, and FUCCI (miRFP670-hGem110), a cell cycle marker. Derived from HL-Q37C-701G7.
RCB5721
	HL-Q37C/CdtRFP-800
		Comment	Currently not ready.
		Comment from the depositor	HeLa cells (RIKEN BRC, RCB0007) expressing QUEEN-37C, an ATP sensor fluorescent protein, and FUCCI (miRFP709-hGem110), a cell cycle marker. Derived from HL-Q37C-701G7.
RCB5722
	HT-Q37C-698
		Comment	Currently not ready.
		Comment from the depositor	HT-1080細胞 (JCRB, JCRB9113) expressing QUEEN-37C, an ATP sensor fluorescent protein.
RCB5723
	JUR-Q37C-752
		Comment	Currently not ready.
		Comment from the depositor	Jurkat cell (RIKEN BRC RCB3052) expressing QUEEN-37C, an ATP sensor fluorescent protein.
RCB5724
	MC-MitOMQ37C/NucQ37C-839
		Comment	Currently not ready.
		Comment from the depositor	MCF7 cell (RIKEN BRC RCB1904) expressing NLS-QUEEN-37C and TOMM-QUEEN-37C. NLS-QUEEN-37C is ATP sensor fluorescent protein QUEEN-37C with localization tag to nucleus. TOMM-QUEEN-37C is ATP sensor fluorescent protein QUEEN-37C with localization tag to outer membrane of mitochondria.
RCB5725
	MC-MitOMQ37C-830
		Comment	Currently not ready.
		Comment from the depositor	MCF7 cell (RIKEN BRC RCB1904) expressing TOMM-QUEEN-37C, an ATP sensor fluorescent protein with localization tago to outer membrane of mitochondria.
RCB5726
	MD-CdtSca-812
		Comment	Currently not ready.
		Comment from the depositor	MDCK cells that stably express FUCCI cell cycle marker.
RCB5727
	MD-ActpHlu-210A
		Comment	Currently not ready.
		Comment from the depositor	MDCK (ATCC, CCL-34)expressing pH sensor fluorescent protein pHluorin with ITPKA, a localization tag to actin filament .
RCB5728
	MD-ActQ37C-185
		Comment	Currently not ready.
		Comment from the depositor	MDCK (ATCC, CCL-34)expressing ATP sensor fluorescent protein QUEEN-37C fused to ITPKA, a localization tag to actin filament .
RCB5729
	MD-ActQ7u-187
		Comment	Currently not ready.
		Comment from the depositor	MDCK (ATCC, CCL-34)expressing ATP sensor fluorescent protein QUEEN-7µ fused to ITPKA, a localization tag to actin filament. Since QUEEN-7µ has high affinity to ATP, QUEEN-7µ is always in the ATP-bound state in physiological ATP concentration. For reference of QUEEN-37C ratio.
RCB5730
	MD-Sca-841E6
		Comment	Currently not ready.
		Comment from the depositor	MDCK (ATCC, CCL-34)expressing fluorescent protein mScarlet.
RCB5731
	MD-NucpHlu-723A9
		Comment	Currently not ready.
		Comment from the depositor	MDCK (ATCC, CCL-34)expressing pH sensor fluorescent protein pHluorin with nuclear localiztaion tag sequence (NLS).
RCB5732
	MD-NucQ37C-631H
		Comment	Currently not ready.
		Comment from the depositor	MDCK (ATCC, CCL-34)expressing ATP sensor fluorescent protein QUEEN-37C with nuclear localiztaion tag sequence (NLS).
RCB5733
	MD-NucQ37C/Q37C-645C1
		Comment	Currently not ready.
		Comment from the depositor	MDCK (ATCC, CCL-34)strongly expressing ATP sensor fluorescent protein QUEEN-37C with nuclear localiztaion tag sequence (NLS), and weakly expressing ATP sensor fluorescent protein QUEEN-37C in cytosol.
RCB5734
	MD-pHlu/NuciRFP-658
		Comment	Currently not ready.
		Comment from the depositor	MDCK (ATCC, CCL-34)expressing pH sensor fluorescent protein pHluorin, and fluorescent protein iRFP fused to nuclear localization tag H2B.
RCB5735
	MD-pHlu/pHRed-674
		Comment	Currently not ready.
		Comment from the depositor	MDCK (ATCC, CCL-34)expressing pH sensor fluorescent protein pHluorin, and pH sensor fluorescent protein pHRed.
RCB5736
	MD-pHlu-209A
		Comment	Currently not ready.
		Comment from the depositor	MDCK (ATCC, CCL-34)expressing pH sensor fluorescent protein pHluorin.
RCB5737
	MD-Q37C-433
		Comment	Currently not ready.
		Comment from the depositor	MDCK (ATCC, CCL-34)expressing ATP sensor fluorescent protein QUEEN-37C.
RCB5738
	MD-Q37C-192A1
		Comment	Currently not ready.
		Comment from the depositor	MDCK (ATCC, CCL-34)expressing ATP sensor fluorescent protein QUEEN-37C.
RCB5739
	MD-Q37C-691D
		Comment	Currently not ready.
		Comment from the depositor	MDCK (ATCC, CCL-34)expressing ATP sensor fluorescent protein QUEEN-37C. Expression is low compared to MD-Q37C-192A1.
RCB5740
	MD-Q37C/GemRFP-795G1
		Comment	Currently not ready.
		Comment from the depositor	MDCK (ATCC, CCL-34)expressing QUEEN-37C, an ATP sensor fluorescent protein, and FUCCI (miRFP670-hGem110), a cell cycle marker.
RCB5741
	MD-Q37C/GemRFP/CdtSca-811E4
		Comment	Currently not ready.
		Comment from the depositor	MDCK (ATCC, CCL-34)expressing ATP sensor fluorescent protein QUEEN-37C and cell cycle markers FUCCI (miRFP670-hGem110) and FUCCI (mScarlet(i)-hCdt100).
RCB5742
	MD-Q37C/CdtRFP-799
		Comment	Currently not ready.
		Comment from the depositor	MDCK (ATCC, CCL-34)expressing ATP sensor fluorescent protein QUEEN-37C and cell cycle marker FUCCI (miRFP709-hCdt100).
RCB5743
	MD-Q37C/Sca-840D11
		Comment	Currently not ready.
		Comment from the depositor	MDCK (ATCC, CCL-34)expressing ATP sensor fluorescent protein QUEEN-37C and fluorescent protein mScarlet.
RCB5744
	MD-Q37C/NucSca-792G11
		Comment	Currently not ready.
		Comment from the depositor	MDCK (ATCC, CCL-34)expressing ATP sensor fluorescent protein QUEEN-37C and fluorescent protein mScarlet with nuclear localization signal.
RCB5745
	MD-Q37C/NucpHlu-722H7
		Comment	Currently not ready.
		Comment from the depositor	MDCK (ATCC, CCL-34)expressing ATP sensor fluorescent protein QUEEN-37C and fluorescent pH sensor protein pHluorin with nuclear localization tag sequence.
RCB5746
	MD-Q37C/pHRed-667B6
		Comment	Currently not ready.
		Comment from the depositor	MDCK (ATCC, CCL-34)expressing ATP sensor fluorescent protein QUEEN-37C and fluorescent pH sensor protein pHRed.
RCB5747
	MD-MitOMQ37C-188
		Comment	Currently not ready.
		Comment from the depositor	MDCK (ATCC, CCL-34)expressing ATP sensor fluorescent protein QUEEN-37C with localization signal of TOMM20 for mitochondria outer membrane localization.
RCB5748
	E14-NucQ37C-653
		Comment	Currently not ready.
		Comment from the depositor	ES cells (RIKEN BRC, AES0135) expressing ATP sensor fluorescent protein QUEEN-37C with nucleus localization tag sequence.
RCB5749
	E14-pHlu-234F11
		Comment	Currently not ready.
		Comment from the depositor	ES cells (RIKEN BRC, AES0135) expressing pH sensor fluorescent protein pHluorin.
RCB5750
	E14-Q37C-233B6
		Comment	Currently not ready.
		Comment from the depositor	ES cells (RIKEN BRC, AES0135) expressing ATP sensor fluorescent protein QUEEN-37C.
RCB5751
	EB-Q37C-810C5
		Comment	Currently not ready.
		Comment from the depositor	ES cells (RIKEN BRC, AES0151) expressing ATP sensor fluorescent protein QUEEN-37C.
RCB5752
	EB-Q37C/iRFP-842S
		Comment	Currently not ready.
		Comment from the depositor	ES cells (RIKEN BRC, AES0151) expressing ATP sensor fluorescent protein QUEEN-37C.
RCB5753
	EB-Q37C/Sca-843S
		Comment	Currently not ready.
		Comment from the depositor	ES cells (RIKEN BRC, AES0151) expressing ATP sensor fluorescent protein QUEEN-37C and fluorescent protein mScarlet.
RCB5754
	PC-ActQ37C-167B5
		Comment	Currently not ready.
		Comment from the depositor	PC12 cells (RIKEN BRC, RCB0009) expressing ATP sensor fluorescent protein QUEEN-37C fused to ITPKA, a localization tag to actin filament .
RCB5755
	PC-ActQ7u-166G3
		Comment	Currently not ready.
		Comment from the depositor	PC12 cells (RIKEN BRC, RCB0009) expressing ATP sensor fluorescent protein QUEEN-7µ fused to ITPKA, a localization tag to actin filament. Since QUEEN-7µ has high affinity to ATP, QUEEN-7µ is always in the ATP-bound state in physiological ATP concentration. For reference of QUEEN-37C ratio.
RCB5756
	PC-Q7u-114C
		Comment	Currently not ready.
		Comment from the depositor	PC12 cells (RIKEN BRC, RCB0009) expressing ATP sensor fluorescent protein QUEEN-7µ. Since QUEEN-7µ has high affinity to ATP, QUEEN-7µ is always in the ATP-bound state in physiological ATP concentration. For reference of QUEEN-37C ratio.
RCB5757
	PC-Q37C-165F1
		Comment	Currently not ready.
		Comment from the depositor	PC12 cells (RIKEN BRC, RCB0009) expressing ATP sensor fluorescent protein QUEEN-37C.
RCB5759
	TD-NucQ37C-827
		Comment	Currently not ready.
		Comment from the depositor	T47D cells (ATCC HTB-133) expressing ATP sensor fluorescent protein QUEEN-37C with nucleus localization tag sequence.
RCB5760
	TD-NucQ37C/Q37C-845
		Comment	Currently not ready.
		Comment from the depositor	T47D cells (ATCC HTB-133) expressing ATP sensor fluorescent protein QUEEN-37C with nucleus localization tag sequence and QUEEN-37C without localization.
RCB5761
	TD-Q37C-826
		Comment	Currently not ready.
		Comment from the depositor	T47D cells (ATCC HTB-133) expressing ATP sensor fluorescent protein QUEEN-37C.
RCB5924
	MELS
		Comment	Currently not ready.
		Comment from the depositor	Anorectal melanoma cell line derived from a primary human rectal tumor. It is the world's first melanoma cell line derived from the rectum.
RCB5925
	8C
		Comment	Currently not ready.
		Comment from the depositor	8C cells were a clonal cell line derived from a feline kidney fibroblast line, CCC, and were transformed by Moloney murine sarcoma virus.
RCB5926
	8C/HTLV-1_2M
		Comment	Currently not ready.
		Comment from the depositor	8C/HTLV-12M cells were HTLV-1 producing cells after cocultivation of 8C cells with lethally irradiated HTLV-1-positive human T-cell line (ATL-2M). Cell-free HTLV-1 prepared from 8C/HTLV-12M cells is highly transmissible.
RCB5927
	8C/HTLV-1_MEL5
		Comment	Currently not ready.
		Comment from the depositor	8C/HTLV-1MEL5 cells were HTLV-1 producing cells after cocultivation of 8C cells with lethally irradiated HTLV-1-positive human T-cell line (SI-5).
RCB5928
	PG-4/HTLV-1_MT-2
		Comment	Currently not ready.
		Comment from the depositor	PG-4 cells were derived from cat brain G355 cells by transformation with Moloney murine sarcoma virus. PG-4/HTLV-1MT-2 cells were HTLV-1 producing cells after cocultivation of PG-4 cells with lethally irradiated HTLV-1-positive Rabbit T-cell line (Ra-1).
RCB5929
	HOS/HTLV-1_MEL5
		Comment	Currently not ready.
		Comment from the depositor	HOS/HTLV-1MEL5 cells were HTLV-1 producing cells after cocultivation of HOS cells with lethally irradiated HTLV-1-positive human T-cell line (SI-5).
RCB5930
	S+L-HOS/HTLV-1_MEL5
		Comment	Currently not ready.
		Comment from the depositor	S+L-HOS/HTLV-1MEL5 cells were HTLV-1 producing cells after cocultivation of Moloney murine sarcoma virus-positive S+L-HOS cells with lethally irradiated HTLV-1-positive human T-cell line (SI-5).
RCB5931
	50A2
		Comment
		Comment from the depositor	Anti-ETNPPL antibody (for immunoprecipitation) producing hybridoma.
RCB5932
	63B2
		Comment
		Comment from the depositor	Anti-ETNPPL antibody (for immunohistochemistry) producing hybridoma.
RCB5933
	94A3
		Comment
		Comment from the depositor	Anti-ETNPPL antibody (for western blotting) producing hybridoma.
RCB5934
	KOG-1
		Comment	Currently not ready.
		Comment from the depositor	KOG-1, was established from ascites fuids isolated from a Japanese woman with pemetrexed-resistant malignant peritoneal mesothelioma.
RCB5935
	LLC/luc
		Comment	Currently not ready.
		Comment from the depositor	A mouse lung cancer cell line that stably retains the firefly luciferase gene.
RCB5936
	MDA-MB-231/luc
		Comment	Currently not ready.
		Comment from the depositor	A human breast cancer cell line that stably retains the firefly luciferase gene.
RCB5937
	PC-3/luc
		Comment	Currently not ready.
		Comment from the depositor	A human prostate cancer cell line that stably retains the firefly luciferase gene.
RCB5938
	786-O/luc
		Comment	Currently not ready.
		Comment from the depositor	A human renal cell adenocarcinoma cell line that stably retains the firefly luciferase gene.
RCB5939
	4T1/luc
		Comment	Currently not ready.
		Comment from the depositor	A murine breast cancer cell line (derived from the mammary gland tissue of a mouse BALB/c strain) that stably retains the firefly luciferase gene.
RCB5940
	MCF7/mKO2-luc2
		Comment	Currently not ready.
		Comment from the depositor	Human breast cancer cell line stably retaining Kusabira　　Orange2 (mKO2) fluorescent protein and firefly luciferase gene
RCB5941
	LLC/mKO2-Rluc8.6
		Comment	Currently not ready.
		Comment from the depositor	Mouse lung cancer cell line stably retaining Kusabira　　Orange2 (mKO3) fluorescent protein and firefly luciferase gene.
RCB5942
	HEK293/κB-Fluc
		Comment	Currently not ready.
		Comment from the depositor	A human embryonic kidney cell line that expresses the firefly luciferase gene in an NF-kB activity-dependent manner.
RCB5943
	LM8/luc
		Comment	Currently not ready.
		Comment from the depositor	High lung metastasis cell line (isolated from C3H mouse Dan osteosarcoma cell line) expressing firefly luciferase in an NF-kB activity-dependent manner.
RCB5944
	LM8-L
		Comment	Currently not ready.
		Comment from the depositor	Low lung metastasis subline isolated from LM8/luc tumors by in vivo bioluminescence imaging.
RCB5945
	LM8-H
		Comment	Currently not ready.
		Comment from the depositor	Highly metastatic lung subline isolated from lung metastases that were incidentally detected after orthotopic transplantation of LM8-L.
RCB5946
	LM8‐L/CYGB‐OE
		Comment	Currently not ready.
		Comment from the depositor	LM8-L cells overexpressing Cygb protein.
RCB5947
	LM8‐H/Cygb‐KO
		Comment	Currently not ready.
		Comment from the depositor	LM8-H cells with Cygb gene knockout using CRISPR-Cas9 system.
RCB5948
	LM8‐H/Lef1‐KO
		Comment	Currently not ready.
		Comment from the depositor	LM8-H cells with Lef-1 gene knockout using CRISPR-Cas9 system.
RCB5953
	HeLa.S3
		Comment	Currently not ready.
		Comment from the depositor
RCB5962
	HUDEP-2-CY1
		Comment	Currently not ready.
		Comment from the depositor	A derivative cell line of HUDEP-2 in which thalassemia mutations are introduced, i.e., homozygous for the HBB IVSI-110 (G>A) mutation (HGVS name; HBB:c.93-21G>A).
RCB5963
	HUDEP-2-CY2
		Comment	Currently not ready.
		Comment from the depositor	A derivative cell line of HUDEP-2 in which thalassemia mutations are introduced, i.e., homozygous for the HBB IVSI-110 (G>A) mutation (HGVS name; HBB:c.93-21G>A).
RCB5964
	S-HUDEP2
		Comment	Currently not ready.
		Comment from the depositor	A derivative cell line of HUDEP-2 carrying a biallelic SCD (sickle cell disease) mutation.
RCB5965
	WIPI1 KO HEK293T
		Comment	Currently not ready.
		Comment from the depositor	HEK293T in which WIPI1 gene was deleted using CRISPR/Cas9-mediated genome editing.
RCB5966
	WIPI2 KO HEK293T
		Comment	Currently not ready.
		Comment from the depositor	HEK293T in which WIPI2 gene was deleted using CRISPR/Cas9-mediated genome editing.
RCB5967
	WIPI3 KO HEK293T
		Comment	Currently not ready.
		Comment from the depositor	HEK293T in which WIPI3 gene was deleted using CRISPR/Cas9-mediated genome editing.
RCB5968
	WIPI4 KO HEK293T
		Comment	Currently not ready.
		Comment from the depositor	HEK293T in which WIPI4 gene was deleted using CRISPR/Cas9-mediated genome editing.
RCB5969
	WIPI1 and WIPI2 double KO HEK293T
		Comment	Currently not ready.
		Comment from the depositor	HEK293T in which WIPI1 and WIPI2 gene was deleted using CRISPR/Cas9-mediated genome editing.
RCB5970
	WIPI3 and WIPI4 double KO HEK293T
		Comment	Currently not ready.
		Comment from the depositor	HEK293T in which WIPI3 and WIPI4 gene was deleted using CRISPR/Cas9-mediated genome editing.
RCB5971
	WIPI1-4 quadruple KO HEK293T
		Comment	Currently not ready.
		Comment from the depositor	HEK293T in which WIPI1–4 gene was deleted using CRISPR/Cas9-mediated genome editing.
RCB5983
	sHUDEP-2
		Comment	Currently not ready.
		Comment from the depositor	A derivative cell line of HUDEP-2 (RCB4557) with the genetic mutation in β globin that causes sickle cell anemia.